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Abstract 
Background  
Tuberculosis (TB) is a global health issue with significant morbidity and mortality. The Hajj 
religious mass gathering represents many of the risk factors for TB transmission and the disease 
has been reported among hospitalised pilgrims during the event. However, little data is 
available on the true burden of TB in Hajj or the management of TB cases in hospitals at the 
event including healthcare worker’s (HCWs) knowledge, attitude and practice (KAP) 
regarding TB. Accordingly, the thesis consists of three separate, but integrated studies, each 
with own objectives, literature review, methodology, result and discussion sections. Thesis 
studies are as follows: 
1. Active PTB among hospitalised and non-hospitalised pilgrims during the Hajj mass 
gathering 
2. Management of hospitalised Pulmonary Tuberculosis (PTB) patients during the Hajj 
mass gathering 
3. TB knowledge, attitude and practice among HCWs during the Hajj mass gathering 
 
Aim 
The overall aim of this research project is to provide evidence-base for improvement of TB 
prevention, management and control during the Hajj mass gathering. The outcomes could be 
beneficial to other mass gatherings worldwide and will enrich knowledge in the new scientific 
discipline of “mass gatherings medicine”. 
 
Method 
The study was conducted in Makkah, Kingdom of Saudi Arabia (KSA), the location of the Hajj 
over 2 Hajj seasons (2016-2017). Structured questionnaires and forms were used to collect 
information related to the study population (non-hospitalised and hospitalized pilgrims with 
productive cough, TB cases admitted to hospitals during Hajj and Hajj healthcare workers). 
Information was also collected in relation to the management of TB cases in Hajj and the 
knowledge attitude and practice of healthcare workers delivering services during the event 
regarding TB and its management. Sputum samples were also collected from the hospitalised 
and non-hospitalised pilgrims and tested for TB using the Xpert MTB/RIF assay. 
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Results  
1. Active PTB among hospitalised and non-hospitalised pilgrims during the Hajj mass 
gathering 
For non-hospitalised pilgrims, out of the 1,510 pilgrims tested, 10 (0.66%) had undiagnosed 
active PTB. Underlying health conditions and cough in the household were independent 
risk factors for TB among this population. For hospitalised pilgrims, among the 304 patients 
investigated, 9 (2.9%) had active PTB and most (77.7%) of these were missed by the 
hospitals including multidrug-resistant TB cases. Previous TB treatment was an 
independent risk factor for TB among this population after adjusting for other variables 
 
2. Management of hospitalized PTB patients during the Hajj mass gathering 
 The study also documented the management of 32 confirmed TB patients during Hajj and 
explored the compliance of healthcare providers with the KSA TB management guidelines 
in hospitals during the mass gathering. Out of a maximum score of 10 for the selected TB 
management themes, the guideline compliance score was highest for infection prevention 
and control and surveillance (9.6) and identifying TB suspects (7.2). The least scores were 
obtained for treating TB (5.0) and diagnosing TB (3.0). 
 
3. TB knowledge, attitude and practice among HCWs during the Hajj mass gathering 
 Finally, the study conducted a KAP survey among 540 HCWs from 13 hospitals serving 
pilgrims in Hajj. In general, HCWs had average knowledge (mean knowledge score of 
52%), above average attitude (mean attitude score of 73%) and good practice (mean 
practice score of 81%) regarding TB, based on the scoring system and cut-off points 
developed in the current study.  
 
Conclusions 
The results of the current study suggest that there are a number of key challenges in relation to 
TB at the Hajj. These include undiagnosed and missed TB cases at the event, inadequacy of 
current national and international TB management guidelines in the context of Hajj and 
important knowledge gaps, negative attitudes and wrong practices among HCWs in relation to 
TB. As such, TB during the Hajj mass gathering needs more attention from the scientific 
community and Hajj stakeholders.  A raft of recommendations are proposed to optimize 
awareness, screening, management and treatment, prevention, and control measures for TB 
during Hajj as well as other mass gatherings both within Saudi Arabia and worldwide.
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AIM, OBJECTIVES AND THESIS ROADMAP 
 
Thesis roadmap  
Mass gatherings introduce a number of public health threats to the host country/community. In 
their simplest definition, mass gatherings involve large numbers of people gathering in a 
particular place for a specific period of time. Hence, one of the major public health threats at 
mass gatherings are infectious diseases. Mass gatherings can increase the risk of an already 
present communicable disease or introduce a completely new infectious disease threat to the 
host (World Health Organization, 2008b). Mass gatherings with international dimensions are 
concerning as these events are capable of importing, spreading and exporting infectious agents 
worldwide in a relatively short time as evidenced by the international meningococcal disease 
outbreaks associated with the Hajj (Yezli et al., 2016).  
 
Tuberculosis is a global health issues with significant mortality and morbidity. The WHO aims 
to end the global TB epidemic, with targets to reduce TB deaths by 95% and to cut new cases 
by 90% between 2015 and 2035, and to ensure that no family is burdened with catastrophic 
expenses due to TB (World Health Organization, 2015a). Early detection and appropriate 
management of TB cases as well as prevention of the disease are cornerstones of this strategy. 
Mass gatherings, such as the Hajj, are potentially an underappreciated source for TB 
transmission and could undermine the WHO’s ambitious targets. The Hajj represents many of 
the risk factors for TB transmission and reactivation of LTBI. It is attended by millions of 
pilgrims, many from TB-endemic countries, with a substantial proportion being elderly with 
underlying health conditions. Crowded conditions, physically demanding religious rites well 
as other factors render pilgrims susceptible to infections and facilitate transmission of 
respiratory agents including TB. Hence, attending the event was reported to be a risk for TB 
infection (Wilder-Smith et al., 2005).  
 
 
On the other hand, Hajj, and other mass gatherings, could be a missed opportunity for global 
control of TB by identifying undiagnosed cases, early detection of cases, as well as preventing 
spread among attendees and the international community. For this to occur, it is important to 
study TB at the Hajj and identify potential issues in the management and control of the diseases 
that could contribute to the spread of the disease or poor outcome for cases. 
Aim, Objectives and Thesis Roadmap 
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Tackling these issues with evidence-based policies that are effective and practical would 
improve patients’ outcome and the prevention, control and management of the disease at the 
Hajj as well as other mass gatherings worldwide. Therefore, contributing to the WHO’s End-
TB targets.  
 
TB at Hajj is multifaceted, complex topic and improving prevention, control and management 
of the disease at this event requires identification of key knowledge gaps in the field, a better 
understanding of the current status and practices related to TB in Hajj, identifying issues and 
areas of concerns and recommending and implementing evidence-based strategies to address 
these issues. The current work aims to contribute to the above by investigating certain aspects 
of TB at the Hajj that would together add to the limited knowledge on the topic as well as 
identify key areas for improvement in the detection, management and prevention of the disease 
at the mass gathering. These areas that could contribute to the transmission of TB during and 
after the Hajj include missed or undiagnosed active cases and the mismanagement of TB 
confirmed cases which may be a result of lack of appropriate guidelines or poor knowledge or 
practice among HCWs involved. Accordingly, the current work will investigate the following 
four topics: 
1. Active PTB among non-hospitalised pilgrims during the Hajj mass gathering 
2. Active PTB among hospitalised pilgrims during the Hajj mass gathering 
3. Management of hospitalized PTB patients during the Hajj mass gathering 
4. TB knowledge, attitude and practice among HCWs during the Hajj mass gathering 
 
General aim and objectives 
General aim 
The overall aim of this research project is to provide evidence-base for improvement of TB 
prevention, management and control during the Hajj mass gathering. The outcomes could be 
beneficial to other mass gatherings worldwide and will enrich knowledge in the new scientific 
discipline of “mass gatherings medicine”. As such, the current work has the below specific 
objectives of the three main studies in the thesis and will follow the roadmap highlighted in 
Figure 1.  
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Specific objectives 
The thesis has below specific objectives that are addressed through the following studies 
A. Active PTB among hospitalised and non-hospitalised pilgrims during the Hajj mass 
gathering 
1. To determine the occurrence of active pulmonary TB (both sensitive and drug 
resistant) among non-hospitalized pilgrims with cough from medium and high 
burden TB countries regardless of health status. 
2. To determine the occurrence of active pulmonary TB (both sensitive and drug 
resistant) among hospitalised pilgrims with cough during Hajj, regardless of the 
admission diagnosis. 
B. Management of hospitalized PTB patients during the Hajj mass gathering 
A. To document how TB patients are managed during the Hajj pilgrimage and 
whether this follows current guidelines. 
C. TB knowledge, attitude and practice among HCWs during the Hajj mass gathering 
1. To determine HCWs’ knowledge and knowledge gaps regarding TB and its 
management and attitudes and behaviours among HCWs that could facilitate 
TB transmission or impact TB management. 
 
Active pulmonary tuberculosis among non-hospitalised pilgrims during the Hajj mass 
gathering 
 
Undiagnosed TB cases in the community have been reported in numerous studies (Deribew et 
al., 2012, Hoa et al., 2010, Kapata et al., 2016, Onozaki et al., 2015, Senkoro et al., 2016, Wood 
et al., 2007, Zaman et al., 2006, Zaman et al., 2012,). Such cases are an important risk for TB 
spread and ongoing community transmission and represent a challenge for TB control efforts 
worldwide. Only one study reported active PTB among non-hospitalised pilgrims in Hajj (Yezli 
et al., 2017b). The study was a proof of concept and limited in its study population as it did not 
include pilgrims from countries with some of the largest Hajj pilgrim populations and those 
with high MDR-TB rates. The current work will identify the burden of undiagnosed TB (both 
sensitive and MDR) among non-hospitalised pilgrims. The work will attempt to confirm the 
results of the previous study and highlight that active PTB among non-hospitalised pilgrims 
occurs in Hajj and that the latter is a significant risk for public health at the event and for global 
health security. It will also investigate pilgrims from a larger number of countries, those with 
high Hajj pilgrims’ populations and those with high MDR-TB rates. 
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 If undiagnosed active MDR-TB is detected in Hajj, this would be an ever bigger threat that 
needs addressing. Proof of undiagnosed active TB among non-hospitalised pilgrims would 
necessitate a number of public health interventions which may include screening pilgrims for 
the diseases pre-event. Logistically, among other limitations, it would be very difficult to 
screen all pilgrims for TB before Hajj. Hence, identifying at-risk populations that could 
undergo targeted screening would make the process more efficient, feasible and less costly. 
As such, the current study will also investigate factors associated with undiagnosed TB 
among non-hospitalised Hajj pilgrims. This will allow the identification of potential risk 
groups that could be targeted for appropriate interventions or investigated further in future 
research.   
 
Active pulmonary tuberculosis among hospitalised pilgrims during the Hajj mass 
gathering 
 
TB has been reported among patients during Hajj (Al-Orainey, 2013, Alzeer et al., 1998, 
Madani et al., 2006). Studies have reported that a significant proportion of TB cases are missed 
among patients admitted to hospitals worldwide (Balabanova et al., 2011, Bobrowitz, 1982, 
Juul, 1977, Katz et al., 1985, Lee and Ng, 1990, Makela et al., 1971, Roberts et al., 1971, 
Rosenthal et al., 1975). A number of reasons can lead to failure to diagnosed TB among patient 
including lack of or limited symptoms, not testing for TB when people do present to health 
facilities and diagnostic tests that are not sufficiently sensitive or specific to ensure accurate 
identification of all cases. Failure to diagnose and adequately treat TB among hospitalised 
patients could lead to premature death and unrecognized transmission of M. tuberculosis 
(Casey, 1966, 1968, Johnson and Johnson, 1959, Medrano et al., 2014, Rosenthal et al., 1975, 
von Delft et al., 2015, Whittington, 1983). This puts family members, other patients and the 
community at increased risk of TB infection and subsequent disease. In addition, the complex 
contact patterns between HCWs and patients potentiate the spread of TB disease in the 
healthcare setting, resulting in an increased occupational risk of TB infection and disease 
among HCWs, practicing medical students and patients (Alele et al., 2018, Boudreau et al., 
1997, Sepkowitz, 1994). The latter are an already vulnerable population more susceptible to 
infection and worsening outcomes. Undiagnosed MDR-TB in healthcare setting has also been 
reported and it represents an even bigger threat given that it is harder to treat with higher 
mortality rate (Bates et al., 2012, Bates et al., 2015, Onozaki et al., 2015).   
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Missed or undiagnosed TB among patient at mass gatherings has more serious consequences 
as it has the potential to transmit infection to a larger number of people given that healthcare 
facilities are usually busier or working to surge capacity during these events as well as the 
crowded conditions outside these facilities. The above is applicable to Hajj where missed TB 
cases among patients in busy hospitals with quick patients’ turnaround represent a serious 
threat to patients, Hajj pilgrims, HCWs, the local population and the international community 
at large. No study investigated undiagnosed or missed TB cases during Hajj. Hence, the current 
work will attempt to define the burden of missed TB cases among hospitalised pilgrims during 
the event. This by identifying undiagnosed TB among patients admitted to hospitals during 
Hajj regardless of their admission diagnosis. This work will also investigate factors associated 
with missed TB among patients so that at-risk populations can be determined and more 
attention can be given to these populations during patient management in Hajj. This may 
include considering these populations as suspect TB cases and investigated for the disease on 
admission to hospitals.  The study will also identify specific factors that could contribute to 
missed TB cases in hospitals and further transmission such as lack of appropriate testing 
techniques, mismanagement of patients on admission and substandard infection prevention and 
control practices. These could also be addressed to reduce the risk of undiagnosed TB among 
patients and transmission in hospitals.  
 
Management of hospitalized pulmonary tuberculosis patients during the Hajj mass 
gathering 
 
Appropriate management of TB cases is key in the prevention and control of TB. Early 
detection of cases and their management with fitting treatment regimen and infection 
prevention practices improve patient outcome and reduce the risk of transmission of the disease 
and development of antibiotic resistance (World Health Organization, 2011a, 2017a,). 
Although there are Saudi and international TB guidelines on the management of TB, currently 
there are no specific guidelines on the management of the disease at mass gatherings including 
Hajj. The TB management approaches during Hajj remained largely undocumented, and it is 
unknown whether these are consistent with the KSA and international TB management 
guidelines (World Health Organization, 2011a, 2017a, Saudi Ministry of Health, 2014). Hence, 
this work will also attempt to document the management of TB patients during Hajj and 
explored the compliance of healthcare providers with the KSA TB management guidelines in 
the Saudi MOH hospitals during the mass gathering. 
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Compliance will be evaluated against four selected TB management themes: identifying TB 
suspects, diagnosing TB cases, treatment of TB cases and finally, infection prevention and 
control and surveillance.By documenting the management of confirmed TB cases during Hajj 
from the moment they present to the hospitals until the cases are resolved, compliance with TB 
management standards can be evaluated through this work. In addition, various aspects of TB 
management during Hajj can be documented and key gaps/malpractices in the TB patients’ 
journey in the hospital can be identified for improvement and interventions. This work will 
also report on the characteristics of the confirmed TB cases admitted to hospitals during Hajj 
which may help identify at-risk populations that should be investigated for TB for the early 
detection, diagnosis and treatment of TB. Outcomes from this work can contribute to the 
national and international guidelines for TB management by providing key information 
regarding management at mass gatherings specifically, which may differ from the standard 
guidelines in non-events settings. 
 
Tuberculosis knowledge, attitude and practice among healthcare workers during the 
Hajj mass gathering 
 
The early diagnosis and appropriate management of TB cases by a knowledgeable and skilled 
healthcare workforce are integral for the success of TB control strategies. HCWs are key 
component of the success of any TB program, yet they are also at increased risk of TB infection 
and disease. High level of knowledge, good attitude and correct practice among HCWs in 
relation to TB are important factors in the appropriate management of TB cases and reducing 
the risk of transmission of the disease including in the healthcare setting and to HCWs 
themselves (World Health Organization, 2008a). Knowledge deficit regarding TB among 
HCWs may result in substandard care, ineffective service provision, inefficient resource use, 
and further inequities in health outcomes as well as risk of TB transmission and development 
of resistance (Langendam et al., 2012, Marahatta, 2010). In addition, the knowledge and 
attitude of HCWs towards TB will determine the type and quality of information passed on to 
the patients during health education (Isara and Akpodiete, 2015). As such, the knowledge, 
attitude and practices of health professionals related to TB affect not only themselves and their 
individual patients, but also the community at large. 
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This work will evaluate the knowledge, attitude and practice of HCWs deployed during Hajj 
regarding TB and its control. It will also identify factors associated with good/poor KAP 
including those related to the type of HCWs, length of experience, experience treating TB 
patients as well as education level and specific training regarding TB. The outcomes of these 
investigations will determine HCWs’ knowledge and knowledge gaps regarding TB and its 
management and attitudes and behaviours among HCWs that could facilitate TB transmission 
or impact TB management during Hajj. In addition to providing evidence base for appropriate 
strategies to improved HCWs KAP regarding TB and its management, this work will also 
identify specific HCWs populations that may need to be targeted with tailored interventions 
such as enhanced training and education. 
 
Thesis structure 
While this work will investigate different aspects of TB management and control at the Hajj, 
many of these are interconnected in the larger context of preventing TB at mass gatherings. 
This work will lead to a better understanding of TB at the Hajj, identifying important areas of 
improvement and investments as well as providing a number of practical recommendations. 
Put all together, this work will contribute to developing evidence-based policies to optimize 
awareness, surveillance, screening, management and treatment, prevention, and control 
measures for TB at Hajj and other mass gatherings worldwide. Accordingly, the thesis is 
structured chapters that reflects the above and based on study objectives. Each study has its 
own literature review, methodology, result and discussion sections. Thesis chapters are as 
follow: 
Chapter 1:  Tuberculosis and the Hajj mass gathering  
Chapter 2:  Active pulmonary tuberculosis among hospitalised and non-hospitalised  
  pilgrims during the Hajj mass gathering 
Chapter 3:  Management of hospitalized pulmonary tuberculosis patients during the Hajj 
  mass gathering 
Chapter 4:  Tuberculosis knowledge, attitude and practice among healthcare workers during 
the Hajj mass gathering 
Chapter 5:  Summary and recommendations 
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Figure 1. Thesis roadmap and methodology for the three studies 
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 Chapter 1: Tuberculosis and the Hajj mass gathering 
 
1.1       Mass Gatherings 
While the term “Mass Gathering” is increasingly used in academic literature, there is actually 
no international consensus on the definition of the term. Traditionally, a mass gathering event 
was defined as a group of over a 1,000 people assembled at a particular location for a specific 
purpose and for a defined period of time. Nevertheless, most of the published literature report 
larger events accounting for more than 25,000 participants (Locoh-Donou et al., 2013, World 
Health Organization, 2008b). This definition is however limiting as it only considers the size 
of the crowd, which is but one descriptor of a varied gathering of human beings at a mass 
gathering event (De Lorenzo, 1997, Locoh-Donou et al., 2013).  
 
Some authors defined mass gatherings from a health prospective, considering a mass gathering 
event as a situation during which a large gathering of people occurs and results in limited access 
to patients, causing delayed public safety response to medical emergencies (Arbon, 2007, 
Locoh-Donou et al., 2013). While going beyond the size of the crowd, this definition is also 
restricting the term to a specific aspect of health related to delivery of medical care. The World 
Health Organization (WHO) definition also takes a broader view of mass gatherings to include 
the public health dimensions and defines mass gatherings as events attended by a sufficient 
number of people to potentially strain the public health resources of the community, city, or 
nation hosting the event (World Health Organization, 2008b).  
 
The WHO definition is purposefully not linked to the size of the gathering or the number of 
people involved because each community has a different capacity to manage crowds of people, 
with some systems, for example, airports or market places, managing upwards of 100,000 
people on a daily basis with minimal difficulties (World Health Organization, 2015d). Mass 
gatherings differ in many aspects including the characteristics of the crowds involved, the 
location of the event, the type of the event, and the public health risks involved. Mass 
gatherings can be either planned or spontaneous and recurrent or sporadic (World Health 
Organization, 2015d).  
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Planned mass gatherings are scheduled in advance, and may include sporting, social, cultural, 
religious, and political events. Examples include: music festivals, Olympic and Paralympic 
Games, the Super Bowl, the World Cup, pilgrimages such as the Hajj and the Kumbh Mela and 
political rallies and protest (World Health Organization, 2015d, Yezli and Alotaibi, 2016). 
Spontaneous mass gatherings by their nature are more difficult to plan for and may include 
events, such as funerals of religious and political figure (World Health Organization, 2008b, 
2015d). In addition, some also consider the gatherings of displaced populations due to natural 
disasters, conflicts, and wars as mass gatherings (World Health Organization, 2015d). Mass 
gatherings can pose several significant public health challenges to the host and the global 
community. This is particularly true for mass gatherings with international dimensions. For 
instance, mass gatherings can place a significant stress on the health system of the host country 
and require intersectoral approaches to risk mitigation and coordination across multiple 
disciplines, sectors, and ministries (World Health Organization, 2015d). Mass gatherings can 
also introduce infectious and non-infectious public health threats to the local, national, or 
international populations during or after the events. International outbreaks of infectious 
diseases after mass gatherings such as meningococcal disease related to the Hajj and to the 
World Scout Jamboree are examples of such threats (Smith-Palmer et al., 2016, Yezli et al., 
2016). In addition to the above, mass gatherings can introduce the risk of deliberate action 
against these events, increasing the likelihood of emergencies resulting in a significant number 
of casualties (World Health Organization, 2015d). 
 
1.2      The Hajj mass gathering 
According to Islam, every physically and financially able Muslim must undertake the Hajj, 
pilgrimage to the Kingdom of Saudi Arabia (KSA), once in his lifetime. During Hajj, millions 
of Muslims retrace the footsteps of the Prophet Mohammed, undertaking identical rituals 
(Ahmed et al., 2006). Hajj represents the culmination of years of spiritual preparation and 
planning. Once they have completed the pilgrimage, pilgrims are given the honorific title Hajji 
(pilgrim) (Gatrad and Sheikh, 2005). The Hajj is one of the largest and most geographically, 
ethnically, and culturally diverse annual mass gatherings in the world, attended by more than 
2 million pilgrims from over 180 different countries each year (Yezli et al., 2017a). The number 
of pilgrims attending Hajj has been gradually increasing over the years to reach around 3 
million pilgrims in 2012 compared with only 135,265 in 1954 (Alotaibi et al., 2017).  
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There was a reduction in the number of pilgrims attending Hajj in the last few years as limited 
permits were granted due to construction work to expand the Sacred Mosque (Yezli et al., 
2017a). Once the expansion work will finish, the number of pilgrims attending Hajj is expected 
to more than double in the coming few years.  
 
The Hajj rituals officially start on the 8th day of the 12th month of the lunar Islamic calendar 
called “Dhul-Hijjah”, but most pilgrims arrive to Makkah few days or weeks earlier. As the 
lunar calendar lags behind the solar calendar by approximately 10 days every Gregorian year, 
Hajj falls in different parts of the Gregorian calendar each year. The Hajj journey is highlighted 
in Figure 2. On arrival at Makkah, each pilgrim, makes seven circumambulations (Tawaf) 
around the Ka’aba (the building Muslims consider the house of God).  On the 9th of the month 
of “Dhul-Hijjah”, pilgrims leave for the Plain of Arafat, around 20 Km east of central Makkah, 
where the Hajj culminates in the “Day of Standing”. From noon until sundown, dressed in the 
simplest possible garb made up of two pieces of unstitched cloth for men (Ihram), with women 
wearing their usual clothing with a headscarf, pilgrims spend much of the day standing in 
humility and prayer at the Mount Arafat(Ahmed et al., 2006, Gatrad and Sheikh, 2005). On the 
way to Arafat, pilgrims make overnight stop in Mina (around 5 Km to the east of central 
Makkah), and in Muzdaliffah (around 10 Km from central Makkah) on return. On returning to 
Mina, the pilgrim stops alJamarat to stone the pillars that are effigies of Satan. The new Hajjis 
then make animal sacrifices (usually by proxy) as thanks for accepted Hajj. After a farewell 
Tawaf, the pilgrims leave Makkah(Ahmed et al., 2006, Gatrad and Sheikh, 2005). While the 
Hajj rituals take place in Makkah, many pilgrims also travel to the holy city of Medina, north 
of Makkah, where the Prophet Mohammed is buried (Yezli et al., 2017a). 
 
1.3       Health risks at the Hajj 
As a major international mass gathering Hajj is associated with number of public health risks 
that may affect the participating pilgrims, the workers involved in the running, management 
and delivery of service during the event, the local population as well as the international 
community. As such, KSA directs huge investments each year towards the optimum planning 
and management of Hajj and preventing, minimizing and responding to public health 
emergencies (Ahmed et al., 2006, Ahmed Q.A. et al., 2009, Alotaibi et al., 2017, Memish, 
2013, Memish and Al-Rabeeah, 2013).  
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Given the characteristics of the Hajj population and the international dimension of the event, 
communicable diseases are one of the major public health threats in Hajj and for global health 
security. In Hajj unhygienic practices and close contacts between pilgrims in overcrowded 
situations during the rituals, as well as international travel, increase the risks of outbreaks and 
the spread of infectious diseases among pilgrims and other individual (Alotaibi et al., 2017). 
 
The threat of transmission of respiratory pathogens are particularly relevant for the event 
including tuberculosis (TB), influenza and more recently the Middle East Respiratory 
Syndrome coronavirus (MERS-CoV). The event has been linked to the importation and 
globalization of respiratory pathogens (Memish et al., 2015a). Historically, several outbreaks 
of infectious diseases have been reported at the Hajj. These include an outbreak of cholera 
during the 1865 Hajj that caused an estimated 30,000 deaths among pilgrims and a number of 
international Hajj-related outbreaks of meningococcal diseases in 1987, 2000 and 
2001(Alotaibi et al., 2017, Yezli et al., 2016). Also, in recent years, Hajj took place during 
outbreaks of number of emerging infectious diseases and diseases declared by the WHO as 
“Public Health Emergency of International Concern”. These include, viral haemorrhagic fever 
syndromes such as those caused by Rift Valley fever virus, Alkhurma virus and Ebola virus, 
respiratory diseases such as Severe Acute Respiratory Syndrome (SARS) and MERS, Avian 
influenza (H5N1), and Swine influenza A (H1N1), and Zika (Ahmed et al., 2006, Bennett and 
Carney, 2017). Thankfully, due to pragmatic public health preparedness strategies for Hajj, no 
major Haj-related outbreaks of such diseases have been reported. Other communicable diseases 
threats of importance during Hajj include traveller’s diarrhoea (Ahmed et al., 2006). Outbreaks 
of cholera have been reported in Hajj as well as cases of food poisoning. Skin infections and 
Blood-borne diseases are also of concern (Ahmed et al., 2006, Gatrad and Sheikh, 2001). The 
threat of the latter is exacerbated by the practice of unhygienic shaving of the heads, which is 
part of the rituals to complete Hajj for Muslim men. Such practices can increase the risk of 
transmission of blood-borne disease, including hepatitis B and C, and HIV (Gatrad and Sheikh, 
2001). The KSA authorities have introduced a number of strict regulations to eliminate these 
practices including legislative stance to prevent unlicensed barbers from operating during the 
Hajj, testing of barbers for hepatitis B and C , and HIV, and the use of disposable single-use 
blades (Al-Salama and El-Bushra, 1998). 
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*From Ahmed et al.(Ahmed et al., 2006) 
While communicable diseases such as respiratory tract infections are the major cause of 
morbidity and hospital admissions during Hajj, non-communicable diseases are the main cause 
of mortality during the event (Ahmed et al., 2006, Al-Ghamdi et al., 2003). Given the  
characteristics of the pilgrims’ population (roughly 25% are at least 65 years old) (Ebrahim et 
al., 2009). 
 
An important proportion of Hajj pilgrims come to the event with underlying health conditions 
(AlBarrak et al., 2018, Alzeer et al., 1998, Gautret et al., 2015, Khan et al., 2006, Madani et 
al., 2006, Mandourah et al., 2012, Memish et al., 2014, Shirah et al., 2017, Yezli et al., 2017b). 
Performing the religious rites under various stressors can exacerbate these conditions. It has 
been reported that cardiovascular disease is the most common cause (43%) of death during the 
Hajj (Ahmed et al., 2006). Heat-related illnesses, especially, heat exhaustion and heatstroke are 
a leading cause of morbidity and mortality during the Hajj, particularly in summer. For 
example, in August 1985, among the 852,000 pilgrims more than 2,134 were victims of 
heatstroke, of whom 1,000 died in just few days (Ghaznawi and Khalil, 1988). There were also 
15,560 pilgrims that suffered from heat exhaustion. While major interventions to reduce heat-
related illnesses over the year have reduced the incidence of such conditions, extreme heat 
remains a major public health concern during Hajj (Abdelmoety et al., 2018, Aleeban and 
Mackey, 2016). Other health risks at Hajj include fire-related injuries, risks of deliberate acts 
against the event and risk of trauma such as that related to stampedes and crushes as evidenced 
by the recent 2015 Hajj crush (Ahmed et al., 2006, Khan and Noji, 2016). 
 
Figure 2. The Hajj journey* 
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1.4       Tuberculosis 
Tuberculosis (TB) is an infectious disease usually caused by the ''slow-growing, chemo-
organotrophic,  non-motile,  non-spore-forming,  aerobicbacillu bacteria Mycobacterium 
tuberculosis'' (Gordon and Parish, 2018). TB may infect any part of the body, but most 
commonly occurs in the lungs, known as pulmonary tuberculosis (PTB) (Lyon and Rossman, 
2017).  
 
Extra-pulmonary TB occurs when TB develops outside of the lungs, although the latter may 
coexist with PTB. Extra-pulmonary sites of infection commonly include lymph nodes, pleura, 
and osteoarticular areas, although any organ can be involved (Golden and Vikram, 2005). 
General signs and symptoms of TB include fever, chills, night sweats, loss of appetite, weight 
loss, and fatigue (Lyon and Rossman, 2017). 
 
TB remains a global public health problem with significant morbidity and mortality. In 2017, 
the WHO estimated that 10 million people (range, 9.0–11.1 million) developed TB, 9% of 
whom were infected with the human immunodeficiency virus (HIV) (World Health 
Organization, 2018b). Two thirds of these were in eight countries: India (27%), China (9%), 
Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) and 
South Africa (3%). These and 22other countries in the WHO’s list of 30 high TB burden 
countries accounted for 87% of the world’s cases. Worldwide in 2017, an estimated 558,000 
people (range, 483,000–639,000) developed TB that was resistant to rifampicin (RR-TB), 82% 
of whom had multidrug-resistant TB (MDR-TB). Three countries accounted for almost half of 
the world’s cases of MDR/RR-TB: India (24%), China (13%) and the Russian Federation 
(10%). Extensively drug resistant TB (XDR-TB) accounted for about 8.5% of the MDR-TB 
cases (World Health Organization, 2018b). Also, in 2017, TB caused an estimated 1.3 million 
deaths (range, 1.2–1.4 million) among HIV-negative people and there were an additional 
300,000 deaths from TB (range,266,000–335,000) among HIV-positive people (World Health 
Organization, 2018b). This makes TB one of the top 10 causes of death worldwide and the 
leading cause of death from a single infectious agent (above HIV/AIDS). 
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Latent tuberculosis infection (LTBI), defined as '' a state of persistent immune response to 
stimulation by Mycobacterium tuberculosis antigens without evidence of clinical and 
radiological disease’’ (Mack et al., 2009), is also important in TB epidemiology. Based on 
information available on the frequency of positive tuberculin skin test (TST) response, it is  
estimated that one third of the world’s population is infected with M. tuberculosis (Dye et al., 
1999). The vast majority of infected persons have no signs or symptoms of TB disease and are 
not infectious, but they are at risk for developing active TB disease and becoming infectious. 
Approximately 5%-10% of those infected will develop active disease, and most will be capable 
of infecting others (Comstock et al., 1974, Jensen et al., 2005). Hence, individuals with LTBI 
represent an important source of new cases of active TB. 
 
1.5       Tuberculosis in Saud Arabia 
Saudi Arabia is not considered by the WHO as a high TB burden country. However, despite 
the remarkable economic and social developments and the large investments in health care 
services over the past 30 years, TB control still faces challenges in the Kingdom (Al-Orainey 
et al., 2013). In 2017, in a population of around 33 million, the WHO reported a TB incidence 
rate of 10/100,000 in Saudi Arabia. The total cases of TB notified to the WHO in 2017 from 
the Kingdom were 2,925 (www.who.int/tb/data). KSA is a fast-developing country that has 
experienced great changes over the previous decades. By improving its standard of living and 
improving social and health services, KSA has succeeded in minimizing infectious disease-
related mortalities. With this rapid development, the Kingdom has become a major destination 
for many immigrants who currently make up about one-third of the Saudi population (Almutairi 
et al., 2018). Most of these originate from developing countries many of which are TB high 
burden countries such as India, Pakistan, Bangladesh and Indonesia.  In addition to its resident 
population, Saudi Arabia hosts the Hajj and Umrah where each year an estimated 10 million 
pilgrims from over 180 countries travel to the Kingdom to attend these mass gatherings (Yezli 
et al., 2017a). These pilgrims, mostly elderly, many from poor countries where TB is endemic, 
gather in close contact to perform physically demanding religious rites. In such conditions, the 
potential for TB transmission is expected to be high (Al-Orainey, 2013). These factors 
influence TB epidemiology in the KSA and beyond and make the country particularly prone to 
the importation and exportation of TB and present many challenges to KSA in controlling TB 
(Al-Orainey et al., 2013, Almutairi et al., 2018). 
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Saudi health authorities implemented an NTP for over 30 years (Abouzeid et al., 2012, Al-
Orainey et al., 2013). Due to the social stigma accompanying TB in KSA, TB care is 
incorporated into the general health services. It is mainly based on finding and treating active 
TB patients, improving methods of reporting and laboratory services. Diagnosis of TB is based 
mainly on sputum smear microscopy, radiography, mycobacterial culture, histopathology, in 
addition to molecular techniques available in some referral laboratories (Abouzeid et al., 2012). 
Bacillus Calmette-Guérin (BCG) vaccination is mandatory to all children at birth, and TB 
treatment is offered freely to all patients in government hospitals (Al-Orainey et al., 2013). In 
the year 2000, the NTP started to implement DOTS in all regions of the Kingdom. This was 
accompanied by a policy change regarding to healthcare for non-Saudis. Before 2000, non-
Saudis were not allowed to reside permanently in the Kingdom. They were not allowed access 
to free government healthcare facilities, and they did not access private healthcare facilities for 
fear of deportation (Abouzeid et al., 2012). Hence, many non-Saudi TB patients were not 
diagnosed or registered, leading to under reporting. Since the end of 2000, non-Saudi patients 
with symptoms suggestive of TB were allowed to access governmental healthcare facilities 
free of charge and were allowed to remain in the Kingdom (Abouzeid et al., 2012, Almutairi 
et al., 2018). This policy change encouraged non-Saudis to use government health care 
facilities, thus increasing case detection rates in non-Saudis. However, this did not eliminate 
the possibility to be dismissed by their employer for having TB, which might still prevent some 
from seeking diagnosis and treatment (Almutairi et al., 2018). 
 
Al-Orainey and colleagues (Al-Orainey et al., 2013) reported on the incidence trends of TB in 
Saudi Arabia over a 20-year period from 1991 to 2010. A total of 64,345 TB cases were 
reported to the Ministry of Health during the study period. Of these, there were 46,827 (73%) 
PTB cases and 17,518 (27%) extra-PTB. The annual incidence of TB ranged between 14 and 
17/100,000 over the study period. The majority of TB cases (62%) were males. TB incidents 
rates among males in KSA have generally been higher than that of females especially among 
Saudi nationals (Abouzeid et al., 2012, Almutairi et al., 2018). This observation has been linked 
to the fact that until recently, males in KSA were more engaged in public events than females 
and to the stigma of being diagnosed with TB among Saudi females (Abouzeid et al., 2012, 
Almutairi et al., 2018). 
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Out of the 64,345 TB cases in KSA between 1991 and 2010, 33,468 (52%) were Saudi patients 
and 30,837 (48%) were non-Saudis (Al-Orainey et al., 2013). Saudis had an incidence between  
8.6 and 12.2/100,000 while non-Saudis had an incidence of 24.3-32.3/100,000. TB incidence 
showed a significant rising trend over the first 10 years of the study period. The trend for non-
Saudis then started to significantly decline, while the trend for Saudis remained flat over the 
last 10 years (Figure3) (Al-Orainey et al., 2013). In general, numerous studies have reported 
that the foreign population in Saudi Arabia have 2-3 times higher TB incidence than Saudi 
nationals (Abouzeid et al., 2012, Al-Orainey et al., 2013, Almutairi et al., 2018, Gleason et al., 
2012). The most represented countries are Indonesia, Yemen, India, Pakistan, Bangladesh and 
the Philippines (Abouzeid et al., 2012, Almutairi et al., 2018). The observation that non-Saudis 
have higher incidence of TB has been attributed to a number of factors including the fact that 
most of the immigrants in KSA come from countries with high TB incidence rates such as 
Pakistan, India, Bangladesh and Indonesia and not all of them are screened for TB at entry (Al-
Orainey et al., 2013). Many of these immigrants live in crowded conditions conducive to TB 
transmission, have poor diets, and engage in physically stressful manual labour, making them 
more susceptible to the disease and reactivation of LTBI (Al-Orainey et al., 2013, Almutairi et 
al., 2018). Moreover, although the government stopped deporting non-Saudis diagnosed with 
TB, many are still afraid to seek medical services because they fear being dismissed by their 
employer (Abouzeid et al., 2012, Almutairi et al., 2018). 
 
TB incidence rates in KSA between 1991 and 2010 increased with age and was highest for 
those older than 45 years (27.4-37/100,000). Children had an incidence of 1.8-2.8/100,000. 
There was no significant change in TB incidence trend for children and adults younger than 45 
years. Those older than 45 showed a significant declining trend over the last 10 years of the 
study (Al-Orainey et al., 2013). Childhood TB is more reflective of new infections and 
transmission from adults in the community. BCG vaccination is compulsory at birth in Saudi 
Arabia, with coverage of 97% of children (Al-Orainey et al., 2013). The fact that TB trend in 
children did not fall over the 20 years of the study period is an indication of the inability of TB 
control efforts to reduce the infection rate and halt transmission of the disease in the Kingdom 
(Al-Orainey et al., 2013).  
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The high incidence of TB in adults is probably due to reactivation of LTBI (Rajagopalan, 
2001). A nationwide community survey of TB done in the early 1990s revealed a high 
prevalence of LTBI in the Kingdom ranging from 45% in the 25-34 year age group to over 
60% in those older than 45 years (al-Kassimi et al., 1993). This large pool of LTBI is likely to 
be the source of active TB in adults and would explain the high incidence rate of the disease in 
the older age groups in the country (Al-Orainey et al., 2013, Almutairi et al., 2018). 
 
TB incidence in the Kingdom show clear variation in different regions of the country.  A study 
of TB trends in KSA between 2005 and 2009 found that Makkah, the location of Hajj, had the 
greatest number of TB cases with the greatest incidence rate in the country (26/100,000 in 
2009)(Gleason et al., 2012). Jazan and Riyadh (the capital) had the second and third highest 
incidence rates for 2009, 18.7/100,000 and 17.7/100,000 respectively. Similarly, a study of TB 
trends between 2005 and 2012 reported that Makkah had a consistently greater incidence rate 
over the study period compared with other regions (25.1/100,000; 95% CI= 24.7–25.56)  
(Almutairi et al., 2018). Riyadh was the region with the second highest incidence rate 
(17.9/100,000; 95% CI= 17.53–18.27) followed by Jazan (17.1/100,000; 95% CI= 16.31–
17.89). Al-Orainey et al. (Al-Orainey et al., 2013) reported on TB trends in the Kingdom 
between 1991 and 2010 and found that over 70% of the TB cases during the study period were 
reported from the Central (including Riyadh) and Makkah regions. These two regions have 
52% of the population of the Kingdom. Incidence rates for Saudis also showed regional 
variation. Makkah and Jazan regions showed the highest incidence rate that reached up to 
29.5/100,000. The trend rose significantly in Makkah over the study period years. Similarly, 
the Central region had a significant rise in incidence climbing from 6.4 to 14.2/100,000 over 
the study period. Other regions showed a much lower and stable incidence of 4-9/100,000 
(Figure 4). 
 
The geographical differences in incidence rates in the Kingdom is linked to number of factors. 
For instance, the reason why Makkah region has a TB incidence rate 2-3 times that of most 
other regions in the Kingdom is the high proportion of non-Saudis in it (Al-Orainey et al., 
2013). They constitute over 40% of the population of the region, many of whom come from 
countries with high TB incidence rates.  
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In addition, this region receives more than 10 million foreign visitors every year for pilgrimage 
(Hajj and Umra), many of them also come from countries with high burden of TB (Al-Orainey 
et al., 2013, Almutairi et al., 2018). Some of them stay for work in the region. These illegal 
immigrants tend to live in poor housing conditions and have limited access to health care 
because of fear of deportation. It is likely that they contribute significantly to the high incidence 
of the disease in Makkah region (Al-Orainey et al., 2013). Jazan region also has a high 
incidence rate for TB, more than 2 times the incidence of the rest of the Southern region of the 
Kingdom (Al-Orainey et al., 2013, Almutairi et al., 2018).This could be attributed to Jazan’s 
proximity to Yemen, which has a high overall TB incidence rate (Almutairi et al., 2018). Jazan 
is a border area with Yemen and receives many illegal immigrants from that country. Other 
illegal immigrants land in Jazan by sea from Sudan, Somalia, and other African countries. Like 
other illegal immigrants, they stay in poor housing conditions and have difficult access to health 
care which may impact the epidemiology of TB in the region (Al-Orainey et al., 2013). Finally, 
the high TB incidence rate seen the Central region, including the capital Riyadh could be 
attributed to a higher frequency of reporting due to the presence of large number of tertiary 
hospitals that treat patients from all over KSA. In addition, it is a major employment destination 
for non-Saudis (Al-Orainey et al., 2013, Almutairi et al., 2018). 
 
Data from the Kingdom suggest that the prevalence of MDR-TB is low though there is a higher 
primary drug resistance. The incidence rate of MDR/RR-TB in the Kingdom in 2017 was 
0.36/100,000 and the percentage of TB cases with MDR/RR-TB was 2.6% among new cases 
and 20% among retreatment (www.who.int/tb/data). In a national, survey conducted between 
2009 and 2010, antimicrobial resistance testing was conducted on samples from 1,904 TB 
patient (Al-Hajoj et al., 2013). The prevalence of resistance to anti-TB drugs were as follows: 
streptomycin (8.1%; 95% CI= 7.2-9.1), isoniazid (5.4%; 95% CI= 4.7-6.2), rifampin (1%; 95% 
CI= 0.7-1.3) and ethambutol (0.8%; 95% CI= 0.5-1.2). MDR-TB was found in 1.8% (95% CI= 
1.4-2.4) and 15.9% (95% CI= 15.4-16.5) of new and previously treated TB cases, respectively. 
The study also found that treatment history of active TB, being foreign-born, having PTB, and 
living in the Western part of the country were the strongest independent predictors of MDR-
TB. 
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 In a recent report on MDR-TB among new cases in Medina (a holy city visited by many Hajj 
and Umrah pilgrims), lower mono-resistance to anti-TB drugs was reported (Elhassan et al., 
2017).  Resistance to streptomycin, isoniazid, rifampin, ethambutol and pyrazinamide were 
reported in 1.9%, 1.8%, 1.4%, 1.1% and 2.1% of the isolates respectively. MDR-TB was 
reported in 4% of the isolates.  
 
The WHO reported the estimated mortality rate from TB (excluding HIV + TB) to be 
3.2/100,000 in Saudi Arabia for 2017, with overall decrease in mortality rates in recent years  
(www.who.int/tb/data). Abouzeid and colleagues (Abouzeid et al., 2013) investigated mortality 
among TB patients in Saudi Arabia over a period of 10 years (January 1, 2001, to December 
31, 2010). All TB cases registered in Saudi Arabia with known outcome of survival or death 
while under anti-TB therapy covering the study period were included. The total case fatality 
rate was significantly higher among Saudis (6.4%) compared to non-Saudis (5.4%). The case 
fatality rate showed an upward trend starting from the year 2001 reaching a peak in the year 
2003 (7.2% and 6.2% among both Saudis and non-Saudis, respectively). Mortality among TB 
patients showed a declining trend among Saudis starting from the year 2003 and a stagnant 
trend among non-Saudis. Mortality was positively correlated with advancing age as the rate 
increased with the increase in age, among both Saudis and non-Saudis. The highest rates were 
reported among those aged ≥65 years (20.8% among Saudis and 25.2% among non-Saudis). 
Mortality was correlated with male sex among Saudis (7.3% compared to 5.3% among 
females), and female sex among non-Saudis (6% compared to 5% among males). Other factors 
reported to be positively correlated with mortality were prior history of anti-TB therapy, smear 
positivity, and HIV seropositivity (Abouzeid et al., 2013). 
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TB=tuberculosis    *Incidence rate /100,000       ** From Al-Orainey et al.(Al-Orainey 
et al., 2013) 
 
Figure 3. Annual tuberculosis patient numbers and incidence rate* in Saudi Arabia 
(1991-2010) ** 
  
 
Figure 4. Tuberculosis incidence rates* and trends for Saudis by region  
                (1991-2010)** 
  
 
  
 
TB=tuberculosis    *Incidence rate /100,000       ** From Al-Orainey et al.(Al-Orainey 
et al., 2013) 
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1.6       Hajj: A risk for tuberculosis and tuberculosis transmission 
Hajj represents many of the risk factors for transmission of respiratory infections including TB. 
The event is one of the largest annual mass gatherings in the world attended by more than 2 
million people from more than 180 countries, many of which are endemic for TB. This mass 
gathering is also characterized by a large elderly population, frequently with underlying health 
conditions. Extended stays at holy sites, along with physical exhaustion, extreme heat, and the 
unavoidable overcrowding in housing, ritual sites and transport services, facilitates 
transmission of infectious agents through shared air and respiratory infections are very 
common among pilgrims (Ahmed et al., 2006, Gautret et al., 2015). As a consequence, pilgrims 
attending Hajj maybe at a high risk of acquiring TB infection. Wilder-Smith and colleagues 
measured the immune response to TB antigens in pilgrims using Quanti-FERON TB assay 
(Wilder-Smith et al., 2005). They reported that 10% (15/149) of pilgrims who were negative 
prior to Hajj had a significant rise in the immune response to TB antigens three months after  
Hajj. This Hajj-related conversion rate (10%) is higher than the reported TST conversion for 
general long-term travelers to TB high-endemicity countries (Cobelens et al., 2000). 
Participating in Hajj may also render pilgrims susceptible to reactivation of LTBI due to 
physical exhaustion, sleep deprivation, poor nutrition, and co-morbid conditions that may 
lower their immunity (Ai et al., 2016). 
 
Under normal not so crowded circumstances, there are approximately 10 close contacts for 
each active TB case (Jereb et al., 2003). The situation during the Hajj season is clearly different. 
Housing areas and ritual sites are excessively congested. Pilgrims remain in close proximity in 
crowded tents or rooms for several hours per day for several days or weeks. In the holy site of 
Mina, 50-100 pilgrims share one tent for four days. In Makkah, housing is also overcrowded 
because of the limited availability of hostels and apartments to accommodate large numbers of 
pilgrims. Such jammed conditions create bigger numbers of close contacts than usual (Al-
Orainey, 2013). Studies have shown that TB infection rate (TST conversion) ranges can be 
over 50% among closed contacts depending on the closeness to the index case, duration of 
contact, and prior risk of exposure (Mensah et al., 2017, Morrison et al., 2008). Other factors 
that may increase the risk of transmission include duration of contact, infectiousness of the 
patient (that is, being smear positive), and poor ventilation. As most pilgrims travel by air, often 
for long hours, there is an increased risk of TB transmission from a TB case to the other 
passengers on board (Centers for Disease and Prevention, 1995, Kenyon et al., 1996).  
 
Chapter 1: Tuberculosis and the Hajj mass gathering 
 
 
15 
There are several reports of documented TB infection acquired during air travel particularly on 
long flights. The risk is greatest for those who sit close to the infectious individual. As such, 
Hajj may be a risk for developing active TB as well as transmission of TB among national and 
international pilgrims, among the local population and among Hajj work force as well as a risk 
for global dissemination of the disease post event.  
 
1.7       Tuberculosis during Hajj 
With only one specific large-scale study to ascertain the TB case load in pilgrims during the 
Haj, (Yezli et al., 2017b), evidence of TB in pilgrims comes mostly from clinical studies of 
causes of hospital admissions during the Hajj. Alzeer et al.1998, reported that M. tuberculosis 
was the commonest cause of pneumonia requiring hospitalization during the 1994 Hajj. In their  
study, all pilgrims who failed the first-line of therapy and admitted with pneumonia to 2 
hospitals in Makkah during the pilgrimage season between 3-28 May 1994 were investigated. 
Of the 64 cases included, the causative organism was identified in 46 (73%) patients. M. 
tuberculosis was isolated in 13 (20.3%) of cases making it the most common cause of 
pneumonia in the study population followed by Gram-negative bacilli (18.8%) and 
Streptococcus pneumoniae (10%). The authors reported that the presentation of M. 
tuberculosis-pneumonia was acute and indistinguishable from pyogenic pneumonia. Thirty-
one per cent of tuberculous cases had upper lobe involvement, 54% lower lobe, and 15% multi-
lobar, which was similar to the radiographic features in non-tuberculous pneumonia cases. 
After administration of first-line anti-TB drugs, 92.3% (12/13) of the TB patients recovered.  
 
Madani and colleagues (Madani et al., 2006) performed a cross-sectional study of patients 
admitted to four hospitals in Mina and three hospitals in Arafat during the 2003 Hajj between 
8-14 February. Pneumonia was found to be the most common cause of admission in the 808 
patients (19.7%). Open PTB accounted for 5.9% (10 patients) of the 169 cases of pneumonia 
and 1.2% of all admissions. Mandourah et al. (Mandourah et al., 2012) conducted a cohort 
study of critically ill Hajj pilgrims over two consecutive Hajj years (18th November to 9th 
December 2009 and 7th November to 1st December 2010).  All patients admitted to the intensive 
care unit (ICU) for at least 4 hours at 15 hospitals in the cities of Makkah and Medina were 
included in the study. 
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Pneumonia was the primary cause of critical illness in 27.2% (123/452) of all ICU admissions 
during Hajj. Of these, M. tuberculosis accounted for 4.9% (6/123) of the cases. Similarly, 
Asghar et al. (Asghar et al., 2011) conducted a cross-sectional study of pilgrim patients with 
suspected pneumonia admitted to three tertiary care hospitals in Makkah during the 2005 Hajj 
(from the 1st  to 20th  day of the Hajj month of the Islamic year 1426; Jan 2005). While the 
majority of the 91 pneumonia cases were caused by Candida albicans (27.5%) and 
Pseudomonas aeruginosa (20.9%), M. tuberculosis was the causative agent in 1 (1.1%) patient. 
A similar proportion was reported by El-Sheikh et al. (El-Sheikh et al., 1998)  who analysed a 
total of 395 sputum specimens from patients referred to one hospital and 3 dispensaries with 
symptoms of respiratory tract infections during the 1991 and 1992 Hajj seasons. They reported 
that 1.2% (5/395) of the samples were positive for TB. While TB is no longer reported as the  
most common cause of pneumonia in Hajj in recent years, TB cases keep being reported in 
hospitalised Hajj pilgrims.  
 
TB found in seriously ill patients during Hajj is probably the tip of the iceberg. Cough among 
pilgrims is very common with rates over 80% having been reported (Deris et al., 2010, Gautret 
et al., 2015). These patients are often diagnosed with upper respiratory tract infections and only 
those requiring hospitalization are thoroughly investigate (Al-Orainey, 2013). Hence, 
undiagnosed TB among non-hospitalised pilgrims could be a serious issue. This was 
highlighted by Yezli et al. (Yezli et al., 2017b) who conducted a cross-sectional study to 
evaluate the burden of undiagnosed active PTB in pilgrims arriving in the KSA for the 2015 
Hajj. The study enrolled 1,164 non-hospitalised adult pilgrims who had cough and could 
voluntarily produce sputum samples. Pilgrims were selected from five TB endemic countries 
in Africa and South Asia. Sputum samples were processed using the Xpert MTB-RIF assay 
with laboratory results being available for 1,063 samples. Fifteen pilgrims (1.4%) had active 
previously undiagnosed drug-sensitive PTB (Afghanistan [12; 80%], Pakistan [2; 13.3%], and 
Nigeria [1; 6.7%]). These TB positive pilgrims pose a risk to other pilgrims from over 180 
countries, the local population and may play a role in the international transmission of the 
disease.  
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Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised 
pilgrims during the Hajj mass gathering 
 
2.1       Executive summary 
Tuberculosis (TB) remains a global public health problem with significant morbidity and 
mortality. In 2017, the World Health Organisation (WHO) estimated that 10 million people 
(range, 9.0–11.1 million) developed TB, 9% of whom were infected with the human 
immunodeficiency virus (HIV). International travel, migration and movement of human 
populations facilitate the spread of TB. In this context the Kingdom of Saudi Arabia (KSA) is 
particularly relevant because of its large expatriates’ population, mainly from TB-endemic 
regions, and its yearly hosting of the Hajj and Umrah mass gatherings.  
 
Hajj represents many of the risk factors for transmission of respiratory infections including TB. 
The event is one of the largest mass gatherings in the world attracting more than 2 million 
pilgrims from over 180 countries. It is characterized by a large elderly population, frequently 
with underlying health conditions, many of which originate from low income countries where 
TB is endemic. Pilgrims gather in close contact to perform physically exhausting religious rites, 
conditions that facilitate TB transmission.  
 
Little data is available on the prevalence of active or latent TB during Hajj and there have been 
no specific large-scale controlled studies to define the burden of TB during the event. As 
pilgrims are not screened before entry to KSA, it is possible that some may enter the Kingdom 
with active TB and are not diagnosed or treated. This is because respiratory tract infections and 
cough are common among pilgrims and a proportion of TB cases may not experience 
symptoms of sufficient severity to prompt health-seeking behavior. In addition, participating 
in Hajj may also render pilgrims susceptible to reactivation of latent TB infection. The above 
may lead to TB being missed both among non-hospitalised and hospitalised pilgrims. The 
current study screened the latter populations to provide the evidence of PTB burden among 
hospitalised and non hospitalised pilgrims and propose interventions to prevent and control TB 
in Hajj and other mass gatherings.     
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For non-hospitalised pilgrims, a large-scale screening for active pulmonary TB (PTB) was 
conducted among pilgrims attending the 2016 Hajj. The study found that 0.66% of pilgrims 
with cough from medium/high TB burden countries (mostly from India and Afghanistan) had 
active PTB. TB prevalence was higher among males, the elderly, those with low level 
education, those residing in South Asia, those with underlying health conditions, those with 
previous TB treatment, those coughing for more than a week, those who have contacts 
diagnosed or treated for TB, those who lived recently in a household with an adult with cough 
and those who traveled outside their current country of residency in the previous year. 
However, the difference was not statistically significant with the exception for underlying 
health conditions and cough duration. Underlying health conditions and cough in the household 
were independent risk factors for TB after adjusting for other variables.  
 
For hospitalised pilgrims, the study conducted the first screening for active PTB among this 
population during the 2016 and 2017 Hajj seasons. The study found that 2.9% of inpatients 
with cough (mostly from Indonesia and India) had active PTB and most (77.7%) of these were 
missed by the hospitals including MDR-TB cases. TB prevalence was higher among those with 
no formal education, those residing in Asia, those with underlying health conditions, smokers, 
those with previous TB treatment, those coughing up blood, those coughing for more than a 
week and those admitted to an isolation ward. However, the difference was statistically 
significant only for previous TB treatment and admission ward. Previous TB treatment was 
independent risk factor for TB after adjusting for other variables.  
 
In light of these results, further studies investigating TB during Hajj and the impact of this mass 
gathering on TB transmission and epidemiology worldwide are warranted. These 
investigations will help inform public health policies and direct interventions for the optimal 
awareness, surveillance, screening, treatment and management, prevention, and control of TB 
during Hajj and other mass gatherings worldwide.  
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2.2       Introduction and literature review      
A search of electronic databases was conducted for relevant literature in English, without time 
restriction. Database searched included Pubmed, Scopus and Google Scholar. A combination 
of the MeSH terms and text words including: “Hajj”, “Pilgrimage”, “Tuberculosis”, “TB”, 
“Pulmonary”, “Undiagnosed”, “Missed”, “Hospitalised”, “Patient”, “Pilgrim”, “Community” 
were used. A manual search was also performed reviewing reference lists of identified 
literature to find additional papers. With few exceptions, only the most relevant and recent 
publications were used to develop the literature review. Undiagnosed and unreported TB is 
significant issues that contribute to the transmission of TB and challenge TB control efforts 
worldwide. Under-diagnosis can occur for reasons such as poor geographical and financial 
access to health care, lack of or limited symptoms that delay seeking of health care, failure to 
test for TB when people do present to health facilities, and diagnostic tests that are not 
sufficiently sensitive or specific to ensure accurate identification of all cases (World Health 
Organization, 2018b).  In 2014, 6 million new cases of TB were reported to WHO, fewer than 
two-thirds (63%) of the 9.6 million people estimated to have fallen sick with the disease (World 
Health Organization, 2015b). This means that worldwide, 37% of new cases went undiagnosed 
or were not reported. In 2017, about 3.6 million (36%) of the estimated 10 million people with 
TB worldwide were either not reported or not diagnosed (World Health Organization, 2018b). 
While many of these people are likely to have been treated by public and private providers who 
are not linked to the National TB Control Programs (NTPs), many would have spent significant 
amount of time in their community without treatment, increasing the risk of TB transmission. 
 
With respect to Hajj, as pilgrims are not screened before entry to the Kingdom, it is likely that 
some may enter Saudi Arabia with active PTB. Because respiratory tract infections and cough 
are common among pilgrims, patients are often diagnosed with upper respiratory tract 
infections and only those requiring hospitalisation may be thoroughly investigated (Al-
Orainey, 2013). This means that potentially many undiagnosed and untreated active PTB cases 
are brought to the Kingdom and infection could be transmitted to other pilgrims and to local 
citizens (Yezli et al., 2017b).  
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Pilgrims infected during the pilgrimage may also spread the infection to contacts in their 
countries. Transmission of MDR-TB is a real concern as MDR-TB requires long, expensive 
and extensive treatment with multiple, potentially toxic drugs and outcomes are poor 
(Orenstein et al., 2009). Also, given the short period pilgrims stay in the Kingdom, short 
inpatient stay and patients load at healthcare facilities during Hajj, TB cases may be missed 
among hospitalised pilgrims. This may contribute to poor outcome and represent a potential 
source of TB infection among pilgrims, other patients and HCWs.  
 
2.2.1 Undiagnosed TB among non-hospitalised populations 
Numerous studies from high TB/HIV burden in Africa reported undiagnosed active TB among 
non-hospitalised individuals in the community. Wood et al.(Wood et al., 2007) conducted a 
cross-sectional survey of PTB and HIV infection in a sub-Saharan community with high 
TB/HIV burden but a well-functioning directly observed therapy short course (DOTS) TB 
control program. Of the 762 participants, TB was diagnosed in 23 (3.3%). Of these, 12 (1.6%) 
were previously undiagnosed definitive TB cases; 6 (5 HIV-positive) smear-positive cases and 
6 (4 HIV-positive) smear-negative/culture positive cases. The study reported that among HIV-
positive and -negative individuals, prevalence of notified smear-positive PTB was 
1,563/100,000 and 352/100,000, undiagnosed smear-positive PTB prevalence was 
2,837/100,000 and 175/100,000, and case-finding proportions were 37% and 67%, 
respectively. Only 17% of the previously undiagnosed PTB cases reported cough as a 
symptom. This lack of symptoms suggestive of PTB was thought to be partly responsible for 
the failure of the passive case-finding DOTS program in adequately identifying PTB cases 
especially among HIV-positive individuals(Wood et al., 2007). 
 
In a rural community screening of 30,040 adults in Ethiopia in 2009, 482 TB suspects were 
identified (Deribew et al., 2012). Among the latter, 9 (1.8%) TB cases were detected using 
smear microscopy and 17 (3.5%) were detected using culture. The prevalence of PTB in the 
study was 30/100,000 based on smear-microscopy and 76.1/100,000 based on culture. All of 
the 17 cases detected by culture and 5 cases detected by smear microscopy were new PTB 
cases. The study reported that there were 4.3 undiagnosed PTB cases for every TB case who 
was diagnosed through the passive case detection mechanism in health facilities. Among the 
undiagnosed PTB cases, there were more females than males.  
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The authors stated that empowerment to seek early health care and low knowledge of women 
about the cause of TB(Abebe et al., 2010) could have been the reasons for this high number of 
undiagnosed female TB patients in the community surveyed (Deribew et al., 2012). In a larger 
national survey among adults in Ethiopia conducted in 2010-2011, the estimated prevalence of 
smear-positive TB and bacteriologically confirmed TB were 108/100,000 and 277/100,000 
(Kebede et al., 2014). A total of 110 bacteriologically confirmed PTB cases were identified 
including 47 smear-positive cases and 63 smear-negative/culture positive cases. Of the TB 
cases identified, 37 (79%) smear-positive and 59 (94%) smear-negative, culture-positive cases 
were new or previously undetected and had not been previously treated. Also, among all 
confirmed TB cases, more than 50% did not report chronic cough and were identified using 
chest X-ray screening (Kebede et al., 2014). In 2017, the WHO reports the incidence of TB in 
Ethiopia as 164/100,000(World Health Organization, 2018b) and the country contributes over 
11,000 Hajj pilgrims each year.  
 
A national survey on the prevalence of PTB in the adult population of Tanzania reported a 
smear-positive TB prevalence of 249/100,000 and a bacteriologically-confirmed TB of 
293/100,000. Both of these numbers were higher than previous WHO estimates for the country 
(Senkoro et al., 2016). Of the 6,302 suspected TB individuals, 154 were bacteriologically 
confirmed TB cases. Of these, only 5 (3%) were on anti-TB treatment at the time of the survey 
and 10 (7%) had received previous anti-TB treatment.  A similarly high percentage of 
undiagnosed TB was reported from the first national TB prevalence survey in Zambia (Kapata 
et al., 2016). The survey was conducted in 2013-2014 and enrolled adult Zambians aged 15 
years and above. Among the 46,099 participants, 6,154 submitted at least one sputum specimen 
for examination. TB was identified in 256/6,123 (4.3%) individuals. The estimated national 
adult prevalence of TB of all forms and that of smear, culture and bacteriologically confirmed 
TB were 455 /100,000, 319/100,000, 568/100,000 and 638/100,000 respectively. Importantly, 
97% of the TB cases were not on anti-TB treatment at the time of the survey, although 49.7% 
of the cases that were not on treatment did seek care for their illness. Also, only 61% of the TB 
cases were symptomatic (Kapata et al., 2016). While the number of Hajj pilgrims from 
Tanzania and Zambia are relatively low compared to other countries, the high incidence of TB 
in these countries and the percentage of undiagnosed/unreported cases are concerning.  
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National TB prevalence surveys from medium-high burden TB countries in Asia also report 
undiagnosed active TB cases among non-hospitalised individuals in the community (Onozaki 
et al., 2015). Pakistan has a TB incidence rate in 2017 of 267/100,000(World Health 
Organization, 2018b). It is one of the largest contributors to the Hajj population with an 
estimated 160,000 pilgrims each year. A national survey in Pakistan of adults >15 years old in 
2010-2011 enrolled 105,913 participants, of whom 10,471 were eligible for sputum 
examination (Qadeer et al., 2016). The reported prevalence estimates for smear and 
bacteriologically positive TB were 270/100,000 and 398/100,000 respectively. The survey 
identified 341bacteriologically positive TB cases of whom 233 had sputum smear-positive TB. 
Only 61% of the diagnosed TB cases screened positive on symptoms (cough >2 weeks), 
whereas the other TB cases were detected based on X-ray abnormalities. Importantly, only 
7.6% of the 341 participants with bacteriologically positive TB reported to be currently on TB 
treatment and the ratio of the prevalence of smear-positive TB to the notification rate of new 
smear-positive TB was 3.1. This suggests significant under detection and under reporting of 
TB in Pakistan. This was supported by the conclusions of a 2014 study conducted in 12 districts 
across Pakistan, which estimated the proportion of cases notified to the NTP in the country to 
be only 32% (Fatima et al., 2014). 
 
Similar observations were reported in prevalence surveys from neighbouring Bangladesh 
(Onozaki et al., 2015, Zaman et al., 2012, Zaman et al., 2006). The country has a TB incidence 
rate of 221/100,000 (World Health Organization, 2018b) and a Hajj pilgrims population of 
around 100,000. Zaman et al. (Zaman et al., 2012) reported the result of TB prevalence survey 
among 52,098 adult participants from Bangladesh conducted between 2007 and 2009. A total 
of 33 smear-positive TB cases were detected among the participants giving an adjusted 
prevalence of 79.4/100,000 (95% CI= 47.1–133.8).At the time of detection, only 3 (9.0%) of 
the 33 detected cases were under DOTS treatment at a local centre and 18 (54.5%) did not 
report cough at the time of the survey. These results mirror those of an earlier population-based 
survey in the rural areas of the country that enrolled 59,395 adults ≥15 years old, 7.1% of whom 
had cough >21 days (Zaman et al., 2006). Sputum specimens were examined for 3,834 persons, 
52 (1.4%) of them were positive for acid-fast bacilli, giving a population-based prevalence rate 
of smear-positive TB cases of 95/100,000.Around 83% of TB positive cases were either not 
treated or treated for <1 month with anti-TB drugs before sputum samples were examined 
(Zaman et al., 2006). 
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In Vietnam, a national survey among 94,179 adult participant conducted in 2006-2007, 
reported a prevalence rate of smear-positive TB of 145/100,000 (95% CI= 110-180) assuming 
no TB in persons aged <15 years (Hoa et al., 2010). Sputum tests were conducted for 7,648 
participants and the results of the sputum test, bacterial culture or both, confirmed 269 TB 
cases, 174 of which were smear-positive. Of the latter, only 6 participants (3.4%) were on TB 
treatment at the time of the study and 30 (17.2%) had a history of TB treatment. TB symptoms 
were not apparent in all TB cases. Among the TB cases, productive cough for >2 weeks was 
reported by 49.6%, any cough for >2 weeks by 54.9%, any cough of any duration by 67.4% 
and any symptom suggestive of TB by 74.2% (Hoa et al., 2010). 
 
China is another important country with regards to TB and Hajj. The country has a TB 
incidence rate of 63/100,000, and while it contributes only around 15,000 Hajj pilgrims each 
year, the country has a high prevalence of MDR-TB among new cases (7.1%) (World Health 
Organization, 2018b). In 2010, a population-based, cross-sectional survey was conducted 
among 54,279 adults in Shandong China (Wei et al., 2014). Adjusted prevalence rate of 
bacteriologically confirmed cases was calculated as 34/100,000. The survey diagnosed 172 
new cases, including 19 new bacteriologically confirmed cases (including 11 sputum and 
culture positive cases, and 8 sputum negative but culture positive cases). A number of these 
did not report symptoms suggestive of TB. The survey identified only 11 existing cases 
registered on the national TB program. A larger survey conducted the same year from all 31 
mainland provinces in China, enrolled 252,940 participants and examined 9,716 sputum 
samples (Wang et al., 2014). The survey detected 1,310 cases of active PTB, of which 347 
were bacteriologically positive (119/100,000 population; 95% CI= 103–135) and 188 were 
sputum smear-positive (66/100,000 population; 95% CI= 53–79). The prevalence of smear-
positive TB among known cases was only 9/100,000. Earlier national surveys conducted in 
China in 1990 and 2000 also reported a significant proportion of new undiagnosed and 
untreated cases of TB identified through the surveys (China Tuberculosis Control, 2004, Wang 
et al., 2014). 
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In general, data from countries in Asia report undiagnosed TB and a significant proportion of 
asymptomatic individuals among TB cases. Onozaki et al. (Onozaki et al., 2015) reported on 
the national prevalence surveys from 20 countries in Asia between 1990 and 2012. The 
prevalence of bacteriologically-positive TB disease among adults aged ≥15 years varied widely 
among countries (120/100,000 population in China in 2010 to 1,500/100,000 population in 
Cambodia in 2002). Importantly, A high proportion of cases (40-79%) did not report TB 
symptoms that met screening criteria (generally cough of ≥2–3 weeks, and blood in the sputum) 
and were only detected due to chest X-ray screening of all survey participants. Also, the ratio 
of prevalent cases to cases notified to national TB programmes was typically around 2, but was 
as high as 3 in some counties like Lao PDR and Pakistan (Onozaki et al., 2015). 
 
As per reports from Pakistan, Bangladesh, Vietnam and China, (China Tuberculosis Control, 
2004, Fatima et al., 2014, Hoa et al., 2010, Qadeer et al., 2016, Wang et al., 2014, Wei et al., 
2014, Zaman et al., 2012, Zaman et al., 2006) data from other Asian countries also report high 
percentage of undiagnosed, untreated TB cases identified in national TB prevalence surveys. 
Studies from Cambodia, Republic of Korea, Myanmar, Lao PDR and Thailand, found that only 
2-4% of bacteriologically-positive TB cases detected by surveys were on treatment for TB 
(Onozaki et al., 2015). 
 
2.2.2 Undiagnosed TB among hospitalised populations 
Failure to diagnose and adequately treat TB among hospitalised patients could lead to 
premature death and unrecognized transmission of M. tuberculosis (Casey, 1966, 1968, 
Johnson and Johnson, 1959, Medrano et al., 2014, Rosenthal et al., 1975, von Delft et al., 2015, 
Whittington, 1983). This puts family members, other patients and the community at increased 
risk of TB infection and subsequent disease. In addition, the complex contact patterns between 
health care workers (HCWs) and patients potentiate the spread of TB disease in the healthcare 
setting, resulting in an increased occupational risk of TB infection and disease among HCWs 
and practicing medical students (Alele et al., 2018, Boudreau et al., 1997, Sepkowitz, 1994). 
For example, Medrano and colleagues (Medrano et al., 2014) reported on a case of missed TB 
that led to widespread transmission in a private hospital in the US. During 2 months in 2010, 
the hospital identified 38 employees with TST conversions within 6 months of having a 
negative TST.  
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Such large number of recently positive TST results within 2 months, with no known 
explanation, prompted the hospital to investigate the matter. One of the 38 employees, a nurse, 
was diagnosed with pulmonary TB (PTB) with a matching M. tuberculosis genotype and drug 
resistance pattern to those of a county jail inmate who was also recently diagnosed with 
pulmonary TB. Although the nurse in question had no known contact with that inmate; another 
inmate from the same jail had been hospitalised under that nurse's care in 2009. That young 
man died, and a post-mortem examination result subsequently confirmed TB, which had not 
been suspected. Exposure to this patient with undiagnosed TB was thought to be responsible 
for the subsequent widespread transmission. Of the 318 hospital-based contacts without 
previous positive TST results 87 (27%) were infected, and 9 contacts had active TB (Medrano 
et al., 2014). 
 
Various studies reported the magnitude of undiagnosed TB among hospitalised patients by 
analysing autopsy reports (Balabanova et al., 2011, Bobrowitz, 1982, Juul, 1977, Katz et al., 
1985, Lee and Ng, 1990, Makela et al., 1971, Roberts et al., 1971, Rosenthal et al., 1975). 
These studies found substantial numbers of undiagnosed TB cases among patients that were 
only detected during autopsy examinations. For example, Katz et al. (Katz et al., 1985) reported 
that during a 21-year period (1960-1980), 82 cases of active TB were diagnosed only at autopsy 
in patients hospitalised in a medical centre in Israel. They found that around 75% of the patients 
were over 50 years old and large number of them suffered from accompanying diseases or drug 
therapy which suppresses the immune system. In 75% of the cases, diagnostic measures for the 
confirmation of TB were not taken. In another study from a general hospital in Hong Kong, 
1,306 autopsy cases were investigated. In these, 63 cases of active TB were identified, 62% of 
them were only diagnosed at autopsy (Lee and Ng, 1990). A study from a Canadian general 
hospital reviewed a 6-year period autopsy reports and identified 24 cases of undiagnosed TB 
(Roberts et al., 1971). These were mostly male, over 60 years old with advanced coexisting 
disease. Factors reported to have contributed to the failure of diagnosing TB were the short 
duration of hospitalization, and the masking of signs, symptoms and radiological findings by 
coexisting disease.  
 
Kilale et al. (Kilale et al., 2013) investigated 74 deceased individuals at a hospital in Tanzania, 
34 (45.9%) of whom received diagnosis before death. The main diagnoses were pneumonia 10 
(13.5%), heart failure 6 (8.1%), AIDS-related illnesses 6 (6.8%) and malaria 5 (6.8%). They 
reported that in 24 out of 71 (33.8%) biopsies acid fast bacilli (AFB) were detected.  
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In Denmark, the incidence of clinically undiagnosed active TB was 0.1% in an autopsy material 
comprising about 75% of all autopsies carried out in the country between 1969 and 1974 (Juul, 
1977). This incidence, corresponded to around one case in every 895 autopsies, mainly among 
elderly patients from medical units. Similarly, in Birmingham England, among the 14,001 
coroner's autopsies performed between 1977 and 1981, 41instances of undiagnosed active TB 
were identified (Whittington, 1983). These constituted 0.3% of the coroner's post-mortem 
examinations and 31% of the 132 deaths from TB in Birmingham during the same period. As 
with other reports, most cases were elderly (20, 48%) and male (29, 71%).  
 
Co-morbidity with other communicable and non-communicable diseases among TB patients is 
a significant reason for missed TB cases in healthcare facilities. The burden of undiagnosed 
TB is especially high among patients with HIV and diabetes (Bates et al., 2012). In resource-
limited settings of the Americas, south Asia and sub-Saharan Africa, post-mortem studies show 
that TB accounts for approximately 40% of HIV-related adult deaths and almost half of these 
TB cases are undiagnosed at the time of death (Gupta et al., 2015).  In South Africa, Cohen 
and colleagues (Cohen et al., 2010)showed that 42% of adults (of whom 94% had HIV) who 
died in hospital had undiagnosed TB. In another study from the same country, TB was 
implicated in 67% of deaths among HIV-positive patients but a third of infections were 
clinically unsuspected (Wong et al., 2012). 
 
Screening of outpatients in South Africa with HIV infection for undiagnosed TB has shown 
rates of 12-20% (Bassett et al., 2010, Kufa et al., 2012, Lawn et al., 2011). In West Africa, 
screening for active TB before INH preventive therapy among HIV-infected adults found that 
1.6% of adults considered free of active TB based on clinical screening, actually had active TB 
(Moh et al., 2017). In India, the prevalence of undiagnosed TB among HIV patients was 
reported as 0.84% among adults and 0.47% among children (Padmapriyadarsini et al., 2016). 
Mntonintshi et al. (Mntonintshi et al., 2017) reported that TB is missed even among HIV 
patients who present with severe anaemia, although TB is a major cause of severe anaemia 
among this population. In one hospital, 50 patients with HIV infection and severe anaemia who 
after treatment was not investigated for TB were recruited for the study. Of the participants, 40 
(80%) had a positive TB symptom with one or more symptoms and 6 (12%) patients had 
physical signs suggestive of extra-PTB that were not noted by the doctors who first assessed 
them.  
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
27 
The overall prevalence of TB was 86%: 43 patients (86%) had either or both bacteriological 
and clinical TB, 42 (84%) had clinical TB and 14 (28%) had bacteriologically proven TB 
(Mntonintshi et al., 2017) 
 
Bates and colleagues reported on the burden of unsuspected PTB and co-morbidity with other 
diseases among sputum producing adult inpatients in a tertiary referral centre in Zambia (Bates 
et al., 2012). The study recruited newly admitted patients who were screened for PTB using 
fluorescent smear microscopy and automated liquid culture. The burden of PTB, unsuspected 
TB, TB co-morbidity with non-communicable and communicable diseases was determined. Of 
the 900 inpatients involved (70.6% HIV infected, 30.8% non-TB suspects, 31.8% TB suspects 
and 37.4% already receiving TB treatment), 202 (22.4%) had culture confirmed TB. Among 
the latter, 27 (13.4%) TB cases were unsuspected on admission and would probably have 
remained undiagnosed if not actively screened on this study. Also, there were 18 confirmed 
cases of MDR-TB, 5 (27.7%) of which were unsuspected. Moreover, roughly half the TB cases 
were co-morbidities with other communicable and non-communicable diseases. Within the 
latter group, there was a significantly higher likelihood of TB co-morbidity in patients with 
renal disorders and those with diabetes compared to other non-communicable diseases patients. 
Such association has been documented by others (Creswell et al., 2011, Young et al., 2009). 
These two patient groups also featured prominently in the unsuspected TB cases, indicating 
that these non-communicable diseases presentations are possibly masking TB and contributing 
to missed cases (Bates et al., 2012). 
 
With respect to Hajj, as pilgrims are not screened before entry to the Kingdom, it is likely that 
some may enter the Kingdom with active PTB. Because respiratory tract infections and cough 
are common among pilgrims, patients are often diagnosed with upper respiratory tract 
infections and only those requiring hospitalization may be thoroughly investigated (Al-
Orainey, 2013). TB cases have been identified among inpatients during Hajj with TB being 
reported as a major cause of pneumonia at the event (Alzeer et al., 1998, Madani et al., 2006). 
Also, given the short period pilgrims stay in the Kingdom, short inpatient stay and patients load 
at healthcare facilities during Hajj, TB cases may be missed. This may contribute to poor 
outcome and represent a potential source of TB infection among pilgrims, other patients and 
HCWs. 
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2.3     Aim and objectives  
The overall aim of this study was to determine the occurrence of active PTB (both sensitive 
and MDR) among hospitalised and non-hospitalised pilgrims during Hajj mass gatherings. 
  
2.3.1 Tuberculosis among non-hospitalised pilgrims     
Specific objectives: 
• To investigate active PTB (both sensitive and drug-resistant) among non-hospitalised 
pilgrims with cough from medium and high burden TB countries regardless of health status 
• To investigate factors associated with active PTB among non-hospitalised pilgrims during 
Hajj  
• To describe the cases of active PTB among non-hospitalised Hajj pilgrims identified in the 
study  
• To propose recommendations for interventions to improve TB case detection, heath-
seeking behavior among pilgrims and prevention and control of TB during Hajj 
 
2.3.2   Tuberculosis among hospitalised pilgrims 
Specific objectives: 
• To investigate active PTB (both sensitive and drug-resistant) among hospitalised pilgrims 
with cough regardless of their admission diagnosis 
• To investigate factors associated with active PTB among hospitalised pilgrims during Hajj  
• To describe the cases of active PTB among hospitalised Hajj pilgrims identified in the study  
• To propose recommendations for interventions to improve TB case detection, heath-
seeking behavior among pilgrims and prevention and control of TB during Hajj  
 
2.4  Methods 
2.4.1 Tuberculosis among non-hospitalised pilgrims 
2.4.1.1 Study design 
The study was a prospective cross-sectional design study to investigate active PTB among non-
hospitalised pilgrims symptomatic for cough during the Hajj. 
2.4.1.2 Study location 
The study was conducted in Makkah, KSA, the site of the Hajj religious mass gathering. 
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2.4.1.3 Study period 
The study was conducted over roughly a one-month period (Hajj month) between 5thSeptember 
2016 and 1st October 2016 (4th-30th Dull Hija 1437H in the Islamic calendar).  
2.4.1.4 Study population 
2.4.1.4.1 Sample size   
Pilgrims were enrolled from 16 selected countries in African, South Asia and the former Soviet 
Union. They were enrolled in the study if they had cough and could voluntarily produce sputum 
samples. The countries were chosen based on their TB endemicity (medium to high), 
prevalence of MDR-TB and the number of pilgrims coming from each country to Hajj each 
year (Table 1). Emphasis was on countries endemic for TB, with high MDR-TB rates and large 
pilgrims’ populations.  
 
The estimated number of Hajj pilgrims in 2016 was around 2 million, and it is estimated that 
over 80% of pilgrims develop cough during Hajj (Gautret et al., 2015). Previous data from 
Hajj(Yezli et al., 2017b) suggest that the prevalence of active TB among non-hospitalised 
pilgrims with productive cough is 1.4%.  The sample size was determined using Epi Info 
version 7ref using a margin of error of 0.5%, a confidence interval (CI) of 95%, and a population 
size of 1,600,000 people. The minimum sample size estimated for the study was 2,118. To 
account for losses, a larger sample size of 2,451 pilgrims was enrolled in the study. 
 
2.4.1.4.2 Eligibility criteria 
Inclusion criteria 
Inclusion criteria for the study were as follows: 
• Consenting adults (>18 years old) 
• Male and female 
• Hajj pilgrims 
• From the selected countries (Table 1) 
• Non-hospitalised, regardless of health status 
• With cough 
• Can voluntarily produce sputum samples 
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Exclusion criteria 
Exclusion criteria for the study were as follows: 
• Non-pilgrims 
• Pilgrims <18 years of age 
• Pilgrims who refuse to give consent for the study 
• Pilgrims asymptomatic of cough or those incapable of producing sputum 
• Pilgrims not from the selected list of countries (Table 1) 
 
 
2.4.1.5 Recruitment process 
Consenting adult pilgrims who have cough and can voluntarily produce sputum samples were 
recruited during the study period from selected countries (Table 1) irrespective of their health 
status. Data and sputum samples were collected from enrolled pilgrims. Data was collected via 
specifically formulated form (see Appendix 1: Data collection form for non-hospitalised 
pilgrims symptomatic for cough). The data collection form was developed after literature 
reviews on TB risk factors and was adopted for the context of Hajj. Data collected include 
contact information, demographics and TB risk factors information (i.e. age, gender, country 
of origin, level of education, occupation, smoking habits, underlying health conditions and 
travel history) as well as previous TB history or treatment.  
 
The study was conducted in Makkah over the Hajj month mainly in the site of the 
accommodation of the pilgrims from the selected countries. This was done at times when the 
pilgrims were free and relaxed avoiding times/dates when pilgrims were busy, under time 
pressure, on the move or involved in Hajj rituals. Hence, recruitment was mainly done during 
the afternoon/evening at the place of residence of the pilgrims.  
 
The research assistants (volunteers from Global Center for Mass Gatherings Medicine 
(GCMGM), Makkah hospitals and medical students) coordinated with the “mutawifs” 
(personnel from the country of origin of the pilgrims who accompany the pilgrims from their 
own country and assist them through the Hajj process until returning to their home countries. 
The mutawifs are an important source of information on the pilgrims’ activities, movements 
and whereabouts during Hajj. They also speak the pilgrims’ native tongue and can assist in 
facilitating communication with and access to pilgrims from a particular country.  
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PI and study team had determined the appropriate time to approach Mutawifs with medical 
missions' support. The study PI conducted training sessions (workshops) aimed to explain the 
aim of the study, objectives and Mutawifs' role during data collection as well as emphasized 
on patients' information confidentiality.   
 
The research assistants approached pilgrims from selected countries at random, introduce 
themselves and tried to locate those with cough. Research assistants approached these 
symptomatic pilgrims and explain the study and obtained consent before enrolment in the 
study. Recruitment continued until the target sample size was reached. Infection control 
measures were reviewed by all the study team that were in contact with pilgrims. Data 
collectors wore a mask during data collection. Sample collectors wore personnel protective 
equipment and washed their hands before and after sputum sample collection. 
 
2.4.2 Tuberculosis among hospitalised pilgrims 
2.4.2.1 Study design 
The study was a prospective cross-sectional design study to investigate active PTB among 
hospitalised pilgrims symptomatic for cough during the Hajj.  
 
2.4.2.2 Study location 
The study was conducted in Makkah, KSA, the site of the Hajj religious mass gathering. It 
comprised 13 hospitals situated in the city comprising Hajj holy sites, including temporary 
hospitals operational only during Hajj days, as shown in Table 2. 
 
2.4.2.3 Study period 
The study was conducted during the Hajj lunar month (1st-30thDulHija) during the 2016 and 
2017 Hajj seasons, corresponding to 2nd September-1st October 2016 and 22nd August-21st 
September 2017, respectively.  
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2.4.2.4 Study population 
2.4.2.4.1 Sample size 
The study enrolled hospitalised pilgrims admitted to the selected healthcare facilities (Table 2) 
during the study period if they had cough and could voluntarily produce sputum samples or 
respiratory samples could be obtained from standard patient care. The patients were enrolled 
irrespective of their admission diagnosis or cause of hospitalization.   
 
It is estimated that around 4,800 pilgrims were hospitalised in the 2015 Hajj month. Also, 
respiratory tract infection and pulmonary diseases are reported to account for up to 40% of 
hospital admissions in Hajj (Madani et al., 2006). Hence, the estimated study pool number was 
1,920. The prevalence of undiagnosed PTB among hospitalised Hajj pilgrims is unknown. 
However data from other settings suggest that around 3% of hospitalised patients with 
suggestive symptoms have active PTB (Assefa et al., 2019). We aimed to enroll all patients 
that fulfilled the inclusion criteria in our study, however a minimum sample size for the study 
was calculated as follows: The sample size was determined using Epi Info version 7ref using a 
margin of error of 2%, a confidence interval (CI) of 95%, a study population size of 1,920 
patients and a TB prevalence of 3% among the hospitalised patients. The minimum sample size 
estimated for the study was 245. A larger sample size of 347 pilgrims was enrolled in the study.  
 
2.4.2.4.2 Eligibility criteria 
Inclusion criteria 
Inclusion criteria for the study were as follows: 
• Consenting adults (>18 years old) 
• Male and female 
• Hajj pilgrims 
• From the selected healthcare facilities (Table 2) 
• Hospitalised, regardless of admission diagnosis 
• With cough 
• Can voluntarily produce sputum samples or respiratory samples can be obtained from 
standard patient care. 
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Exclusion criteria 
Exclusion criteria for the study were as follows: 
• Non-pilgrims 
• Patients <18 years of age 
• Patients who refuse to give consent for the study or consent could not be obtained 
• Patients asymptomatic for cough, those incapable of producing sputum and cases where 
respiratory samples could not be obtained under standard patient care 
• Patients not from the selected healthcare facilities (Table 2) 
 
2.4.2.5 Recruitment process 
Research assistants used hospital logbooks, admission information and information from the 
public health surveillance teams operational during Hajj to locate newly admitted patients to 
the healthcare facilities and asses their eligibility for the study. The research team then 
approached the patients at an appropriate time to minimize any effect on patient care. They 
introduce themselves explain the study and obtained consent before enrolment in the study. For 
severely ill patients, consent was obtained from eligible person and data was collected from 
the patient guardian/escort and other sources (e.g. clinicians and clinical records). Infection 
control measures were reviewed by all the study team that were in contact with patients and 
were implemented during the data and samples collection. This included wearing appropriate 
personal protective equipment and adherence to hand hygiene policies. 
 
Data and sputum samples were collected from enrolled patients. Data was collected via 
specifically formulated form (see Appendix 2: Data collection form for hospitalised pilgrims 
symptomatic for cough). The data collection form was developed after literature reviews on 
TB risk factors and was adopted for the context of Hajj. Data collected include contact 
information, demographics and TB risk factors information (i.e. age, gender, country of origin, 
level of education, occupation, smoking habits, underlying health conditions and travel history) 
as well as previous TB history or treatment. Clinical data relating to the patients was also 
collected, including the admission date, ward and diagnosis, duration of illness, TB screening 
and results, treatment, final diagnosis and hospitalization outcome.  
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2.4.3 Data collection 
• The data collection tools were carefully designed according to the study objectives and 
reviewed to ensure good understanding of questions and acquiring clear and precise 
answers. 
• Questions were developed to be as precise and unambiguous as possible with emphasis on 
multiple choices and close-ended questions for accuracy. 
• Study questionnaires were translated to Arabic using a professional certified medical 
translator. Translated materials were back-translated by someone else other than the first 
translator to make sure that the translation is as accurate as possible. 
• Study tools were tried and tested prior to the actual date of data collection in places different 
from the sample settings. Final versions of research tools were revised carefully. 
• Clear step by step study instructions were produced and distributed to the research 
assistants in Arabic and English so that they maintain a uniform standard way of collecting 
the data. 
• The information sheets as well as the consent statement were also translated into Arabic 
using a professional certified medical translator. Translated materials were back-translated 
by someone else other than the first translator to make sure that the translation is as accurate 
as possible. 
• Researchers conducted interviews in English or Arabic or any other language they master 
from the participants nationalities. Assistance from the Mutawifs was used to ensure 
accurate data collection and clear communication with pilgrims. This was important 
especially in cases of illiterate pilgrims. 
• The data collected and the quality of the information gathered was reviewed at the end of 
each day of the study to identify possible issues and improve data quality going forward. 
• Training in research methods was provided by the principal investigator for the study team 
to ensure that they understood the study collecting tools and research objectives. This 
included the way to conduct the face-to-face interviews. 
• The study team was given training on Good Clinical Practice (GCP) and informed consent 
before starting the data collection. 
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2.4.4 Data entry and cleaning 
Data was entered following the gold standard for professional data entry which is double data 
entry. Data was entered twice in Excel and the two data sets were then compared, differences 
were examined, errors were verified against the original questionnaires and corrections were 
made. The data set was then exported to SPSS software where frequencies for all variables 
were generated. The frequency tables generated were then examined to detect unusual values. 
Final databases were cleaned by the principle investigator to ensure quality before analysis.  
 
2.4.5 Sample collection and processing 
Sputum samples were collected in sterile containers from each participant at the time of 
enrolment. Sputum samples were transported in cold conditions (2-8 °C) to the laboratory within 
24 hours of collection. Once received the samples were stored at -80°C to avoid degradation of 
DNA until processing. All sputum samples were processed at the Haddah Regional Laboratory 
(Makkah) after Hajj using the Xpert MTB/RIF assay as described previously (Helb et al., 2010). 
Briefly, sample reagent was added at a 1:3 ratio to sputum samples (i.e, 0.5 mL of sputum sample 
to 1.5 mL of the sample reagent) and vortexed every 5 min during a 15-min incubation period at 
room temperature. Then, 2 mL of the inactivated sample mixture was transferred to the Xpert 
MTB/RIF assay cartridge and processed in the GeneXpert machine in accordance with 
manufacturer’s instructions (Cepheid, Sunnyvale, CA). 
 
In December 2010, the WHO endorsed the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA) for 
the rapid diagnosis of TB and MDR-TB (World Health Organization, 2010b) The test is 
recommended for use in individuals suspected of MDR-TB or HIV-associated TB (World Health 
Organization, 2010b). The Xpert MTB/RIF assay is capable of detecting the M. tuberculosis 
complex while simultaneously detecting rifampicin resistance in <2 hours  (O'Grady et al., 
2011). The detection of rifampicin resistance is considered a proxy marker for MDR-TB, as an 
estimated 90% of rifampicin-resistant M. tuberculosis isolates are also resistant to isoniazid 
(Chang et al., 2012, Van Rie et al., 2010). The assay has been successfully evaluated and used 
in a number of studies for identifying unsuspected TB among hospitalised and non-hospitalised 
patients (Bates et al., 2013, Bates et al., 2012, O'Grady et al., 2012, Yezli et al., 2017b). 
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2.4.6 Data analysis 
Characteristics of the study population were summarized as frequencies, percentages calculated 
for categorical variables and as means, range and standard deviations (SD) for quantitative 
variables. The association between demographic and clinical variables and TB was evaluated by 
Chi square test or Fisher exact test as appropriate. In addition, odds ratios (ORs) and their CIs 
were calculated. Multiple logistic regression analysis, using penalized likelihood (Firth method), 
were performed to examine the potential impact of the variables that were identified as being 
significant at 0.25 in the bivariate analysis. All of the tests for significance were two-sided and 
p values < 0.05 were considered statistically significant. All analysis were done using SPSS 22.0 
(SPSS Inc., Chicago, USA) and SAS 9.4 (SAS Institute Inc., NC, USA) software program. 
 
2.4.7 Ethics 
The study was approved by the King Fahad Medical City Ethics Committee and the 
Institutional Review Board (IRB log: 16-329E) (Appendix 5) and by Liverpool School of 
Tropical Medicine (LSTM) research Ethics Committee (19-084). The study was conducted in 
accordance with the Ethics Committee’s guidelines. Prior to enrolment in the study, each 
volunteer was informed in detail about the protocol purpose and procedures and the risks and 
discomforts to be expected. Verbal consent was obtained from each volunteer and the person 
explaining and obtaining the consent signed and dated the data collection form. When a patient 
was illiterate or could not understand the consent statement due to language barrier, the consent 
statement was explained in his/her native language via Mutawif, the medical representative or 
a peer/accompanying pilgrim. The information sheet and informed consent statement were 
distributed to the participant to read and ask any questions and the content was explained to 
them. Participants were told that they were free to withdraw their consent and to discontinue 
participation at any time without prejudice or loss of benefits to which they are otherwise 
entitled. The consent statement form had the name and contact details of a study representative 
so that participants had the opportunity to ask further questions if they needed to. 
  
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
37 
2.4.8  Confidentiality 
The importance of privacy and confidentiality of participants was highlighted to the study team. 
Data i.e. human subjects, questionnaires and data collection forms, specimens, and laboratory 
data was linked using a unique patient identification number assigned upon enrolment. All 
relevant data and documents were secured in locked cabinets and/or password-protected files; 
with access given to selected research personnel. 
 
Table 1. Target countries from which pilgrims were enrolled 
Country  TB endemicity* 
Incidence /100,000 
population  
Prevalence of MDR/RR-TB* 
(% among new cases) 
Estimated number of 
Hajj pilgrims in 2015 
 
South Asia    
Afghanistan 189 3.9 25,037 
Bangladesh 221 1.6 102,795 
India 204 2.8 149,008 
Indonesia 319 2.4 169,996 
Malaysia 93 1.5 24,412 
Pakistan 267 4.2 160,611 
North Africa     
Algeria  70 2.5 30,177 
Morocco  99 1.0 31,219 
Ethiopia 164 2.7 11,684 
Nigeria 219 4.3 75,212 
Somalia 266 8.7 2,435 
Sudan 77 2.9 27,490 
South Africa 567 3.4 2,435 
Former Soviet 
countries  
   
Tajikistan 85 20 3,353 
Kazakhstan 66 26 2,729 
Kyrgyzstan 144 26 1,993 
*2017 data (www.who.int/tb/data)    RR-TB=rifampicin-resistant tuberculosis (TB)      MDR-TB=multidrug-resistant TB 
  
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
38 
Table 2. Characteristics of the hospitals included in the study  
Hospital name Operational 
period 
# of medical 
staff 
# of beds #ICU 
beds 
# isolation 
rooms 
Holy sites hospitals  
     
Arafat General Hospital 7 days 406 300 28 1 
East Arafat Hospital 7 days 397 236 52 29** 
Mina Emergency Hospital 19 days 483 190 34 6 
Mina Al-Wadi Hospital 19 days 553 160 25 12 
Mina Al-Jisr Hospital 7 days 413 150 28 3 
Alrahmah Mountain Hospital 7 days 312 140 17 2 
Namera Hospital 7 days 281 90 12 1 
Mina New Street Hospital 
 
7 days 287 50 16 12 
Other Makkah hospitals  
     
Alnoor Specialist Hospital All year 1900 500 65 37* 
King Faisal Hospital All year 935 200 36 10* 
Ajyad Emergency Hospital All year 218 20 20 1* 
King AbdulAziz Hospital All year 1142 300 30 15* 
Hera General Hospital All year 925 279 28 17* 
** 9 negative pressure room and 20 others      *Negative pressure room        ICU=intensive care unit 
2.5 Results 
2.5.1    Tuberculosis among non-hospitalised pilgrims 
The study enrolled 2,451 pilgrims symptomatic for cough of any duration. Of these 939 
(38.3%) produced saliva samples and hence were excluded from the study (Figure5). The 
remaining 1,512 pilgrims were able to produce sputum samples, and these were tested using 
the MTB/RIF assay. Two samples showed invalid results and were excluded from the analysis. 
Hence, overall 1,510 pilgrims with valid sputum sample results were included in the study and 
the analysis.  
 
2.5.1.1 Characteristics of the study population 
Pilgrims originated from 16 countries in Africa, former Soviet countries and South Asia. These 
countries have medium/high TB burden and the former Soviet countries (Tajikistan, 
Kazakhstan, Kyrgyzstan) in particular have high prevalence of MDR/RR-TB among new TB 
cases (Table 1). Many of the countries included in the study (e.g. Bangladesh, India, Indonesia, 
Pakistan and Nigeria) also contribute a considerable number of pilgrims to the total Hajj 
population (Table 1).  
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However, pilgrims were resident (for at least the previous year) in 19 countries, mainly India 
(15.23%), Bangladesh (14.77%) and Ethiopia (11.85%). In general, nearly half (48.71%) of the 
pilgrims were residing in South Asia.  
 
The characteristics of the study population are summarized in Table 3 and Figures6-9. The 
highest number of respondents came from India; 230(15.2%) whereas only 6 (0.40%) were 
from Kyrgyzstan. The mean age of the study population was 56.1 (SD= 12.9 years, range= 19-
90 years) with a male: female ratio of 2.6:1. Nearly 61% of the respondents had no formal 
education and 22.1% declared having an underlying health condition. Hypertension and 
diabetes were the most common co-morbidities identified represent respectively in 56.1% and 
42.6% of those with underlying health conditions (Table 4). Similarly, 21.9% reported that they 
were taking medications at the time of the study. One pilgrim from Sudan declared that she 
was pregnant at the time of enrolment in the study.  
 
Nearly 16% of the respondents declared that they were smokers of tobacco products such as 
cigarettes, cigars or pipes or have smoked such products in the past. However, only 7.43% 
declared they were current smokers at the time of the study (Table 3). A small minority (3.63%) 
of the respondents had occupations associated with increased risk of TB infection (Table 3). 
Travel information indicated that 82 (5.63%) respondents have traveled outside their country 
of residence in the previous year visiting countries in Africa, Asia, the Middle East, Europe 
and Australia. The most common destinations visited were KSA (48.78%), Pakistan, (18.29%), 
India (9.75%), United Arab Emirates (7.31%) and Thailand (7.31%). The purpose of visiting 
KSA in the previous year was probably to perform Umrah/Hajj, as all pilgrims (40/1510, 
2.83%) who reported visiting KSA also reported performing Umrah/Hajj in the previous year.   
 
At the time of recruitment, most pilgrims (85.66%) reported a cough of one week or less in 
duration. Thirty pilgrims (2.14%) declared that they were coughing blood and 161 (15.66%) 
stated that within the previous month they shared the household with an adult with a cough 
(Table 3). A minority of respondents (1.91%) stated that they have had a close contact 
diagnosed or treated for TB. While no pilgrim declared that they were receiving TB treatment 
at the time of enrolment, 8 (0.61%) revealed that they had been treated for TB in the past, 7 of 
whom confirmed that they had completed their TB treatment.  
  
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
40 
However, the reported TB treatment duration was over 6 months in only 6 cases while the other 
2 cases reported treatment duration below 6 months (Table 3). Around 38% (3/8) of those 
previously treated for TB originated from Bangladesh and the rest were nationals of Morocco, 
India, Pakistan and Afghanistan. 
 
Figure 5. Flow chart of the non-hospitalised pilgrims study enrolment and results (By author) 
 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
  
2,451 pilgrims symptomatic for cough of 
any duration from 16medium/ high burden 
TB countries regardless of health status  
1,512 (61.7%) pilgrims produced 
sputum samples 
(Included in the study)   
939 (38.3%) pilgrims produced saliva 
samples   
(Exclude from the study) 
2 (0.1%) samples excluded from 
analysis (invalid results) 
 
1,510 (99.9%) samples with Xpert 
MTB/RIF assay results included in study 
analysis 
0 (0%) drug-resistant (MDR/RR) TB  
 
1,500 (99.33%) samples with TB-
negative results  
 
10 (100%) drug-sensitive TB  
 
10 (0.66%) samples with TB-positive 
results  
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Table 3. Characteristics of the enrolled pilgrims’ population 
Variable  Number 
(n) 
Percentage (%) 
Pilgrims enrolled  1510  
Gender  1458  
Male  1050 72.02 
Female  408 27.98 
Age  1351  
Mean (Range) 56.1 (19-90)  
≤47 328 24.28 
>47-55 266 19.69 
>55-64 384 28.42 
>64 373 27.61 
Nationality 1509  
Afghanistan 88 5.83 
Algeria 60 3.98 
Bangladesh 223 14.78 
Ethiopia 179 11.86 
India 230 15.24 
Indonesia 44 2.92 
Kazakhstan 65 4.31 
Kyrgyzstan 6 0.40 
Malaysia 33 2.19 
Morocco 50 3.31 
Nigeria 40 2.65 
Pakistan 118 7.82 
Somalia 102 6.76 
South Africa 35 2.32 
Sudan 94 6.23 
Tajikistan 142 9.41 
Country of residence in past year 1510  
Afghanistan 88 5.83 
Algeria 60 3.97 
Bangladesh 223 14.77 
Egypt 1 0.07 
Ethiopia 179 11.85 
India 230 15.23 
Indonesia 43 2.85 
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Cont.… Table 3. Characteristics of the enrolled pilgrims’ population 
Variable  Number 
(n) 
Percentage (%) 
Kazakhstan 65 4.30 
Kyrgyzstan 6 0.40 
Malaysia 33 2.19 
Morocco 50 3.31 
Nigeria 40 2.65 
Pakistan 117 7.75 
Qatar 1 0.07 
Saudi Arabia 1 0.07 
Somalia 102 6.75 
South Africa 34 2.25 
Sudan 95 6.29 
Tajikistan 142 9.40 
Region lived in in the past year  1507  
South Asia 734 48.71 
Former Soviets 213 14.13 
Other African Countries 355 23.56 
North Africa 205 13.60 
Level of education  1449  
No formal education 878 60.59 
Primary education 202 13.94 
Secondary education 199 13.73 
University-higher education 170 11.73 
Occupation 1433  
Health care worker 6 0.42 
Miner 37 2.58 
Laboratory personnel 1 0.07 
Refugee camp worker 6 0.42 
Prison staff 2 0.14 
None of the above 1381 96.37 
Pregnancy  1473  
Yes 1 0.06 
No 407 27.63 
NA (male) 1065 72.31 
Underlying health conditions 1443  
Yes 319 22.11 
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Cont.… Table 3. Characteristics of the enrolled pilgrims’ population 
Variable  Number 
(n) 
Percentage (%) 
No 1124 77.89 
Chronic kidney disease 1443  
No 1436 99.51 
Yes 7 0.49 
Chronic liver disease 1443  
No 1440 99.79 
Yes 3 0.21 
Chronic lung disease 1443  
No 1426 98.82 
Yes 17 1.18 
Cardiovascular disease 1443  
No 1423 98.61 
Yes 20 1.39 
Hypertension 1443  
No 1264 87.60 
Yes 179 12.40 
Cancer 1443  
No 1442 99.93 
Yes 1 0.07 
Immunosuppressive illness 1443  
No 1442 99.93 
Yes 1 0.07 
Diabetes 1443  
No 1307 90.58 
Yes 136 9.42 
Stroke 1443  
No 1443 100.00 
Not Listed 1443  
No 1368 94.80 
Yes 75 5.20 
Travel outside current country of residence in the past year  1456  
Yes  82 5.63 
No  1374 94.37 
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Cont.… Table 3. Characteristics of the enrolled pilgrims’ population 
Variable  Number 
(n) 
Percentage (%) 
Hajj/Umrah (Past-year) 1510  
No 1375 97.17 
Yes 40 2.83 
Smoking (Current) 1510  
No 1370 92.57 
Yes 110 7.43 
Past smoking 1510  
No 1231 90.71 
Yes 126 9.29 
Any medication 1510  
No 1136 78.02 
Yes 320 21.98 
Previous TB treatment 1510  
No 1295 99.39 
Yes 8 0.61 
TB treatment duration 1510  
 1 month 1 12.50 
2-5 months 1 12.50 
6-12 months 5 62.50 
 12 months 1 12.50 
TB treatment completed 1510  
Yes 7 100.00 
Current  TB treatment 1510  
No 17 100.00 
Cough in household 1510  
No 867 84.34 
Yes 161 15.66 
Close contacts TB patient 1510  
No 1232 98.09 
Yes 24 1.91 
Cough up blood 1510  
No 1375 97.86 
Yes 30 2.14 
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Cont.… Table 3. Characteristics of the enrolled pilgrims’ population 
Variable  Number 
(n) 
Percentage (%) 
Cough length (Days) 1510  
<= 1 Week 1195 85.66 
>1 to 2 Weeks 84 6.02 
>2 to 3 Weeks 42 3.01 
> 3 Weeks 74 5.30 
TB; Tuberculosis, NA; not applicable 
 
Table 4. Underlying health conditions among enrolled pilgrims  
Underlying health conditions n= 319 Percentage (%) 
Hypertension 179 56.11 
Diabetes 136 42.63 
Chronic kidney disease 7 2.19 
Chronic lung disease 17 5.33 
Chronic liver disease 3 0.94 
Cardiovascular disease 20 6.27 
Stroke 0 0.00 
Cancer 1 0.31 
Immunosuppressive illness 1 0.31 
Other  75 23.51 
 
Figure 6. Pilgrims by age  
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Figure 7. Pilgrims by age group  
 
 
Figure 8. Pilgrims by country of origin  
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Figure 9. Pilgrims by level of education  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5.1.2 Xpert MTB/RIF assay results 
Xpert MTB/RIF assay results were available for 1,510 (99.9%) of the sputum samples collected 
(Figure5). Of these 10 (0.66%) nationals and residents from 7 countries were positive for TB. 
No rifampicin resistance was detected in any of the positive samples; hence by proxy no MDR-
TB was detected. The characteristics of pilgrims with positive TB are summarized in Table 5. 
Most pilgrims originated from India (3, 30%), were male (6, 60%) and had no formal education 
(5, 50%). Pilgrims positive for TB ranged in age from 49 to 82 years old and six of them had 
spent from 17 to 35 days in KSA at the time of enrolment in the study. One pilgrim (10%) had 
traveled to Pakistan in the previous year, five (50%) declared having an underlying health 
condition but none worked in one of the TB risk occupations in the survey (health care worker, 
miner, laboratory personnel, refugee camp worker, prison staff). None of the 10 pilgrims were 
current tobacco (cigarettes, cigars or pipes) smokers but one (10%) had smoked such products 
in the past. None of the TB positive pilgrims declared coughing blood and only one (10%) 
reported having been previously treated for TB. The same pilgrim also declared that one of her 
close contacts was also diagnosed and treated for TB in the past. Three pilgrims (30%) recalled 
recently (within the previous month) sharing the household with an adult with cough.  
 
No formal 
education
60%
Primary education
14%
Secondary education
14%
University-higher 
education
12%
0%
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj mass gathering 
 
48 
Table 5. Characteristics of the tuberculosis positive pilgrims 
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1 Afghanistan 60 M NFE No Pakistan Never CKD No No Yes No No 
2 Afghanistan 60 M NFE No None Never Hypertension  No No Yes No No 
3 Bangladesh 60 M NFE No None Never None No No No Unsure No 
4 India  82 F NFE No None Never Hypertension No No No No No 
5 India  51 F  PE No None Never None No No No No No 
6 India  49 F PE No None Never Diabetes Yes No No Yes No 
7 Indonesia 50 M HE No None Never None No No Yes No No 
8 Pakistan  72 M PE No None Never  ND No No No No No 
9 Somalia  59 M NFE No None Never None Unsure No Unsure No No 
10 South Africa 60 F SE No  None Never Hypertension + Diabetes No No No No No 
 
F= Female, M= Male, NFE= No formal education, PE= Primary education, SE= Secondary education, HE= University/higher education, ND=  not determine, CKD=  
Chronic kidney disease 
*Health care worker, miner, laboratory personnel, refugee camp worker, prison staff 
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2.5.1.3 Association between TB and demographic variables 
The result of the bivariate analysis showing the association between TB and demographic 
variables are summarized in Table 6. TB prevalence was statistically significant higher in those 
with an underlying health condition (p= 0.029), particularly those with chronic kidney disease 
(p =0.429). Similarly, there was a significant difference in TB prevalence in relation to cough 
duration (p= 0.0296), with pilgrims coughing between >1-3weeks having the highest 
prevalence. A near significant association (p= 0.054) was observed in relation to TB treatment.  
 
Although not statistically significant, TB prevalence was also higher in females (1% vs 0.6%), 
those who traveled outside their country of residency in the previous year (1.2% vs 0.7%), 
those who had recently lived in a household with an adult with cough (1.9% vs 0.7%) or had 
close contacts as TB patients (4.2% vs 0.6%), and those taking medications (1.3% vs 
0.5%).Pilgrims who declared having been previously treated for TB had higher TB prevalence 
than those who did not (12.5% vs 0.6%).Similarly, although not statistically significant, 
prevalence of active TB was lowest among the youngest age group (≤47 year old) and generally 
increased with age. Also, TB prevalence was highest in those with primary education and those 
residing in South Asia.  
 
There was a statistically significant increase in risk of TB in relation to having an underlying 
health condition, previous TB treatment and having a TB patient as a close contact (Table 7). 
Pilgrims with underlying health conditions were over 4 times more likely to have TB than those 
who do not have an underlying health condition (OR=4.355; 95% CI= 1.244- 15.249). In 
particular, pilgrims with chronic kidney disease (OR=38.765; 95% CI= 5.171-290.61; 
p=0.0004) and hypertension (OR=3.84; 95% CI= 1.03-14.25; p=0.044). Similarly, pilgrims 
who had previously been treated for TB were 30 times more likely to have TB compared to 
those not previously treated for TB (OR=30.30; 95% CI= 4.19-219.01; p= 0.0007). Pilgrims 
with close contacts as TB patients were 9 times more likely to have TB (OR=9.19; 95% CI= 
1.49-56.45; p= 0.016).  
 
Although the ORs were not statistically significant, the risk of TB also increased for some other 
variables (Table 7). For instance, woman were 1.8 times more likely to be TB positive than 
males. Pilgrims aged >55-64 years old were 2 times more likely to be TB positive than those 
>64 years old (OR=2.15; 95% CI= 0.47-9.68).  
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The OR increased 2.8 times in pilgrims with primary education compared to those with no 
formal education (OR= 2.78; 95% CI= 0.72-10.76). Pilgrims who traveled outside their country 
of residency in the previous year, those taking medications, and those living in the household 
with an adult with cough, all were 2.4-3 times more likely to be TB positive. Finally, pilgrims 
who experienced cough for over 3 weeks were nearly 8 times more likely to be TB positive 
compared to those who had a cough for less than a week (OR= 7.824; 95% CI= 1.231- 49.71). 
 
Only variables found to be significant at the 2.5% level in the bivariate analysis (Age, 
underlying health conditions, region lived in for the past year, previous TB treatment, taking 
medication, cough in household, close contact with TB patient and cough duration) were 
considered as candidates for multiple logistic regression analysis. Penalized likelihood (Firth 
method) was used for the fitting of the logistic regression as the maximum likelihood 
estimation of the logistic regression was not appropriate for our study with such a small number 
of events. Variables that reduced the model performance were removed (close contact with TB 
patient, previous TB treatment and region lived in for the past year). The results (Table 8) 
indicate that having and underlying health conditions, taking medication and living in a 
household with an adult with cough were all significantly associated with TB after adjusting 
for other factors. Pilgrims with underlying health conditions were nearly 6 times more likely 
to develop TB (adjusted OR= 5.89; 95% CI= 1.25-27.80). Similarly, those who recently lived 
in a household with an adult with cough were 4.5 times more likely to have TB (adjusted OR= 
4.46; 95% CI= 1.01-19.58).  Pilgrims on medications were less likely to be TB positive 
(adjusted OR= 0.15; 95% CI= 0.02-0.83).  
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Table 6. Association between tuberculosis and demographic variables 
Variable   n TB+ve % p 
Gender    0.4795 
Female 408 4 1  
Male 1050 6 0.6  
Age    0.1530 
≤47 328 0 0  
>47-55 266 3 1.1  
>55-64 384 5 1.3  
>64 373 2 0.5  
Highest level of education    0.5131 
No formal education 878 5 0.6  
Primary education 202 3 1.5  
Secondary education 199 1 0.5  
University/ Higher education 170 1 0.6  
Travel outside current reside    0.4410 
No 1374 9 0.7  
Yes 82 1 1.2  
Region lived in for the past year    0.2544 
South Asia 734 8 1.1  
Former Soviets 213 0 0  
Other African Countries 355 2 0.6  
North Africa 205 0 0  
Underlying health conditions    0.0293 
No 1124 4 0.4  
Yes 319 5 1.6  
Chronic kidney disease    0.0429 
No 1436 8 0.6  
Yes 7 1 14.3  
Chronic liver disease    1.0000 
No 1440 9 0.6  
Yes 3 0 0  
Chronic lung disease    1.0000 
No 1426 9 0.6  
Yes 17 0 0  
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Cont.…Table 6. Association between tuberculosis and demographic variables 
Variable   N TB+ve % p 
Cardiovascular disease    1.0000 
No 1423 9 0.6  
Yes 20 0 0  
Hypertension    0.0896 
No 1264 6 0.5  
Yes 179 3 1.7  
Diabetes    0.2052 
No 1307 7 0.5  
Yes 136 2 1.5  
Not Listed    1.0000 
No 1368 9 0.7  
Yes 75 0 0  
Smoking    1.0000 
No 1370 10 0.7  
Yes 110 0 0  
Past smoking    1.0000 
No 1231 9 0.7  
Yes 126 0 0  
Previous TB treatment    0.0541 
No 1295 8 0.6  
Yes 8 1 12.5  
Cough in household    0.1545 
No 867 6 0.7  
Yes 161 3 1.9  
Close contacts TB patient    0.1599 
No 1232 8 0.6  
Yes 24 1 4.2  
Any medication    0.2404 
No 1136 6 0.5  
Yes 320 4 1.3  
Cough up blood    1.0000 
No 1375 9 0.7  
Yes 30 0 0  
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Cont... Table 6. Association between tuberculosis and demographic variables 
Variable   N TB+ve % p 
Pregnancy    0.7205 
Not Applicable  1055 6 0.6  
No 417 3 0.7  
Yes 1 0 0  
Current or Past smoker    0.3778 
No 1270 10 0.8  
Yes 236 0 0  
Cough length (Days)    0.0296 
<= 1 Week 1195 5 0.4  
>1 to 2 Weeks 84 2 2.4  
>2 to 3 Weeks 42 1 2.4  
> 3 Weeks 74 1 1.4  
 
Table 7. Demographic variables and risk of tuberculosis 
Variable   n TB +ve % OR (95% CI) p 
Gender      
Female 408 4 1 1  
Male 1050 6 0.6  0.559(0.167,1.873) 0.3461 
Age      
>64 373 2 0.5 1  
≤47 328 0 0 0.226 (0.011,4.749) 0.1750 
>47-55 266 3 1.1 1.974 (0.385,10.107) 0.2269 
>55-64 384 5 1.3 2.154 (0.479,9.689) 0.1370 
Highest level of education      
No formal education 878 5 0.6 1  
Primary education 202 3 1.5 2.786 (0.721,10.762) 0.2112 
Secondary education 199 1 0.5 1.2 (0.195,7.376) 0.7610 
University/ Higher education 170 1 0.6 1.405 (0.228,8.651) 0.9449 
Travel outside current reside      
No 1374 9 0.7 1  
Yes 82 1 1.2 2.645 (0.462,15.158) 0.2747 
Region lived in for the past year      
South Asia 734 8 1.1 1  
Former Soviets 213 0 0 0.2 (0.011,3.505) 0.5449 
Other African Countries 355 2 0.6 0.208 (0.012,3.642) 0.5497 
North Africa 205 0 0 0.604 (0.146,2.495) 0.5675 
Underlying health conditions      
Cardiovascular disease      
No 1423 9 0.6 1  
Yes 20 0 0 3.632 (0.191,69.016) 0.3906 
Hypertension      
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No 1264 6 0.5 1  
Yes 179 3 1.7 3.84 (1.035,14.252) 0.0444 
Diabetes      
No 1307 7 0.5  1  
Yes 136 2 1.5 3.223 (0.759,13.691) 0.1128 
Not Listed      
No 1368 9 0.7 1  
Yes 75 0 0 0.948(0.054,16.733) 0.9711 
Smoking      
No 1370 10 0.7 1  
Yes 110 0 0  0.586 (0.034,10.197) 0.7140 
Past smoking      
No 1231 9 0.7 1  
Yes 126 0 0 0.509 (0.029,8.886) 0.6432 
Previous TB treatment      
No 1295 8 0.6  1  
Yes 8 1 12.5  30.306 (4.193,219.014) 0.0007 
Cough in household      
No 867 6 0.7 1  
Yes 161 3 1.9 2.927 (0.787,10.883) 0.1090 
Close contacts TB patient      
No 1232 8 0.6 1  
Yes 24 1 4.2 9.196 (1.498,56.456) 0.0166 
Any medication      
No 1136 6 0.5  1  
Yes 320 4 1.3 2.473 (0.738,8.292) 0.1423 
Cough up blood      
No 1375 9 0.7 1  
Yes 30 0 0 2.36 (0.128,43.339) 0.5631 
Variable   N TB +ve % OR (95% CI) p 
No 1124 4 0.4 1  
Yes 319 5 1.6 4.355 (1.244,15.249) 0.0214 
Chronic kidney disease      
No 1436 8 0.6 1  
Yes 7 1 14.3 38.765 (5.171,290.62) 0.0004 
Chronic liver disease      
No 1440 9 0.6 1  
Yes 3 0 0 21.514 (0.662,699.27) 0.0841 
Chronic lung disease      
No 1426 9 0.6 1  
Yes 17 0 0 4.264 (0.22,82.449) 0.3373 
Cont.. Table 7. Demographic variables and risk of tuberculosis 
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Cont.…Table 7. Demographic variables and risk of tuberculosis 
Variable   N TB +ve % OR (95% CI) p 
Pregnancy      
Not Applicable  1055 6 0.6 1  
No 417 3 0.7 1.363 (0.369,5.031) 0.1946 
Yes 1 0 0 53.107(0.53,5318.358) 0.1030 
Current or Past smoker      
No 1270 10 0.8  1  
Yes 236 0 0 0.254 (0.015,4.371) 0.3450 
Cough length (Days)      
<= 1 Week 1195 5 0.4  1  
>1 to 2 Weeks 84 2 2.4 4.417 (0.708,27.552) 0.3632 
>2 to 3 Weeks 42 1 2.4 6.559 (1.437,29.929) 0.3106 
> 3 Weeks 74 1 1.4 7.824 (1.231,49.71) 0.8495 
 
Table 8. Results of the multivariate analysis 
Variable   aOR (95% CI) p 
Age   
≤47 1  
>47-55 5.781 (0.382,87.399) 0.5014 
>55-64 9.488 (0.651,138.237) 0.1067 
>64 4.195 (0.247,71.381) 0.9090 
Underlying health conditions   
No 1  
Yes 5.899 (1.252,27.804) 0.0249 
Cough in household   
No 1  
Yes 4.466 (1.019,19.581) 0.0472 
Any medication   
No 1  
Yes 0.152 (0.028,0.834) 0.0301 
Cough length (Days)   
<= 1 Week 1  
>1 to 2 Weeks 1.842 (0.247,13.745) 0.7621 
>2 to 3 Weeks 3.876 (0.479,31.371) 0.4510 
> 3 Weeks 3.784 (0.576,24.862) 0.4399 
aOR=adjusted odd ratio 
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2.5.2 Tuberculosis among hospitalised pilgrims 
The study enrolled 347 pilgrims symptomatic for cough of any duration that were admitted 
during the study period at the selected healthcare facilities. Of these 43 (12.4%) produced saliva 
samples and hence were excluded from the study (Figure10). The remaining 304 patients were 
able to produce sputum samples, and these were tested using the MTB/RIF assay. All these 
patients had valid sputum sample results and were included in the analysis.  
 
2.5.2.1 Characteristics of the study population 
The characteristics of the study population are summarized and presented in Tables 9-11 and 
Figures11-18. Patients were nationals of 44 countries in Africa, Asia, Europe and the United 
States of America (USA) (Table 9). Most of these patients resided in South Asia (29.9%) and 
North Africa (20.4%). Countries of residence most represented among the study population 
were Indonesia (36, 11.8%), India (35, 11.5%), Egypt (28, 9.2%) and Bangladesh (26, 8.6%).  
 
The mean age of the study population was 61.6 (SD= 12.9 years, range= 21-99 years) with a 
male: female ratio of 2:1. Nearly 47% of the patients had no formal education and 65% had 
underlying health conditions. Hypertension and diabetes, chronic lung disease and 
cardiovascular disease were the most common co-morbidities represent respectively in 33%, 
24%, 22.6% and 18% of those with underlying health conditions (Table 10). Similarly, 60% 
reported that they were taking medications at the time of the study. One pilgrim from Ghana 
was pregnant at the time of enrolment in the study.  
 
Nearly 34% of the patients declared that they were smokers of tobacco products such as 
cigarettes, cigars or pipes or have smoked such products in the past. At the time of enrolment, 
19.5% of patients were current smokers (Table 9). A small minority (2.2%) of the patients had 
occupations associated with increased risk of TB infection (Table 9). Travel information 
indicated that 39 (13.4%) patients had traveled outside their country of residence in the 
previous year visiting countries in Africa, Asia, the Middle East and Europe. The most common 
destination visited was KSA (42.5%). The purpose of visiting KSA in the previous year was 
probably to perform Umrah/Hajj, as nearly all patients (14/17, 82.3%) who reported visiting 
KSA also reported performing Umrah/Hajj in the previous year. In general, 7.2% (21/293) of 
the patients reported performing Hajj or Umrah in the previous year.  
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At the time of recruitment, most patients (85.2%) reported a cough of 2 week or less in duration. 
Twenty-four patients (9.7%) declared that they were coughing blood and 33 (12.8%) stated 
that within the previous month they shared the household with an adult with a cough (Table 9). 
A minority of pilgrims (1.9%) stated that they have had a close contact diagnosed or treated 
for TB. Three patients declared that they were receiving TB treatment at the time of enrolment. 
 
Twelve patients (4.4%) declared that they had been previously treated for TB and 5 confirmed 
that they had completed their TB treatment. Of these 5, four reported treatment duration of 6-
12 months while one reported being treated for 2-5 months. In general, the reported TB 
treatment duration was below 6 months in 41.7% of those reporting previous TB treatment 
(Table 9). Half of those previously treated for TB originated from Indonesia. 
 
2.5.2.2 Clinical data of the study population 
Most patients were admitted to emergency rooms (89/295, 30.2%) and isolation wards (28.1%) 
followed by general wards (26.8%). Upon admission, 392 initial diagnoses according to the 
International Classification of Diseases (ICD)-10 were documented in 262 patients (Table 11). 
These were mainly diseases of the respiratory system (252, 64.3%) followed by diseases of the 
circulatory system (35, 8.9%). Pneumonia was the most common admission diagnosis reported 
in 41.6% (109/262) of the cases. MERS-CoV and influenza H1N1 was suspected in 
respectively 21.7% (57/262) and 7.2% (19/262) of the cases.  
 
TB was tested in 26 (9.4%) patients, mainly using sputum AFB (23, 88.5%) and chest X-ray 
(8, 30.8%), but none were tested using GeneXpert MTR/RIF. Of those with TB test results, 5 
(29.4%) cases were positive for TB and in these patients, TB was the final diagnosis. One case 
had a TB result of MDR-TB however, final diagnosis was not reported as TB. Hence, TB was 
reported as final diagnosis in 2.2% (5/225) of the cases (2.2%). Of these, one was discharged, 
one died, one was still an inpatient in the same hospital by the end of the study period, and 2 
were referred to other healthcare facilities for treatment. In general, data on final diagnosis was 
available for 224 cases for whom 300 final diagnoses as per the ICD-10 chapters were made 
(Table 11). Most were diseases of the respiratory system (201, 67%) followed by diseases of 
the circulatory system (29, 9.7%).  
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Pneumonia was the most common final diagnosis reported in 48.6% (109/224) of the cases. 
Influenza H1N1 was identified in 12% (27/224) of the cases and no cases of MERS were 
reported.  
 
Data on the outcome of the cases by the end of the study period was available for 236 cases 
(Table 11). Of these, most (83.9%) were discharged, 13.2% were inpatients, within the same 
healthcare facility or after being referred to other institutions. Mortality was recorded in 6 
(2.5%) cases.  
 
Figure 10. Flow chart of the hospitalised pilgrims study enrolment and results (By author) 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
347 pilgrims symptomatic for cough of 
any duration admitted to selected 
hospitals from TB countries regardless 
304 (87.6%) patients produced 
sputum samples 
(Included in the study)   
43 (12.4%) patients produced 
saliva samples   
(Exclude from the study) 
0 (0%) samples excluded 
from analysis 
 
304 (100%) samples with Xpert 
MTB/RIF assay results included in 
study analysis 
2 (22.3%) drug-resistant 
(MDR/RR) TB  
 
295 (97.1%) samples with 
TB-negative results  
 
7 (77.7%) drug-sensitive TB  
 
9 (2.9%) samples with TB-
positive results  
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Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
Patients enrolled  304  
Gender  302  
Male  202 66.9 
Female  100 33.1 
Age  297  
Mean (Range) 61.63 (21-99)  
<53 74 24.9 
53 – 63 85 28.6 
64 – 70 65 21.9 
>70 73 24.6 
Nationality 304  
Afghanistan 4 1.3 
Algeria 8 2.6 
Bangladesh 26 8.6 
Burkina Faso 2 .7 
Cameroon 1 .3 
Chad 1 .3 
China 3 1.0 
Comoros 1 .3 
Egypt 28 9.2 
Ethiopia 8 2.6 
France 2 .7 
Ghana 2 .7 
Greece 1 .3 
Guinea 1 .3 
India 36 11.5 
Indonesia 36 11.8 
Iran 3 1.0 
Iraq 6 2.0 
Ivory Coast 1 .3 
Jordan 1 .3 
Lebanon 2 .7 
Libya 3 1.0 
Malaysia 7 2.3 
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Cont... Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
Mali 1 .3 
Morocco 15 4.9 
Myanmar 1 .3 
Nepal 3 1.0 
Niger 5 1.6 
Nigeria 10 3.3 
Pakistan 20 6.6 
Palestine 7 2.3 
Philippines 4 1.3 
Saudi Arabia 6 2.0 
Somalia 7 2.3 
Spain 1 .3 
Sudan 8 2.6 
Switzerland 1 .3 
Syria 8 2.6 
Thailand 1 .3 
Tunisia 5 1.6 
Turkey 4 1.3 
United Kingdom 1 .3 
United States 2 .7 
Yemen 11 3.6 
Country of residence in the past year 304  
Afghanistan 4 1.3 
Algeria 8 2.6 
Bangladesh 26 8.6 
Burkina Faso 2 .7 
Cameroon 1 .3 
Chad 1 .3 
China 3 1.0 
Comoros 1 .3 
Egypt 28 9.2 
Ethiopia 8 2.6 
France 3 1.0 
Germany 1 .3 
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Cont.…Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
Ghana 2 .7 
Greece 1 .3 
Guinea 1 .3 
India 35 11.5 
Indonesia 36 11.8 
Iran 3 1.0 
Iraq 6 2.0 
Italy 1 .3 
Ivory Coast 1 .3 
Jordan 3 1.0 
Lebanon 3 1.0 
Libya 3 1.0 
Malaysia 7 2.3 
Mali 1 .3 
Morocco 13 4.3 
Myanmar 1 .3 
Nepal 3 1.0 
Niger 5 1.6 
Nigeria 10 3.3 
Pakistan 20 6.6 
Palestine 6 2.0 
Philippines 3 1.0 
Saudi Arabia 11 3.6 
Somalia 7 2.3 
Sudan 7 2.3 
Syria 5 1.6 
Thailand 1 .3 
Tunisia 4 1.3 
Turkey 5 1.6 
United Kingdom 2 .7 
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Cont.…Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
United States 3 1.0 
Yemen 9 3.0 
Region lived in in the past year  304  
East Asia 51 16.8 
Europe & US 11 3.6 
North Africa 62 20.4 
Other African Countries 41 13.4 
South Asia 91 29.9 
West Asia 48 15.8 
Level of education  290  
No formal education 134 46.2 
Primary education 56 19.3 
Secondary education 63 21.7 
University-higher education 37 12.8 
Occupation 284  
Health care worker 4 1.4 
Miner 1 0.4 
Laboratory personnel 1 0.4 
Refugee camp worker 0 0.0 
Prison staff 0 0.0 
None of the above 278 97.9 
Pregnancy  299  
Yes 1 0.3 
No 83 27.8 
NA  215 71.9 
Underlying health conditions 288  
Yes 187 64.9 
No 101 35.1 
Chronic kidney disease 288  
No 280 97.2 
Yes 8 2.8 
Chronic liver disease 288  
No 283 98.3 
Yes 5 1.7 
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Cont.…Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
Chronic lung disease 288  
No 223 77.4 
Yes 65 22.6 
Cardiovascular disease 288  
No 236 81.9 
Yes 52 18.1 
Hypertension 288  
No 193 67.0 
Yes  95 33.0 
Cancer 288  
No 287 99.7 
Yes 1 0.3 
Immunosuppressive illness 288  
No 288 100 
Yes 0 0.00 
Diabetes 288  
No 219 76.0 
Yes 69 24.0 
Stroke 288  
No 286 99.3 
Yes 2 0.7 
Not Listed 288  
No 269 93.4 
Yes 19 6.6 
Travel outside current country of residence in the past year  290  
Yes  39 13.4 
No  251 86.6 
Hajj/Umrah (Past-year) 293  
No 266 90.8 
Yes 21 7.2 
Don’t recall  6 2.0 
Smoking (Current) 292  
          No 235 80.5 
Yes 57 19.5 
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Cont.…Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
Past smoking 223  
No 187 83.9 
Yes 36 16.1 
Any medication 285  
No 171 60.0 
Yes 114 40.0 
Previous TB treatment 272  
No 236 86.8 
Yes 12 4.4 
Don’t know  24 8.8 
TB treatment duration 12  
 1 month 2 16.7 
2-5 months 3 25.0 
6-12 months 5 41.0 
 12 months 0 0.0 
Don’t recall 2 16.7 
TB treatment completed 10  
Yes 5 50.0 
No 5 50.0 
Current  TB treatment 11  
No 8 72.7 
Yes 3 27.3 
Cough in household 256  
No 219 85.5 
Yes 33 12.9 
Don’t know 4 1.6 
Close contacts TB patient 257  
No 219 85.2 
Yes 5 1.90 
Don’t know 33 12.8 
Cough up blood 248  
No 224 90.3 
Yes 24 9.7 
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Cont.…Table 9. Characteristics of the enrolled patients’ population 
Variable  Number 
(n) 
Percentage (%) 
Cough length (Days) 263  
<= 1 Week 164 62.4 
>1 to 2 Weeks 60 22.8 
>2 to 3 Weeks 14 5.3 
> 3 Weeks 25 9.5 
TB=Tuberculosis, US=United States of America, NA= not applicable 
 
Table 10. Underlying health conditions among enrolled patients 
Underlying health conditions n= 288 Percentage (%) 
Hypertension 95 33 
Diabetes 69 24 
Chronic kidney disease 8 2.8 
Chronic lung disease 65 22.6 
Chronic liver disease 5 1.7 
Cardiovascular disease 52 18 
Stroke 2 0.7 
Cancer 1 0.3 
Immunosuppressive illness 0 0.0 
Other  19 6.6 
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Table 11. Clinical data of the enrolled patients  
Variable  Number 
(n) 
Percentage 
(%) 
Admission ward  295  
Other 13 4.4 
ER 89 30.2 
ICU 21 7.1 
General ward 79 26.8 
Isolation ward 83 28.1 
Surgical ward 10 3.4 
Duration of current illness  261  
<1 week 195 74.7 
1 -2 weeks 56 21.5 
3 - 4 weeks 5 1.9 
>4 weeks 5 1.9 
Patient tested for TB 278  
No 231 83.1 
Yes 26 9.4 
NA 21 7.6 
TB tests performed  26  
Sputum AFB 23 88.5 
Chest X-ray 8 30.8 
GeneXpert MTR/RIF 0 0 
Sputum culture  6 23.1 
TB test positive  17  
No 12 70.6 
Yes 5 29.4 
MDRT-positive results  5  
No 4 80.0 
Yes 1 20.0 
Admission diagnosis by ICD-10 chapters 392  
Diseases of the respiratory system 252 64.3 
Diseases of the circulatory system 35 8.9 
Certain infectious and parasitic diseases 28 7.1 
Symptoms, signs and abnormal clinical and laboratory findings, not 
elsewhere classified 
28 7.1 
Injury, poisoning and certain other consequences of external causes   16 4.1 
Other <4% 33 8.4 
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Cont..Table 11. Clinical data of the enrolled patients  
Variable  Number 
(n) 
Percentage 
(%) 
Final diagnosis by ICD-10 chapters  300  
Diseases of the respiratory system 201 67.0 
Diseases of the circulatory system 29 9.7 
Certain infectious and parasitic diseases 15 5.0 
Injury, poisoning and certain other consequences of external causes   12 4.0 
Other <4% 43 14.3 
Case outcome  236  
Still at the hospital 24 10.2 
Discharged 198 83.9 
Deceased 6 2.5 
Defaulted 1 .4 
Referred 7 3.0 
TB=tuberculosis, NA=not applicable, ICU=intensive care unit, ER=emergency room, AFB=acid fast bacilli, 
ICD=international classification of diseases  
 
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
68 
Figure 11. Patients by age  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Patients by age group  
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Figure 13. Patients by residency region  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Patients by level of education  
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Figure 15. Patients by admission ward   
 
Figure 16. Patients by admission diagnosis (ICD-10 chapters)  
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Figure 17. Patients by final diagnosis (ICD-10 chapters) 
 
Figure 18. Patients by case outcome   
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2.5.2.3 Xpert MTB/RIF assay results 
Xpert MTB/RIF assay results were available for all of the 304 sputum samples collected 
(Figure10). Of these 9 (2.9%) nationals and residents from 6 countries were positive for TB. 
Rifampicin resistance was detected in two samples, hence possible MDR-TB was detected in 
these two (22.2%) cases. The latter cases originated from India and Indonesia. The 
characteristics of pilgrims with positive TB are summarized in Table 12. Most pilgrims 
originated from Indonesia (3, 33.3%) and India (2, 22.2%), were male (6, 66.6%) and had no 
formal education (5, 55.5%). Pilgrims positive for TB ranged in age from 37 to 78 years old. 
Data on arrival date to KSA was available for 3 of the drug-sensitive TB cases and indicated 
that these pilgrims spent 12 to 31 days in KSA before hospital admission. One (11.1%) pilgrim 
with rifampicin-resistant TB indicated traveling outside her country of residency in the 
previous year, visiting Malaysia.  
 
Five (55.5%) pilgrims declared having an underlying health condition but none worked in one 
of the TB risk occupations in the survey (health care worker, miner, laboratory personnel, 
refugee camp worker, prison staff). One (11.1%) pilgrim declared being a current tobacco 
(cigarettes, cigars or pipes) smoker and two (22.2%) had smoked such products in the past. 
None of the TB positive pilgrims declared coughing blood and only two (22.2%) reported 
having been previously treated for TB. Of the latter, one drug-sensitive TB case declared 
having been treated for TB for ≤ 1 month and having not finished their TB treatment. The other 
case, a rifampicin-resistant TB case, declared having been treated for TB in the past for a 
duration of 6-12 months and having completed their TB treatment. None of the TB positive 
pilgrims declared that they had close contacts diagnosed or treated for TB in the past, but one 
(11.1%) recalled recently (within the previous month) sharing the household with an adult with 
cough.  
 
On hospital admission, most TB cases (6, 66.6%), including the two MDR-TB cases, were 
admitted to an isolation ward. Two other cases were admitted to ER and one to a surgical ward. 
Admission diagnosis was available for 7 out of the 9 TB cases, all of whom had diseases of the 
respiratory system, specifically pneumonia (6, 85.7%). In addition to pneumonia, one case also 
had an admission diagnosis of suspected TB. Three of the TB cases were tested for TB in 
hospital: one using chest X-ray and sputum culture and another using chest X-ray and sputum 
AFB. Both cases were diagnosed with TB and were started on anti-TB medication. 
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Although one of these two cases were detected in the study as a MDR-TB case, there was no 
indication that the hospital did diagnose the case as a MDR-TB case. The last case tested in 
hospital for TB was tested using sputum AFB only. Although the case was also identified in 
the current study as a MDR-TB, no information on the final diagnosis of the case or treatment 
were available, hence it is not possible to determine if the hospital did identify the case as TB 
or MDR-TB. Final diagnosis was available for 6 out of the 9 TB cases, two of whom were 
diagnosed with TB (as highlighted above) and the majority of the rest (3/4, 75%) were 
diagnosed with pneumonia. This means that the prevalence of missed active TB among the 
study populations was 2.3% (7/304). 
 
Most cases (5, 55.5%) were discharged from healthcare facilities, three cases (33.3%) were 
still inpatients at the end of the study period, one of whom was referred to another healthcare 
facility for further treatment. As the final diagnosis of one of the MDR-TB detected by this 
study was not documented, and the MDR status of the other MDRT-TB case identified in the 
study was not available, this means that out of the 9 TB cases identified only 2-3 (22.2-33.3%) 
were diagnose by the hospital as TB cases. This means that 66.7-77.8% of the TB cases 
identified in the study were missed by the hospital. Also, potentially none of the MDR-TB 
cases identified in this study were actually diagnosed as MDR-TB by the hospitals.  
 
Results also show that while 5 cases of TB were diagnosed by the healthcare facilities among 
the study population using chest X-ray, sputum culture and/or sputum AFB tests, only 2 (40%) 
of these were positive in the Xpert MTB/RIF assay. Samples from 3 TB confirmed cases by 
the healthcare facilities were negative in the Xpert MTB/RIF assay.  
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Table 12. Characteristics of the tuberculosis positive patients 
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1 India 65 M NFE No None Never None No No No No No No ND 
2 India 78 M NFE ND None Never None Unsure No ND ND Yes No DI 
3 Indonesia 37 F HE No Malaysia  Never Diabetes Yes No No No Yes Yes₸ RF 
4 Indonesia 74 M SE No None Past Hypertension 
Diabetes  
No No No No No No DI 
5 Indonesia 41 M HE No None Current None No No No No No No DI 
6 Nepal 50 M NFE No None Never None No No Yes No No No DI 
7 Pakistan 65 F NFE No None Never Hypertension Unsure No No Unsure No No IP 
8 Philippines ND F NFE No None Past Diabetes Yes No No No No Yes IP 
9 Sudan 45 M PE No None Never CLD No No No No No No DI 
F= Female, M, Male, NFE= No formal education, PE= Primary education, SE= Secondary education, HE= University/higher education, ND= not determine, CLD= Chronic 
lung disease; IP=  Inpatient, RF= Referred, DI= Discharged  
*Health care worker, miner, laboratory personnel, refugee camp worker, prison staff 
₸Detected by the hospital as a TB case but not as MDR-TB case.  
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2.5.2.4 Association between tuberculosis and demographic and clinical variables 
The result of the bivariate analysis showing the association between TB and demographic and 
clinical variables are summarized in Table 13. TB prevalence was statistically significantly higher 
in those who had previously been treated for TB (p= 0.015). A near significant difference (p= 
0.062) was observed in relation to hospital admission wards, with patients admitted to surgical and 
isolation wards having the highest TB prevalence.  
 
Although not statistically significant, TB prevalence was also higher among those residing in East 
Asia (7.8%), among smokers (3.2% vs 2.7%), those symptomatic for cough of over a week (4% 
vs 2.4%). Also, TB prevalence was highest in those under 53 years old, those with university of 
higher education, those with no underlying health conditions and those not on medication (Table 
13).  
 
There was a statistically significant increase in risk of TB in relation to ward of admission and 
previous TB treatment (Table 14). Patients admitted to an isolation ward were over 5 times more 
likely to be TB positive than those admitted to other wards (OR= 5.429; 95% CI= 1.325- 22.242, 
p=0.019).  Similarly, patient who had a history of TB treatment were over 9 times more likely to 
have TB (OR= 9.240; 95% CI= 1.593-53.588, p=0.013).  
 
Although the ORs were not statistically significant, the risk of TB also increased for some other 
variables (Table 14). For instance, patients with no formal education were 1.4 times (OR= 1.473; 
95% CI= 0.387-5.6) more likely to be TB positive compared to those with some form of education 
(primary, secondary of higher education). There was around 1.3 times increase in risk of TB for 
patients who declared being current or past smokers (OR= 1.213; 95% CI= 0.284-5.191) and those 
coughing up blood (OR= 1.348; 95% CI= 0.159-11.443). Patients who had a cough for >2-3 weeks 
were 3 times more likely to be TB positive compared to those with a cough lasting less than a week 
(OR= 3.077; 95% CI= 0.320-29.576). Also, patients residing in Asia had much higher risk of TB 
than those residing in Europe & US or Africa.  
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Only variables found to be significant at the 2.5% level in the bivariate analysis (previous TB 
treatment and admission ward) were considered as candidates for multiple logistic regression 
analysis. Penalized likelihood (Firth method) was used for the fitting of the logistic regression as 
the maximum likelihood estimation of the logistic regression was not appropriate for the current 
study with such a small number of events. The results (Table 15) indicate that previous TB 
treatment was an independent factor associated with TB. Patient who had history of TB treatment 
were 8 times more likely to be TB positive after adjusting for other factors (adjusted OR [aOR]= 
8.1; 95% CI= 1.351-48.464, p= 0.022).   
Table 13. Association between tuberculosis and demographic variables 
Variable  n TB+ve % p 
Gender  
    
Male  100 3 3.0 1.000 
Female  202 6 3.0 
 
Age  
 
  0.149 
Mean (Range) 
 
   
<53 74 4 5.4 
 
53 – 63 85 0 0.0 
 
64 – 70 65 2 3.1 
 
>70 73 2 2.7 
 
Region lived in in the past year  
 
  0.137 
East Asia 51 4 7.8 
 
Europe & US 11 0 0.0 
 
North Africa 62 0 0.0 
 
Other African Countries 41 1 2.4 
 
South Asia 91 4 4.4 
 
West Asia 48 0 0.0 
 
Level of education  
 
  0.614 
No formal education 134 5 3.7 
 
Primary education 56 1 1.8 
 
Secondary education 63 1 1.6 
 
University-higher education 37 2 5.4 
 
Occupation 
 
  1.000 
Health care worker 4 0 0.0 
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Cont. Table 13. Association between tuberculosis and demographic variables 
Variable  n TB+ve % p 
Miner 1 0 0.0 
 
Laboratory personnel 1 0 0.0 
 
None of the above 278 8 2.9 
 
Underlying health conditions 
 
  0.724 
Yes 187 5 2.7 
 
No 101 4 4.0 
 
Chronic kidney disease 
 
  1.000 
No 280 9 3.2 
 
Yes 8 0 0.0 
 
     
Chronic liver disease 
 
  1.000 
No 283 9 3.2 
 
Yes 5 0 0.0 
 
Chronic lung disease 
  
 0.689 
No 223 8 3.6 
 
Yes 65 1 1.5 
 
Cardiovascular disease 
  
 0.371 
No 236 9 3.8 
 
Yes 52 0 0.0 
 
Hypertension 
  
 0.723 
No 193 7 3.6 
 
Yes 95 2 2.1 
 
Cancer 
  
 1.000 
No 287 9 3.1 
 
Yes 1 0 0.0 
 
Diabetes 
   
0.451 
No 219 6 2.7 
 
Yes 69 3 4.3 
 
Stroke 
  
 1.000 
No 286 9 3.1 
 
Yes 2 0 0.0 
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Cont. Table 13. Association between tuberculosis and demographic variables 
Variable  n TB+ve % p 
Not Listed 
  
 1.000 
No 269 9 3.3 
 
Yes 19 0 0.0 
 
Travel outside current country of residence in the past 
year  
   
1.000 
Yes  39 1 2.5 
 
No  251 8 3.1 
 
Hajj/Umrah (Past-year) 
   
0.190 
No 266 8 3.0 
 
Yes 21 0 0.0 
 
Don’t recall  6 1 16.7 
 
Smoked 
   
1.000 
No 187 5 2.7 
 
Yes 93 3 3.2 
 
Any medication 
   
0.745 
No 171 6 3.5 
 
Yes 114 3 2.6 
 
Previous TB treatment 
   
0.015 
No 236 5 2.1 
 
Yes 12 2 16.7 
 
Don’t know  24 2 8.3 
 
Cough in household 
   
1.000 
No 219 7 3.2 
 
Yes 33 1 3.0 
 
Don’t know 4 0 0.0 
 
Close contacts TB patient 
   
1.000 
No 219 7 3.2 
 
Yes 5 0 0.0 
 
Don’t know 33 1 3.0 
 
Cough up blood 
   
0.562 
No 224 7 3.1 
 
Yes 24 1 4.2 
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Cont. Table 13. Association between tuberculosis and demographic variables 
Variable  n TB+ve % p 
Cough length (Days) 
   
0.461 
<= 1 Week 164 4 2.4 
 
>1 to 2 Weeks 60 2 3.3 
 
>2 to 3 Weeks 14 1 7.1 
 
> 3 Weeks 25 1 4.0 
 
Admission ward     0.062 
Other wards 13 0 0.0  
ER 89 2 2.2  
ICU 21 0 0.0  
General ward 79 0 0.0  
Isolation ward 83 6 7.2  
Surgical ward 10 1 10.0  
TB; tuberculosis, ICU; intensive care unit, ER; emergency room, US; United States of America 
 
Table 14. Demographic variables and risk of tuberculosis 
Variable n TB+ve % OR 95% CI p 
Gender  
   
    
Male  100 3 3.0 1    
Female  202 6 3.0 1.010 0.247 4.126 0.989 
Age  
 
      
Mean (Range) 
 
      
<53 74 4 5.4 1    
53 – 63 85 0 0.0 - - - 0.997 
64 – 70 65 2 3.1 .556 0.098 3.137 0.506 
>70 73 2 2.7 .493 0.087 2.778 0.423 
Region lived in in the past year  
 
      
Asia 190 8 4.2 1    
Europe & US 11 0 0 - - - 0.999 
Africa 103 1 0.9 0.223 0.028 1.809 0.160 
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Cont…Table 14. Demographic variables and risk of tuberculosis 
Variable n TB+ve % OR 95% CI p 
Level of education  
 
      
Some form of education 156 4 2.5 1    
No formal education 134 5 3.7 1.473 0.387 5.600 0.570 
        
Underlying health conditions 
 
      
No 187 5 2.7 1    
Yes 101 4 4.0 0.666 0.175 2.538 0.552 
Travel outside current country of 
residence in the past year  
   
    
No 251 8 3.1 1    
Yes 39 1 2.5 0.799 0.097 6.572 0.833 
Hajj/Umrah (Past-year) 
   
    
No 266 8 3.0 1    
Yes 21 0 0.0 - - - 0.998 
Don’t recall  6 1 16.7 6.450 0.673 61.773 0.106 
Smoked 
   
    
No 187 5 2.7 1    
Yes 93 3 3.2 1.213 0.284 5.191 0.794 
Any medication 
   
    
No 171 6 3.5 1    
Yes 114 3 2.6 0.743 0.182 3.034 0.679 
Previous TB treatment 
   
    
No 236 5 2.1 1    
Yes 12 2 16.7 9.240 1.593 53.588 0.013 
Cough in household 
   
    
No 219 7 3.2 1    
Yes 33 1 3.0 .946 0.113 7.948 0.960 
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Cont... Table 14. Demographic variables and risk of tuberculosis 
Variable n TB+ve % OR 95% CI p 
Close contacts TB patient 
   
    
No 219 7 3.2 1    
Yes 5 0 0.0 - - - 0.999 
Don’t know 33 1 3.0 0.946 0.113 7.948 0.960 
Cough up blood 
   
    
No 224 7 3.1 1    
Yes 24 1 4.2 1.348 0.159 11.443 0.784 
Cough length (Days) 
   
    
<= 1 Week 164 4 2.4 1    
>1 to 2 Weeks 60 2 3.3 1.379 0.246 7.732 0.715 
>2 to 3 Weeks 14 1 7.1 3.077 0.320 29.576 0.330 
> 3 Weeks 25 1 4.0 1.667 0.179 15.545 0.654 
Admission ward          
Other wards* 212 3 1.4 1    
Isolation ward 83 6 7.2 5.429 1.325 22.242 0.019 
*ER, ICU, General ward, Surgical ward, other 
TB= tuberculosis, ICU= intensive care unit, ER=emergency room, US= United States of America, OR= odd ratio, 
CI= confidence interval  
 
Table 15. Results of the multivariate analysis 
Variable   aOR (95% CI) p 
Previous TB treatment   
No 1  
Yes 8.1 (1.351-48.464) 0.022 
Admission ward     
Other wards* 1  
Isolation ward 3.0 (0.648-14.497) 0.158 
aOR=adjusted odd ratio, CI=confidence interval, TB=tuberculosis  
*ER, ICU, General ward, Surgical ward, other 
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2.6 Discussion 
Since being declared a global emergency by the WHO in 1993, political and scientific advocacy 
as well as funder investments has resulted in a slow but steady progress in reducing the global TB 
case load and mortality rate (World Health Organization, 2018b, Zumla and Davies, 2016). Part 
of the reason for this slow progress is that a significant proportion of people who fall sick with TB 
are never diagnosed and treated. WHO estimates that 3-4 millionpeople who fall ill with TB each 
year are not diagnosed, not notified, or do not start treatment, leading to the persistence of 
infectious cases and disease transmission (World Health Organization, 2017b, 2018b). Many of 
those who do start treatment have a delayed start due to a range of challenges. These include HIV; 
having chronic cough and/or other lung diseases; negative sputum smear; EPTB; rural residence; 
low access (geographical or sociopsychological); initial visitation of a government low-level 
healthcare facility, private practitioner, or traditional healer; old age; poverty; female gender; 
alcoholism and substance abuse; history of immigration; low educational level; low awareness of 
TB; incomprehensive beliefs; self-treatment; and stigma (Storla et al., 2008). Delays in diagnosis 
and treatment of TB are also important factors in persistent transmission of the disease (Golub et 
al., 2006, Lin et al., 2008). Therefore, identification of individuals with TB and prompt initiation 
of effective treatment to rapidly render them non-infectious are crucial to stop transmission, 
prevent new infections and new TB cases, contributing to the global reduction in TB burden (Yuen 
et al., 2015). 
 
Hajj represents many of the risk factors for transmission of respiratory infections including TB 
and reactivation of LTBI (Ahmed et al., 2006, Ai et al., 2016, Al-Orainey, 2013, Wilder-Smith et 
al., 2005). Little information is available on the prevalence of active TB among pilgrims during 
Hajj. Evidence of TB in pilgrims comes from clinical studies of causes of hospital admissions 
during Hajj which reported the isolation of M. tuberculosis from 5-28% of patients with pneumonia 
during the event (Alzeer et al., 1998, Madani et al., 2006, Mandourah et al., 2012). In any case, 
TB in seriously ill pilgrims is likely to be a great underestimation of the prevalence of TB in the 
general pilgrims’ population, with many cases remaining undiagnosed even amongst hospitalised 
patients.  
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Many cases in which TB is co-morbid with non-communicable or other communicable diseases 
may be missed, and patients with undiagnosed active TB may not be investigated for TB because 
they are asymptomatic or do not meet the criteria for TB screening (Ayles et al., 2009, Bates et al., 
2012, Onozaki et al., 2015). 
 
2.6.1 Tuberculosis among non-hospitalised pilgrims 
In Hajj, only one study conducted in 2015, reported undiagnosed active PTB among non-
hospitalised pilgrims from high-burden TB countries (Yezli et al., 2017b). The study enrolled 
pilgrims from 5 countries: Afghanistan, Bangladesh, Pakistan, Nigeria and South Africa. While 
these countries have high-TB burden and many contribute large number of pilgrims to the Hajj, 
the study did not enroll other countries with significant pilgrim population and TB prevalence such 
as India and Indonesia. These 2 countries have a TB incidence of 204/100,000 and 319/100,000 
(World Health Organization, 2018b), and a Hajj pilgrim population of around 150,000 and 170,000 
respectively. In fact, Indonesia is the country with the largest Hajj pilgrim population accounting 
for around 13% of the Hajj international pilgrims. In addition, while the 2015 study did not report 
MDR-TB among the studied population (Yezli et al., 2017b), this population did not originate 
from countries with the highest MDR-TB rates in the world. The latter also send pilgrims to Hajj, 
comparatively in smaller numbers. Countries such as Tajikistan, Kazakhstan, and Kyrgyzstan 
collectively contribute around 8,000 pilgrims in Hajj and have a prevalence of MDR-TB among 
new cases of 20-26%. This prevalence is 5-14 times that of the countries included in the 2015 
study.  
 
We performed a large-scale screening for active PTB among non-hospitalised pilgrims with 
productive cough during the 2016 Hajj.The1,510 pilgrims screened originated from 16 countries 
in Africa, former Soviet countries and South Asia. The TB incidence rate for these countries ranges 
between 70-567/100,000 with a prevalence of MDR-TB among new cases of 1-26% (World Health 
Organization, 2018b). Seven of these countries (Bangladesh, India, Indonesia, Pakistan, Ethiopia, 
Nigeria and South Africa) are among the WHO’s top 30 high TB burden countries in the world 
(World Health Organization, 2017b, 2018b), hence representing the highest risk for TB 
transmission during Hajj. Combined, the 16 countries included in the study contribute around 
820,000 pilgrims to Hajj each year (62% of the total international Hajj pilgrims).  
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Eight countries (Algeria, Bangladesh, India, Indonesia, Pakistan, Morocco, Nigeria and Sudan) are 
among the top 10 countries with the highest pilgrim population for Hajj. While other countries 
included in the study do not send large numbers of pilgrims to Hajj, they are important as far as 
TB epidemiology is concerned. For instance, South Africa only contribute around 2,400 pilgrims 
to Hajj but it has one of the highest TB incidence rates in the world at 567/100,000(World Health 
Organization, 2018b). Similarly, while countries like Tajikistan, Kazakhstan and Kyrgyzstan only 
contribute similar small number of pilgrims to Hajj, they have some of the highest MDR-TB 
prevalence rates in the world(World Health Organization, 2017b, 2018b). 
 
The study found that 0.66% of pilgrims with productive cough from the enrolled countries had 
active PTB. This is lower than a2015 study which detected active PTB in 1.4% of the study 
population (Yezli et al., 2017b). If analysis of our results is restricted to pilgrims from only the 5 
countries included in the 2015 study, the percentage of active PTB in that population would be 
1%. The 0.66% rate found in the current study is within the lower end range of that found among 
migrants to low-incidence countries (0.1-10%) (Aldridge et al., 2014).Similarly, it is also within 
the higher end range of TB prevalence rates reported for national and large TB surveys among 
adult populations in High and medium burden TB countries in Africa and Asia (0.03-1.5%)(China 
Tuberculosis Control, 2004, Deribew et al., 2012, Hoa et al., 2010, Kapata et al., 2016, Kebede et 
al., 2014, Onozaki et al., 2015, Qadeer et al., 2016, Senkoro et al., 2016, Wang et al., 2014, Wei 
et al., 2014, Zaman et al., 2012, Zaman et al., 2006). Given the short time pilgrims spent in KSA 
at the time of enrolment in the study, it is likely that the identified active TB cases were imported 
or reactivation of LTBI. The 0.66% rate of active TB among pilgrims found in this study means 
that potentially 6 out of each 1,000 pilgrims from the countries enrolled symptomatic for cough 
could have active PTB during Hajj. This is concerning given that the estimated total number of 
pilgrims attending the Hajj from the 16 countries included in the study is around 820,000 pilgrims 
and the prevalence of cough among Hajj pilgrims was reported to be between 51 and 91% (Deris 
et al., 2010, Gautret et al., 2015, Gautret et al., 2009). 
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We detected active TB among pilgrims symptomatic for cough but not seriously ill to be 
hospitalised or require medical attention. This is in accordance with previous prevalence surveys 
conducted in endemic TB countries which have shown that an important proportion of infectious 
individuals with bacteriologically positive sputum do not experience symptoms of sufficient 
severity to prompt health-seeking behaviour (Ayles et al., 2009, Corbett et al., 2010, Hoa et al., 
2010, Onozaki et al., 2015). For example, Ayles and colleagues reported that 2.8% (53/1,920) of 
people symptomatic for cough sampled from a province in Zambia, a country where TB and HIV 
are endemic, had M. tuberculosis in their sputum (Ayles et al., 2009).While the study reported that 
prolonged cough was associated with prevalent TB, out of these 53 TB cases, 17 had a cough of 
between one and 21 days. This suggests that screening only individuals who meet TB screening 
criteria of cough over two or three weeks may result in a sizable proportion of active TB cases to 
be missed (Ayles et al., 2009, Onozaki et al., 2015). Interestingly, eight out of the 79 (10%) TB-
positive cases identified in the study denied having any symptoms at all and only 34 (43%) would 
have been classified as a TB suspect by current guidelines at the time of the study. Corbett et 
al.(Corbett et al., 2010) screened the sputum of 10,092 adult residents of suburbs of Harare, 
Zimbabwe, symptomatic for chronic cough (≥2 weeks). The prevalence of culture-positive TB was 
0.65%, with only 3% of the participants reporting previous TB treatment. In general, TB 
prevalence surveys report undiagnosed TB in the community with 79-98% of the TB cases 
identified through these surveys not being on treatment at the time when the surveys were 
conducted (Hoa et al., 2010, Kapata et al., 2016, Kebede et al., 2014, Onozaki et al., 2015, Qadeer 
et al., 2016, Senkoro et al., 2016, Wood et al., 2007, Zaman et al., 2012). These TB prevalence 
surveys also found that 26-79% of the TB cases were asymptomatic or did not show symptom 
suggestive of TB such as chronic cough (Hoa et al., 2010, Kapata et al., 2016, Kebede et al., 2014, 
Onozaki et al., 2015, Qadeer et al., 2016, Senkoro et al., 2016, Wood et al., 2007, Zaman et al., 
2012). 
 
Most of the TB cases detected in the current study were in pilgrims from India (30%) and 
Afghanistan (20%). India has the second highest incidence of TB (319/100,000) (World Health 
Organization, 2018b) among the 16 countries included in the study and contributed the highest 
number of the enrolled pilgrims (15.24%).  
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Undiagnosed active PTB have been reported in the community in India. Rao et al.(Rao et al., 2012) 
conducted a community based cross-sectional TB survey that screened 95,071 individuals. Of 
these, sputum was collected from 7,533 individuals. The overall prevalence of bacteriologically 
positive PTB was 255.3/100,000 population (95% CI= 195.3–315.4). Of the total 221 
bacteriologically positive PTB cases detected by the survey, only 73 (33.0%) were found to be on 
anti-TB treatment (Rao et al., 2012). While pilgrims from Afghanistan represented less than 6% 
of the study population, and the country has a TB incident rate lower than that of seven countries 
included in the study, it is highly represented among the active TB cases. A similar observation 
was reported in a previous study among non-hospitalised Hajj pilgrims, where 80% of undiagnosed 
active PTB cases were reported in pilgrims from Afghanistan (Yezli et al., 2017b). We hypothesize 
that political instability, conflicts and socioeconomic factors may be responsible for the results 
observed. Afghanistan is one of the poorest countries in the world with some of the lowest 
indicators of socioeconomic and human development indices ratings due to decades of conflict, 
political instability and lack of foreign investment. The WHO describes its health system as one 
of the worst in the world (World Health Organization, 2004). As a consequence, ,health services 
coverage and delivery, including TB services, may be limited resulting in TB cases being not 
diagnosed, notified or treated or in these processes being delayed which lead to persistent 
transmission (Golub et al., 2006, Lin et al., 2008, World Health Organization, 2017b, 2018b). 
 
As per a previous report (Yezli et al., 2017b) undiagnosed active PTB was also identified in 
pilgrims from Bangladesh and Pakistan. In addition, cases were found among pilgrims from 
Indonesia, Somalia and South Africa. With the exception of Somalia, the above countries are 
among the WHO’s top 30 high TB burden countries in the world. Interestingly, only one case of  
active PTB was found among pilgrims fromSouth Africa in the current study and none in a 
previous report (Yezli et al., 2017b). South Africa is among the top countries with the highest TB, 
MDR-TB and TB/HIV burdens in the world (World Health Organization, 2018b). The 
epidemiology of TB in the country is closely related to that of HIV and is regional and linked to 
socioeconomic, behavioural and demographic factors (Kenyon and Zondo, 2011, Nanoo et al., 
2015, Shisana et al., 2014). Most of the Muslim population in South Africa are of Asian (mostly 
Indian) descent who represent around only 2.5% of the population.  
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The difference in the socioeconomic status, behavioural factors and lower prevalence of HIV 
among the different ethnic groups may explain the lower incidence of TB in the Muslim population 
compared to the overall population in South Africa and therefore the results observed in our study 
(Kenyon and Zondo, 2011, Muntingh, 2013, Shisana et al., 2014). 
 
2.6.2 Tuberculosis among hospitalised pilgrims 
This study performed the first screening for active PTB among hospitalised pilgrims with 
productive cough during the 2016 and 2017 Hajj seasons. The 347 inpatient pilgrims screened 
originated from 44 countries in Africa, Asia, Europe and the USA reflecting the diverse Hajj 
pilgrims population who come from up to 180 different countries (Yezli et al., 2017a). The 44 
countries from which the study population originates from have a widely varied TB and MDR-TB 
incidence rates and include both low and high burden TB countries (World Health Organization, 
2018b). Most countries represented among the study population were Indonesia, India, Bangladesh 
and Egypt. This is not surprising given that these countries are respectively ranked number 1, 3, 4 
and 6 in the list of countries with the largest Hajj pilgrims’ population. It is also worth noting that 
out of these 44 countries, 12 (27.2%) are among the WHO’s top 30 high TB burden countries in 
the world (World Health Organization, 2018b). 
 
The patients’ population was also representative of the Hajj pilgrims' population in general, with 
over representation of older males with little or no formal education. Studies among non-
hospitalised pilgrims reported similar observation. For example, in a screening of 1,1,64 Hajj 
pilgrims with productive cough, Yezli et al. (Yezli et al., 2017b) reported that that the mean age 
of the study population was 51.7 years with a male: female ratio of 2.6:1 Over half of the study 
population had no formal education. In another screening of 5,235 Hajj pilgrims from 22 countries, 
Memish et al. (Memish et al., 2014) reported the mean age of the study population to be 51.8 years 
and 54% were male. In general, elderly pilgrims represent a sizable proportion of the Hajj 
population (roughly 25% are at least 65 years old) (Ebrahim et al., 2009). Studies conducted among 
hospitalised Hajj pilgrims also report predominance of older males among inpatients with a mean 
age similar to that reported in the current study and slightly higher than reports from non-
hospitalised pilgrims.  
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For example, a study among 266 inpatients with community-acquired pneumonia in Hajj 2016 
reported the mean age of the study population to be 65.3 years and male: female ratio of 2:1 
(AlBarrak et al., 2018). A similar study conducted in the 1994 Hajj among 64 patients, reported 
that 75% were men with a mean age of 63 years (Alzeer et al., 1998). In a study of all 808 
admissions to hospitals at the Hajj holy sites during the Hajj dates of the year 2003, 62.5% were 
over 50 years old and 57.7% were males (Madani et al., 2006). In another report among 689 
patients admitted to a hospital during the 2005 Hajj, the mean age was 62 years and the male: 
female ratio was 1.8:1(Khan et al., 2006). 
 
Underlying health conditions were present among a sizable number of pilgrims with hypertension, 
diabetes and cardiovascular disease being among the most common conditions. This is in 
accordance with other surveys conducted among both hospitalised and non-hospitalised Hajj 
pilgrims (AlBarrak et al., 2018, Alzeer et al., 1998, Gautret et al., 2015, Khan et al., 2006, Madani 
et al., 2006, Mandourah et al., 2012, Memish et al., 2014, Shirah et al., 2017, Yezli et al., 2017b).  
However, the proportion of patients with underlying heath condition in the current study (65%) is 
higher than those reported previously. For instance, Yezli et al.(Yezli et al., 2017b) found that 
27.7% of non-hospitalised pilgrims with cough had underlying health conditions, mainly 
hypertension, diabetes and cardiovascular disease. Only 4.4% of those with underlying health 
conditions suffered from chronic lung disease. This is in contrast with the current study where the 
proportion was 22.6%. However, this is not surprising given that the current study was focused on 
patients symptomatic for productive cough and most patients were admitted due to disease of the 
respiratory system. Gautret et al. (Gautret et al., 2015) reported that among 382 French pilgrims 
screened between 2012 and 2014, chronic disease was noted in 55.1%, including hypertension 
(30.2%), diabetes (27.5%), chronic cardiac disease (8.4%) and chronic respiratory disease (7.6%). 
Memish et al. (Memish et al., 2014) reported that hypertension and diabetes were found in 
respectively, 13.1% and 6.8% of the 5,235 Hajj pilgrims screened in 2013. In general, among 
hospitalised Hajj pilgrims higher proportions of patients with underlying health conditions were 
reported. For example, Madani and colleagues reported that among the 808 patients admitted to 
hospitals in the 2003 Hajj, 39.2% had co-morbid conditions (Madani et al., 2006). These were 
mainly diabetes (19.4%), hypertension (14.0%) and chronic obstructive pulmonary disease 
(COPD; 7.2%).  
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In another study conducted among 689 patients admitted to a tertiary care hospital during the 2005 
Hajj, 31.9% had diabetes, 37.2% had hypertension, 31.8% had cardiac disease, and 14.9% had 
chronic lung disease (Khan et al., 2006). Among patients admitted for pneumonia, the reported 
prevalence of co-morbidities was over 40% (Mandourah et al., 2012). Among such patients the 
prevalence of diabetes, hypertension, COPD and cardiovascular disease were 34.1%, 32.5-36.4%, 
7.17-35.9%, and 23.3% respectively (AlBarrak et al., 2018, Alzeer et al., 1998, Mandourah et al., 
2012, Shirah et al., 2017). 
Most (over 60%) of patients in the current study had an initial and/or final diagnosis of diseases of 
the respiratory system. This is not surprising given that the study targeted patients symptomatic 
for cough. Pneumonia was the most common admission/final diagnosis reported in over 40% of 
the patients. This is in accordance with many other studies that reported that pneumonia is a leading 
cause of hospital admission (accounting for 15–40% of hospital admissions) during the Hajj 
pilgrimage (Al-Ghamdi et al., 2003, Khan et al., 2006, Madani et al., 2006, Shirah et al., 2017). 
However, given that the current study enrolled patients with cough regardless of the admission 
diagnosis, other diagnosis were also recorded. Also, a significant proportion (28.1%) of patients 
were admitted to isolation wards. This follows the KSA MOH guidelines to prevent and control 
influenza and MERS. MERS causes acute respiratory distress syndrome and while its precise mode 
of transmission is still unclear, it does spreads through infected person's respiratory secretions such 
as through coughing and sneezing (Xiao et al., 2018). Thus, patients admitted to hospitals during 
Hajj symptomatic for cough and suspected of having MERS or influenza are isolated and 
investigated. In the current study, all patients admitted to isolation rooms were MERS or influenza 
H1N1 suspects. However, in the final diagnosis, none had MERS and 12% had H1N1. This is in 
accordance with previous reports showing lack of MERS-CoV  carriage and infection among Hajj 
pilgrims but carriage and infection of some pilgrims with influenza H1N1 (Annan et al., 2015, 
Gautret et al., 2014, Hashem et al., 2019, Ma et al., 2017, Memish et al., 2014, Moattari et al., 
2012, Ziyaeyan et al., 2012). 
 
TB was suspected in 26 (9.4%) patients and was a final diagnosis in 5 (2.2%) cases. These 
observations are in accordance with other studies that have reported cases of TB among 
hospitalised pilgrims during Hajj, especially patients with pneumonia, the major cause of 
admission in the current study.  
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Alzeer et al. (Alzeer et al., 1998) reported that of 46 hospitalised patients with pneumonia during 
the 1994 Hajj, 13 (28%) had confirmed TB. Madani and colleagues  Madani et al., 2006) performed 
a cross-sectional study of patients admitted to ICU in hospitals at Mina and Arafat during the 2003 
Hajj. Sputum culture-confirmed TB was diagnosed in 5.9% of the 808 patients. Mandourah et al. 
(Mandourah et al., 2012) performed a prospective study of patients admitted to ICUs at 15 
hospitals in Makkah and Madinah over two consecutive Hajj years, 2009 and 2010. Of the 452 
patients studied, TB was diagnosed in 4.9%. 
 
The results of the Xpert MTB/RIF assay showed that a number of TB cases were undiagnosed. 
Given the short time pilgrims spent in KSA at the time of enrolment in the study, it is likely that 
the identified active TB cases were imported or reactivation of LTBI. The results indicate that 
2.9% of hospitalised Hajj pilgrims with productive cough had active PTB. These rates are higher 
than those reported for non-hospitalised pilgrims with productive cough from high-TB burden 
countries. In the latter population, active PTB was detected in 1.4% of the study population (Yezli 
et al., 2017b). The 2.9% rate found in the current study is within the range of that found among 
migrants to low-incidence countries (0.1-10%)(Aldridge et al., 2014), but higher than TB 
prevalence rates reported for national and large TB surveys among adult populations in high and 
medium burden TB countries in Africa and Asia (0.03-1.5%) (China Tuberculosis Control, 2004, 
Deribew et al., 2012, Hoa et al., 2010, Kapata et al., 2016, Kebede et al., 2014, Onozaki et al., 
2015, Qadeer et al., 2016, Senkoro et al., 2016, Wang et al., 2014, Wei et al., 2014, Zaman et al., 
2012, Zaman et al., 2006). Also, the current study found that the prevalence of undiagnosed or 
missed TB among the study population was 2.3%. This rate is close to that reported among patients 
with productive cough from a large referral hospital in a high TB and HIV burden country. In a 
hospital in Ethiopia, Assefa et al. (Assefa et al., 2019) screened 300 inpatients not diagnosed with 
TB for TB symptoms and tested their sputum for TB using smear microscopy and Xpert MTB/RIF 
assay. HIV status was documented for 198/300 (66%) of patients, 37 (18.7%) were found to be 
HIV positive. Using Xpert MTB/RIF assay, 10 (3.3%) of the sputum samples were positive for 
TB, with 4/10 also being smear positive. As with the current study, co-morbidity with diabetes 
was reported among the missed TB cases. However, while all TB positive cases found in the study 
by Assefa et al. (Assefa et al., 2019) had cough of over 2 weeks duration, in the current study, 
most cases (62.5%) had cough of less than 2 weeks duration.  
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This is in accordance with numerous reports indicating that an important proportion of individuals 
with active TB do not exhibit prolonged cough or other symptoms typical of TB. For example, 
community TB prevalence surveys from around the world report that 26-79% of TB cases 
identified were asymptomatic or did not show symptom suggestive of TB such as chronic cough 
(Hoa et al., 2010, Kapata et al., 2016, Kebede et al., 2014, Onozaki et al., 2015, Qadeer et al., 
2016, Senkoro et al., 2016, Wood et al., 2007, Zaman et al., 2012). 
 
In low-TB incidence countries such as Denmark and England, autopsy investigations reported the 
prevalence of undiagnosed TB among hospitalised patients to be from 0.1-3% (Juul, 1977, Roberts 
et al., 1971, Whittington, 1983). However, the prevalence is higher in low resources settings 
especially in high TB and HIV burden countries. For example, Kilale et al. (Kilale et al., 2013) 
reported that TB was detected in 33.8% of the 74 deceased individuals at a hospital in Tanzania.  
Bates et al. (Bates et al., 2012) reported that 13.4% of TB cases they identified among inpatients 
at a hospital in Zambia were unsuspected. In resource-limited settings of the Americas, south Asia 
and sub-Saharan Africa, post-mortem studies show that TB accounts for approximately 40% of 
HIV-related adult deaths and almost half of these TB cases are undiagnosed at the time of death 
(Cohen et al., 2010, Gupta et al., 2015, Wong et al., 2012). Screening of outpatients in South Africa 
with HIV infection for undiagnosed TB has shown rates of 12-20% (Bassett et al., 2010, Kufa et 
al., 2012, Lawn et al., 2011). 
 
In the current study, most of the TB cases were in pilgrims from Indonesia (33.3%) and India 
(22.2%). Both these countries are high-TB burden countries with some of the largest pilgrims’ 
populations (World Health Organization, 2018b). While these countries have ongoing NTPs, 
health services coverage and delivery, including TB services, may be suboptimal in certain areas. 
This results in TB cases being not diagnosed, notified or treated or in these processes being delayed 
which lead to persistent transmission (Golub et al., 2006, Lin et al., 2008, World Health 
Organization, 2017b, 2018b). Undiagnosed and delayed TB diagnosis have been reported from 
both India and Indonesia (Ahmad et al., 2011, Daulay et al., 2018, Rao et al., 2012). 
  
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
92 
 
 In addition to Indian and Indonesia, TB cases were detected among patients originating from 
Nepal, Pakistan, Philippines and Sudan. Pakistan and the Philippines are also among the top 30 
high TB burden countries according to the WHO, with the Philippines in particular having a high 
annual incidence rate for the disease. In 2017, the WHO estimated TB incidence rates in the 
Philippines and Pakistan were 554/100,000 and 267/100,000 respectively (World Health 
Organization, 2018b).  Issues with TB diagnosis and management, including missed TB or delayed 
in diagnosis of the disease have been reported from Nepal, Pakistan, Philippines and Sudan 
(Dhungana et al., 2013, Elmadhoun et al., 2016, Laohasiriwong et al., 2016, Lopez et al., 2016, 
Mahato et al., 2015, Querri et al., 2017, Saqib et al., 2011, Saqib et al., 2018, Shuaib et al., 2018). 
Undiagnosed active TB among non-hospitalised Hajj pilgrims from Pakistan has also previously 
been reported (Yezli et al., 2017b). 
 
2.6.3 Multi-drug resistant tuberculosis 
MDR-TB considered as one of the greatest threats to TB control worldwide. Not only is the 
incidence of MDR-TB rising in many countries, each year the number of people developing active 
MDR-TB dramatically outpaces the number of people placed on MDR-TB treatment (Falzon et 
al., 2013). This expanding pool of individuals with untreated MDR-TB represents an important 
and underappreciated source of transmission especially in high-burden countries (Gumusboga et 
al., 2012, Moodley et al., 2011, Zhao et al., 2009).Transmission of MDR-TB is a serious concern 
as MDR-TB requires long (up to 2 years or longer), highly cost and extensive treatment with 
multiple, potentially toxic drugs and outcomes are poor (Orenstein et al., 2009). Among non-
hospitalised pilgrims, no MDR-TB was identified, which is in accordance with a previous report 
mong the same population (Yezli et al., 2017b). While the study enrolled non-hospitalised pilgrims 
from countries with high prevalence of MDR-TB, the result should be interpreted in the context 
of the small number of TB cases detected.  
 
Among hospitalised pilgrims, the study identified missed TB cases among hospitalised patients 
that were rifampicin-resistant and by proxy MDR-TB. Results showed that 0.65% of patients had 
rifampicin-resistant (potential MDR) TB. One case was missed completely, and another was 
diagnosed in the hospital as a TB case but not as an MDR-TB case.  
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This is a concern as the management of these cases as far as treatment and infection prevention 
and control (IPC) would not have been in accordance with MDR-TB management guidelines. 
While both cases were admitted to an isolation ward, and the case identified in the hospital as a 
TB case was referred to another hospital for further treatment at the end of the study period, the 
other undiagnosed MDR-TB was discharged. These cases could have been a source for both 
nosocomial and community transmission of MDR-TB. This is particularly relevant in the Hajj 
context where pilgrims from all over the world are in close contact for prolonged periods of time 
during the pilgrimage.  Hence, as shown for other pathogens, this could lead to the globalization 
of MDR M. tuberculosis strains (Al-Tawfiq and Memish, 2015, Memish et al., 2015a). 
 
While a previous study on undiagnosed TB among non-hospitalised Hajj pilgrims did not identify 
MDR-TB cases (Yezli et al., 2017b), there is evidence of MDR-TB during the mass gathering 
(Elhassan et al., 2017). Also, undiagnosed MDR-TB has been detected among hospitalised and 
non-hospitalised individuals in other communities. In a study from Zambia, 900 newly admitted 
adult patients able to produce sputum at a teaching hospital were screened for TB(Bates et al., 
2012). Culture-confirmed TB was found in 22.4% of the inpatients, 13.4% of these (27/202) were 
non-TB suspects. Furthermore, there were 18 confirmed cases of MDR-TB in the study, five of 
which were unsuspected. Bates et al.(Bates et al., 2015) reported the results of whole-body 
autopsies conducted on inpatients who died in the adult inpatient wards at a hospital in Zambia. 
Among the 125 cases, 78 (62%) patients had TB, of whom 66 (85%) were infected with HIV. 
Among the 78 patients with TB, 20 (26%) were not diagnosed during their life and 13 (17%) had 
undiagnosed MDR-TB. Reports from Asia found that among TB cases detected in community TB 
prevalence surveys, up to 11% were MDR-TB (Onozaki et al., 2015). 
 
2.6.4 Xpert MTB/RIF vs non-molecular techniques for diagnosing tuberculosis 
Out of the 9 TB cases identified by Xpert MTB/RIF assay in the hospitalised pilgrims' cohort, 3 
were also investigated by the hospitals using one or a combination of chest-X ray, sputum AFB 
and sputum culture, and 2 (66.6%) were diagnosed as TB cases. Also, among the 5 cases diagnosed 
as TB cases by the healthcare facilities, only 2 (40%) were positive using the Xpert MTB/RIF 
assay. Such observations have been reported from other studies. 
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 Assefa et al. (Assefa et al., 2019) reported that among the 10 undiagnosed TB cases detected by 
Xpert MTB/RIF assay in their study, 40% were also smear positive. O'Grady et al. (O'Grady et al., 
2012) reported that the Xpert MTB/RIF assay performs better than smear microscopy in an 
inpatient setting in a country where TB and HIV infection are highly endemic. Compared to the 
results of culture as the gold standard, the specificity of the Xpert MTB/RIF assay was 95.0% 
(95% CI= 92.4%–96.8%), and the sensitivity was 86.1% (95% CI= 80.3%–90.4%). In sputum 
smear–negative, culture-positive cases, the assay was 74.7% sensitive (95% CI= 64.6%–82.8%), 
identifying 71 additional TB cases that were not detected by smear microscopy. The sensitivity 
and specificity of the Xpert MTB/RIF assay for detecting culture-confirmed, RR-TB was 81.3% 
(95% CI= 53.7%–95.0%) and 97.5% (95% CI= 90.4%–99.6%), respectively. O'Grady et al. 
(O'Grady et al., 2012) and Mnyambwa et al.  (Mnyambwa et al., 2017) however, found that despite 
the fact that the sensitivity of smear microscopy is inferior to both GeneXpert and mycobacterial 
culture, in their study, 64% of smear-positive sputa were negative in both GeneXpert and 
culture. In general, Xpert MTB/RIF assay has high sensitivity and specify. A meta-analysis of 16 
studies gave a pooled sensitivity of 90% (95% CI= 89%–91%) and a pooled specificity of 98% 
(95% CI= 98%–99%) (Chang et al., 2012). Seven of these studies reported on the use of the Xpert 
MTB/RIF assay to detect rifampicin resistance. pooled sensitivity and specificity were 94% (95% 
CI= 92%–96%) and 97% (95% CI= 96%–98%), respectively (Chang et al., 2012). The assay is 
endorsed by the WHO (World Health Organization, 2010b) and has been successfully evaluated 
and used in a number of studies for identifying unsuspected TB among hospitalised and non-
hospitalised patients (Bates et al., 2013, Bates et al., 2012, O'Grady et al., 2012, Yezli et al., 
2017b). 
 
2.6.5 Tuberculosis and gender 
For non-hospitalised pilgrims, 60% of the TB cases identified were males, although there was no 
statistically significant difference in relation to gender and TB. However, the risk of TB was higher 
among females compared to males, although this was also not significant. Notwithstanding the 
small number of TB cases in our study, some studies reported similar results to ours (Araj et al., 
2016, Codlin et al., 2011, Dogar et al., 2012). For example, TB screening in a rural Ethiopian 
community in 2009 found that among the undiagnosed PTB cases, there were more females than 
males (Deribew et al., 2012).  
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Similarly, reports from various areas of Pakistan indicate that the rates of notified TB cases are 
20-30% higher in young females compared with males, and female rates remain high regardless 
of increasing age (Codlin et al., 2011, Dogar et al., 2012). On the other hand, for hospitalised 
patients, the prevalence of TB in the current study was similar among males and females (3%) and 
there was no significant increase in risk of TB among females compared to males. Bates et al. 
(Bates et al., 2012) also reported that the burden of unsuspected TB among patients in Zambia did 
not differ by gender. However, data on TB among patients detected during autopsy investigations 
suggest that the burden of undiagnosed TB is higher among males (Bates et al., 2015, Roberts et 
al., 1971, Whittington, 1983). 
 
In general, worldwide, the male: female ratio of new TB cases is approximately 2:1. In 2017 the 
WHO reported that the global male: female ratio for notification was 1.7 (World Health 
Organization, 2018b). In contrast, the male to female ratio in 25 national TB disease prevalence 
surveys of adults in African and Asian countries implemented in 2007–2017 was about 2.5 overall, 
ranging from 1.2 (in Ethiopia) to 4.5 (in Vietnam) (Onozaki et al., 2015, World Health 
Organization, 2018b). Results from these surveys show higher burden of TB disease among men 
and also indicate that notification data understate the share of the TB burden accounted for by men 
in some countries. Also,men tend to have higher prevalence of undiagnosed TB than do woman 
(Ayles et al., 2009, Corbett et al., 2010).This gender disparity is even higher in TB prevalence 
surveys conducted worldwide (Borgdorff et al., 2000, Hoa et al., 2010, World Health Organization, 
2018b) suggesting that the differences in notification rates may be largely due to epidemiological 
differences and not to differential access to health care (Borgdorff et al., 2000). This observation 
is supported by the results of reviews of qualitative evidence for gender-related differences in 
accessing TB services which reported that generally there were no gender-related differences in 
barriers and delays limiting access to TB services. When differences were identified, women 
experienced greater barriers and longer delays than men (Krishnan et al., 2014, Yang et al., 2014). 
  
Chapter 2: Active pulmonary tuberculosis among hospitalised and non-hospitalised pilgrims during the Hajj 
mass gathering 
 
96 
 
2.6.6 Tuberculosis and geographic area of residency and travel 
For non-hospitalised pilgrims, there was no significant association between the geographic area of 
residence in the previous year (former Soviet countries, North Africa, Other African countries and 
South Asia) or travel outside the current country of residences in the previous year and TB. 
However, TB prevalence and risk of TB were higher among pilgrims from South Asia and those 
who travelled outside their country of residency in the previous year. The same observation was 
reported in a previous study among non-hospitalised Hajj pilgrims with cough (Yezli et al., 2017b). 
In the non-hospitalised pilgrims cohort, 66.7% of the countries in the “South Asia” category are 
among the top high-TB burden countries in the world compared to 60%, 0% and 0% for the “other 
African countries”, “North Africa” and “former Soviet countries” categories respectively. In 
addition, over 48% of the non-hospitalised pilgrims enrolled in the study resided in South Asian 
countries. This may explain the higher TB prevalence among these pilgrims compared to other 
regions.  
 
Similar observations were noted for hospitalised pilgrims. No significant association between the 
geographic region of residence in the previous year (Africa, Asia, Europe & US) or travel outside 
the current country of residences in the previous year and TB. However, TB prevalence and risk 
of TB were higher among hospitalised pilgrims from Asia, especially those from South and East 
Asia. In the hospitalised pilgrims’ cohort, 62.5% of the patients originated from Asia. Also, among 
the 13 high TB burden countries represented among this cohort, 61.5% were Asian countries. This 
may explain the higher TB prevalence among patient from Asia compared to other regions. 
 
In general it is known that travel to TB-endemic areas is a risk for TB (Bates et al., 2007). Yezli 
et al. (Yezli et al., 2017b) reported that Hajj pilgrims who travelled outside their country of 
residency were nearly twice as likely to have undiagnosed TB (OR= 1.90, 95% CI= 0.59, 6.04). 
While only 5.6% of non-hospitalised pilgrims reported travelling outside their countries in the 
previous year, over 28% of them travelled to India or Pakistan which are in the top 20 countries 
with the highest TB and MDR-TB burdens in the world (World Health Organization, 2018b). 
Among hospitalised pilgrims only 13.4% of patients travelled outside their country of residency 
in the previous year.  
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However, for both cohorts (hospitalised and non-hospitalised pilgrims) over 42% of those who 
travelled outside their country of residency in the previous year visited Saudi Arabia, specifically 
to perform Umrah and Hajj. The Umrah and Hajj mass gatherings have many similarities (Yezli 
et al., 2017a). While performing Umrah has not yet been linked to increase risk of TB infection, 
being involved in Hajj has (Wilder‐Smith et al., 2005). Among non-hospitalised pilgrims, only one 
TB case reported traveling outside their country of residency in the previous year. This case 
travelled to Pakistan which is a high TB burden country (World Health Organization, 2018b). 
Similarly, for hospitalised pilgrims, one TB case reported traveling outside their country of 
residency in the previous year. However, this case travelled to Malaysia which is not a high TB 
burden country (World Health Organization, 2018b). 
 
2.6.7 Tuberculosis and tobacco smoking 
 
For non-hospitalised pilgrims, there was no significant association between tobacco smoking, 
whether active or in the past and TB. This is in accordance with a previous report from Hajj (Yezli 
et al., 2017b). For hospitalised pilgrims, while not statistically significant, there was an association 
between tobacco smoking and TB. Prevalence of TB was higher among smokers compared to 
those who never smoked (3.2% vs 2.7%) and smokers were 1.2 times more likely to have TB 
compared to non-smokers. This is in accordance with the strong evidence that smoking is 
significantly associated with TB. Smoking is associated with increased risks of TB infection and 
disease, TB mortality and recurrent TB (Bates et al., 2007, Khan et al., 2015, Lin et al., 2007). 
Also, TB patients who have smoked are more likely to transmit TB to their contacts (Godoy et al., 
2013). In one study, smoking was associated with a 1.5 increased risk of LTBI among TB contacts 
and was estimated to be responsible for 12.8% of infections among this population (Godoy et al., 
2013).  In addition, exposure to environmental tobacco smoke and passive smoking increases the 
risks of TB infection and developing disease (du Preez et al., 2011, Lin et al., 2007, Sridhar et al., 
2014). It is estimated that by 2050, smoking would lead to an excess of 18 million TB cases 
(Loddenkemper et al., 2016). 
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Smoking also influences the clinical manifestations and outcomes of TB adversely affecting 
baseline disease severity, bacteriological response, treatment outcome and relapse in TB and 
leading to a faster and more severe progression to TB (Altet-Gomez et al., 2005, Leung et al., 
2015, Masjedi et al., 2017). Smokers develop more extensive pulmonary disease, more lung 
capitation and cavitary lesions, more positive sputum smear and culture at the baseline and are 
more likely to require hospitalization (Altet-Gomez et al., 2005, Leung et al., 2015). For example, 
Leung et al. (Leung et al., 2015) assessed the impact of smoking on TB outcome among 16,345 
consecutive patients undergoing chemotherapy for active TB in government chest clinics in Hong 
Kong from 2001 to 2003. These were followed up prospectively for 2 years for treatment outcome 
and subsequently tracked for relapse until the end of 2012. Smoking was associated with more 
extensive lung disease, lung cavitation and positive sputum smear and culture at the baseline. In 
both current smokers and ex-smokers, sputum smears and cultures were significantly more likely 
to remain positive after 2 months of treatment. Smokers (ex—or current) were significantly less 
likely to achieve cure or treatment completion within 2 years. Overall, 16.7% of unsuccessful 
treatment outcomes were attributable to smoking, with the key contributor being default in current 
smokers and death in ex-smokers. Among those who successfully completed treatment, there was 
a clear gradient (hazard ratios of 1.00, 1.33 and 1.63) of relapse risk from never-smokers to ex-
smokers and current smokers, with an overall population attributable risk of 19.4% (current 
smokers: 12.2%; ex-smokers: 7.2%) (Leung et al., 2015). 
 
2.6.8 Tuberculosis and underlying health conditions 
At least 50% of the TB cases among non-hospitalised pilgrims had an underlying health condition, 
mainly hypertension (60%) and diabetes (40%). In a previous study, at least 33%of TB cases 
identified among non-hospitalised pilgrims had underlying health conditions (Yezli et al., 2017b). 
Among these, 40% had diabetes and 40% had hypertension. Similarly, at least 55.5% of TB cases 
among hospitalised pilgrims had an underlying health condition, mainly diabetes (60%) and 
hypertension (40%). A study of undiagnosed TB among 300 patients with productive cough in an 
Ethiopian hospital identified 10 missed TB cases, co-morbidity with diabetes was found in 10% 
of the TB cases(Assefa et al., 2019). 
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Among non-hospitalised pilgrims, TB was statistically significantly more prevalent among 
pilgrims with underlying health conditions and these were at a significantly higher risk of TB. 
Pilgrims with underlying health conditions were nearly 6 times more likely to have TB than those 
without an underlying health condition after adjusting for other variables. Yezli et al. (Yezli et al., 
2017b) reported that TB was more prevalent among non-hospitalised Hajj pilgrims with 
underlying health condition and this population was an increased risk of TB. Although not 
statistically significant, pilgrims with underlying health conditions were over 2 times more likely 
to have TB. For hospitalised pilgrims, there was no association between co-morbidities and TB. 
However, underlying health conditions such as diabetes and chronic lung and kidney disease are 
known risk factors for TB (Marais et al., 2013), and there is a growing awareness of the influence 
of TB co-morbidity with these conditions as well as the burden of unsuspected TB (Bates et al., 
2012, Young et al., 2009). For example, Bates and colleagues (Bates et al., 2012) reported the co-
morbidity of diabetes, respiratory, renal and cardiovascular disorders with culture-positive TB in 
inpatients to be 21.1%, 15.5%, 10.5% and 3.2% respectively. The burden of TB was significantly 
greater in diabetes patients (OR= 6.6, p= 0.025).  
 
The management of non-communicable disease is essential to reduce the burden of these diseases 
during Hajj as well as to reduce the burden of TB. For example, Pan et al. (Pan et al., 2015b) 
investigated the impact of diabetes prevention on TB morbidity and mortality in 13 high burden 
countries without a generalized HIV epidemic. The study found that stopping the rise in the 
prevalence of diabetes would prevent 6 million TB cases and 1.1 million TB deaths in the countries 
studied over 20 years. Aggressive interventions to reduce diabetes incidence would have an even 
larger impact on TB, avoiding 7.8 million cases and 1.5 million deaths. Given the above and the 
fact that around 15% of worldwide TB cases are attributed to diabetes, it was only right that the 
WHO has incorporated the management of diabetes into its strategy to decrease TB incidence by 
90% by 2035 (The Lancet Diabetes, 2014). 
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2.6.9 Tuberculosis and age 
Although not statistically significant, TB was more prevalent among non-hospitalised pilgrims in 
the older age groups and pilgrims in the youngest age group had the lowest risk of TB. After 
adjusting for other variables, non-hospitalised aged >55-64 were over 9 times more likely to have 
TB than those ≤45 years old (aOR= 9.5; 95% CI= 0.65-138.2), although this was not statistically 
significant. For hospitalised pilgrims however, there was no association between age and TB 
among inpatients, similar to what was reported by other(Bates et al., 2012). However, results of 
autopsy reports worldwide, suggest that undiagnosed TB among patients is more common among 
older individual (Juul, 1977, Katz et al., 1985, Roberts et al., 1971, Whittington, 1983). 
Observations from Hajj supports the notion that TB is more prevalent among older pilgrims and 
indicate that TB is commonly diagnosed among this population (Alzeer et al., 1998, Madani et al., 
2006, Mandourah et al., 2012, Yezli et al., 2017b).For instance, Alzeer and colleagues (Alzeer et 
al., 1998) reported that the mean age of TB patients during the 1994 Hajj was 60 years. A study of 
undiagnosed TB among non-hospitalised Hajj pilgrims found that the prevalence of TB increased 
with age and that pilgrims aged over 64 years were 5.3 times more likely to be TB positive than 
those aged 47 years old or less (Yezli et al., 2017b). 
 
Extremes of age are risk factors for TB(Marais et al., 2013), and the disease is generally more 
prevalent among older individuals as evidenced by the results of many TB surveys worldwide 
(Hoa et al., 2010, Onozaki et al., 2015, Qadeer et al., 2016). For instance, Hoa et al. (Hoa et al., 
2010) reported that prevalence rate of smear-positive TB in Vietnam increased significantly with 
age, from 4.2/100,000 in the group aged 15-24 years to 429.3/100,000 in the group aged over 65. 
Similarly, studies from Tanzania, Bangladesh and Pakistan found that the highest TB prevalence 
was in the oldest age groups and increased with age(Qadeer et al., 2016, Senkoro et al., 2016, 
Zaman et al., 2012). A review of national TB prevalence surveys in Asia between 1990 and 2012 
reported that age distribution pattern of TB cases was consistent with a progressive increase in 
rates of disease by age (Onozaki et al., 2015). In all countries investigated, the most recent surveys 
showed that TB prevalence rates peaked at the older age group of >65 years old. In Saudi Arabia, 
TB incidence also increase with age and are highest among the over 65 (Abouzeid et al., 2012, Al-
Orainey et al., 2013).  
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The above findings are significant given that elderly pilgrims represent a sizable proportion of the 
Hajj population, with more than 50% aged over 50 years old and roughly 25% are at least 65 years 
old (Ebrahim et al., 2009). 
 
2.6.10 Tuberculosis and level of education 
Among non-hospitalised pilgrims, 80% of the TB cases identified had only primary or no formal 
education and TB prevalence in general was highest among this group, although the difference 
was not statistically significant. Similarly, for hospitalised pilgrims, 55.5% of the TB cases 
identified had no formal education and the latter population was at an increased risk of TB. 
Although not statistically significant, hospitalised patients with no formal education were 1.5 times 
more likely to have TB than those with some form of education. In a previous Hajj study, 86.6% 
of TB cases identified among non-hospitalised pilgrims had no formal education (Yezli et al., 
2017b). Education was marginally significantly associated with the risk of TB after adjusting for 
other variables. Pilgrims with no formal education were nearly 4 times more likely to develop 
active TB than those with some form of education (aOR= 3.9; 95% CI= 0.98–16.0, P= 0.052)(Yezli 
et al., 2017b). 
 
TB risk, prevalence and impact are associated with socioeconomic status of which education is 
one indicator. Individuals with low socioeconomic status including low or no education have 
higher TB risk and prevalence, are less likely to seek medical care, have longer diagnosis delay 
time and are at higher risk of death from TB (Jurcev-Savicevic et al., 2013, Needham et al., 2001, 
Sanchez-Barriga, 2015). Populations with little or no education are generally disadvantaged from 
a social, geographic or economical point of view, all factors that are associated with TB morbidity 
and mortality (Sanchez-Barriga, 2015). In addition, low education is associated with poor 
knowledge of TB and attitude to the disease, which can facilitate transmissions and can lead to 
delaying health-seeking behaviour, lack of adherence to treatment regimes, treatment failure and 
disease complications and death (Gelaw, 2016). 
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2.6.11 Tuberculosis and previous tuberculosis treatment 
Previous TB treatment was no commonly reported among the non-hospitalised pilgrims 
investigates with only 0.61% reporting previously being treated for TB. However, the treatment 
duration was less than 6 months in 25% of these pilgrims. Also, TB was much more prevalent 
among those who had been previously treated for TB (12.5% vs 0.6%, p= 0.054) and there was a 
significant increase in risk of TB in relation to previous TB treatment. Non-hospitalised pilgrims 
who reported having been treated for TB in the past were 30 times more likely to have TB 
compared to those who were not treated for TB (OR= 30.3; 95% CI= 4.19-219.0). Similar 
observations were found among hospitalised pilgrims, only 4.4% of whom reported previously 
being treated for TB. The treatment duration was less than 6 months in 41.6% of these pilgrims. 
In addition, among the 5 TB cases diagnosed by the healthcare facilities in this current study, 2 
(40%) had previously been treated for TB. These 2 cases were also detected using the GeneXpert 
MTR/RIF assay. In a study from a hospital in Zambia, among the 27 unsuspected TB cases 
identified 5 (18.5%) had history of TB treatment(Bates et al., 2012). We report that TB was 
significantly more prevalent among hospitalised pilgrims who had been previously treated for TB 
and that the latter population was at a significant increase in risk of TB. Patients who reported 
having been treated for TB in the past were 8 times more likely to have TB compared to those who 
were not treated for TB after adjusting for other variables (aOR= 8.1; 95% CI= 1.35-48.4; p= 
0.022). 
 
Given the small number of TB cases identified in both hospitalised and non-hospitalised cohorts, 
it is difficult to draw conclusions from these results. However, it is well documented that 
inappropriate TB treatment is a serious concern and drives the occurrence of relapse and the 
emergence of drug-resistant TB (Fox et al., 1999, Hoffman et al., 2016, van der Werf et al., 2012, 
World Health Organization, 2014a). Treatment against TB may be inappropriate because: 1) the 
treatment duration is too short or the regimen contains too few drugs, has insufficient dose or drugs 
in a wrong combination; or 2) the duration of treatment is too long, with an excessive dose or 
number of drugs (Langendam et al., 2012). Inappropriate treatment of TB is common worldwide.  
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In a systematic review, Langendam et al. (Langendam et al., 2012) assessed the percentage of TB 
patients that received an inappropriate treatment regimen (type, dose, frequency of dosing and 
combination) from 37 studies from 22 countries, and one study was from multiple countries. 
Almost all continents were represented. Inappropriate treatment regimens were prescribed in 67% 
of the studies and the percentage of patients on inappropriate regimens varied between 0.4% and 
100%. While the study did not investigate treatment duration, incomplete TB treatment is not 
uncommon. Although structural factors such as interruptions in drug supply play a role, patient 
default or drop-out from TB treatment is one of the most important reasons for not completing 
treatment (Borgdorff et al., 2002). One of the first reviews of adherence to TB therapy published 
in 1989 found non-adherence rates of 20–50%(Cuneo and Snider, 1989). More recent estimates of 
default rates in DOTS programs range from 6%to 30% (Balasubramanian et al., 2004, Jaiswal et 
al., 2003, Kaona et al., 2004, Zegeye et al., 2019). 
 
2.6.12 Tuberculosis and contacts 
Although not statistically significant, TB was more prevalent in non-hospitalised pilgrims who had 
close contacts diagnosed or treated for TB (4.2% vs 0.6%, p= 0.1599) and those who recently 
shared a household with an adult with cough (1.9% vs 0.7%, p= 0.1545). Having a close contact 
diagnosed or treated for TB significantly increased the risk of TB by 9 times (OR= 9.19; 95%CI= 
1.49-56.4, p= 0.0166). In the multivariate analysis, those who recently shared a house with an adult 
with cough were 4.5 times more likely to have TB than those who didn’t, after adjusting for other 
variables (aOR= 4.4; 95% CI= 1.01-19.5, p=0.047). Such associations were not observed among 
the hospitalised pilgrims. However, It is well documented that contacts of TB patients are a high-
risk group for developing TB, particularly within the first year (Fox et al., 2013, Mendes et al., 
2013, National Tuberculosis Controllers et al., 2005). Fox et al. (Fox et al., 2013) conducted a 
systematic review and meta-analysis of all studies reporting the prevalence of TB and LTBI, and 
the annual incidence of TB among contacts of patients with TB. In studies from low- and middle-
income settings, the prevalence of active TB in all contacts was 3.1% (95% CI= 2.2–4.4%), 
microbiologically proven TB was 1.2% (95% CI= 0.9–1.8%), and LTBI was 51.5% (95% CI 47.1–
55.8%).  
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The prevalence of TB among household contacts was 3.1% (95% CI= 2.1–4.5%) and higher among 
contacts of patients with MDR- or XDR-TB (3.4%; 95% CI= 0.8–12.6%). Incidence was greatest 
in the first year after exposure. In studies from high-income settings, the prevalence of TB among 
contacts was 1.4% (95% CI= 1.1–1.8%), and the prevalence of LTBI was 28.1% (95% CI= 24.2–
32.4%).  
 
Given the increased risk of TB among contacts, contact screening, as a strategy to identify recently 
infected individuals, is part of the TB elimination strategy (Mendes et al., 2013). It follows risk 
stratification concerning the infectiousness of the index patient, the duration and proximity of 
exposure, and the susceptibility of the contact (National Tuberculosis Controllers et al., 2005). In 
one study, older contact age (OR= 1.03, 95% CI= 1.02–1.05), cohabitation (OR= 4.26, 95% CI= 
2.10–8.65), positive sputum analysis (smear or culture) (OR= 2.01, 95% CI= 1.06–3.82) and 
duration of the index patient symptoms (OR= 1.006, 95% CI= 1.001–1.011) were independent risk 
factors for positive screening (LTBI or TB) among contact. (Mendes et al., 2013). The study 
reported increased risk of M. tuberculosis transmission for households, which is already well 
documented (National Tuberculosis Controllers et al., 2005). 
 
2.6.13 Tuberculosis and cough duration 
Among the non-hospitalised pilgrims, there was a significant difference in TB prevalence in 
relation to cough duration (p= 0.0296), with pilgrims coughing between >1-3 weeks having the 
highest TB prevalence. Similarly, while not statistically significant, the risk of TB increased with 
increasing duration of cough. After adjusting for other variables, pilgrims who had symptoms >1-
3 weeks were 1.8-3.8 times more likely to have TB than those who had cough for one week or 
less. Similar observations were found for the hospitalised pilgrims’ cohort. In the latter, TB 
prevalence was higher among patients who had cough for over a week, with pilgrims with 
prolonged cough (>2 weeks) having the highest prevalence rates. Similarly, while not statistically 
significant, the risk of TB increased with increasing duration of cough. Compared to patients with 
a cough duration of less than a week, those coughing for >2-3 weeks had 3 times increase in the 
risk of TB. 
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Many studies have shown that an important proportion of infectious individuals with 
bacteriologically positive sputum do not experience symptoms suggestive of TB. In these studies 
from 40-79% of TB cases did not report TB symptoms that met screening criteria (generally cough 
of ≥2–3 weeks, and blood in the sputum) (Ayles et al., 2009, Hoa et al., 2010, Onozaki et al., 
2015). However, cough is the most common symptom of PTB and is used as criteria for TB 
suspicion (World Health Organization, 2011a, 2013c). Lowering the cut-off duration for cough 
increases the sensitivity of cough-based symptomatic screening, but reduces the specificity of the 
screening method (Aleyamma et al., 2008, Santha et al., 2005). An Indian study showed a 23% 
rise in smear positive TB case detection using cough duration of ≥ 2 weeks for screening, in 
comparison with using cough duration of ≥ 3 weeks (Aleyamma et al., 2008).However, increased 
cough duration is correlated with TB. For example, Ayles and colleagues (Ayles et al., 2009), 
reported that prolonged cough was strongly associated with prevalent TB among individuals in 
Zambia. Having a cough of short duration (<21 days) was a risk factor culture-positive M. 
tuberculosis (aOR= 3.07, 95% CI= 1.62–5.81) but coughing for more than 3 weeks provided the 
strongest association with culture-positive M. tuberculosis (aOR= 12.72, 95% CI= 7.05–22.94). 
 
2.6.14 Tuberculosis and admission ward for hospitalised pilgrims 
In the bivariate analysis, patients admitted to an isolation ward were significantly more likely to 
have TB compared to those admitted to other wards (OR= 5.4; 95% CI= 1.32-22.2; p=0.019). After 
adjusting for other variables, patients admitted to an isolation ward were 3 times more likely to 
have TB compared to patients admitted to other wards, although this was not statistically 
significant. Given the inclusion criteria for the study and the context of the Hajj and the MERS 
prevention measures during this mass gathering, a large proportion of pilgrims were admitted to 
isolation rooms. Yet, a number of detected TB cases in the current study were admitted to other 
department such as ER and surgery ward. Undiagnosed TB cases were reported among patients 
not admitted to isolation wards including in general wards were IPC measures are less stringent, 
hence representing a higher risk for TB transmission. For example, in one study, among 300 
patients not diagnosed with TB in a general medical ward in a large referral hospital in Ethiopia, 
10 (3.3%) patients were found to have active PTB (Assefa et al., 2019). The above highlights the 
importance of strict adherence to IPC measures in healthcare facilities during Hajj, including in 
what is perceived as lower risk wards. 
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2.6.15 Results outcomes 
The WHO and partners set out a post-2015 TB strategy with the goal of ending the global TB 
epidemic. The Sustainable Development Goals (SDGs) adopted by the UN in September 2015 
covering the period 2016–2030 and the End TB Strategy endorsed by WHO’s Member States at 
the 2014 World Health Assembly spanning a 20-year timeframe (2016–2035), aim to achieve this 
ambitious goal (World Health Organization, 2006a, 2015a). Targets set in the End TB Strategy are 
a 95% reduction in TB deaths and a 90% reduction in TB incidence by 2035 compared with 
2015.The 2030 targets are a 90% reduction in TB deaths and an 80% reduction in the TB incidence 
rate. The most immediate milestones, set for 2020, are a 35% reduction in TB deaths and a 20% 
reduction in the TB incidence rate, compared with levels in 2015 (World Health Organization, 
2006a).TB prevention and control at Hajj is an important priority and will go a long way towards 
achieving the WHO post-2015 End TB Strategy goals (Zumla et al., 2016). This is because Hajj 
has been linked to the importation and globalization of respiratory pathogens as well as 
antimicrobial resistance determinants and the event is a risk for TB infection (Al-Tawfiq et al., 
2016, Al-Tawfiq and Memish, 2015, Memish et al., 2015a, Wilder-Smith et al., 2005).  Hence this 
mass gathering is likely to impact TB epidemiology in KSA and worldwide and TB during Hajj is 
a matter of global health security.  
 
The results of the current study highlight the need for more attention toward TB and its burden 
during Hajj, including the issue of missed TB among hospitalised patients. This requires 
formulation and implementation of appropriate policies and interventions for early TB diagnosis, 
proper treatment and management as well as prevention of TB infection and transmission. In 
addition, training and education of HCWs to recognize symptoms of TB and implement 
appropriate screening strategies for early diagnosis of the disease are necessary. In the context of 
early diagnosis of TB among hospitalised patients, the introduction and use during Hajj of new 
and rapid point-of-care molecular diagnostic technologies such as the Xpert MTB/RIF assay and 
the now WHO endorsed next-generation Xpert Ultra (World Health Organization, 2017e) would 
be most beneficial. During Hajj, the healthcare system operates at near surge capacity with large 
volume of patients admitted to hospitals serving pilgrims.  
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Many of these pilgrims have respiratory symptoms, have co-morbidities and are keen to be 
discharged to continue their Hajj rituals. Short duration of hospitalization, and the masking of 
signs, symptoms and radiological findings by coexisting disease are documented contributing 
factors to failure to diagnose TB among  patients (Roberts et al., 1971). The result of the study also 
highlight the importance of adherence to strict IPC measures in healthcare facilities during Hajj as 
nosocomial transmission of infection, including TB, during the mass gatherings may not only have 
implication on inpatients and HCWs but also on the larger pilgrims population, the local 
community and have global health security implications.  
 
In addition, the results of the study suggest that there may also be a need for a pre-Hajj TB 
screening for pilgrims from certain endemic countries to prevent TB importation by prompt 
detection of cases and initiation of effective treatment to rapidly render them non-infectious (Al-
Orainey et al., 2013). Such TB screening programs are already in effect in a number of high-
income, low TB incidence, countries as pre-entry requirements for immigrants and were shown to 
have the highest impact and be most cost effective if they are targeted towards arrivals from high 
TB-endemic countries (Aldridge et al., 2014). The introduction of such screening programs for 
Hajj pilgrims will require further research and considerations into the target countries as well as to 
the practicalities, benefits and cost of such undertakings. These include the establishment, 
management and sustainability of such screening programs as well as the availability and 
accessibility to TB health services for those identified to have active TB. Given that countries most 
likely to require a pre-Hajj TB screening are also those with the lowest income and least developed 
infrastructures to manage and sustain such screening programs, international engagement and 
collaboration, funding and investment are required. Nevertheless, the use of rapid point-of-care 
molecular diagnostic technologies such as the Xpert MTB/RIF and Xpert Ultra assays assay 
(World Health Organization, 2017e), would facilitate screening. While these diagnostic methods 
can be expensive, they may be subsidized in low-income countries to reduce the cost (World 
Health Organization, 2018b). 
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2.7 Study limitations 
The current study has some limitations. In the non-hospitalised pilgrims’ cohort we only screened 
1,512 pilgrims from 16 countries which represent only a small proportion of the Hajj pilgrims’ 
populations which exceeds 2 million and originates from over 180 different countries. The study 
detected a small number of TB cases among the population investigated. However, as many reports 
suggest that a sizable proportion of people with TB do not present with cough, the results may be 
an under estimation of the true prevalence of TB among non-hospitalised Hajj pilgrims. Future 
studies investigating a larger number of pilgrims from a greater number of countries with large 
pilgrims’ populations and high TB and MDR-TB burdens such as Turkey, Egypt, China, Kenya, 
Myanmar, Russian Federation, Tanzania and Zambia, are warranted. Finally, while remote, we 
cannot eliminate the possibility that some of the non-hospitalised pilgrims investigated were 
already TB patients but chose not to disclose this information to the study investigators.  
For the hospitalised pilgrims’ cohort, the study only screened 304 inpatients symptomatic for 
cough. While the study systematically enrolled eligible patients, this number represents a small 
proportion of the total Hajj pilgrims admitted to healthcare facilities each year. Also, the study 
detected a small number of TB cases among the population investigated. Similar as above, 
numerous studies have reported TB cases among patients who were asymptomatic or did not have 
cough. Hence the reported prevalence of TB in the study may be an underestimation of the true 
prevalence of undiagnosed TB among hospitalised pilgrims in Hajj. On the other hand, the study 
population is not representative of the broader hospitals' population. Future studies investigating a 
larger number of patients may be warranted. Finally, for both cohorts, due to cultural and ethical 
considerations, our study did not collect data on the HIV status or on alcohol or substance abuse 
among pilgrims, which are established risk factors for TB (Marais et al., 2013). 
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2.8 Summary 
In summary, the study conducted a large-scale screening for active PTB among non-hospitalised 
pilgrims attending Hajj. The study found that 0.66% of pilgrims with cough from high and medium 
TB burden countries (mostly from India and Afghanistan) had undiagnosed active PTB. 
Underlying health conditions and cough in the household were independent risk factors for TB 
after adjusting for other variables. The study also investigated for the first time the burden of 
undiagnosed active PTB among hospitalised pilgrims during the 2016 and 2017 Hajj seasons. It 
reports that among inpatients with cough admitted to hospitals serving Hajj pilgrims, 2.9% (mostly 
from Indonesia and India) had active PTB and most (77.7%) of these were missed by the hospitals 
including MDR-TB cases. Previous TB treatment was independent risk factor for TB after 
adjusting for other variables. In light of these results, further studies investigating TB during Hajj 
and the impact of this mass gathering on TB transmission and epidemiology worldwide are 
warranted (Zumla et al., 2016). These investigations will help inform public health policies and 
direct interventions for the optimal awareness, surveillance, screening, treatment and management, 
prevention, and control of TB during Hajj and other mass gatherings worldwide. 
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3.1    Executive summary 
International travel, migration and movement of human populations facilitate the spread of 
Tuberculosis (TB). In this context, the Kingdom of Saudi Arabia (KSA) is particularly relevant 
because of its population dynamics and flow through the year as well as its hosting of mass 
gatherings such as the Hajj. The latter is an annual event in the Kingdom attended by over 2 million 
pilgrims from more than 180 different countries. As screening for TB is not a requirement for 
pilgrims before attending Hajj, potentially undiagnosed/untreated active TB brought to KSA 
during Hajj may have a major impact on the national and international epidemiology of TB. Hajj 
has been linked to increased risk of TB infection and both diagnosed and undiagnosed TB among 
pilgrims have been reported at the event. The TB management approaches during Hajj remained 
largely undocumented, and it is unknown whether these are consistent with the KSA and 
international TB management guidelines. 
 
This study documents the management of TB patients during Hajj and explores the compliance of 
healthcare providers with the KSA TB management guidelines in the Ministry of Health (MOH) 
hospitals during the mass gathering. This to provide evidence base to optimize awareness, 
surveillance, screening, management and treatment, prevention, and control measures for TB 
during Hajj as well as other mass gatherings both within the Kingdom and worldwide. 
 
The study used a cross sectional design to document the current TB management during the 2016 
and 2017 Hajj seasons. The study was conducted over a one-month period (1-30thDulHija, Hajj 
lunar month) in hospitals in Makkah and holy sites including temporary hospitals operational only 
during Hajj days. Structured questionnaires were used to retrieve relevant indices on TB 
management from hospital records, healthcare providers and patients during the study period. The 
data was cleaned and analyzed in SPSS and results were presented as frequencies, percentages and 
means. A scoring system was developed to assess the compliance of health providers with key 
aspects of the KSA TB management guidelines. 
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There were 31 cases of drug-susceptible TB and 1 case of extensively drug-resistant TB (XDR-
TB). Although the TB patients were nationals of 10 countries, 66.7% of them were KSA residents. 
Out of a maximum score of 10 for the selected TB management themes, the guideline compliance 
score was highest for infection prevention and control (IPC) and surveillance (9.6) and identifying 
TB suspects (7.2). The least scores were obtained for treating TB (5.0) and diagnosing TB (3.0). 
About half of the TB patients were separated from other patients at registration in the hospitals. 
The proportion of TB patients that were isolated in designated isolation rooms/wards rose from 
77.4% pre-diagnosis to 96.7% on confirmation of TB diagnosis. All suspected TB patients were 
correctly screened using appropriate TB symptoms and chest X-ray was conducted for 67.7% of 
TB patients. Contrary to guideline recommendations, culture was the only diagnostic test applied 
in nearly 2/3rd of the TB patients. Smear microscopy was done sparingly, and no Xpert MTB/RIF 
assay was conducted for the TB patients. Additionally, only a fraction of TB patients were 
questioned about their Human Immunodeficiency Virus (HIV) status (20.7%) or tested for HIV 
(12.9%). Regarding treatment of drug-susceptible TB, only 37% of TB patients received four 1st-
line anti-TB drugs, the majority received either three 1st-line anti-TB drugs (40.7%) or two 1st-line 
anti-TB drugs (11.1%). For TB notification, all confirmed TB cases with known notification status 
were reported to the KSA MOH, but the confirmed-TB status of two international pilgrims was 
not reported to their country health representatives/medical missions. 
 
Based on observations from the current study a number of recommendations can be proposed. 
These are as follows: 
• Develop and disseminate an international Hajj- and Umrah-specific TB control and 
management protocol to provide guidance on: TB surveillance, IPC, screening and 
diagnostic methods, choice of treatment and care models and patient transfer, including 
strategies for maintaining the continuum of care during and after the mass gatherings. 
• Update the current KSA TB national guidelines to adopt new diagnostic recommendations 
and to highlight the treatment pathway for drug-resistant TB, in line with current global 
standards. 
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• Improve knowledge and practice of healthcare providers regarding TB management 
through the provision of training and periodic refresher courses as well as guidance 
materials. 
• Monitor the TB management practices in MOH and non-MOH health facilities regularly 
to make recommendations for improvement. 
• Provide the Xpert MTB/RIF Ultra assay testing capability at the point of care to facilitate 
same day TB diagnosis including MDR-TB. 
• Raise awareness among healthcare providers about the need for mandatory screening and 
testing for HIV and other comorbidities in suspected TB patients.  
• Consider conducting systematic/targeted TB screening for pilgrims arriving from within 
the Kingdom for the Hajj, based on a pre-established criteria. 
 
3.2    Introduction and literature review 
3.2.1 Introduction 
Globally, there were an estimated 10.4 million new TB cases and 1.67 million deaths from 
tuberculosis (TB), in 2016 (World Health Organization, 2017b). Multidrug-resistant tuberculosis 
(MDR-TB) is defined as ''the resistance of the TB bacteria to at least rifampicin (RIF) and isoniazid 
(INH)'' (Falzon et al., 2011). In 2016, an estimated 490,000 new MDR-TB cases occurred 
globally(World Health Organization, 2017b). Despite past achievements in preventing TB 
morbidity and mortality, significant gaps in TB case detection and treatment success rates persist 
and undermine global TB control efforts. In 2016, the proportion of estimated new cases of drug-
susceptible TB and MDR-TB that were detected were 61% and 22% respectively (World Health 
Organization, 2017b). The treatment success rate was 83% for drug-susceptible TB and 54% for 
MDR-TB (World Health Organization, 2017b). These figures show that a large proportion of TB 
infections remain undetected or untreated in the community and contribute to sustained community 
transmission of TB. The End-TB strategy aims to reduce the overall number of TB deaths by 95% 
and the TB incidence rate by 90% in 2035 compared with the 2015 baseline incidence and 
mortality figures (World Health Organization, 2015a).  
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One of the key pillars of the strategy is the integrated patient-centered care, which encompasses 
early diagnosis through systematic screening of high-risks groups and case-contacts, preventive 
treatment and vaccination, treatment for all people with TB and collaborative TB/HIV activities 
and management of comorbidities (World Health Organization, 2015a). 
 
International travel, migration and movement of human populations facilitate the spread of TB. In 
this context, the Kingdom of Saudi Arabia (KSA) is particularly relevant because of its population 
dynamics and flow through the year as well as its hosting of mass gatherings such as the Hajj 
(Yezli and Memish, 2012).  The latter is an annual event in the Kingdom attended by over 2 million 
pilgrims from more than 180 different countries(Yezli et al., 2017a). These pilgrims, mostly 
elderly, many from poor countries where TB is endemic, gather in close contact to perform 
physically challenging religious rites. Such conditions are ideal for transmission of respiratory 
infections including TB (Al-Orainey, 2013). 
 
 As screening for TB is not a requirement for pilgrims before attending Hajj, potentially 
undiagnosed/untreated active TB brought to KSA during Hajj (transmitted to other pilgrims, to 
local citizens and exported outside KSA) has potentially a major impact on the national and 
international epidemiology of TB. Hajj has been linked to increased risk of TB infection and both 
diagnosed and undiagnosed TB among pilgrims were reported (Al-Orainey, 2013, Alzeer et al., 
1998, Alzeer, 2009, Wilder-Smith et al., 2005, Yezli et al., 2017b). Hospitals in Makkah serve 
both Hajj pilgrims as well as local residents and the Hajj workforce during the mass gathering free 
of charge. The additional stress on these health facilities during Hajj may compromise the services 
provided for all patients during the event, including those diagnosed with TB. No investigations 
were undertaken into whether the current KSA TB management guidelines during Hajj are 
followed in practice or if they are appropriate and effective for this unique event. This study 
documents the management of TB cases during the Hajj and explores the compliance of healthcare 
providers with the KSA TB management guidelines in the MOH hospitals during the mass 
gathering. This to provide evidence base to optimize awareness, surveillance, screening, 
management and treatment, prevention, and control measures for TB during Hajj as well as other 
mass gatherings both within the Kingdom and worldwide. 
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3.2.2 Literature Review 
 
Chapter three is an overview of how TB patients admitted to the Makkah and holy sites hospitals 
were managed during the Hajj mass gathering and explore which guidelines the Saudi MoH 
followed to manage TB patients (pilgrims and non-pilgrims) during Hajj. Unfortunately, TB 
management approaches during this unique event remained largely undocumented, and it is 
unknown whether these are consistent with the KSA and international TB management guidelines.  
A search of electronic databases was conducted for relevant literature in English, without time 
restriction. Database searched included Pubmed, Scopus and Google Scholar. A combination of 
the MeSH terms and text words including: “Tuberculosis”, “TB”, “Pulmonary”, “Management”, 
“Treatment”, “Screening”, “Guideline”, “Patient”, “Pilgrim”, “Infection prevention and control” 
and “Diagnosis” were used. A manual search was also performed reviewing reference lists of 
identified literature to find additional papers. With few exceptions, only the most relevant and 
recent publications were used to develop the literature review. In addition, a review of both the 
World Health Organization (WHO) and KSA TB management guidelines was conducted to 
elucidate acceptable TB management approaches and to identify differences and similarities in 
national and global TB treatment strategies that may impact on TB management during Hajj and 
Umrah.  
 
3.2.2.1 Early tuberculosis diagnosis through systematic screening of high-risks groups 
and case-contacts 
Early detection through systematic screening of TB suspects is a major strategy for improving TB 
case detection. The WHO recommends that persons with signs and symptoms consistent with TB 
should be evaluated for TB to ensure prompt diagnosis and treatment (World Health Organization, 
2011a, 2017a). Similarly, the Saudi TB guideline recommends that healthcare workers (HCWs) 
should be knowledgeable about TB symptoms to facilitate the efficient identification of TB 
suspects for diagnosis and treatment(Saudi Ministry of Health, 2014). In addition, both guidelines 
recommend that all close contacts of patients with pulmonary TB (PTB) should be screened for 
TB especially if they have signs and symptoms consistent with TB, are aged < 5years, have 
recognized or suspected immune compromising conditions or were in contact with patients with 
drug-resistant TB.  
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Systematic screening of people living with HIV and workers exposed to silica for active TB disease 
is mandatory, but priority should be given to other high-risk populations based on their contexts 
in terms of TB epidemiology, health system capacity, resource availability and the accessibility of 
the “at risk” populations. Some high risks groups for TB disease are enumerated in the KSA TB 
guidelines as: people with chronic diseases, such as diabetes mellitus and chronic renal failure; 
those with health conditions that require immunosuppressive or corticosteroid treatment; 
foreigners from countries with high TB disease burden; alcoholics and intravenous drug users; and 
people living in correctional facilities or prisons treatment (Saudi Ministry of Health, 2014). 
Several studies have shown that individuals with history of diabetes, tobacco-smoking related 
conditions, alcohol use, malignancies, silicosis and those on treatment with immunosuppressive 
medicines are at increased risks of TB disease (Cegielski and McMurray, 2004, Lönnroth et al., 
2008, Rieder, 1999, Slama et al., 2007, Stevenson et al., 2007). 
 
Cough is the most common symptom of PTB (World Health Organization, 2011a). Thus, a patient 
who presents to a health facility with history of cough of 2-3 weeks durations is expected to be 
screened for TB disease. Lowering the cut-off duration for cough increases the sensitivity of 
cough-based symptomatic screening, but reduces the specificity of the screening method 
(Aleyamma et al., 2008, Santha et al., 2005). An Indian study showed a 23% rise in smear positive 
TB case detection using cough duration of ≥ 2 weeks for screening, in comparison with using 
cough duration of ≥ 3 weeks (Aleyamma et al., 2008). Other symptoms that are useful for TB 
screening include hemoptysis, weight loss, fever and night sweats. As PTB screening tools, 
prolonged cough (lasting >2-3 weeks) has lower sensitivity (35%; CI: 24%-46%) and higher 
specificity (95%; CI: 93%-97%) than screening based on any cough duration (sensitivity: 57%; 
CI: 40%-74%, specificity: 80; CI: 69%-90%) and screening based on any TB symptom 
(sensitivity: 77%; CI: 68%-86%, specificity: 68; CI: 50%-85%), using culture-confirmed PTB as 
gold standard (Van’t Hoog et al., 2013).  
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As another PTB screening tool, chest radiography has higher sensitivity, but less distinguishable 
specificity than symptom-based screening. The pooled sensitivity and specificity of chest 
radiography for PTB, using culture-confirmed PTB as gold standard is described as: for any chest 
radiography abnormality compatible with active or inactive TB (sensitivity: 98%; CI: 95%-100%, 
specificity: 75; CI: 72%-79%), chest radiograph abnormalities suggestive of active TB (sensitivity: 
87%; CI: 79%-95%, specificity: 89; CI: 87%-92%) and chest radiography after positive screening 
for symptoms (sensitivity: 90%; CI: 81%-96%, specificity: 56; CI: 54%-58%) (Van’t Hoog et al., 
2013, World Health Organization, 2013c). Thus, the WHO recommends the use of chest 
radiography as a secondary screening test to enhance case detection, for all people with cough 
lasting more than 2 weeks, those who screened positive with TB symptoms and those with 
abnormal chest radiograph findings indicative of PTB (World Health Organization, 2013c, 2017a). 
 
In the KSA TB guidelines, chest radiography is recommended as a non-diagnostic screening test 
for the following  groups: people with positive tuberculosis skin test (TST) reaction (≥ 5mm 
induration), contacts with symptoms and signs of active TB, contacts with HIV infection, 
individuals with evidence of converting from negative to positive TST reaction within the past 2 
years, those on treatment for latent TB infection  (LTBI) who develop symptoms and signs of 
active TB, as well as children (under 5 years of age) who have a positive TST reaction( Saudi 
Ministry of Health, 2014). 
 
3.2.2.2 Diagnosing active tuberculosis 
The safe and efficient diagnosis of TB disease depend on the existence of an integrated network 
of multi-level laboratories with adequate biosafety standards, quality-assured capacity, mechanism 
for specimen referral and complimentary TB and HIV testing capability (World Health 
Organization, 2017a). In many settings with high TB burden, smear microscopy for acid fast bacilli 
(AFB), with 2 sputum samples is still the principal diagnostic testing method (World Health 
Organization, 2017a).  
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The standard application of 3 sputum samples for smear microscopy is not superior to 2-spot 
sputum sample collection technique, in terms of diagnostic sensitivity. Considering the clear 
advantage of a shorter diagnostic period, the 2-spot sputum collection method for smear 
microscopy is the current standard global practice (Mase et al., 2007, Rieder et al., 2005, World 
Health Organization, 2010a).  Direct Ziehl-Neelsen stained sputum smear with conventional light 
microscopy is the most common and affordable method for PTB diagnosis, especially in low and 
middle income countries. Regular light microscopy has high specificity in areas with high TB 
burden but there is significant variability in its sensitivity (20-80%) for the detection of AFB in 
sputum samples. In comparison, conventional fluorescence microscopy is 10% (95% CI: 5–15%) 
more sensitive in detecting AFB in clinical specimens, has comparable specificity, and produces 
test results in significantly shorter time than light microscopy (Steingart et al., 2006, World Health 
Organization, 2015c). However, the widespread use of conventional fluorescence microscopy was 
hindered by the high cost of the required mercury vapour light sources and the additional 
requirement for regularly-maintained dark room (World Health Organization, 2011b). 
 
As a result, the fluorescent light-emitting diode (LED) microscope was developed to increase the 
uptake of fluorescent microscopy, especially in resource limited settings. LED microscopy is 
relatively inexpensive, performs equally well in lighted rooms and is not associated with the 
emission of toxic mercury products if damaged (World Health Organization, 2011b, 2015c). In 
terms of diagnostic capacity, LED microscopy is 6% (95% CI, 0.1–13%) more sensitive than light 
microscopy and 5% (95% CI, 0–11%) more sensitive than conventional fluorescence microscopy 
in detecting AFB in clinical samples (World Health Organization, 2011b). Other comparative 
advantages of LED microscopy include reduced time to reading results, improved cost-
effectiveness in resource limited settings and increased opportunity for integrated laboratory 
services based on its potential application  for the diagnosis of other diseases, such as malaria and 
trypanosomiasis (World Health Organization, 2011b). Therefore, the WHO recommends the 
replacement of conventional fluorescence microscopy with LED microscopy in all settings where 
fluorescence microscopy is currently being applied for TB diagnosis (World Health Organization, 
2011b). 
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The WHO also recommends a carefully phased implementation of LED microscopy as an 
alternative to regular light microscopy in all laboratories, using appropriate LED technology that 
meets approved specifications (World Health Organization, 2011b). Regardless, the general TB 
diagnostic applicability of sputum microcopy is limited by the need for quality assured laboratory 
processes, the inability to distinguish mycobacterium species and its relatively low sensitivity 
(World Health Organization, 2015c). 
 
Generally, about eight organisms (Mycobacterium tuberculosis, M.bovis, M.caprae, M. africanum, 
M. microti, M.pinnipedis, M. mungi, M. orgis and M. cannetti) constitute the mycobacterium 
tuberculosis complex (MTB). These organisms are associated with variable spectrum of human 
and animal diseases, many of which are still poorly understood (Niemann et al., 2000).Thus, specie 
differentiation through solid or liquid culture is important for epidemiological considerations and 
for individualized patient management (e.g. M. bovis is generally resistant to PZA) (Kasper et al., 
2015, World Health Organization, 2015c).Detection of mycobacterium species through culture 
provides a definitive diagnosis of TB. Compared to sputum microscopy, culture increases TB case 
detection by 30-50% (World Health Organization, 2015c). However, culture is not 100% sensitive 
for TB diagnosis because the decontamination procedures that limit the overgrowth of other 
microorganisms during sample processing for culture potentially have lethal effects on 
mycobacterium and hence compromise the yield of the bacteria during the procedure (World 
Health Organization, 2015c). Culture is also useful for monitoring response to MDR-TB 
chemotherapy and it is only recommended for high level and intermediate level facilities due to 
the additional skills and biosafety standards required for laboratory operations (World Health 
Organization, 2015c). In comparison with microscopy, culture is expensive, delicate and takes 
longer period to process samples and generate results. Liquid culture is less time-consuming and 
increases TB case detection by 10%, compared to solid culture (Organization and Organization, 
2007).This advantage is however undermined by the relative high cost and additional biosafety 
measures required for liquid culture (Organization and Organization, 2007, World Health 
Organization, 2015c).  
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Both phenotypic and genotypic methods are available for the differentiations of cultured 
mycobacterium species (Niemann et al., 2000, Parsons et al., 2002).Strip tests for speciation 
(immunochromatographic assays) is the method of choice, since they can differentiate 
mycobacterium tuberculosis complex specie within 15 minutes (Organization., 2007). 
 
The End-TB Strategy focuses on improving TB case detection rates, as one of the key strategies 
for TB control. Hence, molecular techniques are increasingly taking preeminence for TB diagnosis 
due to their rapid diagnostic speed and accuracy, as well as the reduced need for intensive biosafety 
measures. Xpert MTB/RIF is an automated real-time molecular diagnostic test that simultaneously 
detects drug-susceptible TB and RIF resistance (Nicol et al., 2013, World Health Organization, 
2011c).The significantly reduced need for maintenance of extensive laboratory biosafety standards 
makes Xpert MTB/RIF a suitable diagnostic test for resource-limited TB endemic settings (World 
Health Organization, 2017a). In 2010, based on pooled evidence of Xpert MTB/RIF diagnostic 
accuracy, operational feasibility, cost-effectiveness and mean-time to TB detection, the WHO 
recommended the use of Xpert MTB/RIF, as initial TB diagnostic tests for people living with HIV 
and those suspected to have MDR-TB and for further testing of smear negative specimens (World 
Health Organization, 2011c). 
 
With new evidence from Cochrane reviews, the 2010 recommendations was revised in 2013 to 
include conditional recommendations for the use of Xpert MTB/RIF, as initial TB diagnostic tests 
in all adults and children, rather than conventional microscopy and culture (World Health 
Organization, 2013a, 2014d). In the reviews, Xpert MTB/RIF had a pooled sensitivity of 88% 
(95% Credible Interval [CrI], 84-92%) and a pooled specificity of 99% (95% CrI, 98-99%), as an 
initial diagnostic test replacing sputum smear microscopy (Steingart et al., 2013, World Health 
Organization, 2013a). Additionally, Xpert MTB/RIF had a pooled sensitivity of 94% (95% CrI, 
90-97%) and a pooled specificity of 98% (95% CrI, 97-99%) for the detection of RIF resistance 
(Steingart et al., 2013, World Health Organization, 2013a). 
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Xpert MTB/RIF was also proven useful for the diagnosis of other forms of TB. Compared to 
culture, the pooled sensitivities of Xpert MTB/RIF for various extra-pulmonary samples include: 
lymph node tissues/fluids (84.9%; 95% CrI, 72.1-92.4%), gastric fluid (83.8%; 95% CrI, 65.9-
93.2%), cerebrospinal fluid (79.5%; 95% CrI, 62.0-90.2) and pleural fluid (43.7%; 95% CrI 24.8-
64.7%) (World Health Organization, 2013a). The specificities of Xpert MTB/RIF for TB diagnosis 
using these extra-pulmonary samples range from 98.1%-99.9% (World Health Organization, 
2013a). Nevertheless, most studies included in these reviews were conducted in highly controlled 
research laboratories. The evidence pooled from monitoring Xpert MTB/RIF performance in less-
controlled settings is potentially a better indicator of the applicability and usefulness of Xpert 
MTB/RIF for TB diagnosis and the detection of RIF resistance.  
 
To improve the sensitivity of molecular testing for the diagnosis of TB, especially in smear 
negative, culture positive TB cases and HIV positive TB cases, the Xpert MTB/RIF Ultra assay 
(Ultra) was developed by Cepheid Inc. Ultra was 5% (95% CI: +2.7, +7.8) more sensitive and 
3.2% (95% CI: -2.1, -14.7) less specific than Xpert MTB/RIF, in a multi-center non-inferiority 
study (Bisallah et al., 2018). The difference in sensitivity was highest among smear-negative 
culture-positive patients (+17%, 95% CI: +10, +25) and among people living with HIV (+12%, 
95% CI: +4.9, +21) (World Health Organization, 2017f). Based on the above evidence, the WHO 
now recommends Ultra, as the initial diagnostic test for all patients with signs and symptoms of 
PTB who are capable of producing sputum, as well as for the diagnosis of TB meningitis (World 
Health Organization, 2017a). Ultra is also recommended as the initial diagnostic test for detection 
of RIF resistance, and as an alternative for testing specific non-respiratory specimens from patients 
suspected of having extra-PTB (World Health Organization, 2017a). 
 
Loop-mediated isothermal amplification for detecting TB is another molecular test, which is 
recommended by the WHO as an alternative test or a secondary test to smear microscopy for 
diagnosing PTB in adults with signs and symptoms of TB, in settings where conventional smear 
microscopy could be performed (World Health Organization, 2016b). 
  
 Chapter 3: Management of hospitalized pulmonary tuberculosis patients during the hajj Mass gathering 
 
 
121 
 
The lateral flow urine lipoarabinomannan assay is recommended to assist the diagnostic process 
for HIV positive patients with CD4 cell count <100 cells/µL, those with an unknown CD4 count 
and seriously ill HIV positive inpatients (World Health Organization, 2015e). 
 
The growing burden of drug-resistant TB constitutes a significant challenge for TB control. 
Current control measures aim to rapidly detect drug-resistant TB cases and commence treatment 
to prevent TB complications and reduce further spread of drug-resistant TB in the community. To 
this end, the WHO recommended that drug-susceptibility testing (DST), using approved rapid tests 
should be performed for all new and retreatment TB patients, prior to commencing treatment 
(World Health Organization, 2017a). On detection of RIF resistance, the WHO recommends the 
use of rapid molecular tests to promptly detect the resistance to INH, fluoroquinolones and 2nd-
line injectable agents to confirm diagnosis and inform treatment of MDR-TB and extensively drug-
resistant TB (XDR-TB). The latter is defined as MDR-TB plus resistance to any fluoroquinolone 
and at least one of three injectable second-line drugs.2 Commercially available molecular line 
probe assays (LPAs) are preferred to  phenotypic culture-based DST, as initial diagnostic tests to 
detect TB bacteria resistance to RIF and INH for persons with a sputum smear-positive specimen 
(direct testing) or a cultured MTB complex (indirect testing) (World Health Organization, 2016c, 
2017a). In patients with confirmed RIF-resistant TB (RR-TB) or MDR-TB, molecular LPAs are 
preferred to phenotypic culture-based DST, as the initial test to detect resistance to 
fluoroquinolones and second-line injectable agents(World Health Organization, 2016d, 
2017a).Culture-based phenotypic DST for selected anti-TB medicines should be performed for 
patients, who have initiated treatment for drug-resistant TB (World Health Organization, 2017a, 
2018d). 
 
3.2.2.3 Treating drug-susceptible tuberculosis 
 
Starting TB treatment early and ensuring people with TB stay on treatment for the entire duration 
of treatment is a global TB control strategy. Drug-susceptible TB is curable, but inappropriate 
regimen prescription and non-adherence to recommended dosages contribute to poor treatment 
outcomes.  
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The WHO recommends the administration of standardized first-line anti-TB treatment regimen, 
consisting of an initial 2 months of treatment with INH, RIF, PZA and EMB and subsequently 
treatment with INH-RIF for the next 4 months. The 6 months TB treatment regimen is 
recommended for TB patients with drug-susceptible TB, those without prior history of starting 
treatment with anti-TB agents and those without recognized risk factors for drug resistance, while 
awaiting DST results (World Health Organization, 2017a, 2017c).Global TB control target is to 
reduce the duration of TB treatment to promote anti-TB drug compliance and reduce the exposure 
of patients to drug adverse events. As a result, the efficacy of a shorter (4 months) fluoroquinolone-
containing anti-TB regimen was explored in various studies (Gillespie et al., 2014, Jindani et al., 
2014, Merle et al., 2014). Higher relapse rates of the shorter fluoroquinolone-based regimen at 18 
months follow-up, compared with the standard 6-months anti-TB regimen hindered its subsequent 
endorsement by the WHO (World Health Organization, 2017c). 
 
Latest evidence suggest that fixed-dose combination (FDC) therapy for TB is as effective as single-
drug formulations in terms of treatment outcomes (Gallardo et al., 2012). Considering some 
potential benefits of FDC-based TB regimen, which includes improved supply management, 
simplified prescription plan and increased patient satisfaction with reduced pill burden, the WHO 
recommends the administration of FDC formulations in the treatment of drug-susceptible TB 
(World Health Organization, 2017c). 
 
The reduced pill burden of FDC regimen may be particularly useful for children who have 
difficulty ingesting multiple drugs and TB patients who are on other medications, such as HIV 
patients. In some settings, intermittent dosing gained popularity as a strategy for improving 
treatment adherence and reducing the impact of daily, directly observed treatment (DOT) on the 
health system (World Health Organization, 2017c). Indeed, intermittent (thrice weekly) dosing 
was recommended in 2010 by the WHO, as alternative choice wherever optimal daily dosing was 
unfeasible (Menzies D. et al., 2009, Mwandumba and Squire, 2001, World Health Organization, 
2010d). However, concerns about higher risks of treatment failures, relapse and acquired drug-
resistance led to the suspension of intermittent dosing as an alternative choice to optimal daily 
dosing, in 2017 (World Health Organization, 2017c).   
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Hence, the current recommendation specifies the use of the optimal daily dosing strategy in the 
treatment of all TB patients with drug-susceptible TB (World Health Organization, 2017c). 
 
The KSA TB guideline is largely comparable to the aforementioned 2010 WHO guidelines for the 
treatment of drug-susceptible TB. The KSA guideline stipulates optimal daily dosing and the 
conventional 6 months treatment duration for drug-susceptible TB (Saudi Ministry of Health, 
2014). It also makes provision for thrice weekly dosing in the continuation phase or throughout 
the entire duration of treatment, when daily dosing is not feasible (Saudi Ministry of Health, 2014).  
Like previous WHO guidelines, the 2014 KSA TB management guideline also recommended that 
the 8-months retreatment (CAT II) regimen, which included daily streptomycin (STM) injections  
in the intensive phase (2 INH-RIF-PZA-EMB-STM/ 1 INH-RIF-PZA-EMB) and 5 months 
exclusively-oral anti-TB agent in the continuation phase (5 INH-RIF-EMB) should be 
administered to relapsed and defaulted TB patients, while awaiting DST result (Saudi Ministry of  
Health, 2014). However, empirical treatment of such cases with CAT II regimen rather than 
performing DST to inform treatment choice leads to delays in commencing standard treatment for 
drug-resistant TB and unduly exposes TB patients to the toxic effects of STM (Gegia et al., 2017, 
Menzies Dick et al., 2009, World Health Organization, 2017c). Besides, the addition of STM to a 
previously failed TB regimen, which defines the CAT II regimen potentially propagates the 
development of resistance and culminates in the loss of STM as a 2nd line anti-TB drug (World 
Health Organization, 2017c). Thus, the WHO currently prohibits the prescription of CAT II 
regimen for TB retreatment and stipulated that DST should be performed to guide the choice of an 
appropriate TB treatment regimen in patients who require retreatment for TB (World Health 
Organization, 2017c). The use of adjuvant corticosteroid is indicated for the treatment of 
extrapulmonary TB (Saudi Ministry of Health, 2014, World Health Organization, 2017c). In TB 
meningitis, anti-TB therapy with adjuvant steroids are associated with reduced risks of disability, 
severe adverse events, relapse and mortality (Prasad et al., 2016, Thwaites et al., 2004, World 
Health Organization, 2017c). Similarly, adjuvant steroid administered with anti-TB treatment for 
the management of TB pericarditis improves treatment adherence and reduces the risk of death 
and complications, such as constrictive pericarditis (Wiysonge et al., 2017, World Health 
Organization, 2017c). 
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In TB patients living with HIV, early commencement of antiretroviral treatment (ART) improves 
wellbeing and reduces mortality. Various studies showed a link between “early” ART (initiated 
before 8 weeks of commencing anti-TB treatment) and the reduction in overall mortality, 
regardless of CD4 cell count (Blanc et al., 2011, Mfinanga et al., 2014, Yan et al., 2015).  In 
addition to reduced mortality, “earlier” ART (commenced within 2 weeks of commencing anti-TB 
treatment) is associated with reduced risks of Acquired Immunodeficiency Syndrome (AIDS)-
defining illnesses (Havlir et al., 2011). Nonetheless, both “early and earlier” ART, as opposed to 
delayed ART (commenced after 8 weeks of onset of anti-TB treatment), are associated with a 
higher risk of immune reconstitution inflammatory syndrome (IRIS) (Naidoo et al., 2012). Since 
potential benefits outweigh risks, the WHO recommends that TB patients living with HIV should 
receive appropriate anti-TB treatment initially and then ART should be commenced within the 
first 8 weeks of TB treatment (World Health Organization, 2016a). For patients with CD4 cell 
counts <50 cells/mm3, ART should be commenced within the first 2 weeks of commencing anti-
TB treatment (World Health Organization, 2016a). 
 
3.2.2.4 Treating drug-resistant tuberculosis 
 
The transmission of drug-resistant TB, in various TB endemic settings, presents additional 
challenges for global TB control. Compared with drug-susceptible TB, the treatment of drug-
resistant TB often involves prolonged treatment courses, use of potentially toxic drugs and poor 
treatment outcomes. The common forms of drug-resistant TB include INH-resistant TB, RR-TB, 
MDR-TB and XDR-TB. RIF-susceptible,  INH-resistant TB is an emerging threat, which accounts 
for about 8% of TB cases worldwide (World Health Organization, 2017b, 2018e).  Previous 
recommendations for INH-resistant TB treatment were based on expert opinion due to lack of 
evidence base (Jaramillo, 2008, World Health Organization, 2006b). In 2017, based on a 
systematic analysis of individual patient’s data, the WHO recommended that patients with 
confirmed RIF-susceptible, INH-resistant TB should receive RIF-PZA-EMB and levofloxacin for 
a duration of 6 months (World Health Organization, 2018e). 
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The conventional treatment choice for RR-TB and MDR-TB are the same and involves the use of 
2nd-line anti-TB drugs in appropriate regimen (World Health Organization, 2016e). The Saudi 
guideline for the treatment of drug-resistant TB is limited to a general provision that recommends 
commencing empirical MDR-TB regimen upon the detection of RIF resistance and subsequent 
regimen adjustment in accordance with DST result. The provision makes no reference to the type 
and dosage of anti-TB drugs that should be considered in the composition of the MDR-TB regimen 
(Saudi Ministry of Health, 2014). In contrast, the WHO’s 2011 guidelines for the programmatic 
management of drug-resistant TB specified the inclusion of at least four 2nd-line anti-TB drugs in 
a regimen consisting of PZA, one fluoroquinolone, one injectable agent, EMB (or prothionamide) 
and cycloserine (or para aminosalicylic acid) in the treatment regimen for  MDR-TB (Falzon et 
al., 2011). 
 
The 2011 guidelines also indicated that new MDR-TB cases should receive the appropriate 
regimen for 20 months, including an intensive phase of 8 months. Overall, none of the cohorts 
included in the meta-analysis used for development of the 2011 guidelines stemmed from 
randomized control trials. Secondly, substantial risk of bias was attributed to under-representation 
of some geographical areas in the included studies and the tendency for certain drugs to be reserved 
for the treatment of patients who have severe clinical disease (Akçakir, 2009, Johnston et al., 2009, 
Orenstein et al., 2009).  Ever since, the effectiveness of a shorter MDR-TB treatment regimen 
which potentially offers superior cost-effectiveness and less exposure to the toxic side effects of 
chemotherapy has been explored in various studies (Kuaban et al., 2015, Nunn et al., 2014, 
Piubello et al., 2014, Van Deun et al., 2010). Pooled data analysis from these studies showed that 
patients who received the shorter MDR-TB regimen have higher likelihood of treatment success 
than those who received longer regimens (90% versus 78%) (Falzon et al., 2017).  For patients 
receiving the shorter MDR-TB regimens, who have additional resistance to PZA and/or 
fluoroquinolones, the observed proportion of treatment success was lower but exceeded (without 
statistical significance) those on longer MDR-TB regimen.  
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Accordingly, the WHO updated the guidelines for the programmatic management of drug-resistant 
TB in 2016. The update includes the approval of a shorter MDR-TB regimen of 9–12 months, as 
potential replacement for the longer regimens in  the treatment of RR-TB or MDR-TB, for patients 
having no prior treatment exposure to 2nd-line anti-TB drugs and those with excluded or highly 
unlikely risk of resistance to fluoroquinolones and 2nd-line injectable drugs (Falzon et al., 2017). 
This recommendation is applicable to adults and children with RR-TB and MDR-TB, regardless 
of their HIV status. However, the use of a shorter MDR-TB regimen is contraindicated in 
pregnancy and for the treatment of extra PTB (Falzon et al., 2017). 
 
In cases where the shorter MDR-TB regimen is not applicable, an individualized regimen 
comprising of at least five effective anti-TB drugs in the intensive phase and four drugs in the 
continuation phase should be administered for 20 months or more (Falzon et al., 2017). The five 
drugs in the intensive phase should comprise of PZA, one drug each selected from group A and B 
and at least two drugs selected from group C (Table 16). The use of D2 and D3 drugs may be 
considered, if the regimen cannot be constituted as described above (Falzon et al., 2017). 
Bedaquiline and delamanid may improve treatment outcome in longer regimens, but usage beyond 
24 months is not recommended due to uncertainties about their safety and efficacy beyond this 
period (Gler et al., 2012, Pontali et al., 2016, World Health Organization, 2017a).  
 
Partial resection surgery is a recommended adjunct to standard MDR-TB regimen, since it is 
associated with improved treatment success for MDR-TB (Falzon et al., 2017, Harris Rebecca C 
et al., 2016). However, careful assessment of the individual patient’s fitness for surgery, the state 
of surgical facilities and the availability of highly skilled surgeon should be considered before 
decisions are made to perform partial resection surgery (Falzon et al., 2017). 
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Table 16. Classification of 2nd-line anti-tuberculosis drugs 
Group Composition 
Group A. Fluoroquinolones Levofloxacin,   
Moxifloxacin,   
Gatifloxacin  
Group B.  Second- line Injectable agents Amikacin,  
Capreomycin,   
Kanamycin,   
(STM)  
Group C.  Other core second-line agents Ethionamide (or Prothionamide),  
Cycloserine (or Terizidone),   
Linezolid,   
Clofazimine  
Group D.  Add on agents      
D1 PZA  
EMB  
High-dose INH 
D2                            Bedaquiline,  
Delamanid 
D3 Aminosalicylic acid,   
Imipenem–Cilastatin,  
Meropenem,   
Amoxicillin clavulanate  
  (Thioacetazone) 
INH= isoniazid, EMB= ethambutol, PZA= pyrazinamide, STM= streptomycin 
 
3.2.2.5 Monitoring tuberculosis treatment and enhancing surveillance 
Both the WHO and KSA TB guidelines recommend that all patients with PTB being treated with 
the 1st-line regimen should have their sputum samples tested by the end of the 2nd, 5th and 6th 
month of treatment (Saudi Ministry of Health, 2014, World Health Organization, 2010d). The 
WHO guideline also recommends that DST should be performed to detect resistance to at least 
RIF, if sputum samples remained smear positive or culture positive at the end of the 2nd month of 
treatment(World Health Organization, 2010d).  
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The KSA guideline differs slightly; it stipulates that a repeat sample should be collected and tested 
at the end of the 3rd month, if the initial sample collected at the end of the 2nd month of treatment 
remained smear positive (Saudi Ministry of Health, 2014). Culture and DST are indicated to detect 
resistance, if repeat samples collected at the end of the 3rd month remained smear positive (Saudi 
Ministry of Health, 2014). 
 
Treatment monitoring standards for MDR-TB are well-highlighted in the WHO guidelines but 
there are no apparent provisions in the Saudi guidelines regarding treatment monitoring for MDR-
TB (Falzon et al., 2017, Saudi Ministry of Health, 2014).  In patients with MDR-TB, smear 
microscopy and culture are recommended by WHO, rather than smear microscopy alone, for 
treatment monitoring (Falzon et al., 2011, World Health Organization, 2014a). Generally, monthly 
smear-microscopy and sputum culture throughout treatment are the preferred monitoring choice 
(World Health Organization, 2014a). However, resource constrained settings could perform 
monthly smear microscopy and sputum culture until culture conversion, and subsequently reduce 
the frequency of performing culture to every alternate month (World Health Organization, 2014a).  
Daily assessment by clinicians is recommended in the first week for hospitalized MDR-TB patients 
on treatment and weekly for outpatients, until the treatment is well-tolerated. Afterwards, clinical 
assessment should be performed monthly or twice monthly.  
 
In the continuation phase, except otherwise indicated by medical reasons, the DOT supporter 
should visit the patient daily to monitor adherence and tolerance and discuss any concerns with 
the physician/clinician (World Health Organization, 2014a). Weight monitoring (baseline, twice 
weekly for 3 months, then monthly throughout treatment) and height measurement (at the start of  
treatment) is required for BMI calculation. In children, monthly height measurement is indicated 
for monitoring growth (World Health Organization, 2014a). Chest X-ray should be performed at  
baseline and 6 monthly afterwards (World Health Organization, 2014a).  For 1st-line and 2nd-line 
anti-TB drugs, DST should be performed at baseline and repeated for MDR-TB patients who 
remain culture positive or revert after the 4th month of commencing treatment (World Health 
Organization, 2014a). 
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Global TB policy mandates all providers to report both new and retreatment TB cases, including 
treatment outcomes, to their national public health authorities (World Health Organization, 
2013b). In Saudi Arabia, TB is a notifiable disease for immediate reporting once the decision to 
commence treatment is taken. The legal framework authorizes the regular enforcement and 
evaluation of mandatory and timely reporting by providers, laboratories and hospitals (Saudi 
Ministry of Health, 2014). Electronic case-based reporting has replaced paper-based notification 
system in many settings. Electronic reporting promotes timeliness, ensures improved data access 
and reduces errors, such as duplication of data (World Health Organization, 2012). The most 
common variables used for TB reporting includes demographic data, prior TB treatment history 
and the current TB treatment information (World Health Organization, 2012). 
 
3.2.2.6 Supportive approaches for tuberculosis management 
Effective triage management that involves prompt detection of persons with TB symptoms and 
separation of TB suspected patients from others in a well-ventilated area is standard global practice 
(World Health Organization, 2009b). Patients who are immunosuppressed, such as HIV patients 
should be separated from those with suspected or confirmed infectious TB. Furthermore, patients 
with suspected or confirmed drug resistant TB should be separated from other TB patients, 
especially on the basis of their drug resistance profile (World Health Organization, 2009b). Upon 
separation, TB suspects should be educated about good cough etiquette and respiratory hygiene 
and be given priority considerations for prompt TB testing. Use of physical barriers, such as 
handkerchiefs, piece of tissue and surgical masks are preferred methods for promoting good cough 
and sneezing etiquette, if these materials are properly disposed of use. In the absence of physical 
barriers, the bend of the elbow and hand may be used to cover the mouth and nose when sneezing 
or coughing, but ensuring immediate cleaning afterwards is paramount (World Health 
Organization, 2009b). 
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Similarly, the Saudi national guideline for TB recommended the implementation of a symptom-
based screening protocol for patients presenting with cough and respiratory symptoms in 
healthcare settings (Saudi Ministry of Health, 2014). Suspicious cases so identified are required to 
wear a surgical facemask and be immediately separated from others in a private examination room 
(Saudi Ministry of Health, 2014). Staff accessing such waiting areas and those in contact with 
infectious TB cases are advised to wear a National Institute for Occupational Safety and Health 
(NIOSH)-approved and fit-tested N95 respirator (Saudi Ministry of Health, 2014).  It is unclear to 
what extent the use of surgical facemasks contributes to reducing nosocomial transmission of TB, 
but there are strong hypothetical considerations justifying the use of surgical mask, especially 
when infectious patients come in contact with vulnerable individuals (World Health Organization, 
2009b). The WHO also recommends the use of particulate respirators by staff and visitors in 
enclosed space with infectious TB patients, health workers caring for suspected or confirmed 
MDR-TB and XDR-TB patients, as well as those engaged in aerosol-generating procedures 
associated with increased risk of TB transmission, such as intubation and bronchoscopy. 
Particulate respirators are not recommended for use by TB patients (World Health Organization, 
2009b). 
 
Adequate natural ventilation enhanced by using large-sized windows that are located on opposite 
walls is an important IPC measure in healthcare facilities. In areas with insufficient natural 
ventilation, mixed-mode ventilation using appropriate fans may be useful for maintaining adequate 
air dilution.  Mechanical ventilation may be considered in settings with insufficient natural and 
mixed-mode ventilation systems, but systems that maintain adequate air changes per hour should 
be prioritized. In areas where climatic factors (e.g. cold, hot), infrastructural designs and high TB 
transmission associated morbidity and mortality risks (e.g. MDR-TB wards) exist and prevent the 
maintenance of adequate ventilation,  complementary use of upper room or shielded ultraviolet 
germicidal irradiation devices are recommended (World Health Organization, 2009b). 
 
  
 Chapter 3: Management of hospitalized pulmonary tuberculosis patients during the hajj Mass gathering 
 
 
131 
 
Both the KSA and WHO TB guidelines consider the pursuit of a patient-centered approach to TB 
treatment, a necessary strategy for promoting treatment adherence, improving the quality of life of 
TB patients and alleviating suffering (Saudi Ministry of Health, 2014, World Health Organization, 
2017a). Before initiating treatment, a rapid needs assessment is required to inform interventions 
(including combinations of psychological and material support, patient and staff education, tracer 
and use of medication support) that ensure treatment adherence and hence impact positively on 
outcomes (World Health Organization, 2009b, 2017a). Considering the cost effectiveness of 
community-based approaches and the reduced risk of TB transmission in households that 
implement adequate infection control measures, hospitalization for TB treatment is generally 
unwarranted (World Health Organization, 2009b). Thus, the WHO recommends that patients with 
drug-susceptible TB should be treated in home-based care, unless there are complications or 
comorbidities that necessitate hospital admission (World Health Organization, 2009b). Similarly, 
ambulatory-care models for MDR-TB are generally preferred to models of care that are based 
mainly on hospitalization (Falzon et al., 2011, Falzon et al., 2017). Decentralized care for MDR-
TB provided by non-specialized providers and treatment supporters in local communities where 
patient reside has higher treatment success rate and reduced loss to follow up than centralized care 
for MDR-TB, which involves support by specialists providers and may include care at hospital 
outpatient clinics (Ho et al., 2017). 
 
In both decentralized and centralized care, DOT is the standard practice, despite inconclusive 
evidence about the clear advantages of DOT over self-administered treatment (SAT) (World 
Health Organization, 2017c).  Community or home-based DOT takes preeminence over hospital-
based DOT, and trained providers administered DOT is superior to DOT provided by TB patient 
family members (World Health Organization, 2017c). In settings where technology and the 
requisite operational resources are available, video-observed treatment (VOT) is recommended as 
a potential replacement for DOT (World Health Organization, 2017c). Regardless, evidence from 
two cohort studies showed the lack of statistically significant difference between VOT and DOT, 
in terms of treatment completion and mortality (Chuck et al., 2016, Wade et al., 2012).  
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However, it is rationalized that VOT provides flexibility for TB patients daily schedule and 
facilitates adherence monitoring, especially when travel disrupts a planned DOT visit (World 
Health Organization, 2017c). 
 
In the KSA guideline, individualized evaluation of TB patients for the choice of care model, 
whether hospitalization or ambulatory care, is mandatory. TB patients who are medically and 
mentally stable, having verifiable addresses and identification cards and are not residing in a 
congregate setting could be treated on ambulatory basis (Saudi Ministry of Health, 2014). By 
definition, ''congregate settings include prisons, military barracks, refugee camps, homeless 
shelters, dormitories and nursing homes'' (World Health Organization, 2009b).  
 
It is uncertain whether mass gatherings, such as the Hajj constitutes a congregate setting. The KSA 
guidelines further recommend hospitalization after strict application of standard IPC measures in 
the following groups: critically ill TB patients, MDR-TB or XDR-TB patients, TB patients with 
comorbidity (HIV or uncontrolled diabetes) and those with history of non-compliance with TB 
treatment (Saudi Ministry of Health, 2014). 
 
Safeguarding TB patients’ access to palliative care alongside TB treatment alleviates suffering, 
especially for those with limited option for effective treatment, such as XDR-TB patients. The 
WHO recommends that the sufferings associated with TB should be tackled by providing 
accessible care services, ensuring adequate management of adverse events and addressing the 
psycho-social consequences of TB disease and its treatment, such as stigma and discrimination 
(World Health Organization, 2017a). Maintenance of IPC measures in the patients’ residence, 
hospital and hospice is a necessary tool for end-of-life management of TB patients with exhausted 
treatment options to protect public health (World Health Organization, 2017a). 
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3.2.3 Conclusion 
In conclusion, the KSA TB guideline largely evolved from the WHO TB treatment guidelines. 
Nonetheless, recent updates in the latter are not yet captured in published Saudi TB guideline. 
There is a need to update the national guideline based on current global TB management 
approaches, such as the withdrawal of CAT II regimen for TB retreatment and the phased 
introduction of Ultra for TB diagnosis. The diagnostic and treatment approaches for drug-resistant 
TB should be clearly addressed in the national guidelines to guide providers’ treatment choices 
and to keep them regularly informed about latest evidence-based approaches, in this ever-evolving 
and vastly complex aspect of TB management and control. 
 
3.3 Aims 
 
The study overall aim was to document and asses the management of TB cases during the Hajj 
mass gathering and whether this follows current guidelines. The main objectives of the study were: 
 
• To identify gaps and deficiencies in the management of TB cases during Hajj and areas for 
improvement. 
• To assess whether the current national/international guidelines for TB management are 
suitable/appropriate for effectively managing TB cases in the unique and specific context of 
Hajj.  
• To recommend best practices and public health policies for the optimal management of TB 
during the Hajj mass gathering which could also be beneficial to other mass gatherings 
worldwide. 
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3.4 Methods 
3.4.1 Study design 
A cross sectional study to document and assess the management of PTB cases during Hajj. 
  
3.4.2 Study location 
The study took place in Makkah, (KSA), the site of the Hajj pilgrimage. It comprised 13 hospitals 
situation in the city including Hajj holy sites, including temporary hospitals operational only 
during Hajj days, as shown in Table 2.  
 
3.4.3 Study period 
The study was conducted during the Hajj lunar month (1st-30thDulHija) during the 2016 and 2017 
Hajj seasons, corresponding to 2nd September-1st October 2016 and 22nd August-21st September 
2017, respectively.  
 
3.4.4 Study population 
The study enrolled hospitalized patients diagnosed with PTB during the study period under the 
below inclusion and exclusion criteria.   
 
3.4.4.1 Eligibility criteria 
Inclusion criteria 
Inclusion criteria for the study were as follows:   
• Consenting adults (>18 years old)  
• Male and female 
• Pilgrims or non-pilgrims 
• Admitted to any of the selected hospitals during the study period and diagnosed with PTB 
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Exclusion criteria 
Exclusion criteria from the study were as follows:   
• <18 years of age 
• Those who refuse to give consent for the study or consent could not be obtained 
• Not diagnosed with PTB 
 
3.4.5 Recruitment and data collection 
3.4.5.1 Recruitment Process 
Research assistants used hospital logbooks, admission information and information from the 
public health surveillance teams operational during Hajj to locate admitted patients with TB. The  
research team then approached the patients at an appropriate time to minimize any effect on patient 
care and obtained consent and enrolled the patients in the study. For severely ill patients, consent 
was obtained from eligible person and data was collected from the patient guardian/escort and 
other sources (e.g. clinicians and clinical records). 
 
The management of TB patients in healthcare facilities during Hajj was documented using a 
specific data collection form (see Appendix 3: Data collection form for management of 
hospitalized patients with TB) and data was collected from patient’s records, attending physician 
and through interviews with patients. Appropriate infection control measures using personal 
protective equipment (PPE) were used by researchers during visits to TB wards and during contact 
with hospitalized TB patients 
 
3.4.5.2 Data collection tools 
The data collection tools were carefully designed according to the study objectives and reviewed 
to ensure good understanding of questions and acquiring clear and precise answers. Questions were 
developed to be as precise and unambiguous as possible with emphasis on multiple choices and 
close-ended questions for accuracy. The study questionnaire and information sheet were translated 
to Arabic using a professional certified medical translator. Translated materials were then back-
translated by someone else other than the first translator to make sure that the translation was as 
accurate as possible.  
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The study tools were tried and tested prior to the actual date of data collection in places different 
from the sample settings. Final versions of research tools were revised carefully. The researchers 
conducted all interviews in English, Arabic and other participant languages with assistance from 
the Mutawif to facilitate clear communication with pilgrims, especially non-literate pilgrims.  The 
research team had training on good clinical practice and informed consent before starting data 
collection. The principal investigator also provided training on research methods to ensure that the 
study team understood the study collecting tools and research objectives. Clear step-by-step 
instructions regarding data collection was developed in English and Arabic and disseminated to 
the research assistants to maintain a standardized data collection process. PI and study team had 
determined the appropriate time to approach Mutawifs with medical missions' support. The study 
PI conducted training sessions (workshops) aimed to explain the aim of the study, objectives and 
Mutawifs' role during data collection as well as emphasised on patients' information 
confidentiality. 
 
3.4.6 Data entry and cleaning 
Data was entered following the gold standard for professional data entry which is double data 
entry. Data was entered twice in Excel and the two data sets were then compared, differences were 
examined, errors were verified against the original questionnaires and corrections were made. The 
data set was then exported to SPSS where frequencies for all variables were generated. The 
frequency tables generated were then examined to detect unusual values. Final database was 
cleaned by the principle investigator to ensure quality before analysis.  
 
3.4.7 Data analysis 
The survey questionnaire data was analyzed using SPSS 22.0 as the data management and analysis 
tool. Variables were characterized using frequencies and mean for the respective categorical and 
continuous variables. Then, a scoring system was developed, having identified four key themes from 
the questionnaire and literature review which were relevant to TB management in Hajj. The themes 
include identifying TB suspect, IPC and surveillance, diagnosing TB and treating TB. For each 
theme, we identified relevant indicators from the questionnaire that were related to the national 
guideline for TB management.  
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A score of 1 was assigned for each indicator/variable that was consistent with the 2014 KSA TB 
management guideline (latest version during study period) and 0 for inconsistency with the 
guideline. The indicator sub-score (x) for guideline consistency was obtained as follows: 
 
 X = Number of cases consistent with guidelines (c)/ Total number eligible of cases (d) * 10  
The eligible cases summed the consistent and inconsistent responses with TB guideline and strictly 
excluded missing data and unknown responses.  The guideline consistency score was obtained by 
calculating the mean of the indicator sub-scores for each theme. 
 
3.4.8 Ethics 
The study proposal was reviewed and approved by the King Fahd Medical City Internal Review 
Board (IRB log: 16-329E) (Appendix 5) and by LSTM REC approval (19-084). The study was 
conducted in accordance with the Ethics Committee’s guidelines. Prior to enrolment in the study, 
potential participants were informed in detail about the protocol purpose and procedures and the 
risks and discomforts to be expected.  Verbal consent was obtained from each participant and the 
person explaining and obtaining the consent signed and dated the data collection form. When a 
patient was illiterate or could not understand the consent statement due to language barrier, the 
consent statement was explained in his/her native language via Mutawif, the medical 
representative or a peer-pilgrim.  The information sheet and informed consent statement were 
distributed to the participant to read and ask any questions and the content was explained to them.  
The participants were informed that they were free to withdraw their consent and to discontinue 
participation at any time without prejudice or loss of benefits to which they were otherwise entitled. 
The consent statement had the name and contact details of a study representative so that 
participants had the opportunity to ask further questions if they needed to.  
 
3.4.9 Confidentiality 
The importance of privacy and confidentiality of participants was highlighted to the study team. 
All relevant data and documents were secured in locked cabinets and/or password protected files; 
with access given to selected research personnel. 
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3.5 Results 
The result of the study is discussed in several sections, depicting the main themes that were applied 
for assessing TB management in the Hajj. These include: 
 
3.5.1 Sociodemographic characteristics of tuberculosis cases 
 
Characteristics of the study population are presented in Table 17. For the two years period, 32 TB 
patients were recruited for the study from the included MOH hospitals serving pilgrims during the 
2016 and 2017 Hajj seasons. Overall, 31 patients were being managed for drug-susceptible TB 
and 1 patient had XDR-TB. The mean age of the study population was 51.3 years (SD = 18.2 years, 
range 21-83 years). Most were males (25, 78.1%) and over half (17, 58.6%) were over 50 years 
old. However, 6 patients (20.7%) were in the age group 21-30 years. Few had higher education 
(10.0%) and over half (56.7%) had only primary or no formal education.  
 
The TB patients were nationals of 10 countries (most from Saudi Arabia [34.4%] and the 
Philippines [12.5%]) but the majority (66.7%) had been residing in Saudi Arabia for at least one 
year (Table 17). Over one third of the TB confirmed cases (37.5%, 9/24) did not complete their 
Hajj rituals while the status of 50% of the cases (12/24) was not known. Three confirmed TB cases 
(12.5%) did complete their Hajj rituals in individual ambulances. For cases where the final 
outcome at the end of the study period was recorded (28 cases), 50% were discharged, 42.9% were 
still inpatients and 7.1% were referred. No mortality was recorded among the TB patients at the 
time when the study ended.   
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Table 17. Sociodemographic characteristics of the tuberculosis cases 
 
  
Variable Frequency n (%) 
Gender 
 
Male 25 (78.1) 
Female 7 (21.9) 
Age group 
 
21-30 6 (20.7) 
31-40 4 (13.8) 
41-50 2 (6.9) 
51-60 7 (24.1) 
61-70 6 (20.7) 
>70 4 (13.8) 
Level of education  
 
No Formal Education 11 (36.7) 
Primary Education  6 (20.0) 
  
Secondary Education  10 (33.3) 
University/Higher Education 3 (10.0) 
Nationality  
Saudi Arabia 11 (34.4) 
Philippine 4 (12.5) 
Indonesia 2 (6.3) 
India 3 (9.4) 
Mali 2 (6.3) 
Sudan 2 (6.3) 
Somalia 2 (6.3) 
Pakistan 3 (9.4) 
Myanmar 2 (6.3) 
Chad 1 (3.1) 
Residence in the past year 
Saudi Arabia 18 (66.7) 
India 3 (11.1) 
Pakistan 1 (3.7) 
Philippine 1(3.7) 
Indonesia 1 (3.7) 
Somalia 1 (3.7) 
Chad 1 (3.7) 
Myanmar (3.7) 
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3.5.2 Tuberculosis risk factors patient characteristics 
 
The proportion of drug-susceptible TB cases with potential or recognized TB risk factors was 
assessed in this study. These risk factors include history of recent travel to TB endemic countries, 
previous Hajj or Umrah performance, current and past tobacco smoking status and prevalence of 
chronic diseases among patients (Table 18). 
 
The majority of respondents (21, 70%) reported they had not travelled outside their current 
residential areas in the previous 1 year. Only 25% (2/8) of  respondents who reported prior travel 
visited high-burden countries (Pakistan and Indonesia). Regarding possible risk of TB exposure in 
a congregate setting, 69% (20/29) of respondents reported that they had not performed Hajj or 
Umrah within the past 1 year. The majority (75%, 6/8) of the previous Hajj or Umrah pilgrims 
were Saudi residents.  
 
Tobacco smoking was not a predominant risk factor among drug-susceptible TB patients; the 
majority (72.2%, 21/29) indicated they were not current tobacco smokers. Only a small proportion 
(27.8%, 5/18) of the current non-smokers had prior history of smoking tobacco products. Unlike 
tobacco smoking, chronic diseases were highly prevalent among drug-susceptible TB patients. 
Nearly two-thirds of respondents (63.0%, 17/27) reported having various forms of existing chronic 
diseases, including diabetes (44.4%, 12/27), hypertension (25.9%, 7/27), cardiovascular diseases 
(14.8%, 4/27), chronic lung diseases (11.1%, 3/27) and chronic kidney disease (3.7%, 1/27).  
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Table 18. Results of risk factors characteristics of tuberculosis patients 
Did you travel outside your current residential area in the past year?  
Yes 9 (30) 
No 21 (70) 
If yes, which country (s) did you visit?  
Saudi Arabia 5 (55.6) 
Indonesia 1 (11.1) 
Pakistan 1 (11.1) 
Morocco 1 (11.1) 
Sri Lanka 1 (11.1) 
Have you performed Hajj or Umrah in the past year?  
Yes 8 (27.6) 
No 20 (69.0) 
Don’t recall 1 (3.4) 
Do you currently smoke any tobacco product?  
Yes 8 (27.6) 
No 21 (72.2) 
If no, did you ever smoke tobacco product in the past?  
Yes  5 (27.8) 
No 13 (72.2) 
Do you have any chronic health condition?  
Yes 17 (63.0) 
No 10 (37.0) 
If yes, do you have any of the following:  
Diabetes  
Yes   12 (44.4) 
No 15  (55.6) 
Chronic kidney disease  
Yes 1 (3.7) 
No 26 (96.3) 
Chronic lung disease  
Yes 3 (11.1) 
No 24 (88.9) 
Cardiovascular disease  
Yes 4 (14.8) 
No 23 (85.2) 
Hypertension   
Yes 7 (25.9) 
No 20 74.1) 
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3.5.3  Infection prevention and control 
 
Upon registration, most (76.6%, 23/30) suspected TB patients were admitted to an isolation room 
or ward. Otherwise, the patients were either admitted into the ER (6.7%, 2/30), ICU (6.7%, 2/30), 
neurosurgery ward (3.3%, 1/30), orthopedic ward (3.3%, 1/30) or general ward (3.3%, 1/30). 
While a proportion (48.4%, 15/32) of suspected TB patients was separated from other patients 
during registration, the triaging status of 45.2% (14/32) of suspected TB patients was not reported 
(Table 19). In a few instances (6.5%, 2/32), the suspected TB patients were not separated from 
other TB patients in the hospital.  
 
While waiting diagnosis, most suspected TB patients (77.4%, 24/31) were housed in an isolation 
room or ward. Otherwise, the suspected TB patients were housed either in ER (12.9%, 4/31), ICU  
 (3.2%, 1/31), neurosurgery ward (3.2%, 1/31), or general ward (3.2%, 1/31). On confirmation of 
drug-susceptible TB diagnosis, the proportion of TB cases isolated rose to 96.7% (30/31). Only 1 
(3.2%) confirmed TB patient was managed in the ER. Generally, most (93.1%, 27/29) confirmed 
drug-susceptible TB patients spent less than 1 day in the health facilities before they were isolated. 
Delays in the isolation of confirmed drug-susceptible TB patient was documented in 2 cases, one 
3-7 days and another over 7 days delay. 
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Table 19. Results of infection prevention and control tuberculosis management theme 
TB=tuberculosis, PTB=pulmonary tuberculosis, ER=emergency room, ICU=intensive care unit 
 
3.5.4 Early detection of drug-susceptible tuberculosis through systematic screening 
 
This section focuses on the level of compliance with key recommendations for systematic 
screening of TB suspects to aid timely detection of TB cases (Table 20). In all cases, appropriate 
symptoms were sought from TB suspects. The most common symptoms obtained from TB 
suspects were cough ≥ 2 weeks duration (64.5%, 20/31) and fever with chills/ night sweat (67.7%, 
21/31). Other TB symptoms were less frequently reported, and these include weight loss (32.3%, 
10/31), any productive cough (22.6%, 7/31), chest pain (16.1%, 5/31) and hemoptysis (6.5%, 
2/31).  
 
Infection prevention and control  Frequency n (%) 
Was the patient separated from other patients during registration (triaging)? 
Yes 15 (48.4) 
No 2  (6.5) 
Don’t Know 14 (45.2) 
Where was the TB suspected patient admitted while awaiting diagnosis? 
General Ward 1 (3.2) 
ER 4 (12.9) 
Isolation ward/room 24 (77.4) 
ICU 1 (3.2) 
Neurosurgery ward 1 (3.2) 
Where was the confirmed PTB patient admitted in the healthcare facility? 
ER 1 (3.2) 
Isolation ward/room  29 (93.5) 
Neurosurgery isolation ward 1 (3.2) 
How long was the confirmed PTB patient in the healthcare facility from arrival to isolation? 
<1 day 27 (93.1) 
1-2 days 0 (0.0) 
3-7days 1 (3.4) 
>7days 1 (3.4) 
 Chapter 3: Management of hospitalized pulmonary tuberculosis patients during the hajj Mass gathering 
 
 
144 
 
The history of contact with active TB cases was obtained from 45.2% (14/31) of suspected TB 
cases. Nonetheless, the proportion of suspected TB cases for which providers did not obtain the 
history of contact with active TB cases was disproportionately lower (12.9%, 4/31), due to the 
large proportion of unknown responses (41.9%, 13/31) that were reported for this variable. In 
general, 44.8% (13/29) of the TB suspects were questioned about TB risk factors. Specifically, the  
proportion of TB suspects questioned about their country of residency, HIV status and potential 
occupational exposure to TB were 27.6% (8/29), 20.7% (6/29) and 27.6% (8/29) respectively. 
Furthermore, in the majority of case, providers used recommended screening test for active TB in 
case management; chest X- ray was conducted for 67.7% (21/31) of the TB suspects. 
 
 
Table 20. Results for systematic screening of tuberculosis patients 
Early TB detection through systematic screening           Frequency n (%) 
Has the history of contact with active TB cases been obtained from suspected TB case? 
Yes 14 (45.2) 
No 4  (12.9) 
Don’t Know 13 (41.9) 
Has the suspected TB case been questioned about other TB risk factors? 
Yes 13 (44.8) 
No 16 (55.2) 
Was the suspected TB case asked about HIV status? 
Yes 6 (20.7) 
No 23 (79.3) 
Was the suspected TB case asked about occupational risk factors? 
Yes 8 (27.6) 
No 21 (72.4) 
Was the suspected TB case asked about its country of residence? 
Yes 8 (27.6) 
No 21 (72.4) 
What symptom warranted the suspicion of PTB? 
Cough ≥ 2 weeks 
Yes   20 (64.5) 
No 11  (35.5) 
Hemoptysis 
Yes 2 (6.5) 
No 29 (93.5) 
Any productive cough 
Yes 7 (22.6) 
No 24 (77.4) 
Chest pain 
Yes 5 (16.1) 
No 26 (83.9) 
Fever/Night sweats/chills 
Yes   21 (67.7) 
No 10  (32.3) 
Weight loss 
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Cont..Table 20. Results for systematic screening of tuberculosis patients 
Early TB detection through systematic screening           Frequency n (%) 
 
Yes 10 (32.3) 
No 21 (67.7) 
 
Other symptoms 
Yes 9 (29.0) 
No 22 (70.9) 
Was an appropriate screening test for active TB conducted? 
Yes 21 (67.7) 
No 10 (32.3) 
TB= tuberculosis, PTB=pulmonary tuberculosis, HIV=human immunodeficiency virus 
 
3.5.5 Diagnosing drug-susceptible tuberculosis 
 
In terms of diagnostic period, 50% (5/10) of TB suspected patients within known health facilities 
visits status had > 2 visits to the health facilities before appropriate screening/diagnostic tests were 
ordered (Table 21). However, the period between patient registration/arrival in the health facilities 
and order of screening/diagnostic test was ≤12 hours in 77.4% (24/29) of cases. In nearly half 
(46.7%, 14/30) of the cases, the period between ordering screening/diagnostic tests and 
confirmation of TB diagnosis was 1-2 days. This diagnostic period was shorter (< 1 day) in 36.7% 
(11/30) and longer (3-7 days) in 16.7% (5/30) of cases. Using the difference between the date of 
confirmation of diagnosis and the arrival date as secondary proxy, the proportion of cases 
confirmed within each diagnostic period is given as: <1 day (16.6%, 4/24), 1 day (20.8%, 5/24), 2 
days (25%, 6/24), 3 days (12.5%, 3/24), 4 days (12.5%, 3/24) and 5 days ( 8.3%, 2/24).  
 
Sputum culture was the diagnostic test utilized in the majority (67.7%, 21/29) of cases. Smear 
microscopy alone and sputum culture combined with smear microscopy was used less frequently 
in 9.7% (3/29) and 19.4% (6/31) of cases respectively. Xpert MTB/RIF assay was not utilized for 
TB diagnosis. In one instance, none of the recommended diagnostic tests were ordered for the TB 
suspected patient. Only 12.9% (4/28) of suspected/confirmed TB cases were screened for HIV 
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Table 21. Results of variables related to tuberculosis diagnosis 
TB; tuberculosis, PTB, pulmonary tuberculosis, HIV; human immunodeficiency virus 
 
3.5.6 Treating drug-susceptible tuberculosis 
This section explores the compliance of providers with the requirements for drug-susceptible TB 
treatment, including the choice of an appropriate TB regimen. In over half of cases (58.1%, 18/31), 
the TB suspected patients were questioned about their previous TB treatment (Table 22). However, 
in quarter of the cases (25.8%, 8/31), it was not known if the previous history of TB treatment was 
obtained from the TB suspected patient. Regarding TB treatment regimen, the majority of 
confirmed TB patients (77.7%, 21/27) received either four 1st-line anti-TB drugs (INH-RIF-PZA-
EMB) in 37.0% (10/27) of the cases or three 1st-line anti-TB drugs (40.7%, 11/27).  
  
Diagnosing TB Frequency n (%) 
Number of visits to the healthcare facility before screening/diagnosis tests were ordered for the patient 
1 visit 3 (30.0) 
2 visits  2 (20.0) 
>2 visits  5 (50.0) 
Which diagnostic tests were ordered for the TB suspected patient? 
Sputum culture 21 (67.7) 
Smear microscopy 3 (9.7) 
Sputum culture + smear microscopy 6 (19.4) 
None 1 (3.2) 
Time between patient registration/arrival and the order of screening/diagnostic tests 
<1 hour 3 (9.7) 
1-12 hours 21 (67.7) 
>12-24 hours 2  (6.5) 
>24 hours 3 (9.7) 
Time between order of screening/diagnostic tests and confirmation of active PTB? 
<1 day 11 (36.7) 
1-2 days 14 (46.7) 
3-7 days 5  (16.7) 
Was the suspected/confirmed TB patient screened for HIV? 
Yes   4 (12.9) 
No 21 (87.1) 
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Among those that received three 1st-line anti-TB drugs, 54.5% received RIF-PZA-EMB, 36.6% 
had RIF-INH-EMB and 9.0 % were given INH-EMB-PZA. For the remaining patients, 11.1% 
(3/27) received two 1st-line anti-TB drugs (66.6% INH-RIF, 33.4% RIF-EMB), 7.4% (2/27) 
received one anti-TB drug (RIF) and one case was recorded to have received no anti-TB drugs. In 
general, RIF was the most subscribed anti-TB drug (in 25 cases), followed by EMB (in 22 cases) 
and INH and PZA (both in 17 cases).  
 
Based on the duration of Hajj season (about one month), the possibility of monitoring treatment 
completion is unfeasible in a Hajj study. Thus, appropriate post-Hajj referral and provision of 
drugs to last during the referral period were proxies for estimating possible continuity of care. In 
most cases it was not known whether confirmed TB patients were referred for further treatment 
after completion of Hajj (77.3%, 17/22) or were given enough anti-TB drugs to last until they 
arrive in their country of residence (61.6%, 11/18).  
 
Table 22. Results of variables related to tuberculosis treatment 
 
 
Treating TB Frequency n (%) 
Has the TB suspected patient been questioned about his/her TB history? (i.e. previous TB diagnosis, 
previous TB treatment) 
Yes 18 (58.1) 
No 5 (16.1) 
Don’t know 8 (25.8) 
Was the confirmed PTB patient prescribed an appropriate treatment regimen? 
Four 1st-line agents 10 (37.0) 
Three 1st-line agents 11 (40.7) 
Two 1st-line agents 3 (11.1) 
One 1st-line agents 2 (7.4) 
None 1 (3.7) 
Was the confirmed PTB patient given enough TB treatment to last until his arrival to his/her country of 
origin? 
Yes 6 (33.3) 
No 1 (5.6) 
Don’t know 11  (61.1) 
Was the confirmed PTB patient referred for further treatment after Hajj? 
Yes   1 (4.5) 
No 4 (18.2) 
Don’t know 17 (77.3) 
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3.5.7 Tuberculosis case notification 
 
This section focuses on the compliance of providers with the mandatory requirement for 
notification of TB cases. In 76.7% (23/30) of cases, the confirmed TB cases were reported to the 
KSA MOH preventive medicine department (Table 23). The reporting status of 23.3% (7/30) of 
the TB patients was unknown. A proportion (44.8%, 13/29) of the confirmed TB cases was 
reported to the appropriate country medical missions’ office. This excludes the 48% (14/29) of 
confirmed TB cases with unknown medical missions’ reporting status. Among the latter, 57.1%  
were Saudi residents. The study also showed that the confirmed TB case status of two residents of 
Pakistan and Myanmar were not reported to their respective country medical mission’s office. 
 
Table 23. Results of tuberculosis notification variables 
Notification Frequency n (%) 
Was the confirmed PTB patient reported to his country’s medical office? 
Yes 13 (44.8) 
No 2 (6.9) 
Don’t know 14 (48.3) 
Was the confirmed PTB patient reported to the Ministry of Health preventative medicine department? 
Yes 23 (76.7) 
Don’t know 7  (23.3) 
PTB=pulmonary tuberculosis 
 
3.5.8 Guideline compliance scores 
 
As illustrated in Figure 19, out of a maximum possible score of 10, the guideline compliance score 
was highest for the themes IPC and surveillance (9.6) and identifying TB suspects (7.2). The least 
scores were obtained for the themes treating TB (5.0) and diagnosing TB (3.0). Tables 24-27 show 
how these scores were calculated and the contribution of variables to their respective final theme 
score is depicted as sub-scores in Figure20.  
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For identifying TB suspects, a maximum compliance sub-score (10) was obtained for 
“implementing symptom-based screening”. Lower but above average sub-scores were recorded 
for “obtaining relevant history of TB close-contact” (7.8) and “conducting appropriate TB 
screening tests” (6.8). The least sub-score (4.5) was obtained for “obtaining history of TB risk 
factors”. A maximum sub-score (10) were also obtained for “pre-diagnosis admission ward” and 
case notification, under the IPC and surveillance theme. Slightly lesser sub-scores were calculated 
for other variables, including “post-diagnosis admission ward” (9.7) and “triage management” 
(8.8).  
 
For diagnosing TB, the sub-score for “number of diagnostic visit” was 5.0.  In comparison, the 
sub-scores obtained for “appropriate diagnostic tests” and “HIV testing” were 2.9 and 1.3 
respectively. These latter sub-scores further downgraded the total theme score for diagnosing TB. 
Similarly, the sub-scores of two variables further reduced the final theme score for treating TB 
(Figure20). Despite scoring 7.5 for “pre-diagnosis treatment”, the sub-scores for “appropriate TB 
regimen” (3.1) and “transfer out” (2.0) reduced the final theme score for treating TB to less than 
average.  
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Table 24. Calculating guideline consistency score for identifying tuberculosis suspects theme 
Indicator KSA TB management guideline Total 
eligible 
cases1 (d) 
Number of cases 
consistent with 
guideline (c) 
Indicator score 
(x) 
Symptoms and signs was basis for screening 
suspected TB case? 
Persons with signs and symptoms consistent 
with TB should be evaluated for TB 
31 31 31/31*10 
X =10 
TB suspect questioned about history of close 
contact active PTB cases?  
All close contacts of patients with PTB 
should be screened for TB 
18 14 14/18*10 
X =7.77 
 
TB suspect questioned about TB risk 
factors? 
 
Systematic screening of high risk groups, 
especially people living with HIV and 
workers exposed to silica for active TB  
29 13 13/29*10 
X =4.48 
 
Which screening tests were ordered for the 
TB suspected patient? 
Chest radiography is recommended as a non-
diagnostic screening test for active PTB 
31 21 21/31*10 
X =6.77 
 
Guideline compliance score     
 
29.02/4 
=7.25 
1=Excludes missing data and unknown response 
KSA; Kingdom of Saudi Arabia, TB; tuberculosis, PTB, pulmonary tuberculosis, HIV; human immunodeficiency virus 
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Table 25. Calculating guideline consistency score for infection prevention and control and surveillance theme 
      Indicator KSA TB management guideline Total 
eligible 
cases1 (d) 
Number of cases 
consistent with 
guideline (c) 
Indicator score 
(x) 
TB patient separated from other patients in 
the healthcare facility during registration 
(triaging) 
people suspected of having TB must be 
separated from other patients, placed in 
adequately ventilated areas 
17 15 15/17*10 
X =8.82 
Where the TB suspected patient admitted 
while awaiting diagnosis 
 
TB suspects should not be admitted to wards 
harboring severely immunocompromised 
patients 
31 31 31/31*10 
X =10 
 
Where the confirmed PTB patient admitted 
in the healthcare facility? 
In case of hospitalization, TB patients 
should be admitted into TB wards 
31 30 30/31*10 
X =9.67 
 
Confirmed PTB patient reported to the 
Ministry of Health preventative medicine 
department 
All providers must report TB cases and their 
outcomes to appropriate local authorities in 
line with local policies and laws 
23 23 23/23*10 
X =10 
 
      Total guideline  
      consistency score 
   38.49/4 
=9.62 
1=Excludes missing data and unknown responses 
KSA; Kingdom of Saudi Arabia, TB; tuberculosis, PTB; pulmonary tuberculosis 
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Table 26. Calculating guideline consistency score for diagnosing tuberculosis theme 
Indicator KSA TB management guideline Total 
eligible 
cases1 (d) 
Number of cases 
consistent with 
guideline (c) 
Indicator score 
x 
1. Appropriate diagnostic tests were 
ordered for the TB suspected patient 
• Sputum microscopy should follow chest 
radiographic findings consistent with TB  
 
31 9 9/31*10 
X =2.90 
2. Was the new TB patient screened for 
HIV 
• Test all TB patients for HIV before 
starting TB treatment 
31 4 4/31*10 
X =1.29 
3. ≤ 2 visits before TB diagnosis was 
confirmed 
 
• Examine two consecutive smears over 2 
days (including 1 early morning sample)  
10 5 5/10*10 
X =5.0 
Total guideline  
  consistency score 
   9.19/3*10 
=3.06 
1=Excludes missing data and unknown response 
KSA=Kingdom of Saudi Arabia, TB=tuberculosis, PTB=pulmonary tuberculosis, HIV=human immunodeficiency virus 
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Table 27. Calculating guideline consistency score for the treating drug-susceptible tuberculosis theme 
Indicator KSA TB management guideline Total 
eligible 
cases1 (d) 
Number of cases 
consistent with 
guidelines (c) 
Indicator score 
x 
1. Patient received potential 1st-line or 
2nd-line agents before confirmation of 
PTB? 
• TB treatment must not be started before 
confirmation of TB diagnosis 
18 17 17/18*10 
X =9.44 
2. Was the confirmed PTB patient 
prescribed an appropriate treatment 
regimen  
• 2INH-RIF-PZA-EMB/4INH-RIF 
implies use of 4 drugs in the intensive 
phase and 2 drugs in the continuation 
phase 
27 10 10/27*10 
X =3.70 
 
 
3. Was the confirmed PTB patient 
referred for further treatment after 
Hajj? 
 
• -Optimal daily dosing required 
throughout treatment 
• -Linkage to continuous care (transfer-
out) is vital for preventing treatment 
interruption  
5 1 1/5*10 
X =2.0 
Total guideline compliance score     15.1/3 
=5.04 
1=Excludes missing data and unknown response 
KSA=Kingdom of Saudi Arabia, TB=tuberculosis, PTB=pulmonary tuberculosis, INH=isoniazid, EMB=ethambutol, PZA=pyrazinamide 
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Figure 19. Chart showing tuberculosis guidelines compliance scores (out of 10) for tuberculosis management 
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Figure 20. Shows sub-scores (out of 10) for each main theme describing the level of compliance with tuberculosis guideline
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3.5.9 Managing extensively drug-resistant tuberculosis 
 
The management approaches for the single case of XDR-TB is discussed in this section. 
The confirmed XDR-TB patient was a 32-year-old female Philippine national, who has been 
residing in Saudi Arabia for at least the previous 1 year. She had only primary education and 
did not work in fields of increased occupational exposure or risk of TB. She was known to be 
diabetic and had no recent history of travel from her country of residence in the previous year. 
She had not performed Hajj or Umrah in the past and had no current or prior history of tobacco 
smoking. It was unknown whether providers obtained relevant history of TB risk factors, 
including HIV status, from the patient. 
 
The patient presented to the healthcare facility on the 18th of August 2016 and on arrival, 
providers separated her from other patient based on her presenting signs and symptom (chest 
pain). She was initially admitted in the ER with an admission diagnosis of community acquired 
pneumonia. The case was confirmed to have TB on the same day of arrival at the healthcare 
facility and was transferred to an isolation room where she remained until discharge. The 
records showed that the TB screening and diagnostic tests carried out for the patient were chest 
X-ray and sputum culture. Other vital investigations for TB such as smear microscopy and HIV 
testing were not ordered for the patient. The patient was questioned regarding previous TB 
treatment and defaulting from it, but it was not reported if she was questioned regarding relapse 
after previous TB treatment. The case was confirmed as XDR-TB on the 5th September 2016, 
18 days after admission and isolation.  
 
The confirmed XDR-TB patient was notified to the MOH’s preventive health department, as 
well as her medical officer. The patient was treated and discharged but it was not known if she 
was discharged to complete her Hajj rites, or whether she was referred after Hajj or given 
sufficient treatment for the transit period. It was also unclear, if she was commenced on a 
recommended regimen for XDR-TB 
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3.6 Discussion 
This study exemplifies the compliance of tertiary healthcare providers with national guidelines 
for TB management. The result showed high level of compliance with the assessed indices for 
systematic screening of TB suspects, IPC and case notification, but low compliance scores 
were obtained for prompt TB diagnosis and use of standardized treatment regimen for drug 
susceptible TB. 
 
Most TB cases in the current study were males (78.1%) which is in accordance with global 
data. The WHO estimates that in 2016, among the 10.4 million people who fell ill with TB, 
65% were males (World Health Organization, 2017b). Data from national TB surveys from 
numerous countries indicate higher burden of TB disease among males with the male to female 
ratios of cases ranging from 1.2 (in Ethiopia) to 4.5 (in Vietnam) for bacteriologically 
confirmed TB. In most countries, the ratio was in the range 2-4(World Health Organization, 
2017b). Over half of the TB cases were over 50 years old (58.6%) with primary or no formal 
education (56.7%). Extremes of age are risk factors for TB,(Marais et al., 2013) and the 
prevalence of TB increases with age (Hoa et al., 2010, Onozaki et al., 2015, Qadeer et al., 
2016). Similarly, TB risk, prevalence and impact are associated with socioeconomic status of 
which education is one indicator.  
 
Individuals with low socioeconomic status including low or no education have higher TB risk 
and prevalence, are less likely to seek medical care, have longer diagnosis delay time and are 
at higher risk of death from TB (Jurcev-Savicevic et al., 2013, Needham et al., 2001, Sanchez-
Barriga, 2015). Studies conducted among Hajj pilgrims also found supportive results. For 
instance, Alzeer and colleagues (Alzeer et al., 1998) reported that the mean age of TB patients 
during the 1994 Hajj was 60 years, while in 2015, Yezli et al.(Yezli et al., 2017b) found that 
the age of undiagnosed TB cases among pilgrims was 58.5 years. In the latter study, pilgrims 
aged over 64 years were 5.3 times more likely to be TB positive than those aged 47 years old 
or less. Also, education was strongly associated with TB prevalence and pilgrims with no 
formal education being 4 times more likely to have TB (Yezli et al., 2017b). 
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Beside the predominant older males distribution of cases, socio-demographic risk factors for 
TB, such as history of tobacco smoking, visit to, or residence in high-burden countries and 
occupational exposure were uncommon among TB patients in the study. Yezli and colleagues 
(Yezli et al., 2017b) reported that the prevalence of undiagnosed TB in Hajj was higher among 
pilgrims residing in South Asia and those who traveled outside their current country of 
residency in the previous year, although the association was not statistically significant for 
these factors. Among the TB cases identified, 80% were from Afghanistan 13.3% from 
Pakistan and 6.7% from Nigeria. Also, 26.6% of the cases reported traveling to a TB endemic 
country in the previous year. It is known that travel to TB-endemic areas is a risk for TB 
(Marais et al., 2013). 
 
In our study, around 28% of the TB cases reported being current smokers and a similar 
proportion indicated that they did smoke in the past. This is higher than that reported in another 
study among Hajj pilgrims with TB (13.3%) (Yezli et al., 2017b) but lower than figures from 
international reports (Brunet et al., 2011, Kolappan and Gopi, 2002, Mahishale et al., 2015).  
There is strong evidence that smoking is significantly associated with increased risks of TB 
infection and disease, TB mortality and recurrent TB (Bates et al., 2007, Khan et al., 2015, 
Kolappan and Gopi, 2002, Lin et al., 2007). Also TB patients who have smoked are more likely 
to transmit TB to their contacts (Kenyon and Zondo, 2011). In addition, exposure to 
environmental tobacco smoke and passive smoking increases the risks of TB infection and 
developing disease (du Preez et al., 2011, Lin et al., 2007, Sridhar et al., 2014).  Smoking also 
influences the clinical manifestations and outcomes of TB adversely affecting baseline disease 
severity, bacteriological response, treatment outcome and relapse in TB and leading to a faster 
and more sever progression to TB (Altet-Gomez et al., 2005, Leung et al., 2015). Smokers 
develop more extensive pulmonary disease, more lung capitation and cavitary lesions, more 
positive sputum smear and culture at the baseline and are more likely to require hospitalization 
(Altet-Gomez et al., 2005, Leung et al., 2015). It is estimated that by 2050, smoking would 
lead to an excess of 18 million TB cases (Loddenkemper et al., 2016). 
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Previous Hajj or Umrah performance were uncommon among TB patients in this study. While 
these events are not an established risk factor for TB transmission, few studies have shown that 
clinically-recognized or undiagnosed active TB are potential sources of TB transmission during 
these mass gatherings (Alzeer et al., 1998, Wilder-Smith et al., 2005, Yezli et al., 2017b). 
Pilgrims were reported to have a 10% risk of acquiring TB infection after attending the Hajj 
(Wilder-Smith et al., 2005). Given the overcrowded living conditions of pilgrims, which are 
similar to the situation in highlighted congregate settings for TB transmission (prisons, refugee 
camps etc.), Hajj or Umrah performance may have far-reaching implications in the global 
epidemiology of TB.  
 
The majority (66.7%) of TB patients in this study were KSA residents. This may be explained 
by the fact that the study included both pilgrims and non-pilgrims and that healthcare facilities 
in Makkah provide healthcare to pilgrim and non-pilgrim during the Hajj. Although Saudi 
Arabia is not a high TB burden country, TB incidence in the country show significant regional 
variation with the Makkah region showing much higher TB incidence rates than the rest of the 
country and rising trend (Al-Orainey et al., 2013, Yezli and Memish, 2012). In addition to the 
hosting of the Hajj and Umrah mass gatherings, this high TB incidence may also be related to 
the fact that 40% of the Makkah region population are non-Saudis, many originate from and 
frequently visit high TB burden countries (Al-Orainey et al., 2013, Yezli and Memish, 2012). 
Some of this population are illegal immigrants who also tend to live in poor housing conditions 
and have limited access to healthcare because of fear of deportation. It is likely that they 
contribute significantly to the high incidence of the disease in the Makkah region (Al-Orainey 
et al., 2013). Regardless, it is evident that previously postulated control measures for TB, such 
as pre-arrival screening for active TB should not only target international pilgrims or those 
arriving from high burden countries (Yezli et al., 2017b),  it should also identify effective 
strategies for systematic/targeted screening of intending pilgrims from within the Kingdom. 
 
Beyond socio-demographic risk factors, 63% of the TB patients in this study reported they had 
coexisting chronic diseases. This includes 44.4% of TB patients that had diabetes. This is 
higher than that reported internationally (Bates et al., 2012, Hochberg et al., 2017, Peltzer, 
2018). The presence of chronic diseases, especially immunosuppressive health conditions, 
increases the risk of TB disease, predisposes to severe illness and complicates TB treatment 
(Falzon et al., 2011, Stevenson et al., 2007). 
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 In a study among Hajj pilgrims, at least 33% of TB cases had an underlying health condition, 
mainly diabetes or hypertension and although not statistically significant, pilgrims with 
underlying health conditions were twice more likely to have TB than those without an 
underlying health condition (Yezli et al., 2017b). Bates and colleagues (Bates et al., 2012) 
reported the co-morbidity of diabetes, respiratory, renal and cardiovascular disorders with 
culture-positive TB in inpatients to be 21.1%, 15.5%, 10.5% and 3.2% respectively. The burden 
of TB was significantly greater in diabetes patients (OR =6.6, p= 0.025). As such, the 
management of co-morbidities is now a key focus of the integrated, patient-centered care and 
prevention strategy of global TB control (World Health Organization, 2015a). 
 
Generally, home-based care for TB is preferred to methods of care that are based on strict 
hospitalization (Saudi Ministry of Health, 2014, World Health Organization, 2016e).  In the 
KSA context, medical or mental instability and residence in congregate settings are among 
factors that may warrant hospitalization (Saudi Ministry of Health, 2014). In this study, most 
of the suspected and confirmed TB patients were admitted and isolated for TB management. 
To the best of our knowledge, there is no standardized global protocol guiding the choice of 
suitable models of care-whether home based or hospitalized care- during international mass 
gatherings. However, considering the constant mobility of pilgrims and challenges in verifiable 
or stable residences for pilgrims during Hajj, hospitalization, although undesirable, seems a 
logical and practical choice for TB management during the mass gathering. Nonetheless the 
psycho-social consequences of prolonged isolation could be exacerbated among TB patients 
that are unable to or hindered from performing their Hajj rites due to hospitalization. In addition 
to the psycho-social needs of TB patients, hospitalization fuels the nosocomial transmission of 
TB especially in resource-limited settings lacking adequate IPC measures (Escombe et al., 
2010, Kanjee et al., 2011). 
 
IPC in healthcare settings is one of the key strategies for TB control (World Health 
Organization, 2009b). However, implementation of IPC recommendations seems to be 
inadequate with several studies reporting poor TB infection control measures in health facilities 
(Demissie Gizaw et al., 2015, Farley et al., 2012, He et al., 2010, Ogbonnaya et al., 2011). 
Further, many HCWs are practicing without adequate infection control training and often lack 
knowledge on TB infection control strategies (Demissie Gizaw et al., 2015, Kanjee et al., 2011, 
Shrestha et al., 2017, Woith et al., 2012).  
 Chapter 3: Management of hospitalized pulmonary tuberculosis patients during the hajj Mass gathering 
 
 
161 
In the current study, we report high compliance with the aspects of TB IPC measures 
investigated, with a combined compliance score for IPC and surveillance of 9.6 out of a 
maximum score of 10. Effective separation of patients presenting with symptoms and signs 
consistent with TB (Triage) was reported in nearly half of cases though the triage management 
of a similar proportion of patients was unknown. The result also showed that the majority 
(76.6%) of TB suspects were admitted in an isolation ward or room, while awaiting TB 
diagnosis. On confirmation of TB diagnosis, all but 2 patients were admitted in negative 
pressure isolation rooms for TB management.  
 
The high compliance scores for IPC may stem from measures taken by the KSA MOH to 
prevent and control the recent national healthcare-related outbreaks (not Hajj-related) of 
Middle East Respiratory Syndrome (MERS) in some major cities in the Kingdom (Rabaan, 
2017) MERS causes acute respiratory distress syndrome and while its precise mode of 
transmission is still unclear, like TB, it does spreads through infected person's respiratory 
secretions such as through coughing and sneezing (Xiao et al., 2018). Thus, the infection 
control practices for TB and MERS are comparable and targeting one disease may have dual 
impact on both diseases control efforts. The implementation of standard TB infection control 
practices is often challenging in low-income countries, due to the high cost of achieving and 
maintaining the requisite standards. In such settings, TB infection control is undermined by 
inadequate staff training, lack of infection control policy and unavailability of effective 
screening procedures and suitable isolation areas for suspected TB patients (Escombe et al., 
2010, Kanjee et al., 2011). Since a proportion of these low-income countries send pilgrims to 
the Hajj and set up clinics to provide health services for their pilgrims, the aforementioned 
factors may also impact on TB control during the pilgrimage, especially if these largely 
temporary health facilities are poorly monitored and regulated by the KSA MOH.   
 
In the current study, providers utilized presenting symptoms to correctly identify suspected TB 
patients in all cases. Cough and fever with chills/night sweat were the most frequent symptoms 
among patients. This finding corroborates existing evidence that identifies cough as the most 
common symptom of PTB (Santha et al., 2005, World Health Organization, 2011a, 2013c). 
Adequate knowledge of TB symptoms and risk factors among providers are prerequisites for 
correct and prompt identification of suspected TB patients for screening and diagnosis (Saudi 
Ministry of Health, 2014, World Health Organization, 2017a).  
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In such regards, we found that less than half of the TB suspected cases were questioned about 
TB risk factors. In majority of cases (67.7%), chest X-ray, a recommended screening tool for 
active TB, was conducted for the TB suspects. Chest X-ray is particularly more sensitive for 
TB screening after a positive symptom screening (Van’t Hoog et al., 2013, World Health 
Organization, 2013c). In view of the significant use of both symptom-based and radiological 
screening methods in this study, a total guideline compliance score of 7.2 out of 10 was 
obtained for the prompt identification and screening of TB suspects theme for TB 
management.     
 
A low guideline compliance score was obtained for the TB diagnosis theme with reference to 
national and international diagnostic standards. Sputum culture was the only recommended 
diagnostic test applied in about 70% of cases. Since TB testing using sputum culture takes at 
least 2-3 weeks to produce results, the application of sputum culture as the singular diagnostic 
test is not consistent with approved standards for TB diagnosis. By the third day of arrival in 
the health facility, 79.1% of the suspected TB cases had been confirmed to have drug-
susceptible TB. Apparently, while still waiting for sputum culture results, providers relied on 
screening tests, such as chest X-ray for the confirmation of TB diagnosis. This practice is 
inconsistent with both national and international guidelines; chest radiography is only 
recommended for screening purposes.  
 
The 2014 KSA TB guidelines recommended that appropriate sputum samples should be 
obtained for microscopy from all suspected TB patients following chest radiology or symptom-
based screening (Saudi Ministry of Health, 2014). The guideline further recommended the use 
of Xpert MTB/RIF as an initial diagnostic test for all suspected TB patients, on a conditional 
basis(Saudi Ministry of Health, 2014). As such, the latter was not included in the scoring 
criteria for this study; scoring was premised on the inclusion of sputum microscopy in the 
diagnostic cascade for TB. Nonetheless, Xpert MTB/RIF, which could detect TB and MDR-
TB by proxy in the same da y(World Health Organization, 2010b), was not applied for TB 
diagnosis in this study. 
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 This is potentially related to lack of knowledge regarding this recent technology and lack of 
Xpert MTB/RIF testing capability in many settings across the Kingdom. Although available in 
a number of Saudi hospitals, the roll out of Xpert MTB/RIF has been slow, and the application 
of the molecular testing method is mainly confined to reference laboratories for diagnosis and 
research but not for point-of-care testing (Somily et al., 2016, Yezli et al., 2017b). 
 
Understandably, KSA is not among the countries with high-burden of TB globally and there 
are other competing national public health priorities (World Health Organization, 2017b) 
However given that the Kingdom regularly hosts pilgrims from several countries, including 
high-burden countries, the Hajj and Umrah-related prevalence and epidemiology of TB may 
differ from those of the entire country. Evidently, Kingdom-wide, TB infection is more 
prevalent in the Hajj and Umrah host cities (Jeddah, Makkah and Medina) (Yezli and Memish, 
2012).  In addition to the epidemiological considerations, access to same day diagnosis of TB 
could prove valuable in a highly mobile Hajj population where follow-up visits to the same 
health facility may not be guaranteed. For example, the observed prolonged delay in the 
confirmation of the only MDR-TB case in the current study could have been avoided if Xpert 
MTB/RIF testing was available and used. As such, KSA authorities should consider the 
provision of Xpert MTB/RIF testing capability in health facilities within the Hajj areas to 
facilitate rapid (same day) diagnosis of TB during the mass gatherings, in line with national 
and international TB control goals.  
 
The risk of developing TB is estimated to be 20 (17-23) times greater in people living with 
HIV than among those without HIV infection and TB is the leading cause of death among 
people with HIV (World Health Organization, 2017d).  In 2017, an estimated 920,000 people 
living with HIV worldwide fell ill with TB and 300,000 people died from HIV-associated TB 
in the same year (World Health Organization, 2017b, 2017d). Due to the synergistic 
relationship between HIV and TB, it is recommended that all TB patients should be screened 
for HIV (World Health Organization, 2017a). Yet, only a fraction of TB patients were 
questioned about their HIV status (20.7%) or tested for HIV (12.9%) in this study. This is much 
lower than what is reported globally. According to the WHO, 60% of new and relapse TB 
patients (3.8 million) in 2017 had a documented HIV test (World Health Organization, 2017d). 
As a low prevalence setting, knowledge of HIV among healthcare workers is low in Saudi 
Arabia (Memish et al., 2015b).  
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 On the other hand, in high HIV/TB prevalence countries such as South Africa, it was reported 
that 94% of healthcare workers screen TB patients for HIV (Bhebhe et al., 2014). Considerably, 
HIV could be a more frequent comorbidity among pilgrims who arrive with active TB from 
areas with high HIV disease prevalence (World Health Organization, 2017b).  
 
More so, a missed or delayed HIV diagnosis in a TB patient stalls the commencement of 
appropriate treatment and results in poor outcomes for the patient, community and health 
system (Yan et al., 2015).  Therefore, healthcare providers in KSA ought to be trained and 
guided to conduct screening for HIV and other comorbidities in all suspected TB patients 
irrespective of their nationality. 
 
The main strategies to control TB are early diagnosis and prompt treatment initiation. Delayed 
diagnosis of TB can enhance the transmission of infection, worsen the disease, increase the risk 
of death, and may be a reason why TB incidence has not declined substantially, despite the 
global scale-up of DOTS (Dye and Williams, 2010, Golub et al., 2006, Pablos-Mendez et al., 
1996). Several reasons for delays have been identified and have typically been attributed to 
either patients or the health system (Finnie et al., 2011, Rossato Silva et al., 2012, 
Sreeramareddy et al., 2009). Patients not seeking medical care in a timely fashion cause patient-
related delay. Health-system delays are primarily due to healthcare professionals not 
considering TB at the point of care. Reports have implicated inexperience diagnosing and 
treating TB as a reason for missed opportunities to diagnose TB (Chen et al., 2010, Golub et 
al., 2005). Studies have also reported poor knowledge and practices in relation to TB diagnosis 
among healthcare workers including physicians (Wahab et al., 2016). In the current study, 50% 
of TB cases had more than 2 visits to healthcare facilities before TB screening/diagnosis tests 
were ordered for the patients. Other studies also reported such findings. One US study found 
that within 30 days before an initial TB diagnosis, 15.9% of patients (25.7% for 90 days) had 
a respiratory-related hospitalization or emergency department visit (Miller et al., 2015). Over 
half of the 5795 initial TB diagnoses had at least one previous visit to healthcare facility without 
a TB diagnosis. In a systematic review on delays in diagnosis and treatment of PTB in India, 
about 48% of all patients first consulted private providers and 2.7 healthcare providers, on 
average, were consulted before diagnosis (Sreeramareddy et al., 2009). Yet, our results are 
concerning, as delays in diagnosing TB during Hajj may lead to significant transmission given 
the crowded setting during the event.  
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 As such, because of delays in diagnosis and failure to utilize the appropriate diagnostic tests 
for suspect TB patients, the combined score for the TB diagnosis theme was 3 out of a 
maximum of 10, the lowest score of all TB management themes in the current study. 
 
Both the KSA and WHO guidelines for TB management recommend the use of four 1st-line 
anti-TB drugs (INH, RIF, PZA and EMB) in the treatment of drug-susceptible TB (Saudi 
Ministry of Health, 2014, World Health Organization, 2017a). The guideline compliance score 
for TB treatment in this study was 5 out of 10; partly because the majority (63%) of TB patients 
received fewer than four 1st-line anti-TB drugs. A significant proportion (40.7%) of the TB 
patients received three 1st-line anti-TB drugs, mostly in regimens containing RIF-PZA-EMB 
and INH-RIF-EMB. This finding is consistent with the result of a Spanish study which showed 
that 44.3% of TB patients received three 1st-line anti-TB drugs in the intensive phase of TB 
treatment (Garcia-Garcia et al., 2016). The rate of inadequate TB drug regimen prescribing was 
73% in another study that assessed the compliance of doctors with TB management guidelines 
in China (Zheng et al., 2014). In general, inappropriate treatment of TB is common worldwide. 
In a systematic review, Langendam et al. (Langendam et al., 2012) assessed the percentage of 
TB patients that received an inappropriate treatment regimen (type, dose, frequency of dosing 
and combination) from 37 studies from 22 countries, and one study was from multiple 
countries. Almost all continents were represented. Inappropriate treatment regimens were 
prescribed in 67% of the studies and the percentage of patients on inappropriate regimens 
varied between 0.4% and 100%. Poor knowledge of national and international TB management 
guidelines contributes to inappropriate prescription of anti-TB drugs by healthcare providers, 
and the use of inappropriate regimen drives the occurrence of relapse and the emergence of 
drug-resistant TB (Fox et al., 1999, Hoffman et al., 2016, van der Werf et al., 2012, World 
Health Organization, 2014a). 
 
Indeed, one case of XDR-TB was observed in this study. An estimated 6.2 % of MDR-TB 
patients have XDR-TB and many remain undetected due to unavailability of requisite 
laboratory capacity for drug-resistant TB diagnosis (World Health Organization, 2017b). The 
singular XDR-TB patient was known to have diabetes and had been on TB treatment before 
admission. Diabetes is a known risk factor for XDR-TB (World Health Organization, 2014a). 
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 The patient was diagnosed with TB and isolated on the same day of arrival to the healthcare 
facility which potentially reduced the risk of nosocomial transmission of primary XDR-TB 
infection. However, there was a prolonged delay before the case was confirmed as XDR-TB.  
 
It is unclear whether this delay had an impact on the treatment or outcome of the case. In 
general, while individuals with MDR-TB with a prolonged delay to treatment are perceived 
as more likely to have a higher bacillary burden, more extensive lung damage and, as a result, 
active TB disease that is harder to treat, little evidence is available to support these 
assumptions (Harris R. C. et al., 2016). Nevertheless, rapid diagnosis of MDR- and XDR-TB 
is crucial to reduce the risk of transmission, especially in congregated settings and crowded 
environments such as the Hajj. Access to rapid molecular point of care testing is needed in 
KSA and the Hajj to speed up MDR/XDR-TB diagnosis and ensure the immediate isolation 
of MDR/XDR-TB patients to prevent community and healthcare-related transmission of the 
primary MDR/XDR form of the TB bacilli.  
 
Notification of all confirmed TB cases is mandatory under national and international TB 
regulations. All confirmed TB cases with known notification status were reported to the Saudi 
health authorities, including the XDR-TB case. However, 2 cases of TB, involving 
international pilgrims were not notified to their country health representatives during Hajj. 
Without adequate proof of notification, it is unknown whether the continuum of care was 
maintained for the two international pilgrims who had to return to their home countries soon 
after the pilgrimage (before the end of the treatment period). Any travel-related treatment 
interruptions could breed treatment relapse and drug-resistance and propagate community 
spread of TB. Perhaps there is no formal mechanism for reporting of notifiable diseases to the 
country health missions/representatives. The existing notification framework mandates country 
health missions/representatives to report cases of certain notifiable diseases encountered in 
their country health facilities to the Saudi health authorities (Alotaibi et al., 2017). Even so, the 
compliance with the notification protocol has been variable and occasionally low. 
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 Both national and international TB guidelines fall short of providing guidance on TB control 
at international mass gatherings, including procedures for ensuring access to care and support 
services during travel. Thus, the development and dissemination of a multi-national Hajj and 
Umrah-specific TB protocol is needed to provide guidance on: TB case notification, IPC, 
screening and diagnostic methods, TB treatment regimen and models of care. The protocol 
should include pathways for the safe transfer across borders and follow up of TB patients 
involved in the mass gatherings.  
 
3.7 Study strengths and limitations 
The current study is among the foremost surveys of TB management at international mass 
gatherings. While the small number of cases and high proportion of unknown responses for 
some variables constituted limitations, the TB management indices obtained was a fair 
representation of the compliance of providers with national and international TB guidelines in 
MOH hospitals during the Hajj.  
 
3.8 Summary 
In summary, the study investigated for the first time the management of TB cases in MOH 
hospitals serving pilgrims during the Hajj mass gathering. Data was collected from 31 TB cases  
during the 2016 and 2017 Hajj seasons. Out of a maximum guideline compliance score of 10 
for the selected TB management themes, scores were highest for IPC and surveillance (9.6) 
and identifying TB suspects (7.2). The least scores were obtained for treating TB (5.0) and 
diagnosing TB (3.0). These findings provides a basis for the review of existing practices across 
settings-private and public sector vs national and foreign health facilities- and serves as a 
reference for the development of appropriate guideline and protocol for TB management at the 
Hajj and Umrah, as well as other settings with similar health system resources and population 
dynamics hosting recurrent international mass gatherings. 
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Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare  workers 
during the 2016 hajj mass gathering 
 
4.1 Executive summary 
TB is a global health issue with significant morbidity and mortality. Knowledge deficiencies 
and poor attitude and practices of HCWs related to TB can have a detrimental impact not only 
themselves and their individual patients, but also the global population as a whole.  
 
Annually, over 2 million pilgrims attend the Hajj religious mass gathering in Saudi Arabia. The 
latter, ensures healthcare for pilgrims through numerous health facilities across the holy cities 
of Makkah and Madinah that are fully equipped and staffed by 1000s HCWs drafted from 
across the Kingdom. We investigated KAP of HCWs deployed in Hajj in relation to TB and its 
management.  
 
A KAP survey was conducted among 540 HCWs from 13 hospitals serving pilgrims during the 
2016 Hajj. HCWs originated from 17 different countries and included physicians, nurses as 
well as other HCWs. Nearly half of the participants declared dealing with TB patients during 
their day-to-day work. In general, we report that HCWs had average knowledge (mean 
knowledge score of 52%), above average attitude (mean attitude score of 73%) and good 
practice (mean practice score of 81%) regarding TB, based on our scoring system and cut-off 
points.  
 
Knowledge gaps were identified in relation to the definition of MDR-/XDR-TB and LTBI, 
smear microscopy results, length of standard TB treatment for drug-sensitive TB, 2nd-line anti-
TB drugs, BCG vaccination, and appropriate PPE to be used with active PTB patients. Poor 
attitudes were found in relation to willingness to work in TB clinic/ward and to the management 
and treatment of TB patients. In addition, HCWs were not aware of the actual risk of TB 
infection connected with their work. Poor practices were reported for commencing anti-TB 
treatment on suspected TB cases before laboratory confirmation and in increasing natural 
ventilation in TB patients’ rooms.  
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There was a statistically significant difference in knowledge scores in relation to age, gender, 
nationality, level of education, occupation and length of work experience as well as a 
significant difference in practice scores in relation to the level of education. There was a weak 
but statistically significant positive correlation between knowledge and attitude and between 
attitude and practice.  
 
Given the context of Hajj, the potential global health consequences of mismanagement of TB 
cases at the event and the results of the current study, we recommend the following:  
 
• HCWs should receive tailored, high quality, periodic TB education and training including 
before deployment to Hajj with ongoing monitoring and evaluation of the impact. Training 
should be determined according to job categories, needs, and educational backgrounds.  
• Training should not only emphasise the theoretical aspects of training but also skill-based 
components to impact on practice. Various means shown affective in bringing about 
behavioral change among HCWs should be used including traditional and non-traditional 
methods of communicating information. 
• HCWs should be encouraged to keep up-to-date with recent scientific literature and 
advances in TB management and control as well as being aware of national and 
international guidelines and best practices.  
• Special attention should also be given to addressing factors beyond training (e.g. lifestyle, 
health system, job satisfaction as well as Hajj-related factors) that could influence HCWs’ 
KAP regarding TB, so as not to reinforce the limitations and weaknesses of current 
practices.  
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4.2 Introduction and literature review 
A search of electronic databases was conducted for relevant literature in English, without time 
restriction. Database searched included Pubmed, Scopus and Google Scholar. A combination 
of the MeSH terms and text words including: “Tuberculosis”, “TB”, “Pulmonary”, 
“Occupation”, “Risk”, “Latent”, “Prevention”, “Knowledge”, “Attitude”, “Practice”, 
“Healthcare workers” were used. A manual search was also performed reviewing reference 
lists of identified literature to find additional papers. With few exceptions, only the most 
relevant and recent publications were used to develop the literature review. 
 
4.2.1 Tuberculosis and occupation 
Tuberculosis (TB) is a treatable, communicable disease that has two general states: latent 
infection and active disease. With few exceptions, only those who develop active TB in the 
lungs or larynx can infect others, usually by coughing, sneezing, or otherwise expelling tiny 
infectious particles that are inhaled by others (Institute of Medicine, 2001). TB is not only a 
public health concern but also an occupational health concern as it can be directly related to 
work. Rodriguez Bayarri and Madrid San Martin(Rodriguez Bayarri and Madrid San Martin, 
2004) noted that most adults work as part of a team rather than in isolation, spending on average 
1,540 hours a year together. Given the mode of transmission of TB, potential TB contacts and 
infections may occur at the workplace. The risk of infection is dependent on the potential of 
coming in contact with the bacillus and may include a number of factors such as the prevalence 
of TB in the community and the population of workers, the number of workers who come into 
contact with TB cases, the type of work undertaken, the virulence and infectious dose emitted 
by the person with TB, as well as susceptibility of the host to infection (Institute of Medicine, 
2001, Rodriguez Bayarri and Madrid San Martin, 2004). The risk of contact with and 
contracting TB is particularly high in certain settings such as in healthcare facilities, geriatric 
facilities, homeless shelters, and prisons (Institute of Medicine, 2001). 
 
TB infection has been linked to various occupations and increased incidence of TB has been 
observed in particular types of jobs which are invariably associated with an elevated risk of TB 
including impoverished and unskilled workers, occupations which increase susceptibility to the 
infectious organism, such as in mining and pottery work, and occupations which may increase 
the likelihood of exposure to transmission.  
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The latter includes working in acute care hospitals, extended care facilities, and 
mycobacteriology laboratories (Institute of Medicine, 2001, Usui et al., 2000). Snider(Snider, 
1991) classified the professions or occupations carrying risk of TB into 3 categories (Table 28). 
The first category included occupations, and therefore workers, who are more affected by TB, 
usually for sociocultural reasons. Categories 2 and 3 relate to occupations where there is a 
possibility of TB infection that occurs when work material or workplace procedure are able to 
actively transmit pathogens or passively provoke susceptibility to the disease in workers who 
are performing their normal duties (Rodriguez Bayarri and Madrid San Martin, 2004, Snider, 
1991). Rodriguez Bayarri and Madrid San Martin(Rodriguez Bayarri and Madrid San Martin, 
2004) further explored these categories (Table 28). They noted the 3 categories as: category 1; 
nonoccupational TB with no causal relationship to the workplace, which comprise those in 
workers of a similar sociocultural status, for example immigrants or unskilled workers, who 
congregate in the same jobs and workplaces, and therefore face a higher risk of contagion 
among themselves because of a coincidental occupational relationship. Category 2; 
occupational TB with a direct passive causal relationship considered intrinsic to the workplace. 
This category include work that involve increase susceptibility to TB due to silicosis and 
pneumoconiosis related to inhalation of free silica dust and exposure to asbestos and other 
organic and non-organic dusts (Davies, 2001, Horai, 1975, Rees and Murray, 2007); Category 
3; occupational TB with an active intrinsic causal relationship to the workplace resulting from 
the work material or workplace procedure being the source or origin of the bacilli causing the 
disease. Examples of such occupations include healthcare workers (HCWs), laboratory 
workers, and those working in facilities housing people with high prevalence of TB such as 
workers with refugees and asylum seekers, prison inmates and immigrants (Institute of 
Medicine, 2001, Rodriguez Bayarri and Madrid San Martin, 2004). 
 
4.2.2 Tuberculosis and the risk for healthcare workers: a historical prospective 
Although TB is a well-established occupational risk for HCWs and the concern about the threat 
of TB to HCWs is considered long-standing, the certainty and unanimity on the idea that care 
of patients with TB represents a risk to HCWs is in fact relatively recent. Sepkowitz 
(Sepkowitz, 1994) reviewed the medical literature from the 1900s onwards and noted that a 
combination of genuine confusion, ignorance, and willful neglect conspired to keep the debate  
on the risk of TB to HCWs active and unsettled as late as the 1950s.  
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He highlighted a number of factors that contributed to the delay in recognizing TB as a risk for 
HCWs including liability concerns, loss of patronage for private hospitals, the fear of scaring 
young woman away from nursing as well as some experts simply believing that the higher 
incidence of TB among HCWs was a results of increased surveillance in this population 
compared to the general public and not evidence of increased risk (Sepkowitz, 1994). The 
debate moved from TB being considered not a risk for HCWs to a recognition of increased risk 
of primary TB infection among HCWs but not of disabling TB, to the current understanding 
that TB infection in all its forms is an occupational hazard for HCWs (Baussano et al., 2011, 
Kilinc et al., 2002, Nasreen et al., 2016, Seidler et al., 2005, Sepkowitz, 1994). 
 
Early literature on the subject not only reported that TB was not a health risk for HCWs but 
that caring for TB patients conferred a health advantage to the care provider (Sepkowitz, 1994). 
The latter notions were supported by a number of early studies and observations in the field. In 
studies conducted in 1882 and 1909, Williams, of the Brompton Hospital for Consumption in 
London, UK,  reported that of hundreds of workers at Brompton who had cared for thousands 
of cases of TB, none had developed TB (Williams, 1882, 1909). A similar claim was noted in 
1930 by Baldwin, Director of the Trudeau Foundation, New York, USA, who stated that no 
case of pulmonary TB has been known to develop among hundreds of healthy employees at 
the Trudeau Sanitorium during 45 years (Baldwin, 1930). Other studies in the early 1900s of 
more than 18,000 sanatoriums workers in Europe (Sepkowitz, 1994) further reinforced the 
widely held view in the medical world at the time that TB work involved no special hazard 
among those engaged in it (Dublin, 1914). 
 
In the 1920s however, the results of several studies conducted at a time where the prevalence 
of TB among young adults was much lower than that of previous generations, begin to 
determine objectively the risk to HCWs including nurses and doctors (Sepkowitz, 1994). The 
risk of TB infection among nurses was first to be recognized starting by landmark series of 
articles from Oslo by Heimbeck (Heimbeck, 1928, 1936). In 1924, Heimbeck reported that 
among the 220 tuberculin negative nursing students at time of entry to nursing school, 210 
(95%) had converted by the time they graduated. Moreover, 48 (22%) cases of TB occurred in 
this group compared with 3 (1.5%) among 200 initially tuberculin-positive nurses (Heimbeck, 
1928).  
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Further studies in the 1930s and 1940s in nursing schools, sanatoria, and other medical facilities 
reported rate of tuberculin conversion above that expected in the general population, and many 
found an increase in cases of TB especially among those initially turbeculin-negative 
(Sepkowitz, 1994). Reported tuberculin conversion rates among nurses ranged between 79 and 
100% with cases of TB found in 2-12% of the study population (Sepkowitz, 1994). One study 
concluded that nurses were 500 times more likely than the general public to develop TB 
(Boynton, 1939). Moreover, results of a survey that reported on 10,000 HCWs, as well as on 
20,000 additional cases reported in the literature, found that TB was 3 times more likely in 
initially tuberculin-negative persons compared with those who were initially tuberculin-
positive (Daniels, 1944, Daniels et al., 1948). The latter findings led to a recommendation from 
many experts that “tuberculin-negative nurses should not work in the TB wards" (Daniels et 
al., 1948). 
 
Similar to nurses, risk to medical students, physicians and other HCWs was also recognized 
relatively recently with mounting evidence from studies reporting conversion rates or rates of 
active TB among this group of HCWs in the early and mid1900s. For instance, Abruzzi 
(Abruzzi and Hummel, 1953) used data from 42,000 persons who were medical students from 
1940 to 1950 to calculate a rate of active TB of 334/100,000 per year which was 3 to 10 times 
higher than that in the general population in the 1940  (Rose, 1953). Mikol et al. (Mikol et al., 
1952) determined the relative risk of TB according to hospital occupation and found that 
persons with direct patient contact, such as nurses and technical workers, were 8 to 10 times 
more likely to develop TB than those at the same institution who did not have patient contact. 
However, even with such evidence, many still argues that although primary TB infection was 
occurring at alarming rates among HCWs, these primary infections did not translate into active 
disabling TB and the rates of active TB or mortality from TB among this population was not 
different from that in the community. For instance, Amberson and Riggins (Amberson and 
Riggins, 1936) noted that their TB ward at the Bellevue Hospital, New York, USA, had over 
3,100 patients between 1931 and 1936, cared for by over 1,000 nurses. While most of the 
initially tuberculin-negative nurses did convert, they reported that only 8 out of 539 (1.5%) of 
nurses developed active TB during the study period (6 of these cases were mild), an attack rate 
similar to that to be expected in the general community according to the authors.  
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This view appeared to be backed by early reports on mortality rates due to TB among HCWs, 
which showed that few physicians died of TB compared to men in other occupations 
(Sepkowitz, 1994). For instance, physicals had a TB date rate of 23.7/100,000, close to that of 
bankers, brokers and lawyers (18.3-19.3/100.000) but much lower than that of coal mine 
operatives, waiters and factory and construction laborers (106/100,000, 180/100,000 and 
227.3/100,000 respectively) (Brandy, 1940, Sepkowitz, 1994). 
 
It was only in the 1950s that the medical community finally agreed that a significant 
occupational risk existed with regards to HCWs and TB. As the incidence of TB declined in 
the later years, so did the concern about TB as an occupational hazard for HCWs (Sepkowitz,  
1994). However, poor implementation of infection control measures, the effect of the human 
immunodeficiency virus (HIV) epidemic on TB, and the emergence of multidrug-resistant 
(MDR) strains which resulted in the re-emergence of nosocomial transmission of TB and 
MDR-TB in the 1980s and 1990s, including numerous outbreaks and TB-related deaths among 
HCWs, led to the issue of TB and HCWs’ safety being once again of the highest importance in 
recent years (Sepkowitz, 1994, von Delft et al., 2015). 
 
4.2.3 Tuberculosis and the risk for healthcare workers 
4.2.3.1  Infection, active disease and mortality 
TB has long been recognised as an important occupational hazard for HCWs, although medical 
consensus on the topic was only achieved in the 1950s in resource-rich countries (Sepkowitz, 
1994). The risk of exposure to infectious TB in healthcare settings is generally expected to be 
higher than that in the community and TB has been reported as the most common occupational 
infectious diseases among HCWs in a number of countries (Ahn and Lim, 2008, Malangu and 
Legothoane, 2012). However, based on surveillance data and studies' findings in different 
healthcare settings, this issue remains heated in controversies (Tam and Leung, 2006). This is 
mainly due to the fact that outcomes of studies reporting risk of TB infection, disease and 
mortality among HCWs differ depending on numerous factors. These include pre- vs post-
chemotherapy ears and outbreak vs non-outbreak settings. For example, Menzies et al. 
(Menzies et al., 1995) reviewed the risks of TB infection and disease among HCWs reported 
in the medical literature, as well as risk factors found for single case transmission and prolonged 
hospital TB outbreaks.  
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They reported a significantly increased risk of TB was found in the pre-chemotherapy era. 
However, in the post-chemotherapy era, the risk ratios ranged from 0.6 to 2.0, with the highest 
risk occurring among those whose occupations involved the preparation of histological 
specimens and involvement with autopsy procedures. In outbreak reports included in the 
review, the percentages of exposed HCWs being infected ranged from 14 to 55%, whilst the 
percentages of those developing active disease ranged from 2.2 to 8.4%. Some of the factors 
reported to have contributed to the outbreaks were delay in diagnosis, poor infection prevention 
and control practices,  jet irrigation of thigh abscess, and autopsy procedures (Menzies et al., 
1995). Tam and Leung (Tam and Leung, 2006) noted however, that there were a number of 
important limitations to the studies included in the review, including lack of age adjustment, 
healthy worker effect, possible misclassification of occupation, recall bias, and low response 
rates in some of the questionnaire studies. 
 
Another important consideration is the actual contribution of community vs occupational 
exposure to TB among HCWs and risk attributable to nosocomial transmission as well as the 
incidence of the disease in the general population. Nardell and Sepkowitz (Nardell and 
Sepkowitz, 2004) reported that in the USA community-based exposure predominated before 
1985 as studies from the period showed that the HCW tuberculin conversion rate was related 
to socio-economic status or place of residence rather than the job categories. During the period 
1985 to 1992, occupational risk was reported mainly in outbreak settings related to HIV 
infection or MDR-TB which demonstrated that jobs with higher TB exposure risks were 
associated with tuberculin conversion (Greenaway et al., 2002, Louther et al., 1997). Lack of 
evidence for occupational risk outside the outbreaks settings in the USA, led the Centers for 
Disease Control and Prevention (CDC) and others to conclude that outside outbreak settings, 
community exposure was the dominant risk factor for tuberculin test conversion in the USA 
HCWs and that the occupational risk to HCWs of TB infection is close to that in their 
community of residence (Institute of Medicine, 2001, Nardell and Sepkowitz, 2004). 
 
However, given that the USA is a high-income country, the CDC’s conclusions may not be 
applicable to countries with limited resources. In a review of the risk of TB infection and 
disease among HCWs , Menzies et al. (Menzies et al., 2007) reported on studies published 
between 1950 and 2005 for low- and middle income countries and studies post 1995 for high-
income countries.  
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They found that the median annual incidence of TB infection attributable to healthcare work 
was 5.8% ranging from 0 to 11% in low- and middle-income countries and 1.1%, ranging from 
0.2 to 12% in high-income countries. The observed differences probably reflected the 
availability of resources and infection control measures in healthcare settings. Other reports 
from both high and low- middle income countries found that 32 to 80% of TB cases among 
HCWs were work-related  (Fica et al., 2008, Nienhaus, 2009).  
 
In a recent review, Baussano et al. (Baussano et al., 2011) demonstrated that the risk for TB 
among HCWs was consistently higher than the risk among the general population worldwide, 
confirming that TB is an occupational disease. They also reported that in low, intermediate and 
high TB incidence countries, 49%, 27% and 81% of TB cases respectively, among HCWs were 
attributable to exposure in the healthcare settings. 
 
In addition to the above, a number of other factors have been reported in the literature to impact 
the risk of TB infection and diseases among HCWs. These include: 1). Factors related to the 
patients’ population and the management of TB patients, the prevalence of TB among the 
patient’s population, the number of TB patients examined, the number of patients with 
unrecognized TB, delays in diagnosing TB, number of patients with MDR-TB and those 
receiving inappropriate treatment, have all been reported to be risk factors (Alele et al., 2018, 
Baussano et al., 2011, Fica et al., 2008, von Delft et al., 2015) 2).  
 
Factors related to the HCWs’ age, gender, duration of employment as well as their individual 
susceptibility/immune status. (Alele et al., 2018, Fica et al., 2008, Malangu and Legothoane, 
2012, von Delft et al., 2015) 3). Factors related to healthcare settings, access to appropriate 
ventilations systems, and adequacy of infection prevention and control measures. These include 
poor ventilation without negative pressure in isolation rooms or not keeping the doors closed, 
high levels of air recirculation, inadequate use of masks by HCWs, noncompliance with aerosol 
dissemination precautions such as during mechanical ventilation, bronchoscopy, dress change, 
jet irrigation of thigh abscess, and autopsy procedures (Alele et al., 2018, Baussano et al., 2011, 
Fica et al., 2008, Menzies et al., 1995, von Delft et al., 2015) 4).  
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Certain clinical procedures increase the risk of infection from clinical contacts. For example, 
procedures that provoke cough to induce sputum, therapeutic tracheobronchial intubations, 
anesthetic intubations, intubations for examination or simple cleaning of the upper airways, 
bronchoscopies, lung function tests, or the administration of curative or preventive 
pharmacological aerosols (Menzies et al., 1995, Rodriguez Bayarri and Madrid San Martin, 
2004) In addition, other procedures undertaken during laboratory work and autopsies such as 
the use of electric saws or pneumatic aspirators-injectors during autopsies and shaking or 
stirring of clinical samples in laboratories, also increase the risk of transmission (Rodriguez 
Bayarri and Madrid San Martin, 2004). As such, certain types of occupations and wards, or 
work locations have been linked to increased risk of TB. These include hospital employees in 
wards with TB patients, chest disease wards, emergency rooms; nurses in hospitals; nurses 
attending HIV-positive or drug-addicted patients; pathology and laboratory workers; 
respiratory therapists and physiotherapists; physicians in internal medicine, anaesthesia, 
surgery and psychiatry; paramedics and non-medical hospital personnel in housekeeping and 
transport work (Fica et al., 2008, Joshi et al., 2006, Kilinc et al., 2002, Seidler et al., 2005, von 
Delft et al., 2015). 
 
4.2.3.2 Tuberculosis infection (Latent tuberculosis) 
HCWs are at increased risk of being exposed to and acquiring TB than the general population 
especially in high-burden countries (Nasreen et al., 2016). HCWs may develop active TB and 
become an important source of TB infection to others in both healthcare and community 
settings. However, HCWs may also be infected without showing signs of TB or being 
infectious, termed latent TB infection (LTBI). While LTBI does not produce disease 
manifestations and is not infectious, it does result in persistent immune response against 
Mycobacterium tuberculosis antigens. There is also a 10–15% life-time risk of developing 
active TB. Several factors increase the risk of progressing from infection to active TB, 
including HIV infection or immunosuppressive treatment, malnutrition, diabetes and alcohol 
abuse as well as being infected within previous 2 years (Getahun et al., 2015, Jensen et al., 
2005). Therefore, preventing active TB by addressing these risk factors as well as proper 
diagnosis and treatment of LTBI in selected risk groups such as HCWs is important for the 
individual and for public health (Jensen et al., 2005). 
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According to the WHO, in countries with a low TB incidence, systematic testing and treatment 
for LTBI may be considered for HCWs (Jensen et al., 2005). Periodic screening of HCWs in 
considered an important component of TB programs in many countries according to the 
background TB incidence in the population. In fact, serial testing for TB among HCWs seems 
to be more appropriate in order to identify recent infections and to target infected individuals 
for preventive therapy (Pai et al., 2014). 
 
There is no gold standard test for diagnosis of LTBI. Tuberculin skin test (TST) and blood 
interferon-gamma release assay (IGRA) tests (especially Quantiferon, QFT) are performed to 
diagnose LTBI (Lamberti et al., 2015). However, these tests are limited in their ability to 
distinguish latent infection from cured or treated infections and to predict progression to active 
TB (Trajman et al., 2013).  Other limitations including TST’s reduced sensitivity due to 
malnutrition, severe TB diseases and immunodeficiency, TST’s decreased specificity in 
settings where non-tuberculous mycobacteria are prevalent and in populations who have 
received the Bacillus Calmette-Guérin (BCG) vaccine post-infancy or via multiple 
vaccinations as well as frequent reversion and conversion reported from serial testing by IGRA 
rendering interpretation difficult (Lamberti et al., 2015, Trajman et al., 2013). In addition to 
their limitations, it appears that the results of these tests are not always in agreement. Lamberti 
et al. 
 
(Lamberti et al., 2015) conducted a recent systematic review and meta-analysis of 29 studies 
and found that the Cohen’s k for agreement between TST and QFT for 24 of them was 0.28 
(95% CI: 0.22-0.35), with the best value being in high TB burden countries and lowest rate of 
BCG vaccination. They concluded that “currently, there is no gold standard for TB screening 
and the most-used diagnostic tools show low agreement. For evidence-based health 
surveillance in HCWs, occupational physicians need to consider a number of factors 
influencing screening results, such as TB incidence, vaccination status, age and working 
seniority” (Lamberti et al., 2015).  Nevertheless, TST remains the major tool used around the 
world for diagnosis of LTBI because of well-established algorithms for test interpretation and 
cost-effectiveness. 
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A number of studies reported the prevalence of LTBI or incidence of LTBI (conversion rate) 
among HCWs dating back to the early 1900s. Investigations among nurses in the USA between 
1924  and 1943 reported that over half had LTBI with the prevalence of TST-positive results 
ranging between 48 and 59% (Sepkowitz, 1994).  The incidence of LTBI were high with the 
majority of TST-negative nurses seroconverting by the end of the study periods (TST 
conversion rates ranged between 79 and 100%). Studies conducted during TB outbreaks in the 
1970s reported TST concession rates among HCWs of 31-35% (Craven et al., 1975, 
Ehrenkranz and Kicklighter, 1972). The USA CDC investigated a number of  hospital 
outbreaks in the early 1990s and reported TST conversion rates ranging from 33 to 50% 
(Sepkowitz, 1994).  In recent years, there have been a number of reviews in relation to the risk 
of TB among HCWs reporting prevalence and incidence of LTBI (Table 29, Table 30). The 
reported rates differed depending on a number of factors including the countries income and 
TB endemicity, the characteristics of the HCWs population studies (age, gender, level of 
education, BCG vaccination, length of employment, job characteristics and location), study 
setting, study date and duration, the type and characteristics of test used to determine LTBI, 
and infection prevention and control measures at the study sites.  
 
In 2005, Seidler et al. (Seidler et al., 2005) systematically reviewed reports on LTBI among 
HCWs included studies from low incidence, high income countries the USA, Spain, Canada, 
Germany, Australia and UK during 1971–1999 and found prevalence of LTBI ranging from 
5% to 55% in different occupations. They also reported that the annual risk of TB ranged from  
0.1 to 1.2% (Seidler et al., 2005). In 2006, Joshi et al (Joshi et al., 2006) reported on the 
incidence and prevalence of LTBI among HCWs in low- and middle-income countries 
including Uganda, India, Brazil, Iran, Ivory Coast, Turkey, Mexico, Thailand, Peru, Trinidad 
and South Africa. The prevalence of LTBI among HCWs was, on average, 54% (range 33-
79%). The prevalence of LTBI among nurses, a subgroup with high level patient contact, 
ranged from 43 to 87%. The review also reported the prevalence of LTBI among medical and 
nursing students which was found to vary widely between studies from 2 to 40% with an overall 
pooled prevalence of 12%(Joshi et al., 2006). BCG vaccination rates ranged between 66 and 
100% for medical and nursing students and 33 and 79% for all HCWs. The estimates of annual 
risk of LTBI (tuberculin conversion) ranged from 0.5 to 14.3%, after accounting for the 
incidence of TB infection in the general population, and the risk attributable to occupational 
exposure ranged from 2.6% to 11.3%.  
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Another review in 2007 summarized data from studies published between 1950 and 2005 from 
low- and middle-income countries and 1990 and 2005 from high-income countries. The median 
prevalence of LTBI in HCWs was 63% (range 33–79%) in low- and middle-income countries 
and 24% in high-income countries (range 4–46%). BCG vaccination was mostly above 60% 
for HCWs from low- and middle-income countries and ranged between 0 and 89% for studies 
from high- income countries. Among HCWs from low- and middle-income countries, LTBI 
was consistently associated with markers of occupational exposure, but in high-income 
countries it was more often associated with non-occupational factors (Menzies et al., 2007). 
The median annual risk of TB infection in low- and middle-income countries was estimated at 
5.3%, ranging from 0.5 to 14.3%. Incidence estimates were lower in studies that recruited 
young medical and nursing students. After accounting for the incidence of TB infection in the 
population, the risk attributable to occupational exposure ranged from 0 to 11.3%, with a 
median of 5.8%. For high-income countries, the median annual risk of TB infection was lower, 
1.1% (range 0.2-12). The risk attributable to occupational exposure ranged from 0.1 to 11.8% 
(Menzies et al., 2007).  
 
A systematic review and meta-analysis published in 2011 included studies from previously 
published reviews (Joshi et al., 2006, Menzies et al., 1995, Menzies et al., 2007) and additional 
studies published during between 2005 and 2010 worldwide (Baussano et al., 2011). The 
stratified pooled estimates for the LTBI rate for countries with low (<50 cases/100,000 
population), intermediate (50–100 cases/100,000 population), and high (>100 cases/100,000 
population) TB incidence were 3.8% (95% CI: 3.0%–4.6%), 6.9% (95% CI 3.4%–10.3%), and  
8.4% (95% CI: 2.7%–14.0%), respectively. The stratified pooled annual risk of LTBI estimates 
were 3.8% (95% CI: 3.0%–4.6%), 6.9% (95% CI: 3.4%–10.3%), and 8.4% (95% CI: 2.7%–
14.0%), respectively. Given that most studies in the meta-analysis were from countries with 
low TB incidence and that the variability of estimates was higher from countries with 
intermediate and high TB incidence, the overall pooled estimates of annual risk of LTBI was 
4.6% (95% CI: 4.1%–5.6%) (Baussano et al., 2011). A 2016 review and meta-analysis 
investigated literature published between 2005 and 2015 on the prevalence of LTBI among 
HCWs from 7 high-burden countries (Bangladesh, Brazil, China, India, South Africa, Uganda, 
and Zimbabwe)(Nasreen et al., 2016).  
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The prevalence of LTBI ranged from 6.9% among medical students to 97.6% among all types 
of HCWs. The pooled prevalence among all HCWs and among medical and nursing students 
was 47% (95% CI: 34%-60%,) and 26% (95% CI: 6%-46%) respectively. Incidence of LTBI 
was available for HCWs in Brazil, China, South Africa and Zimbabwe. The cumulative 
incidence ranged from as low as 2.8% among Brazilian medical students to as high as 38% 
among all types of HCWs in South Africa (Nasreen et al., 2016). 
 
Few studies reported on LTBI among HCWs in Saudi Arabia in general or among those 
working during the Hajj. A population based study in Saudi Arabia conducted between 2010 
and 2013 found that the prevalence of LTBI among 1,369 subjects from the general population 
was 9.1% using the Quantiferon-TB gold in tube (QFT-GIT) test and 9.3% using TST (Balkhy 
et al., 2017).  Abbas et al. (Abbas et al., 2010) investigated the prevalence of LTBI among 
newly hired HCWs in 4 major tertiary care hospitals in Riyadh city in KSA. Of the 2,650 HCWs 
surveyed between 2008 and 2009, 291 (11%) were positive for TST with the highest rates 
among physicians (14.9%) nurses (12.9%) and those aged 50 years or older (32.6%). El-Helaly 
and colleagues (El-Helaly et al., 2014) conducted a retrospective cross-sectional study among 
1,412 HCWs screened for LTBI between 2009 and 2011 at a tertiary care hospital in Riyadh. 
The majority of the HCWs (92.6%) had received BCG vaccination. LTBI prevalence was 
29.8% and 23.6% using the TST and the QFT-GIT test respectively. Similar results were also 
reported from another tertiary care center in Riyadh among 1,595 HCWs, most of whom 
(90.6%) had BCG vaccination. TST positivity was observed in 31.5% of the HCWs while QFT-
GIT test was positive in 25%(Al Hajoj et al., 2016). Balkhy et al. (Balkhy et al., 2014) 
investigated HCWs who were exposed to patients with TB at medical city in Riyadh. Of the 
298 HCWs identified most were female (62.9%), non-Saudi (83.9%), nurses (68.6%), and 
working in critical care locations (72.8%). The prevalence of LTBI at start of the employment 
was 51.2% (63/123). Of the 115 exposed HCWs who had negative or unknown pre-exposure 
TST status 53 (46.1%) were positive after exposure and were diagnosed with post-exposure 
LTBI. Although most were prescribed and started LTBI therapy, 82.6% of those starting 
therapy failed to complete the recommended course.  
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Only one study specifically investigated the prevalence of LTBI among HCWs working during 
Hajj. In 2015, Bukhary et al. (Bukhary et al., 2018) screened 520 HCWs working at multiple 
secondary care hospitals in the Hajj pilgrimage region for LTBI using QFT-GIT. They included 
HCWs who had previously worked in the Hajj and who had no close contact with pulmonary 
TB patients within the previous 3 months or recent history of a positive TST. Over half of the 
HCWs were males (66.9%) and non-Saudi (57.5%) and most (98.5%) had BCG vaccination. 
Nearly 40% had contact with TB patients more than 4 months prior to participating in the study 
and 8.5% were TST positive. Of the 520 HCWs enrolled 50% were clinical staff involved with 
direct patient care including nurses (30.8%) and physician (19.2%). The prevalence of LTBI 
was 10.8% and was significantly higher in physicians, in HCWs working at chest hospitals and 
those with longer employment duration.  
4.2.3.3 Developing tuberculosis 
In addition to the risk of infection, HCWs are at risk of developing TB disease (Table 31). 
There is historical evidence of documented increased risk of TB disease among HCWs. For 
instance, one study from 1939 concluded that nurses were 500 times more likely than the 
general public to develop TB (Boynton, 1939).  
 
Another report from the 1950s found that medical students had 3 to 10 times higher rates of 
TB disease than that in the general population (Abruzzi and Hummel, 1953, Rose, 1953).Even 
in recent years, TB may be responsible for up to 5 additional cases of TB per 100,000 
individuals among HCWs in relation to the general population in developing countries (Fica et 
al., 2008).  Seidler et al.(Seidler et al., 2005) reported that the overall incidence of TB disease 
among native-borne HCWs in high-income countries was 25/100,000 per year compared to 
10/100,000 per year in the general population.  
 
Data from low- and middle-income countries found higher rates with annual incidence of TB 
disease among HCWs ranging from 69 to 5,780/100,000 with an attributable risk of TB disease 
in HCWs, compared with the general population, ranging from 25 to 5,361/100,000 per year 
(Joshi et al., 2006). HCWs in facilities with fewer HCWs for every TB patient seen (HCW-to-
patient ratio less than 50/100 TB patients), had a higher incidence of TB disease. Baussano et 
al. (Baussano et al., 2011) reviewed TB among HCWs from countries with low, intermediate 
and high TB incidence.  
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They reported that the median estimated annual incidence of TB among HCWs was 67/100,000 
(Inter quartile range; IQR 40–142), 91/100,000 (IQR 81–723) and 1,180/100,000 (IQR 91–
3,222) for studies from countries with low, intermediate, and high TB incidence, respectively. 
These estimates where higher than those estimated for the general population from countries 
in all three categories (33/100,000 (IQR 27–37), 82/100,000 (IQR 58–223), and 311/100,000 
(IQR 168–405), respectively). Median estimated annual TB incidence rate ratio (IRRs) were 
2.0 (IQR 1.5–4.1), 1.4 (IQR 0.4–8.8), and 5.4 (IQR 1.7–9.1), respectively. 
 
Deaths among HCWs due to TB have been reported, (Marcus et al., 1997, Pan et al., 2015a, 
Sepkowitz, 1994, Tudor et al., 2014, von Delft et al., 2016) and although available data do not 
allow comparisons of mortality risk, but HCWs are at high risk of death if they contract MDR-
TB disease (Institute of Medicine, 2001, von Delft et al., 2016).  HCWs are up to 6 times more 
likely to be hospitalized for drug-resistant TB than the population they care for (IRR= 5.46 for 
MDR and 6.28 for XDR) (O'Donnell et al., 2010). Furthermore, HCWs with drug-resistant TB 
are diagnosed late and have poor treatment outcomes, even when HIV-uninfected (Jarand et 
al., 2010, Tudor et al., 2014). 
 
4.2.4 Prevention of tuberculosis in healthcare settings 
Given the risk of TB infection among HCWs and patients, and the essential role HCWs play in 
managing active cases and in preventing further transmission of M. tuberculosis, in addition to 
general infection prevention and control measures, various guidelines have been developed 
specifically for the prevention of TB in healthcare settings. These include WHO and CDC 
guidelines (Jensen et al., 2005, World Health Organization, 1999, 2009b). While these 
guidelines are relatively recent, many of the TB prevention measures in healthcare settings 
have been proposed long before there was a consensus on the risk of TB for HCWs. Back in 
1930, Myers (Myers, 1930) had recommended how best to control TB in hospitals. He 
suggested five steps that included performing tuberculin testing and chest radiographs on all 
new employees and doing follow-up testing every 6 to 12 months. Also, excluding TB in all 
new patients admitted to the hospital, including initiating routine admission chest radiography. 
Finally, establishing a TB service in all hospitals and practicing aseptic technique as was 
routine for other infections such as diphtheria and scarlet fever.  
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The WHO policy on TB infection control recommends four levels of protection: an overarching 
managerial level, administrative control, environmental control, and personal respiratory 
protection (World Health Organization, 2009b). Similarly, in the CDC’s guidelines, all 
healthcare settings should have a TB infection control program. The latter should be designed 
to ensure prompt detection, airborne precautions, and treatment of individuals who have 
suspected or confirmed TB disease1 and should be based on a three-level hierarchy of controls, 
including administrative, environmental, and respiratory protection (Jensen et al., 2005). 
 
The facility-level managerial activities recommended by the WHO constitute the framework 
for setting up and implementing the other controls at facility level. They include identifying 
and strengthening local coordinating bodies for TB infection control, developing a facility plan 
for implementation as well as monitoring and evaluating the TB infection control measures. 
Also, WHO advocates for conducting on-site surveillance of TB disease among HCWs and 
assess the facility (World Health Organization, 2009b). 
 
Administrative controls are measures aimed at preventing HCWs, other staff, and patients from 
being exposed to TB and reducing the transmission of infection by ensuring the rapid diagnosis 
and treatment of patients and staff with TB (Jensen et al., 2005). Administrative controls are 
the most important level of all protection and control programs as without effective 
administrative controls, environmental measures and personal respiratory protection are of 
limited value (Jo, 2017, World Health Organization, 2009b). 
 
Administrative control measures recommended by the WHO and the CDC include prompt 
identification of people with TB symptoms (triage), isolation of infectious patients, control of 
the spread of the pathogen  (e.g. cough etiquette and respiratory hygiene), and minimization of 
time spent in health care facilities to significantly reduce the risk of TB transmission by 
preventing the generation of droplet nuclei (Jensen et al., 2005, World Health Organization, 
2009b).  Administrative controls also involve baseline and serial screening for LTBI of HCWs 
at risk for exposure to TB(Jensen et al., 2005, Jo, 2017). 
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Environmental control measures are the second line of defence for the prevention of 
nosocomial M. tuberculosis transmission to HCWs and are used to reduce the concentration of 
infectious droplet nuclei to which HCWs or patients may be exposed. A variety of simple to 
complex environmental controls can be used depending on the design of the healthcare facility, 
climate of the area, type of patient population served, number of TB patients cared for in the 
facility, and resources available (World Health Organization, 1999, 2009b). In general, primary 
environmental controls consist of controlling the source of infection by using local exhaust 
ventilation (e.g., hoods, tents, or booths) and diluting and removing contaminated air by using 
general ventilation (e.g. open windows) (Jensen et al., 2005, World Health Organization, 
2009b). Secondary environmental controls consist of controlling the airflow to prevent 
contamination of air in areas adjacent to the source and cleaning the air by using high efficiency 
particulate air (HEPA) filtration or using ultraviolet germicidal irradiation (UVGI) to kill M. 
tuberculosis (World Health Organization, 2009b). 
 
Administrative and environmental controls minimize the number of areas in which exposure 
to M. tuberculosis might occur and, therefore, minimize the number of persons exposed. These 
control levels also reduce, but do not eliminate, the risk for exposure in the limited areas in 
which exposure can still occur. Because persons entering these areas might be exposed to M. 
tuberculosis, the use of respiratory protective equipment in situations that pose a high risk for 
exposure is the last line of defence for HCWs against nosocomial MTB infection (Jensen et al., 
2005). Personal respiratory protection refers to ''the use of respiratory protective devices by 
HCWs that fit over the mouth and nose to protect against transmission of M. tuberculosis by 
reducing the risk of inhaling infectious droplet nuclei''. Because widespread and constant use 
of respirators is impractical, it is recommended that they should be used on a limited basis in 
specified high risk areas in conjunction with other administrative and environmental control 
measures (World Health Organization, 2009b). To reduce the risk of exposure the CDC 
recommends the implementation of a respiratory-protection program, training HCWs on 
respiratory protection, and training patients on respiratory hygiene and cough etiquette 
procedures (Jensen et al., 2005). 
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The impact of the various control measures on TB transmission in the healthcare setting is still 
not well studied specially in low-income settings (Joshi et al., 2006, Menzies et al., 2007). 
However, in general, evidence suggests that control measures, particularly administrative 
controls, appear to have an impact on TB transmission (Menzies et al., 2007). Few studies 
evaluated the impact of infection control strategies on risk of TB infection or disease in low-
income settings; therefore, it is difficult to make any inferences regarding the effectiveness of 
control measures (Joshi et al., 2006). One study found that administrative measures had little 
impact on the development of TB disease, but after only one year, a relatively short interval to 
detect changes (Harries et al., 2002). Two other studies reported significant reduction of TB 
infection within a year following introduction of multiple infection control measures (Roth et 
al., 2005, Yanai et al., 2003). In studies conducted in high-income countries, indicators of 
nosocomial transmission rapidly declined following the application of a full hierarchy of 
recommended infection control measures (Menzies et al., 2007). Due to the simultaneous 
introduction of the various interventions, identifying a single key measure responsible for 
decrease transmission is difficult. However, Moro et al. (Moro et al., 2000) reported that in one 
hospital, implementation of only administrative controls resulted in the complete elimination 
of MDR-TB transmission. In two other studies, the implementation of administrative controls 
also resulted in reduced transmission and subsequent implementation of environmental 
controls led to further decreases (Blumberg et al., 1995, Jarvis, 1995). Other studies also 
reported decrease in transmission following intervention measures that included environmental 
controls such as improved ventilation (Behrman and Shofer, 1998, Fridkin et al., 1995). 
 
4.2.5 Knowledge, attitude and practice of healthcare workers in relation to 
tuberculosis 
Advocacy, communication and social mobilization (ACSM) are three distinct sets of activities, 
all aimed at bringing about behavioral change. In relation to TB, the WHO considers ACSM 
and important part of TB programs and well-designed and rigorously conducted KAP surveys 
can produce data that are informative, insightful and broadly useful in the planning of ACSM 
activities for TB control as well as providing an evidence base for refining and evaluating 
ACSM work (World Health Organization, 2008a). 
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 In general, a KAP survey is a representative study of a specific population to collect 
information on what is known (knowledge), believed (attitude) and done (practice) in relation 
to a particular topic (Wahab et al., 2016). TB KAP surveys can identify knowledge gaps, 
cultural beliefs, or behavioral patterns and can reveal misconceptions or misunderstandings 
that may facilitate understanding and action, as well as pose problems or create barriers for TB 
control efforts. They can identify unknown factors influencing people’s behaviour, reasons for 
their attitudes, and how and why people practice certain health behaviours (World Health 
Organization, 2008a). Information gained from TB KAP surveys enables decision makers to 
set TB programs’ priorities (e.g. to address the most common or pressing issues or to identify 
specific subgroups whose needs may differ from other groups), to estimate resources required 
for various actions, to select the most effective communication channels and messages, to 
establish baseline levels and measure change that results from TB interventions (World Health 
Organization, 2008a). 
 
Given the central role HCWs play in diagnosing and managing TB patients and implementing 
infection prevention and control measures as well as them being an important source of 
information regarding the disease to patients and the public in general, understanding HCWs 
KAP with regards to TB and its management is essential. Gaps in knowledge, negative attitudes 
or wrong practices in relation to TB and its management among HCWs can have detrimental 
effects not only on the patients they serve but on themselves, the TB program on institutional 
and national levels as well as on the global population in general. Information collected from 
TB KAP surveys among HCWs can serve as a basis for identifying difficulties, limitations and 
capacities for enhancement, and direct resources and efforts towards the appropriate 
interventions for improvement. Numerous studies reported on knowledge, attitude and/or 
practice regarding TB, its management or its prevention and control among HCWs from around 
the world (Bhebhe et al., 2014, Doosti Irani et al., 2015, Engelbrecht et al., 2016, Hashim et 
al., 2003, Hoffman et al., 2016, Hong et al., 1995, Kiefer et al., 2009, Lai et al., 1996, Malangu 
and Adebanjo, 2015, Naidoo and Mahommed, 2002, Noe et al., 2017, Singla et al., 1998, 
Temesgen, 2011, Tenna et al., 2013, van der Werf et al., 2012, Wahab et al., 2016, Woith et 
al., 2012). These studies report that HCWs have numerous knowledge gaps in relation to TB 
diagnosis, treatment and infection prevention and control, have some negative attitudes and 
stigma connected with the disease and engage in poor practices, all of which contribute to their 
increased risk of infection and negative impacts on patients and the community.  
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In the context of Hajj, 1000s of HCWs are drafted each year from across the Kingdom of Saudi 
Arabia (KSA) to deliver healthcare at facilities in Makkah and Madinah for pilgrims arriving  
from across the world for the pilgrimage. Hajj has been linked to increased risk of TB infection 
as many pilgrims come from TB endemic countries and both diagnosed and undiagnosed TB 
among pilgrims were reported (Al-Orainey, 2013, Alzeer et al., 1998, Alzeer, 2009, Wilder-
Smith et al., 2005, Yezli et al., 2017b).  HCWs serving during Hajj come from different 
nationalities, educational, institutional and working backgrounds and work in different 
specialties. Many are deployed to temporary healthcare facilities attending large numbers of 
patients in a limited period of time. While this workforce receives various trainings in 
preparation for Hajj work, it is unclear whether this is adequate to improve their collective 
knowledge, attitude or practice to TB and its management during or after the event.  
 
One study investigated the KAP of HCWs working in Hajj in relation to infect control. Ghabrah 
et al. (Ghabrah et al., 2007) found that HCWs correctly answered only about half the questions 
on the knowledge concerning important aspects of standard and transmission based 
precautions. There was significant deficiency of knowledge regarding the type of isolation 
precautions required for infections transmitted by droplets and airborne routes, including 
pulmonary TB, as well as lacks in other important hospital infection control measures. In the 
self-reported assessment of practice, HCWs reported suboptimal compliance with standard 
precautions practices, particularly with regard to wearing eye shields and gowns when there is 
any risk of blood splash and wearing gloves when drawing blood from patients. These results 
suggest that there is need for more training to improve KAP of HCWs deployed for Hajj in 
relation to infection control, including TB control. No study specifically investigated KAP of 
HCWs working in Hajj in relation to TB and its management.  
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Table 28. Occupational risk of tuberculosis  
Categories according to Snider(Snider, 
1991) 
Categories according to Rodriguez Bayarri and Madrid 
San Martin(Rodriguez Bayarri and Madrid San Martin, 
2004) 
Category 1: occupations of workers at 
high risk of contracting TB 
 
Example 
Immigrant workers 
Laundry workers 
Food operatives 
Prison warders 
Poorly qualified manual workers 
Category 1: Nonoccupational TB-no causal relationship 
to the workplace 
 
Example  
Immigrants, who congregate in the same jobs and 
workplaces 
 
Category 2: occupations that increase 
susceptibility to development of active 
disease 
 
Example 
Work with risk of contact with silica 
Extraction industries (mines, quarries) 
Sand-blasting 
Ceramic industries 
Iron and steel works 
Tunneling (civil engineering works) 
Category 2: occupational TB cases with a direct passive 
causal relationship considered intrinsic to the workplace 
 
 
Example 
Work done in mines, tunnels, quarries and galleries  
Cutting or polishing of silica rock  
Masonry work 
Dry grinding, sieving and handling of minerals and rocks  
Production of silicon carbide, glassware, porcelain, 
earthenware and other ceramic products 
Production and maintenance of abrasives and other detergent 
powders 
Removal of pieces from molds 
Trimming and desanding in casting  
Work with grinders (polishing and finishing) that contain 
free silica  
Sandblasting and stone polishing.  
Extraction, handling, and treatment of asbestos minerals or 
rocks 
Production of asbestos textiles, card, and paper 
Preparation of asbestos fibers (combing, spinning, weaving)  
Pistol application of asbestos (chimneys and car and wagon 
bases) 
Work with thermal insulation in shipping and buildings and 
their demolition 
Production of brake and clutch pads, fiber cement products, 
firefighting equipment, and asbestos and rubber seals 
Disassembly and demolition of facilities that contain 
asbestos 
Category 3: occupations that increase the 
risk of exposure 
 
Example  
Those at risk of contact with TB (people or 
animals) 
Geriatric facilities 
Homeless shelters 
Healthcare facilities 
Drug rehabilitation centers 
Prisons and reformatories 
Animal research facilities 
Category 3: occupational TB with an active intrinsic 
causal relationship to the workplace 
 
Example 
Healthcare workers  
Laboratory workers  
Veterinary workers  
Workers with the population of homeless refuges and 
shelters, prison inmates, and refugees and asylum seekers  
 
TB= tuberculosis  
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Table 29. Prevalence of latent tuberculosis infection among healthcare workers* 
Reference  Country  Year N BCG % TST+ve (%) 
He(He et al., 2015) China 2015 875 36 19.5 
McCarthy(McCarthy et al., 
2015) 
South Africa 2015 199 - 44.7 
Adams(Adams et al., 2015) South Africa 2015 329 92 84 
Islam(Islam, 2014) Bangladesh 2014 449 82 54 
de Souza(de Souza et al., 
2014) 
Brazil 2014 632 86 40 
Zhou(Zhou et al., 2014) China 2014 529 32 43.9 
Christopher(Christopher et 
al., 2014, Rogerio et al., 
2013) 
India 2014 755 81 45 
Rogerio(Rogerio et al., 
2013) 
Brazil 2013 225 - 24 
Zhang(Zhang et al., 2013) China 2013 96 98 55.2 
Wei(Wei et al., 2013) China 2013 85 94 97.6 
Jo(Jo et al., 2013) South Korea 2013 493 81 36.7 
Whitaker(Whitaker et al., 
2013) 
Georgia  2013 260 90 55.8 
Spindola De 
Miranda(Spindola De 
Miranda et al., 2012) 
Brazil 2012 251 40 60 
Zwerling(Zwerling et al., 
2012) 
Canada  2012 387 36 5.7 
Larcher(Larcher et al., 
2012) 
Italy 2012 549 38 29.1 
Freeman(Freeman et al., 
2012) 
New Zealand 2012 317 67 21.1 
Jung(Jung et al., 2012) South Korea 2012 153 86 15.0 
He(He et al., 2012) Mongolia 2012 917 34 47.9 
Teixeira(Teixeira et al., 
2011) 
Brazil 2011 1032 83 6.9 
Severo(Severo et al., 2011) Brazil 2011 55 98 47.3 
Talebi-Taher(Talebi-Taher 
et al., 2011) 
Iran 2011 200 100 52.5 
Khoury(Khoury et al., 
2011) 
USA 2011 611 82 8.2 
Torres Costa(Torres Costa 
et al., 2011) 
Portugal 2011 2884 100 72.9 
Rafiza(Rafiza et al., 2011) Malaysia 2011 95 100 58.9 
Moon(Moon et al., 2011) South Korea 2011 156 100 33.3 
He(He et al., 2010) China 2010 2153 36 51.4 
Fox(Fox et al., 2009) Israel 2009 91 37 34.1 
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Cont..Table 29. Prevalence of latent tuberculosis infection among healthcare workers 
Vinton(Vinton et al., 2009) Australia  2009 341 78 33.4 
Girardi(Girardi et al., 
2009) 
Italy 2009 115 37 53.0 
Tripodi(Tripodi et al., 
2009) 
France 2009 148 100 65.5 
Alvarez-Leon(Alvarez-Leon 
et al., 2009) 
Spain 2009 123 35 7.3 
Casas(Casas et al., 2009) Spain 2009 145 16 69.7 
Topic(Topic et al., 2009) Croatia 2009 54 100 63.0 
Lee(Lee et al., 2009) South Korea 2009 196 93 47.4 
Lien(Lien et al., 2009) Vietnam 2009 255 33 63.9 
Nienhaus(Nienhaus et al., 
2008) 
Germany 2008 261 38 24.1 
Choi(Choi et al., 2008) South Korea 2008 80 100 45.0 
Mirtskhulava(Mirtskhulava 
et al., 2008) 
Georgia  2008 265 78 66.8 
Pai(Pai et al., 2008) India 2008 719 71 41.4 
Rabahi(Rabahi et al., 2007) Brazil 2007 413 71 51 
Soborg(Soborg et al., 2007) Denmark 2007 139 76 33.8 
Hotta(Hotta et al., 2007) Japan 2007 202 93 59.4 
Ozdemir(Ozdemir et al., 
2007) 
Turkey 2007 76 91 53.9 
Kayanja(Kayanja et al., 
2005) 
Uganda 2005 396 66 57 
Pai(Pai et al., 2005) India 2005 720 71 41 
Roth(Roth et al., 2005) Brazil 2005 4419 67 49 
Keskiner(Keskiner et al., 
2004) 
Turkey 2004 491 93 72 
Yanai(Yanai et al., 2003) Thailand 2003 1202 82 63 
Bonifacio(Bonifacio et al., 
2002) 
Peru 2002 97 - 60 
Naidoo(Naidoo and 
Mahommed, 2002) 
South Africa 2002 78 - 33 
Alonso-Echanove(Alonso-
Echanove et al., 2001) 
Peru 2001 270 - 63 
Garcia-Garcia(Garcia-
Garcia et al., 2001) 
Mexico 2001 823 84 34 
Plitt(Plitt et al., 2001) Canada  2001 560 44 46 
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Stuart(Stuart et al., 2001) Australia  2001 4070 89 19 
Kassim(Kassim et al., 2000) Ivory cost  2000 512 83 79 
Orrett(Orrett, 2000) Trinidad 2000 182 4 44 
Do(Do et al., 1999) Thailand  1999 911 77 68 
Zahnow(Zahnow et al., 
1998) 
USA 1998 1014 8 24 
Menzies(Menzies et al., 
1998) 
Canada  1998 4651 31 29 
Manusov(Manusov et al., 
1996) 
USA 1996 501 0 4 
Bailey(Bailey et al., 1995) USA 1995 6070 0 11 
Molina-Gamboa(Molina-
Gamboa et al., 1994) 
Mexico 1994 175 80 70 
Fraser(Fraser et al., 1994) USA 1994 351 12 25 
Dooley(Dooley et al., 1992) USA 1992 880 <5 25 
*adapted from Joshi et al.(Joshi et al., 2006), Nasreen et al.(Nasreen et al., 2016), Lamberti et al.(Lamberti et al., 
2015) and Menzies et al.(Menzies et al., 2007) 
LTBI=latent tuberculosis infection, HCW=healthcare worker, BCG=bacille Calmette-Guerin, TST=tuberculin 
skin test 
 
Table 30. Incidence of latent tuberculosis infection among healthcare workers* 
Reference  Country  Year N ARTI in 
HCWs (%) 
ARTI attributable to nosocomial 
transmission (%) 
Levy(Levy et al., 
2005) 
Brazil 2005 46 0.5 0 
Maciel(Maciel et 
al., 2005) 
Brazil 2005 76 5.3 4.8 
Pai(Pai et al., 2005) India 2005 147 4.1 2.6 
Roth(Roth et al., 
2005) 
Brazil 2005 1209 8.7 8.2 
Yanai(Yanai et al., 
2003) 
Thailand 2003 331 7.2 5.8 
Larsen(Larsen et 
al., 2002) 
USA 2002 5773 0.38 0.28 
Miller(Miller et al., 
2002) 
USA 2002 3248 2.1 1.4 
Bonifacio(Bonifacio 
et al., 2002) 
Peru 2002 35 14.3 11.3 
Silva(Silva et al., 
2002) 
Brazil 2002 414 3.9 3.4 
Warren(Warren et 
al., 2001) 
USA 2001 731 1 - 
Menzies(Menzies et 
al., 2000) 
Canada 2000 1289 1.2 - 
Behrman(Behrman 
and Shofer, 1998) 
USA 1998 2514 2 1.8 
Blumberg(Blumber
g et al., 1998) 
USA 1998 2144 1.6 - 
Cont..Table 29. Prevalence of latent tuberculosis infection among healthcare workers 
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Cont... Table 30. Incidence of latent tuberculosis infection among healthcare workers* 
Reference  Country  Year N ARTI in 
HCWs (%) 
ARTI attributable to nosocomial 
transmission (%) 
Christie(Christie et 
al., 1998) 
USA 1998 28916 0.2 - 
LoBue(LoBue and 
Catanzaro, 1998) 
USA 1998 9905 0.6 - 
Zahnow(Zahnow et 
al., 1998) 
USA 1998 766 1.8 1.7 
Louther(Louther et 
al., 1997) 
USA 1997 898 7.2 7.1 
Rullan(Rullan et 
al., 1996) 
Spain 1996 92 10.4 10.1 
Bailey(Bailey et al., 
1995) 
USA 1995 3106 0.9 0.8 
Adal(Adal and 
Hospital, 1994) 
USA 1994 11188 0.2 0.1 
Ramirez(Ramirez 
et al., 1992) 
USA 1992 6452 0.7 0.6 
*adapted from Joshi et al.(Joshi et al., 2006), Nasreen et al.(Nasreen et al., 2016), Baussano et al.(Baussano et 
al., 2011) and Menzies et al.(Menzies et al., 2007) 
LTBI=latent tuberculosis infection, HCW=healthcare worker, ARTI=annual risk of tuberculosis infection 
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Table 31. Tuberculosis disease among healthcare workers* 
Reference Country  Year HCWs exposed/TB 
patients seeking care 
Incidence of TB 
disease in HCWs 
(per 100,000) 
Incidence rate ratio 
(relative risk) (95% 
CI) 
Risk of TB disease 
attributable to 
nosocomial transmission 
Naidoo(Naidoo and 
Jinabhai, 2006) 
South Africa 2006 49392/NR 1180 1.6 (1.5 to 1.8) 462 
Hosoglu(Hosoglu et al., 
2005) 
Turkey 2005 734/NR 199.9 5.0 (2.8 to 8.6) 160 
Jiamjarasrangsi(Jiamja
rasrangsi et al., 2005) 
Thailand 2005 3959/NR 188 1.32 (1.0 to 1.7) 46 
Dimitrova(Dimitrova et 
al., 2005) 
Russia 2005 64855/2445 81.2 0.7 (0.6–0.9) -32 
Rao(Rao et al., 2004) India 2004 NR 1260 7.5 (3.9 to 13.2) 1092 
Jelip(Jelip et al., 2004) Malaysia 2004 7312/NR 280.4 2.69 (2.1 to 3.4) 176.4 
Gopinath(Gopinath et 
al., 2004) 
India 2004 6016/1174 208 1.2 (1.0 to 1.6) 40 
Kanyerere(Kanyerere 
and Salaniponi, 2003) 
Malawi 2003 571/3607 5780 13.8 (9.4 to 19.6) 5361 
Eyob(Eyob et al., 2002) Ethiopia 2002 90/4862 5556 20.0 (6.5 to 47.3) 5279 
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Cont.. Table 31. Tuberculosis disease among healthcare workers* 
Reference Country  Year HCWs exposed/TB 
patients seeking care 
Incidence of TB 
disease in HCWs 
(per 100,000) 
Incidence rate ratio 
(relative risk) (95% 
CI) 
Risk of TB disease 
attributable to 
nosocomial transmission 
Harries(Harries et al., 
2002) 
Malawi 2002 2979/NR 3222 8.3 (6.5 to 10.3) 2833 
Cuhadaroglu(Cuhadar
oglu et al., 2002) 
Turkey 2002 3359/NR 96 3.2 (1.8 to 5.5) 67 
Kilinc(Kilinc et al., 
2002) 
Turkey 2002 6156/NR 69 1.8 (1.2 to 2.7) 28 
Alonso-
Echanove(Alonso-
Echanove et al., 2001) 
Peru 2001 2300/NR 391 3.5 (2.4 to 5.1) 280 
Krunner(Kruuner et 
al., 2001) 
Estonia 2001 14730/806 91 1.4 (1.0 to 2.0) 25 
Skodric(Skodric et al., 
2000) 
Serbia 2000 267/600 287 4.8 (2.1 to 9.7) 228 
Harries(Harries et al., 
1999) 
Malawi 1999 3042/14532 3550 9.1 (7.3 to 11.3) 3161 
Wilkinson(Wilkinson 
and Gilks, 1998) 
South Africa 1998 725/760 506 1.33 (0.8 to 2.0) 127 
Balt(Balt et al., 1998) South Africa 1998 NR 275 0.7 (0.08 to 2.6) -104 
Harries(Harries et al., 
1997) 
Malawi 1997 310/1112 1935 4.9 (2.5 to 8.8) 1546 
Babus(Babus, 1997) Croatia 1997 170/610 703 9.5 (5.3 to 16.1) 629 
*adapted from Joshi et al.(Joshi et al., 2006) and Menzies et al.(Menzies et al., 2007) 
TB=tuberculosis, HCW=healthcare worker, CI=confidence interval, NR=not reported  
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4.3 Aims 
The study overall objective is to determine HCWs’ knowledge and knowledge gaps regarding TB 
and its management and attitude and behaviours among HCWs that could facilitate TB 
transmission or impact TB management. 
 
Specific objectives: 
1. To investigate level of knowledge of HCWs regarding TB and its management and their 
attitudes and behaviours in practice in relation to the disease.  
2. To study factors associated with poor knowledge and attitude or bad practice regarding TB and 
its managements among HCWs. 
3. To propose interventions to address knowledge gaps or poor attitudes among HCWs and 
improve best practices in the management of the disease during the Hajj mass gathering. 
 
4.4 Methods 
4.4.1 Study design 
A cross sectional study to assess KAP of HCWs working during the Hajj regarding TB and its 
management.  
 
4.4.2 Study location 
The study took place in Makkah, (KSA), the site of the Hajj pilgrimage. It included 13 hospitals 
situation in the city including Hajj holy sites as shown in Table 2.  
 
4.4.3 Study period 
The study was conducted during Hajj season from 2nd to 12th September 2016 corresponding to 
the 1st to 11th of DulHija 1437 H in the Islamic calendar.  
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4.4.4 Study population 
4.4.4.1 Sample Size 
It is estimated that 13,000 HCWs are mobilised during Hajj. The sample size was determined using 
Epi InfoTM using a margin of error of 5%, a CI of 95%, a population size of 13,000, and an expected 
response rate of 50% to most of the main questions. The minimum sample size estimated for the 
study was 374. We enrolled a larger sample size of 540 HCWs to account for errors and non-
respondents.  
 
4.4.4.2 Eligibility criteria 
Inclusion criteria 
Inclusion criteria for the study were as follows:   
• HCWs (physicians, nurses, pharmacist, laboratory personnel, other) from selected healthcare 
facilities (Table 2)  
• Male and female 
• Saudi and non-Saudi 
• Willing to participate in the study  
 
Exclusion criteria 
Exclusion criteria from the study were as follows:   
• Refusal to participate in the study  
• Not a HCW  
 
4.4.5 Recruitment and data collection 
4.4.5.1 Recruitment Process 
The appropriate authorizations were obtained for conducting the study at the selected hospitals 
prior to starting data collection. Hospital directors were informed of the study, its objectives and  
the date/times that the research teams will be conducting the study. HCWs were selected randomly 
without presumption of potential occupational exposure to TB. The research team members 
distribute and collect the study questioners from HCWs after introducing themselves and 
explaining the survey’s purpose and the objectives of the study.  
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The questionnaires also had a cover letter that explained the aim and objectives of the study and 
the research coordinator’s contact email and phone number if HCWs had any further queries. 
 
4.4.5.2   Data collection tools 
Data was collected using an anonymous self-administered questionnaire developed in both English 
and Arabic languages (see appendix 4: data collection form for the knowledge, attitude and 
practice survey of healthcare workers regarding TB). The survey was designed to collect KAP 
information concerning TB and its management and infection prevention and control measures. 
The questionnaire was developed by reviewing available questionnaires in the literature (Bhebhe 
et al., 2014, Kanjee et al., 2011, Malangu and Adebanjo, 2015, Temesgen, 2011) and the WHO 
guidelines for TB KAP surveys (World Health Organization, 2008a) but was tailored for the Hajj 
setting and the study objectives. The following was performed to ensure the quality of the data 
collected: 
 
1. The questionnaire was carefully designed according to the study objectives and reviewed to 
ensure good understanding of questions and acquiring clear and precise answers. Questions 
were developed to be as precise and as unambiguous as possible with multiple choices and 
close-ended questions for accuracy. Study questionnaire was translated to Arabic using a 
professional certified medical translator. Translated questionnaire was back-translated by 
someone else other than the first translator to make sure that the translation was as accurate as 
possible.  
2. The questionnaire was piloted prior to the actual date of data collection in places different from 
the sample settings. The questionnaire was distributed to 20 randomly selected HCWs working 
in Riyadh. The questionnaire had a comment section related to any unclear questions or 
sections in the questionnaire so these could be improved in the final version. Final version of  
the questionnaire was revised carefully. The Cronbach’s alpha, (coefficient α), for the 
knowledge, attitude and practice sections of the final questionnaire were 0.78, 0.72 and 0.86 
respectively and were deemed acceptable. 
  
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj mass 
gathering 
 
199 
3. The information sheet accompanying the questionnaire was also translated into Arabic using a 
professional certified medical translator and back-translated for accuracy. The data collected 
and the quality of the information gathered was reviewed at the end of each day of the study 
to identify possible issues and improve data quality going forward. The principle investigator 
provided training for the study team. The aim of such trainings is to ensure that they understood 
the study objectives, their roles and collecting tool. The training was half day lectures and 
workshops for 2 days to explain the overall aim of the study, objectives, data collection tools 
included Clear step by step study instructions were also produced and distributed to the 
research team in Arabic and English, importance of patients' information and confidentiality 
as well as the role of each member of the team. The PI conducted a meeting at the end of each 
day to discuss the challenges and the progress of work 
 
4.4.6 Data entry and cleaning 
Data was entered following the gold standard for professional data entry which is double data 
entry. Data was entered twice in Excel and the two data sets were then compared, differences were 
examined, errors were verified against the original questionnaires and corrections were made. The 
data set was then exported to SPSS where frequencies for all variables were generated. The 
frequency tables generated were then examined to detect unusual values. Final databases were 
cleaned by the principle investigator to ensure quality before analysis.  
 
4.4.7 Knowledge attitude and practice scores 
The KAP questions were scored as follows:  
For questions with one possible correct/appropriate answer (including multiple choice questions), 
a score of 1 was given for choosing the correct/appropriate answer; a correct/appropriate response 
being that based on current literature and practice. A 0 score was given for choosing the 
wrong/inappropriate answer, choosing an uncertain response (I don’t know) or choosing any 
combination of correct/appropriate answer, wrong/inappropriate answer or uncertain response.  
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For multiple-choice questions where more than one correct/appropriate answer was possible, 
highlighted by the wording “Tick all that apply” in the questionnaire (see appendix 1), the scoring 
was calculated as follows:  
 
▪ Respondents were scored 1 point for ticking the correct/appropriate answer, 1 point for not 
ticking the wrong/inappropriate answer or the uncertain answer (don’t know). Zero score 
was given for ticking wrong/inappropriate answers, uncertain answers or not ticking the 
correct/appropriate answer. The total points were summed for each question and a weighed 
score was generated by dividing the total score of each question by the number of multiple 
choices in it so that the final score would range between 0 and 1.  
 
▪ For questions that had a “not applicable” option, the score for each question was as follows:  
A score of 1 was given for the correct/appropriate answer, and 0 score was given for the 
wrong/inappropriate answer or a “not applicable” answer.  
 
The overall total knowledge score, attitude score or practice score was computed by totaling the 
score for each question in the section and a weighed score for each section was generated by diving 
the overall total score for each section by the number of applicable questions within the section. 
The number of applicable questions refers to the number of questions in each section that do not 
include the “not applicable” option. For sections which include the “not applicable” options, the 
applicable number of questions in each section for each participant was the number of questions 
answered without ticking the “not applicable” option. This was to ensure that participants who 
ticked “not applicable” as a reply were not penalised in the final scoring by being counted in the 
same category as participants who answered the question wrongly/inappropriately. This scoring 
strategy ensured that overall knowledge score, attitude score or practice score for each participant 
were weighed correctly and ranged from 0 to 1.  
 
The overall scores were further divided into 5 categories to reflect the level of KAP among HCWS. 
These were: poor (score 0-0.2), below average (score >0.2-0.4), average (score >0.4-0.6), above 
average (score >0.6-0.8), good (score >0.8-1). 
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4.4.8 Statistical analysis 
Data was analysed using SPSS 22.0 /and or SAS 9.4 software programme. Descriptive statistics 
such as frequency, mean, standard deviation (SD), median, minimum and maximum and IQR were 
computed for quantitative variables and frequencies and percentages were calculated for 
categorical variables. Cronbach’s α, was used to measure reliability and internal consistency for 
the KAP questions. 
 
To evaluate different variables associated with the knowledge levels, attitude or practice, age was 
grouped into ordinal categories to facilitate analysis. Demographic variables examined include 
gender, age groups (<30, 30-39, 40-49, >49), nationality (Saudi, non-Saudi), level of education 
(diploma, bachelor, master, doctorate/specialty certificate, other), occupation (physician, nurse, 
other), current job position length (<1 year, 1-5 years, >5-10 years, >10 years), ward stationed in 
during Hajj and non-Hajj work and contact with TB patients during Hajj or non-Hajj work (Yes, 
No). The difference of KAP score with respect to individual covariates was evaluated by the non-
parametric Mann–Whitney U test or Kruskal-Wallis test as appropriate. Quantile regression was 
used to investigate the association between variables and the overall KAP scores across the 
different score levels including the 25th, 50th, and 75th quantiles. Correlation between knowledge 
attitude and practice was examined using the Spearman correlation coefficient. All of the tests for 
significance were two-sided and p values < 0.05 were considered statistically significant.  
 
4.4.9 Ethics 
The study was approved by the King Fahad Medical City Ethics Committee and the Institutional 
Review Board (IRB log: 16-329E) (Appendix 5) and by LSTM REC (19-084). All participants 
gave verbal consent before enrolment and the study was conducted in accordance with the Ethics 
Committee’s guidelines. 
 
 
4.4.10 Confidentiality 
The HCWs KAP survey forms were anonymous and did not include any identifiers or personal 
information of the participants.  
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4.5 Results 
 
4.5.1 Demographic characteristics 
Data was collected from the 2nd to 12th September 2016 (1st to 11th of Dul-Hijah 1437) from 540 
HCWs employed at 13 holy sites hospitals. Characteristics of the study population are summarised 
in Table 32.  
 
4.5.1.1 Age 
Age was recorded for 464 out of the 540 participants (Figure 21). The mean age of recorded 
respondents was 35.09 (SD= 8.92) years ranging from 22 to 64 years. Age variable was converted 
into a categorical variable with the following age groups: <30 years, 30-39 years, 40-49 years and 
>49 years (Table 32). In general, most of the study population was less than 40 years old.  
 
4.5.1.2 Gender 
Gender was recorded in 535 individuals. There were 277 (51.8%) females and 258 (48.2%) males 
in the study sample (Table 32) with a sex ratio of male to female of 1:1.  
 
4.5.1.3 Nationality 
Nationality was recorded in 474 HCWs. The highest number of respondents were Saudi nationals 
246 (52.1%) (Table 32). Among the non-Saudi nationals, the highest number of HCWs were from 
the Philippines (63, 27.9%), Egypt (53, 23.5%) and India (31, 13.7%) (Table 33).  
 
4.5.1.4  Level of education 
Out of the 529 respondents, most had either a Bachelor degree (237, 44.8%) or a Diploma (191, 
36.1%) (Table 32). 
 
4.5.1.5 Occupation 
Occupation was recorded in 531 HCWs. Of these, over half (275, 51.8%) were nurses, 154 (29.0%) 
were physicians and 102 (19.2%) reported their occupation as “other” (Table 32). Among 
physicians, 18 (11.8%) were general practitioners, 69 (45.1%) were specialists, 44 (28.7%) were 
residents and 19 (12.4%) were consultants.  
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Three physicians declared their position to be “other”. Of these one was specialist in diagnostic 
radiology, one was a psychologist and another was Saudi board certified member. Among the 243 
nurses, 8 (3.3%) declared being infection control nurses, while the rest indicated varying areas of 
work, mainly general (83, 46.6%), ICU (22, 12.4%), surgical (14, 7.8%) and ER (13, 7.3%) nurses. 
Among the 102 HCWs who reported their occupation as “other”, 48 (47.1%) were 
laboratory/diagnostic staff, and 35 (34.3%) were pharmacists. Another 19 HCWs reported work in 
other specialties, one being an epidemiologist and 3 working in respiratory therapy. The rest did 
not specify their work area.  
 
4.5.1.6 Non-Hajj employment 
Experience in current (non-Hajj) employment position 
HCWs were asked how long they have been working in their current non-Hajj position. The 
majority had from 1-5 years' experience (177, 33.9%) or >5-10 years' experience (169, 32.4%). 
Few (30, 5.7%) had <1 year work experience (Table 32). 
 
Ward stationed in during non-Hajj employment        
HCWs were questioned on the wards they are stationed in at their healthcare facilities during non-
Hajj work. Of the respondents, 76 (14.4%) worked in ICUs, 110 (20.9%) worked in ERs, 91 
(17.3%) worked in medical words, 50 (9.5%) worked in isolation wards, 81 (15.4%) worked in 
surgical wards, 24 (4.57%) worked in pediatric wards, 24 (4.57%) worked in maternity (O&G) 
wards and 203 HCWs declared being positioned in other wards not listed in the questionnaire. Of 
the latter, the majority were stationed in laboratory and blood bank departments (42, 20.6%), 
outpatients departments (39, 19.1%), radiology departments (25, 12.2%) or in pharmacies (26, 
12.7%).  
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4.5.1.7 Hajj employment 
Ward stationed in during Hajj employment   
HCWs were questioned on the wards they are stationed in at their healthcare facilities during Hajj 
work. Of the respondents, 72 (13.9%) worked in ICUs, 149 (28.8%) worked in ERs, 112 (21.6%) 
worked in medical words, 48 (9.3%) worked in surgical wards, 6 (1.1%) worked in pediatric wards, 
5 (0.1%) worked in maternity (O&G) wards and 188 HCWs declared being positioned in other 
wards not listed in the questionnaire. Of the latter, the majority were stationed in laboratory and 
blood bank departments (49, 26.8%), outpatients departments (67, 36.6%), radiology departments 
(25, 13.6%) or in pharmacies (27, 14.8%). 
 
4.5.1.8 Contact with tuberculosis patients during employment 
HCWs were asked if they do/did come into contact with TB patients during their Hajj or non-Hajj 
duties. The results are shown in Table 32. 
 
4.5.1.9 Contact with tuberculosis patients during non-Hajj employment  
Of the 510 HCWs who reported on their contact with TB patients during their non-Hajj duties, 261 
(51.2%) declared that they do come into contact with TB patients.   
 
4.5.1.10 Contact with tuberculosis patients during Hajj employment  
Of the 469 HCWs who reported on their contact with TB patients during their Hajj duties, 85 
(18.1%) declared that they did come into contact with TB patients during Hajj work. 
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Figure 21. Histogram for age of healthcare workers in years  
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Table 32. Characteristics of the study population 
Overall Summary Category Freq % 
Age 
 
  
 
<30 158 34.10 
 
30-39 190 40.90 
 
40-49 71 15.30 
 
>49 45 9.70 
Gender 
 
  
 
Female 277 51.78 
 
Male 258 48.22 
Nationality  
 
  
 
Saudi  246 52.10 
 
Non-Saudi  226 47.90 
Education Level 
 
  
 
Other 8 1.51 
 
Diploma 191 36.11 
 
Bachelor 237 44.80 
 
Master 53 10.02 
 
Doctorate/Specialty certificate 40 7.56 
Occupation 
 
  
 
Other 102 19.21 
 
Physician 154 29.00 
 
Nurse 275 51.79 
Current position length    
 <1 year 30 5.76 
 1 - 5 years 177 33.97 
 >5 - 10 years 169 32.44 
 >10 years 145 27.83 
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Cont. Table 32. Characteristics of the study population 
Overall Summary Category Freq % 
Non-Hajj TB patients contact    
 No 249 48.82 
 Yes 261 51.18 
Ward in Hajj work 
 
  
 
ICU 72 13.93 
 
ER 149 28.82 
  Medical ward  112 21.66 
 
Surgical ward 48 9.28 
 
Paediatrics ward 6 1.16 
 
Maternity (O&G) ward 5 0.97 
 
Other 188 36.86 
Hajj TB patients contact  
 
  
 
No 384 81.88 
 
Yes 85 18.12 
ICU=intensive care unit, ER= emergency room, O&G=obstetrics and gynaecology, TB= tuberculosis, 
Freq=frequency 
 
Table 33. Nationality of the non-Saudi Healthcare workers in the study 
Nationality  Frequency Percentage (%) 
Bangladeshi 4 1.8 
Chinese 1 0.4 
Egyptian 53 23.5 
Filipino 63 27.9 
Indian 31 13.7 
Indonesian 2 0.9 
Jordanian 11 4.9 
Lebanese 1 0.4 
Pakistani 22 9.7 
Palestinian 3 1.3 
Sudanese 26 11.5 
Syrian 5 2.2 
Thai 1 0.4 
Tunisian 1 0.4 
Turkish 1 0.4 
Yemeni 1 0.4 
Total 226 100.0 
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4.5.2  Tuberculosis knowledge among healthcare workers 
4.5.2.1  Personal development in relation to knowledge about tuberculosis among 
healthcare workers 
To assess if HCWs were regularly attending information sessions regarding TB and its 
management to help maintain their knowledge and best practice as well as being aware of the 
recent knowledge in the area, HCWs were asked if they have attended a lecture / seminar / 
workshop on TB in the previous 12 months. Results showed that of the 523 respondents, only 129 
(24.7%) attended a lecture, seminar or a workshop on TB in the previous year. Of these, 45.7% 
were nurses and 26.3% were physicians.  
 
4.5.2.2 Knowledge questions regarding tuberculosis 
HCWs were asked 23 questions to assess their knowledge regarding TB and its management. 
These questions were related to:  
 
1. What type of infection is pulmonary TB (PTB) infection  
2. Main symptoms of PTB 
3. Diagnostic tests for PTB 
4. Mode of transmission of PTB 
5. Screening tests for LTBI  
6. Percentage of active PTB positive for TB on smear microscopy  
7. Most useful sputum collection method for PTB diagnosis  
8. 1st-line anti-TB drugs 
9. 2nd-line anti-TB drugs 
10. Definition of MDR-TB  
11. Definition of XDR-TB  
12. Length of standard treatment of drug-sensitive TB  
13. Whether or not HIV patients are more vulnerable to contracting TB 
14. Whether or not PTB is curable  
15. Whether or not MDR-TB is curable  
16. Whether or not BCG vaccination was protective against TB 
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17. Whether or not PTB is transmitted via the airborne route 
18. Latent TB spread 
19. Whether or not patients with LTBI have positive reaction on TST/IGRA tests 
20. Whether or not patient with TB become non-infectious soon after initiating appropriate 
 treatment  
21. Whether or not only patients with active TB can spread the disease  
22. Appropriate Personal Protective Equipment (PPE) to use with active PTB patients  
23. Importance of using PPE to protect HCWs from TB infection 
 
The results are presented in Table 34. 
 
What type of infection is pulmonary tuberculosis infection? 
Over 75% of HCWs correctly identified TB as a bacterial infection (Table 34). However, 101 
(20.8%) thought TB was caused by a virus. Among the 121 HCWs who did not identify TB as a 
bacterial infection, most were nurses (67%) and reported a diploma as their highest level of 
education (72.2%). Physicians represented only 4.1% of HCWs who did not identify TB as a 
bacterial infection. Of the HCWs who declared that they deal with TB patients during their non-
Hajj work (n= 239), 21.3% provided the wrong answer to the question.   
 
Main symptoms of pulmonary tuberculosis 
HCWs were presented with a list of symptoms and were asked to tick all which they thought were 
main symptoms of PTB. Nearly all HCWs (97.9%) answered the question regarding TB 
symptoms. The percentage of HCWs who identified symptoms as those of PTB were: 79.2% for 
cough ≥3 weeks, 63.1% for fever/chill, 9.4% for dizziness, 46.7% for tiredness/fatigue, 75.6% for 
cough with blood, 71.3% for weight loss, 16.3% for headache, 1.9% for pain when urinating, 9.2% 
for diarrhoea, 40.2% for chest pain, 56.7% for loss of appetite, 1.3% for memory loss, 52.7% for 
night sweats and 2.1% for blurry vision. Overall, only 3.6% (19/521) of HCWs correctly identified 
all the main symptoms of PTB in the list of options, 66.6% of whom were physicians. When 
analysis was restricted to physicians only, in general the percentage of individuals who correctly 
identified the main symptoms of TB increased.  
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj mass 
gathering 
 
210 
The percentage of physicians who identified symptoms as those of PTB were: 88.7% for cough ≥3 
weeks, 75.5% for fever/chill, 13.9% for dizziness, 66.9% for tiredness/fatigue, 80.8% for cough 
with blood,88.7% for weight loss, 19.8% for headache, 1.9% for pain when urinating, 7.9% for 
diarrhoea, 39.0% for chest pain, 76.8% for loss of appetite, 2.1% for memory loss, 80.1% for night 
sweats and 5.9% for blurry vision. 
 
Diagnostic tests for pulmonary tuberculosis 
HCWs were presented with a number of tests and were asked to identify which test(s) is/are used 
to diagnose PTB in practice. Most, (97.4%) answered the question, while 14 HCWs declared they 
did not know the answer (Table 34). Among those who answered the questions, the proportion of 
HCWs who identified the various tests as diagnostic tests for PTB were as follows: 65.7% for TST, 
69.4% for sputum culture, 2.9% for urine examination, 11.9% for the GeneXpert MTB/RIF test, 
57.6% for sputum acid-fast bacilli (AFB) smear test, 13.3% for IGRA, 8.3% for liver function test, 
13.1% for complete blood count (CBC), 11.8% for blood culture and 71.3% for chest X-ray. 
Overall, only 1.6% (8/520) HCWs correctly identified all the diagnostic tests for PTB from the list 
of options.  
 
Mode of transmission of pulmonary tuberculosis 
HCWs were asked about the mode of transmission of PTB and 529 (97.9%) answered the question. 
The proportion of HCWs who identified the various transmission modes as those for PTB were as 
follows: 9.6% for blood transmission, 93.0% for coughing, 27.0% for sharing food or drink, 41.8% 
for contaminated surfaces, 65.0% for sneezing, 36.9% for kissing and 16.8% for hand shaking. 
Overall, only 7% (37/529) of HCWs correctly identified all the modes of transmission of PTB in 
the listed options.  
 
Screening tests for latent tuberculosis infection 
HCWs were presented with a list of tests and were asked to identify which test(s) is/are used to 
screen for LTBI in practice. Most, (92.8%) answered the question, while 38 HCWs declared they 
did not know the answer (Table 34).  
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Among those who answered, the proportion of HCWs who identified the various tests as screening 
tests for LTBI was as follows: 60.0% for TST, 44.4% for sputum culture, 2.3% for urine 
examination, 7.2% for the GeneXpert MTB/RIF test, 35.3% for sputum AFB smear test, 12.7% 
for IGRA, 5.1% for liver functiontest, 7.8% for CBC, 6.2% for blood culture and 53.0% for chest 
X-ray. Overall only one nurse correctly identified all the screening tests for LTBI in the list of 
options.  
 
Percentage of active pulmonary tuberculosis positive for tuberculosis on smear microscopy 
HCWs were questioned regarding the usual percentage of active PTB positive for TB on smear 
microscopy. All HCWs answered the question but over half (292, 54.1%) reported that they did 
not know the answer (Table 34). The majority of the rest thought that the percentage of active PTB 
that would be positive for TB on smear microscopy was 80% (112, 20.7%) or 50% (88, 16.3%). 
Out of the 48 HCWs who reported their occupation as laboratory/diagnostic staff, only 18.7% 
correctly chose 50% as their answer.  
 
Most useful sputum collection method for pulmonary tuberculosis diagnosis 
HCWs were asked about the best timing/collection methods of sputum for TB diagnosis. Of the 
524 HCWs who answered, 88 (16.8%) declared that they did not know the answer (Table 34). The 
proportion of HCWs who identified the various sputum timing/collection methods to be the most 
useful for TB diagnosis was as follows: 87.4% for 3 samples (spot, morning, spot), 6.4% for 3 
samples (2 spot, 1 spot), 4.1% for a spot sample, and 2.3% for 2 spot samples. 
 
First line anti- tuberculosis drugs 
HCWs were asked to identify the 1st-line anti-TB drugs from a list of options. Of those who 
answered (526 HCWs), 145 (27.6%) declared that they did not know the answer (Table 34). The 
proportion of HCWs who identified the various antibiotics as the 1st-line anti-TB drugs was as 
follows: 78.5% for INH, 83.5% for RIF, 9.4% for CIP, 54.9% for PZA, 2.1% for LEV, 3.7% for 
KAN, 3.1% for AMK, 58.0% for EMB and 1.3% for CAP. Overall, only 6% (23/381) correctly 
identified all the 1st-line anti-TB drugs (INH, RIF, PZA and EMB) in the list of options.  
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When analysis was restricted to physicians only, in general the percentage of individuals who 
correctly identified the 1st-line anti-TB drugs increased. The proportion of physicians who 
identified the  various antibiotics as the 1st-line anti-TB drugs was as follows: 88.9% for INH, 
89.7% for RIF, 3.6% for CIP, 62.5% for PZA, 0.7% for LEV, 2.2% for KAN, 0.74% for AMK, 
66.9% for EMB and 0.0% for CAP. 
 
Second-line anti- tuberculosis drugs 
HCWs were asked to identify the 2nd-line anti-TB drugs from a list of options. Of those who 
answered (505 HCWs), 197 (39.0%) declared that they did not know the answer (Table 34). The 
proportion of HCWs who identified the various antibiotics as the 2nd-line anti-TB drugs was as 
follows: 31.2% for INH, 30.2% for RIF, 32.5% for CIP, 27.6% for PZA, 16.6% for LEV, 26.6% 
for KAN, 27.3% for AMK, 28.2% for EMB and 15.9% for CAP. Overall, 4.5% (14/308) of HCWs 
correctly identified all the 2nd-line TB drugs (CIP, LEV, KAN, AMK and CAP) in the list of 
options. When analysis was restricted to physicians only, the percentage of individuals who 
correctly identified the 2nd-line anti-TB drugs increased. The proportion of physicians who 
identified the various antibiotics as the 2nd-line anti-TB drugs was as follows: 21.2% for INH, 
21.2% for RIF, 46.0% for CIP, 20.3% for PZA, 26.5% for LEV, 37.1% for KAN, 40.7% for AMK,, 
17.7% for EMB and 27.4% for CAP. 
 
Definition of multidrug-resistant tuberculosis 
HCWs were questioned regarding the definition of MDR-TB. Of those who answered (501 
HCWs), 206 (41.1%) declared that they did not know the answer (Table 34). A quarter (25.0%) of 
HCWs correctly identified that MDR-TB is cause by bacteria resistant to at least INH and RIF, 
The proportion of HCWs who noted various other definitions as the definition of MDR-TB was as 
follows: 3.8% for resistance to INH, 2.4% for resistance to RIF, 1.6% for resistance to EMB, 2.6% 
for resistance to at least CIP and KAN and 2.4% for a combination of the various options. A further 
106 HCWs (21.2%) thought that the definition of MDR-TB included all the above possibilities. 
Of the 125 HCWs who correctly identified the definition of MDR-TB, 52.0% were physicians and 
33.6% were nurses. Of the HCWs who declared that they deal with TB patients during their non-
Hajj work (n= 240), 25.8% knew the definition of MDR-TB.   
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Definition of extensively drug-resistant tuberculosis 
HCWs were questioned regarding the definition of XDR-TB. Of those who answered (479 
HCWs), 259 (54.1%) declared that they did not know the answer (Table 34). The proportion of 
HCWs who noted the various definitions as the definition of XDR-TB was as follows: 12.7% for 
MDR-TB resistant to any fluoroquinolone and at least one of three injectable 2nd-line drugs 
(correct answer), 21.1% for TB resistant to all 1st-line anti-TB drug and 11.3% for TB resistant to 
any fluoroquinolone and at least one of three injectable 2nd-line drugs. Four (0.8%) of HCWs 
answered a combination of the various options above. Of the 61 HCWs who chose the correct 
definition of XDR-TB, 46.5% were physicians and 47.4% were nurses. Of the HCWs who declared 
that they deal with TB patients during their non-Hajj work (n= 234), 14.1% ticked the correct 
definition of XDR-TB.   
 
Length of standard treatment for new patient with drug-sensitive tuberculosis 
HCWs were questioned regarding the standard treatment duration for a new patient with drug-
sensitive TB. Of those who answered (513 HCWs), 108 (21.1%) declared that they did not know 
the answer (Table 34). The proportion of HCWs who picked various treatment durations was as 
follows: 18.5% for 1-3 months, 23.8% for 4-6 months, 31.0% for 6-9 months (correct answer) and 
5.1% for greater than 12 months. Three HCWs (0.5%) answered a combination of the various 
options above. Out of the 154 physicians, 44.1% correctly answered the question.  
 
Are human immunodeficiency virus patients more vulnerable to contracting tuberculosis? 
HCWs were questioned about whether HIV patients were more vulnerable to contracting TB. Of 
those who answered (519 HCWs), 62 (11.9%) declared that they did not know the answer (Table 
34). Most HCWs (422, 81.3%) thought that HIV patients were more vulnerable to contracting TB.  
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Is pulmonary tuberculosis a curable disease 
HCWs were questioned if they thought PTB was a curable disease. Of those who answered (517 
HCWs), 39 (7.5%) declared that they did not know the answer (Table 34). Most HCWs (456, 
88.2%) thought that PTB was a curable disease, while 22 (4.3%) did not think it was curable. Of 
the 61 HCWs who did not know the answer to the question or thought TB was not curable, 18.3% 
were physicians and 53.3% were nurses.  
 
Is multidrug-resistant tuberculosis a curable disease 
HCWs were questioned if they thought MDR-TB was a curable disease. Of those who answered 
(504 HCWs), 161 (31.9%) declared that they did not know the answer (Table 34). About half of 
the HCWs (256, 50.8%) thought that MDR-TB was a curable disease, while 87 HCWs (17.3%) 
did not think it was curable. Of the 248 HCWs who did not know the answer to the question or 
thought MDR-TB was not curable, 21.9% were physicians and 51.6% were nurses. 
 
Bacilli Calmette-Guerin vaccination and protection against developing active tuberculosis 
HCWs were questioned about whether people who had received BCG vaccination were protected 
against developing active TB. Of those who answered (514 HCWs), 140 (27.2%) declared that 
they did not know the answer (Table 34). Similar proportions of HCWs (36.8% and 36.0% 
respectively) thought BCG was protective or not protective.  
 
Pulmonary tuberculosis is transmitted via the airborne route 
HCWs were questioned about whether the airborne was a mode of transmission of PTB. Of those 
who answered (507 HCWs), 39 (7.7%) declared that they did not know the answer (Table 34). 
Most HCWs (424, 83.6%) correctly thought TB was transmitted via the airborne route. Of the 
HCWs who declared that they deal with TB patients during their non-Hajj work (n= 246), 86.6% 
provided the correct answer.  
 
Latent tuberculosis and spread of tuberculosis 
HCWs were asked if a patient with latent TB can transmit the disease. Of those who answered 
(515 HCWs), 62 (12.0%) declared that they did not know the answer (Table 34). Over half of the 
HCWs (284, 55.1%) thought that a patient with latent TB can spread the disease.  
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A patient with latent tuberculosis has a positive reaction to tuberculin skin test or 
interferon-gamma release assay 
HCWs were asked if a patient with latent TB would have a positive TST or IGRA tests results. Of 
those who answered (505 HCWs), 160 (31.7%) declared that they did not know the answer (Table 
34). Over half of the HCWs (290, 57.4%) thought that a patient with latent TB would have a 
positive result in a TST or an IGRA test.  
 
Tuberculosis patients become non-infectious soon after initiating the appropriate treatment 
HCWs were asked whether TB patients become non-infectious soon after initiating the appropriate 
treatment. Of those who answered (512 HCWs), 76 (14.8%) declared that they did not know the 
answer (Table 34). About 40% of HCWs thought that patients with TB would become non-
infectious soon after initiating appropriate treatment.  
 
Only patient with active tuberculosis can spread the disease 
HCWs were asked if only patients with active TB can spread the disease. Of those who answered 
(511 HCWs), 63 (12.3%) declared that they did not know the answer (Table 34). About 60% of 
HCWs thought that only patients with active TB can spread the disease. 
 
Appropriated personal protective equipment to be use when dealing with a patient with 
active pulmonary tuberculosis 
HCWs were asked to identify the most appropriated PPE to be used when dealing with patients 
with active PTB from a list of options or if PPE was needed at all. Of those who answered (514 
HCWs), 25 (4.9%) declared that they did not know the answer (Table 34). Most HCWs (393, 
76.5%) believed that N95 respirators should be used when dealing with PTB patients. About 18% 
thought that surgical masks should be used, while 4 (0.8%) HCWs thought no PPE was necessary. 
Of the HCWs who declared that they deal with TB patients during their non-Hajj work (n= 250), 
82% provided the correct answer to the question.   
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Importance of using personal protective equipment to protect healthcare workers from 
tuberculosis 
HCWs were questioned about the importance of using PPE when dealing with patients with TB. 
Of those who answered (522 HCWs), 29 (5.6%) declared that they did not know the answer (Table 
34). Most HCWs (469, 89.8%) believed that using PPE to protect HCWs when dealing with TB 
patients was important, while 24 (4.6 %) thought it was not important. Of those who did not know 
the answer or thought PPE was not important when dealing with TB patients, 41.5% were doctors 
and 35.8% were nurses. Of the HCWs who declared that they deal with TB patients during their 
non-Hajj work (n= 254), 91.3% declared that using PPE was important when dealing with TB 
patients.  
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Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
Knowledge question Category Freq  % 
1. TB falls under 
 
    
 
Viral infection 101 20.82 
 
Bacterial infection 364 75.05 
 
Don't know 19 3.92 
 
Both 1 0.21 
2. PTB main symptoms 
 
    
 
Don't know 11 2.07 
 
Answered 520 97.93 
  
    
 
Cough ≥3 weeks 412 79.23 
 
Fever/chills 328 63.08 
 
Dizziness 49 9.42 
 
Tiredness/ fatigue 243 46.73 
 
Cough with blood 393 75.58 
 
Weight loss 371 71.35 
 
Headache 84 16.15 
 
Pain with urination 10 1.92 
 
Diarrhoea 48 9.23 
 
Chest pain 209 40.19 
 
Loss of appetite 295 56.73 
 
Memory loss 7 1.35 
 
Night sweats 274 52.69 
 
Blurry vision 11 2.12 
 
Cont.. Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
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Knowledge question Category Freq  % 
3. PTB diagnostic tests 
 
    
 
Don't know 14 2.63 
 
Answered 519 97.37 
  
    
 
TST 341 65.70 
 
Sputum culture 360 69.36 
 
Urine examination 15 2.89 
 
GeneXpert MTB/RIF 62 11.95 
 
Sputum AFB smear 299 57.61 
 
IGRA 69 13.29 
 
Liver function 43 8.29 
 
CBC 68 13.10 
 
Blood culture 61 11.75 
 
Chest X-ray 370 71.29 
4. PTB transmission  
 
    
 
Answered 529 97.9 
  
    
 
Blood transmission 51 9.64 
 
Coughing 492 93.01 
 
Sharing food or drink 143 27.03 
 
Contaminated surfaces 221 41.78 
 
Sneezing 344 65.03 
 
Kissing 195 36.86 
 
Shaking hand 89 16.82 
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Cont.. Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
Knowledge question Category Freq  % 
5. Latent TB screening tests 
 
    
 
Don't know 38 7.24 
 
Answered 487 92.76 
  
    
 
TST 292 59.96 
 
Sputum culture 216 44.35 
 
Urine examination 11 2.26 
 
GeneXpert MTB/RIF 35 7.19 
 
Sputum AFB smear 172 35.32 
 
IGRA 62 12.73 
 
Liver function 25 5.13 
 
CBC 38 7.80 
 
Blood culture 30 6.16 
 
Chest X-ray 258 52.98 
6. Percentage of active PTB positive for TB on smear microscopy 
 
     
10% 24 4.40  
20% 24 4.40  
50% 88 16.3  
80% 112 20.7  
Don’t know  292 54.1 
7. Most useful sputum collection method for PTB diagnosis 
 
     
Don't know 88 16.83  
Answered 436 83.17  
3 samples (spot-morning-spot) 380 87.36  
2 spot, 1 spot samples 28 6.44  
1 spot sample 18 4.14  
2 spot samples 10 2.30 
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Cont.. Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
Knowledge question Category Freq  % 
8. 1st-line anti-TB drugs 
 
    
 
Don't know 145 27.57 
 
Answered 381 72.43 
  
    
 
INH 299 78.48 
 
RIF 318 83.46 
 
CIP 36 9.45 
 
LEV 8 2.10 
 
CAP 5 1.31 
 
KAN 14 3.67 
 
EMB 221 58.01 
 
PZA 209 54.86 
 
AMK 12 3.15 
9. 2nd-line anti-TB drugs 
 
     
Don't know 197 39.01  
Answered 308 60.99   
     
INH 96 31.17  
RIF 93 30.19  
CIP 100 32.47  
LEV 51 16.56  
CAP 49 15.91  
KAN 82 26.62  
EMB 87 28.25  
PZA 85 27.60  
AMK 84 27.27 
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Cont. Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
Knowledge question Category Freq  % 
10. MDR-TB bacteria is resistant to 
 
    
 
INH 19 3.79 
 
RIF 12 2.40 
 
At least INH & RIF 125 24.95 
 
EMB 8 1.60 
 
At least CIP & KAN 13 2.59 
 
All of the above 106 21.16 
 
Don't know 206 41.12 
 
Any combinations of the above  12 2.40 
11. XDR-TB is 
 
     
Don't know 259 54.07  
MDR-TB resistant to any fluoroquinolone and at least 
one of three injectable 2nd-line drugs 
61 12.73 
 
TB resistant to any fluoroquinolone and at least one of 
three injectable 2nd-line drugs 
54 11.27 
 
TB resistant to all 1st-line anti-TB drugs 101 21.09  
Any combinations of the above  4 0.84 
12. Length of standard treatment of drug-sensitive TB 
 
    
 
Don't know 108 21.05 
 
1-3 Months 95 18.52 
 
4-6 Months 122 23.78 
 
6-9 Months 159 30.99 
 
>12 Months 26 5.07 
 
Any combinations of the above  3 0.58 
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Cont.. Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
Knowledge question Category Freq  % 
13. HIV patients are more vulnerable to contracting TB 
 
    
 
Don't know 62 11.95 
 
True 422 81.31 
 
False 35 6.74 
14. PTB is curable  
 
    
 
Don't know 39 7.54 
 
True 456 88.2 
 
False 22 4.26 
15. MDR-TB is curable  
 
    
 
Don't know 161 31.94 
 
True 256 50.79 
 
False 87 17.26 
16. BCG vaccination is protective against TB 
 
    
 
Don't know 140 27.24 
 
True 189 36.77 
 
False 185 35.99 
17. PTB is transmitted via the airborne route 
 
    
 
Don't know 39 7.69 
 
True 424 83.63 
 
False 44 8.68 
18. Patients with latent TB can spread the disease  
 
    
 
Don't know 62 12.04 
 
True 284 55.15 
 
False 169 32.82 
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj mass gathering 
 
223 
Cont.. Table 34. Summary statistics of knowledge questions regarding tuberculosis among healthcare workers 
Knowledge question Category Freq  % 
19. Patients with latent TB have positive reaction on TST/IGRA tests 
 
    
 
Don't know 160 31.68 
 
True 290 57.43 
 
False 55 10.89 
20. Patient with TB become non-infectious soon after initiating appropriate 
treatment  
 
    
 
Don't know 76 14.84 
 
True 208 40.63 
 
False 228 44.53 
21. Only patients with active TB can spread the disease  
 
    
 
Don't know 63 12.33 
 
True 306 59.88 
 
False 142 27.79 
22. Appropriate PPE to use with active PTB patients  
 
    
 
Don't know 25 4.86 
 
Surgical mask 92 17.9 
 
N95 respirator 393 76.46 
 
No PPE is needed 4 0.78 
23. Using PPE to protect HCWs from TB is important 
 
    
 
Don’t know  29 5.56 
 
Yes 469 89.85 
  No 24 4.60 
TB=tuberculosis, PTB=pulmonary tuberculosis, HIV=human immunodeficiency virus, PPE=personal protective equipment, HCW=healthcare worker, MDR= multidrug-resistant, XDR=extensively 
drug-resistant, TST=tuberculin skin tests (TST), AFB=acid-fast bacilli, IGRA= interferon gamma release assay, CBC= complete blood count, INH=Isoniazid, RIF; Rifampicin, CIP=Ciprofloxacin, 
PZA=Pyrazinamide, LEV=Flevofloxacin, KAN=Kanamycin, AMK=Amikacin, EMB=Ethambutol , CAP=Capreomycin, BCG=Bacillus Calmette-Guéri
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4.5.2.3 Knowledge section scores 
The mean scores for each knowledge question (min 0, max 1) are presented in Table 35. 
 
Table 35. Mean knowledge scores for healthcare workers regarding tuberculosis and its 
management  
Knowledge question N Min Max Mean SD 
TB falls under 485 0 1 0.75 0.43 
PTB main symptoms 520 0.40 1 0.76 0.14 
PTB diagnostic tests 519 0.27 1 0.68 0.13 
PTB transmission 540 0.29 1 0.71 0.15 
Latent TB screening tests 487 0.27 1 0.74 0.11 
Percentage of active PTB positive for TB on smear microscopy 540 0 1 0.16 0.37 
Most useful sputum collection method for PTB diagnosis 435 0 1 0.87 0.33 
1st-line anti-TB drug 381 0.40 1 0.85 0.10 
2nd-line anti-TB drug 308 0.10 1 0.50 0.24 
MDR-TB bacteria is resistant to 501 0 1 0.25 0.43 
XDR-TB is 479 0 1 0.13 0.33 
Length of standard treatment of drug-sensitive TB 513 0 1 0.31 0.46 
HIV patients are more vulnerable to contracting TB 519 0 1 0.81 0.39 
PTB is curable 517 0 1 0.88 0.32 
MDR-TB is curable 504 0 1 0.51 0.5 
BCG vaccination is protective against TB 514 0 1 0.36 0.48 
PTB is transmitted via the airborne route 507 0 1 0.84 0.37 
Patients with latent TB can spread the disease 515 0 1 0.33 0.47 
Patients with latent TB have positive reaction on TST/IGRA tests 505 0 1 0.57 0.49 
Patient with TB become non-infectious soon after initiating 
appropriate treatment 
512 0 1 0.41 0.49 
Only patients with active TB can spread the disease 511 0 1 0.60 0.49 
Appropriate PPE to use with active PTB patients 514 0 1 0.82 0.38 
Using PPE to protect HCWs from TB is important 522 0 1 0.90 0.30 
TB; tuberculosis, PTB; pulmonary tuberculosis, HIV; human immunodeficiency virus, PPE; personal protective 
equipment, HCW; healthcare worker, MDR; multidrug-resistant, XDR; extensively drug-resistant, TST: tuberculin 
skin tests (TST), AFB; acid-fast bacilli, IGRA; interferon gamma release assay, CBC; complete blood count, BCG; 
Bacillus Calmette-Guérin, Min; minimum, Max, maximum, SD; standard deviation, N; number of observations  
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4.6 Attitude of healthcare workers towards tuberculosis 
Information on HCWs’ attitude toward TB was collected by asking the following 11 
questions/statements:   
 
1. Would you be willing to work in a TB clinic/ward? 
2. Would you resign from work if you are posted to a TB clinic/ward? 
3. Would you be willing to be screened for TB if you had suggestive symptoms? 
4. Do you think all TB patients should be isolated for treatment? 
5. It is ok to allow a TB patient to leave the hospital soon after initiating appropriate treatment 
6. Would you be willing to attend seminars on TB? 
7. Would you recommend the suspension of treatment if a TB patient is feeling better? 
8. Would you start TB treatment for a TB patient before diagnosis is confirmed if a suspected TB 
patient is very ill? 
9. Would you use a face mask when dealing with a PTB patient even when it is uncomfortable? 
10. Would you trust the result the laboratory provides you on sputum cultures? 
11. I would not accept to examine/treat TB patients 
 
The answers to the questions were coded in the database (section) to reflect whether the 
participants have a positive or a negative attitude and used to calculate the overall attitude scores.  
Participants were also presented with 4 further questions/statements relating to their perception 
about the risk of TB infection related to their work and their willingness to teach others in relation 
to TB. These were the following:  
 
1. I have a very low risk of acquiring TB from my patients 
2. I worry about acquiring active TB disease while at work 
3. Would you be willing to teach patients and co-workers about TB prevention? 
4. Would you be willing to teach patient how to collect sputum sample? 
 
Response to these 4 questions were not included in the calculation of the overall attitude 
scores. 
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4.6.1 Individual questions about attitude towards tuberculosis 
Results of response to attitude questions are summarised in Table 36.  
 
Would you be willing to work in a tuberculosis clinic/ward? 
Of those who answered the question (521 HCWs), 309 (59.3%) declared that they would not be 
willing to work in a TB clinic or ward. The percentage of doctors who declared they were not 
willing to work in a TB clinic was slightly higher than that of nurses (60.1% vs 58.2% 
respectively).  
 
Would you resign from work if you are posted to a tuberculosis clinic/ward? 
Of those who answered the question (515 HCWs), 433 (84.1%) declared that they would not resign 
from their work if they were to be posted to a TB clinic or ward, yet 82 HCWs declared that they 
would resign. The proportion of nurses who would resign if posted to a TB clinic was slightly 
higher than that for physicians (16.1% vs 14.4% respectively).  
 
Would you be willing to be screened for tuberculosis if you had suggestive symptoms? 
Of those who answered the question (512 HCWs), most, 483 (94.3%), declared that they would 
be willing to be screened for TB if they had suggestive symptoms. The proportion of HCWs with 
occupation defined as “other” (including laboratory/diagnostic staff and pharmacists) who 
declared they would not be willing to be screened for TB (13.6%) was higher than that of 
physicians and nurses (2.7% and 4.5% respectively). 
 
Do you think all tuberculosis patients should be isolated for treatment? 
Of those who answered the question (527 HCWs), 336 (63.8%) declared that they thought that all 
TB patients should be isolated for treatment. Some HCWs (21, 4%) declared that they did not 
know the answer to this question, while 170 (32.3%) thought that not all TB patients should be 
isolated. There was a clear difference in the answer to this question by occupation.  
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While 53.7% of physician thought that not all TB patients should be isolated, 69.6% of nurses and 
75.2% of those with occupation defined as “other” thought they should. Of the HCWs who 
declared that they deal with TB patients during their non-Hajj work (n= 257), 65.3% provided the 
wrong answer to the question.   
 
It is ok to allow a tuberculosis patient to leave the hospital soon after initiating appropriate 
treatment? 
Of those who answered the question (521 HCWs), 254 (48.8%) declared that they thought it was 
ok to allow a TB patient to leave the hospital soon after initiating appropriate treatment. Some 
HCWs (44, 8.4%) declared that they did not know the answer to this question, while 223 (42.8%) 
thought that it was not ok to allow a TB patient to leave the hospital soon after initiating appropriate 
treatment. Nurses were more often in agreement with the statement than doctors (54.4% vs 44.8%). 
Of the HCWs who declared that they deal with TB patients during their non-Hajj work (n= 253), 
more than half (51.3%) disagreed with the above statement.  
 
Would you be willing to attend seminars on tuberculosis? 
Of those who answered the question (512 HCWs), most, 487 (95.1%), declared that they would 
you be willing to attend seminars on TB. 
 
Would you recommend the suspension of treatment if a tuberculosis patient is feeling 
better? 
Of those who answered the question (518 HCWs), 411 (79.3%) declared that they would not 
recommend the suspension of treatment if a TB patient was feeling better, while 46 (8.9%) reported 
that this question was not applicable to them. Some HCWs however (61, 11.8%) declared that they 
would recommend the suspension of treatment if a TB patient was feeling better. Around 6% of 
physicians would recommend suspension of TB treatment compared to 15.3% of nurses.  
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Would you start tuberculosis treatment for a tuberculosis patient before diagnosis is 
confirmed if a suspected tuberculosis patient is very ill? 
Of those who answered the question (515 HCWs), 287 (55.7%) declared that they would not start 
TB treatment for a TB patient before diagnosis was confirmed if a suspected TB patient was very  
ill, while 43 (8.3%) reported that this question was not applicable to them. Some HCWs however 
(185, 35.9%) declared that they would start TB treatment for a TB patient before diagnosis was 
confirmed if a suspected TB patient was very ill. Among doctors, 53.7% declared they would start 
TB treatment before diagnosis is confirmed.   
 
Would you use a face mask when dealing with a pulmonary tuberculosis patient even when 
it is uncomfortable? 
Of those who answered the question (521 HCWs), 428 (82.1%) declared that they would use a 
face mask when dealing with a PTB patient even when it is uncomfortable, while 93 (17.9%) 
reported that they would not. More doctors than nurses indicated that they would use a face mask 
even when it is uncomfortable (85.6% vs 79.2%). Of the HCWs who declared that they deal with 
TB patients during their non-Hajj work (n= 253), 20.5% disagreed with the above statement.  
 
Would you trust the result the laboratory provides you on sputum cultures? 
Of those who answered the question (524 HCWs), 448 (85.5%) declared that they would trust the 
result the laboratory provides them on sputum cultures, while 30 (5.7%) reported that this question 
was not applicable to them. Some HCWs however (46, 8.8%) declared that they would not trust 
the result the laboratory provides them on sputum cultures. The proportion of those who indicated 
they trust the laboratory results was comparable across occupations.  
 
I would not accept to examine/treat tuberculosis patients 
Of those who answered the question (510 HCWs), 435 (85.3%) declared that they would accept 
to examine/treat TB patients, while 75 (14.7%) reported that they would not be willing to do so. 
The lowest proportion of HCWs who declared they would not be willing to examine TB patients 
was among physicians (11.6%) followed by nurses (14.5%).  
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I have a very low risk of acquiring tuberculosis from my patients 
HCWs were asked if they thought they had very low risk of acquiring TB from their patients. Of 
those who answered the question (517 HCWs), 253 (48.9%) declared that they thought they did 
not have very low risk of acquiring TB from their patients, while 155 (30%) thought they had very  
low risk of acquiring TB from their patients. Around 20% of HCWs (109) declared that they did 
not know the answer to this question. The highest proportion of HCWs who thought they did not 
have a very low risk of acquiring TB from their patients were physicians (53.7%) and nurses 
(48.8%). Among those who declared that they thought they had very low risk of acquiring TB 
from their patients, 51.3% were nurses and 30.2% were doctors.  
 
I worry about acquiring active tuberculosis disease while at work 
HCWs were asked if they worried about acquiring active TB disease while at work. Of those who 
answered the question (510 HCWs), 350 (68.6%) declared that they worried about acquiring active 
TB disease while at work, while 160 (31.4%) did not worry. The proportion of HCWs who were 
worried about acquiring active TB while at work was higher among those who declared that they 
deal with TB patients during their non-Hajj work compared to those who did not (72% vs 64%). 
 
Would you be willing to teach patients and co-workers about tuberculosis prevention? 
Of those who answered the question (513 HCWs), most, 480 (93.6%) declared that they would be 
willing to teach patients and co-workers about TB prevention.  
 
Would you be willing to teach patient how to collect sputum sample? 
Of those who answered the question (510 HCWs), 447 (87.6%) declared that they would be willing 
to teach patient how to collect sputum sample, while 63 (12.4%) reported that they would not be 
willing to do so.  
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Table 36. Summary statistics of healthcare workers’ attitude towards tuberculosis  
Attitude statement/question  Category Freq  % 
1.      Would you be willing to work in a TB clinic/ward? 
 
     
No 309 59.31  
Yes 212 40.69 
2.      Would you resign from work if you are posted to a TB clinic/ward? 
 
     
No 433 84.08  
Yes 82 15.92 
3.      Would you be willing to be screened for TB if you had suggestive symptoms? 
 
     
No 29 5.66  
Yes 483 94.34 
4.      Do you think all TB patients should be isolated for treatment? 
 
     
No 170 32.26  
Yes 336 63.76  
Don't know 21 3.98 
 5.      It is ok to allow a TB patient to leave the hospital soon after initiating appropriate treatment? 
 
     
No 223 42.8  
Yes 254 48.75  
Don't know 44 8.45 
6.      Would you be willing to attend seminars on TB? 
 
     
No 25 4.88  
Yes 487 95.12 
7.      Would you recommend the suspension of treatment if a TB patient is feeling better? 
 
     
No 411 79.34  
Yes 61 11.78  
NA 46 8.88 
 8.      Would you start TB treatment for a TB patient before diagnosis is confirmed if a suspected TB patient is very ill? 
 
     
No 287 55.73  
Yes 185 35.92  
NA 43 8.35 
9.      Would you use a face mask when dealing with a PTB patient even when it is uncomfortable? 
 
     
No 93 17.85  
Yes 428 82.15 
10.   Would you trust the result the laboratory provides you on sputum cultures? 
 
     
No 46 8.78  
Yes 448 85.5  
NA 30 5.73 
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Cont. Table 36. Summary statistics of healthcare workers’ attitude towards tuberculosis  
Attitude statement/question  Category Freq  % 
11.   I would not accept to examine/treat a TB patients 
 
    
 
No 435 85.29 
 
Yes 75 14.71 
12.   I have a very low risk of acquiring TB from my patients 
 
    
 
No 253 48.94 
 
Yes 155 29.98 
 
Don't know 109 21.08 
13.   I worry about acquiring active TB disease while at work 
 
    
 
No 160 31.37 
 
Yes 350 68.63 
  
    
14.   Would you be willing to teach patients and co-workers about TB prevention? 
 
    
 
No 33 6.43 
 
Yes 480 93.57 
  
    
15.   Would you be willing to teach patient how to collect sputum sample? 
 
    
 
No 63 12.35 
  Yes 447 87.65 
NA: not applicable, TB; tuberculosis, PTB; pulmonary tuberculosis, Freq; frequency   
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4.6.2 Attitude section scores 
Mean scores for each attitude question/statement (min 0, max 1) are presented in Table 37.  
 
Table 37. Mean attitude scores for healthcare workers regarding tuberculosis  
                 and its management  
Attitude statement /question  N Min Max Mean SD 
Would you be willing to work in a TB clinic/ward? 521 0 1 0.41 0.49 
Would you resign from work if you are posted to a TB clinic/ward? 515 0 1 0.84 0.37 
Would you be willing to be screened for TB if you had suggestive 
symptoms? 
512 0 1 0.94 0.23 
Do you think all TB patients should be isolated for treatment? 527 0 1 0.66 0.47 
It is ok to allow a TB patient to leave the hospital soon after initiating 
appropriate treatment? 
521 0 1 0.53 0.50 
Would you be willing to attend seminars on TB? 512 0 1 0.95 0.22 
Would you recommend the suspension of treatment if a TB patient is 
feeling better? 
518 0 1 0.87 0.34 
Would you start TB treatment for a TB patient before diagnosis is 
confirmed if a suspected TB patient is very ill? 
515 0 1 0.61 0.49 
Would you use a face mask when dealing with a PTB patient even when it 
is uncomfortable? 
521 0 1 0.82 0.38 
Would you trust the result the laboratory provides you on sputum cultures? 524 0 1 0.91 0.29 
I would not accept to examine/treat TB patients 510 0 1 0.85 0.35 
TB=tuberculosis, PTB=pulmonary tuberculosis, Min=minimum, Max, maximum, SD=standard deviation,  
N=number of observations  
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4.7 Tuberculosis practice among healthcare workers 
Information on HCWs’ practice regarding TB and its management was collected from answers to 
the following 13 statements: 
 
1. I usually perform hand hygiene and wear PPE before contact with PTB patient/TB samples 
2. I usually wear N95 respirator when caring for patient with PTB/working on TB samples 
3. I request sputum tests when I suspect active TB 
4. Always put the patient with active TB in the isolated room 
5. I open windows when possible in TB patient rooms to increase natural ventilation 
6. I order HIV test when I diagnose active TB 
7. Always put the patient with known TB separated from HIV patients 
8. Sometimes I use wet or soiled N95 respirator  
9. I always make sure that samples are sputum and not saliva before sending them to 
laboratory/before testing in the laboratory 
10. I commence anti-TB drugs on suspect TB cases before lab confirmation 
11. I request contact tracing for all confirmed TB cases 
12. I request liver function tests before starting anti-TB treatment 
13. I start contacts of active TB cases who are positive for IGRA/TST tests on INH /RIF 
prophylaxis 
 
4.7.1  Individual practice statements 
Results of response to practice statements are summarised in Table 38. 
 
I usually perform hand hygiene and wear personal protective equipment before contact 
with pulmonary tuberculosis patient/tuberculosis samples 
Of those who answered the question (519 HCWs), 453 (87.3%) declared that they usually perform 
hand hygiene and wear PPE before contact with PTB patient/TB samples, while 27 (5.2%) reported 
that this question was not applicable to them. Some HCWs however (39, 7.5%) declared that they 
don’t usually perform hand hygiene and wear PPE before contact with PTB patient/TB samples. 
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I usually wear N95 respirator when caring for patient with pulmonary tuberculosis 
/working on tuberculosis sample 
Of those who answered the question (514 HCWs), 400 (77.8%) declared that they usually wear 
N95 respirator when caring for patient with PTB/working on TB samples, while 34 (6.6%) 
reported that this question was not applicable to them. Some HCWs however (80, 15.6%) declared 
that they don’t usually wear N95 respirator when caring for patient with PTB/working on TB 
samples. Nurses had the highest proportion of right practice (84.9%) followed by physicians and 
those with occupation defined as “other”, 70.5% and 69.1% respectively.  
 
I request sputum tests when I suspect active tuberculosis 
Of those who answered the question (516 HCWs), 445 (86.2%) declared that they request 
sputum tests when they suspect active TB, while 38 (7.4%) reported that this question was not 
applicable to them. Some HCWs however (33, 6.4%) declared that they don’t request sputum 
tests when they suspect active TB. The wrong practice was more common among physicians 
(8.2%) compared to nurses (5.2%). 
 
Always put the patient with active tuberculosis in the isolated room 
Of those who answered the question (511 HCWs), 433 (84.7%) declared that they always put the 
patient with active TB in the isolated room, while 43 (8.4%) reported that this question was not 
applicable to them. Some HCWs however (35, 6.8%) declared that they don’t always put the 
patient with active TB in the isolated room. The proportion of nurses who stated that they always 
isolate active TB patients was higher than that among physicians (90.5% vs 82.7%).  
 
I open windows when possible in tuberculosis patient rooms to increase natural ventilation 
Of those who answered the question (511 HCWs), 219 (42.9%) declared that they open windows 
when possible in TB patient rooms to increase natural ventilation, while 63 (12.3%) reported that 
this question was not applicable to them. A sizable proportion of HCWs however (229, 44.8%) 
declared that they don’t open windows when possible in TB patient rooms to increase natural 
ventilation. The practice of opening the windows for ventilation was more common among doctors 
(45.5%) than nurses (38.9%). 
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I order human immunodeficiency virus test when I diagnose active tuberculosis 
Of those who answered the question (513 HCWs), 319 (62.2%) declared that they order HIV test 
when they diagnose active TB, while 81 (15.8%) reported that this question was not applicable to 
them. A sizable proportion of HCWs however (113, 22.0%) declared that they don’t order HIV 
test when they diagnose active TB. The latter practice was more common among nurses (28.1%) 
compared to doctors (17.0%) and HCWs with occupation as “other (14.9%).  
 
Always put the patient with known tuberculosis separated from human immunodeficiency 
virus patient 
Of those who answered the question (522 HCWs), 432 (82.8%) declared that they always put the 
patient with known TB separated from HIV patient, while 48 (9.2%) reported that this question 
was not applicable to them. Some HCWs however (42, 8.0%) declared that they don’t always put 
the patient with known TB separated from HIV patient. More physicians than nurses (10.1% vs 
6.6%) declared that they don’t always put TB patients separate from HIV patients.  
 
Sometimes I use wet or soiled N95 respirator 
Of those who answered the question (519 HCWs), 401 (77.3%) declared that they don’t use wet 
or soiled N95 respirator, while 64 (12.3%) reported that this question was not applicable to them. 
Some HCWs however (54, 10.4%) declared that sometimes they use wet or soiled N95 respirator. 
This was especially common among doctors (15.5%) compared to other HCWs.  
 
I always make sure that samples are sputum and not saliva before sending them to 
laboratory/before testing in the laboratory 
Of those who answered the question (519 HCWs), 408 (78.6%) declared that they always make 
sure that samples are sputum and not saliva before sending them to laboratory/before testing in the 
laboratory, while 65 (12.5%) reported that this question was not applicable to them. Some HCWs 
however (46, 8.9%) declared that they don’t always make sure that samples are sputum and not 
saliva before sending them to laboratory/before testing in the laboratory. 
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I commence anti- tuberculosis drugs on suspect tuberculosis cases before lab confirmation 
Of those who answered the question (522 HCWs), 302 (57.9%) declared that they do not 
commence anti-TB drugs on suspect TB cases before lab confirmation, while 68 (13.0%) reported 
that this question was not applicable to them. Some HCWs however (152, 29.1%) declared that 
they commence anti-TB drugs on suspect TB cases before lab confirmation including 28.3% of 
doctors.  
 
I request contact tracing for all confirmed tuberculosis cases 
Of those who answered the question (515 HCWs), 391 (75.9%) declared that they request contact 
tracing for all confirmed TB cases, while 70 (13.6%) reported that this question was not applicable 
to them. Some HCWs however (54, 10.5%) declared that they do not request contact tracing for 
all confirmed TB cases. Wrong practice was more prevalent among nurses (12.2%) than doctors 
(8.7%). 
 
I request liver function tests before starting anti- tuberculosis treatment 
Of those who answered the question (523 HCWs), 412 (78.8%) declared that they request liver 
function tests before starting anti-TB treatment, while 69 (13.2%) reported that this question was 
not applicable to them. Some HCWs however (42, 8.0%) declared that they do not request liver 
function tests before starting anti-TB treatment including 4% of physicians. 
 
I start contacts of active tuberculosis cases who are positive for tuberculin skin test 
/interferon-gamma release assay tests on Isoniazid /Rifampicin prophylaxis 
Of those who answered the question (516 HCWs), 317 (61.4%) declared that they start contacts of 
active TB cases who are positive for IGRA/TST tests on INH/RIF prophylaxis, while 114 (22.1%) 
reported that this question was not applicable to them. Some HCWs however (85, 16.5%) declared 
that they do not start contacts of active TB cases who are positive for IGRA/TST tests on INH/RIF 
prophylaxis. The latter practice was more common among physicians than nurses (16.9% vs 
14.3%). 
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Table 38. Summary statistics of healthcare workers’ practice regarding tuberculosis and its management  
Practice statement  Category Freq  % 
  
    
1.    I usually perform hand hygiene and wear PPE before contact with PTB patient/TB samples 
 
     
No 39 7.51  
Yes 453 87.28  
NA 27 5.20   
    
2.    I usually wear N95 respirator when caring for patient with PTB/working on TB samples 
 
     
No 80 15.56  
Yes 400 77.82  
NA 34 6.61   
    
3.    I request sputum tests when I suspect active TB 
 
     
No 33 6.40  
Yes 445 86.24  
NA  38 7.36   
    
4.    Always put the patient with active TB in the isolated room 
 
     
No 35 6.85  
Yes 433 84.74  
NA 43 8.41   
    
5.    I open windows when possible in TB patient rooms to increase natural ventilation 
 
     
No 229 44.81  
Yes 219 42.86  
NA 63 12.33   
    
6.    I order HIV test when I diagnose active TB 
 
     
No 113 22.03  
Yes 319 62.18 
7.    Always put the patient with known TB separated from HIV patients 
 
    
 No 42 8.05 
 Yes 432 82.76 
 NA 48 9.20 
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Cont. Table 38. Summary statistics of healthcare workers’ practice regarding tuberculosis and its management  
Practice statement  Category Freq  %   
      
    
8.    Sometimes I use wet or soiled N95 respirator  
 
     
No 401 77.26  
Yes 54 10.40  
NA 64 12.33   
    
9.    I always make sure that samples are sputum and not saliva before sending them to laboratory/before testing in the 
laboratory 
 
    
 
No 46 8.86  
Yes 408 78.61  
NA 65 12.52   
    
10. I commence anti-TB drugs on suspect TB cases before lab confirmation 
 
     
No 302 57.85  
Yes 152 29.12  
NA 68 13.03   
    
11. I request contact tracing for all confirmed TB cases 
 
     
No 54 10.49  
Yes 391 75.92  
NA 70 13.59   
    
12. I request liver function tests before starting anti-TB treatment 
 
     
No 42 8.03  
Yes 412 78.78  
NA 69 13.19   
    
13. I start contacts of active TB cases who are positive for IGRA/TST tests on INH /RIF prophylaxis 
 
     
No 85 16.47  
Yes 317 61.43 
  NA 114 22.09 
NA: not applicable, TB; tuberculosis, PTB; pulmonary tuberculosis, HIV; human immunodeficiency virus, PPE; personal protective equipment, TST; tuberculin 
skin tests (TST), IGRA; interferon gamma release assay, INH; isoniazid, RIF; rifampicin, Freq; frequency 
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4.7.2  Practice section scores 
Mean scores for each practice statement (min 0, max 1) are presented in Table 39. 
 
Table 39. Mean practice scores for healthcare workers regarding tuberculosis and its 
management  
Practice statement  N  Min Max Mean SD 
I usually perform hand hygiene and wear PPE  519 0 1 0.92 0.27 
I usually wear N95 respirator when caring for patient with PTB/working 
on TB samples 
514 0 1 0.83 0.37 
I request sputum tests when I suspect active TB 516 0 1 0.93 0.25 
Always put the patient with active TB in the isolated room 511 0 1 0.93 0.26 
I open windows when possible in TB patient rooms to increase natural 
ventilation 
511 0 1 0.49 0.50 
I order HIV test when I diagnose active TB 513 0 1 0.74 0.44 
Always put the patient with known TB separated from HIV patients 522 0 1 0.91 0.28 
Sometimes I use wet or soiled N95 respirator  519 0 1 0.88 0.32 
I always make sure that samples are sputum and not saliva before sending 
them to laboratory/before testing in the laboratory 
519 0 1 0.90 0.30 
I commence anti-TB drugs on suspect TB cases before lab confirmation 522 0 1 0.67 0.47 
I request contact tracing for all confirmed TB cases 515 0 1 0.88 0.33 
I request liver function tests before starting anti-TB treatment 523 0 1 0.91 0.29 
I start contacts of active TB cases who are positive for IGRA/TST tests on 
INH/RIF prophylaxis 
516 0 1 0.79 0.41 
TB; tuberculosis, PTB; pulmonary tuberculosis, HIV; human immunodeficiency virus, PPE; personal protective 
equipment, TST: tuberculin skin tests (TST), IGRA; interferon gamma release assay, INH; isoniazid, RIF; rifampicin, 
Min; minimum, Max, maximum, SD; standard deviation, N; number of observations 
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4.8  Overall mean knowledge, attitude and practice scores 
The mean overall KAP scores among HCWs regarding TB and its management are summarized 
in Table 40. The results suggest that in general HCWs had average knowledge (mean score >0.4-
0.6), above average attitude (mean score >0.6-0.8) and good practice (mean score .0.8-1) in 
relation to TB and its management.  The proportion of HCWs in each scale category are 
summarized in Table 41. Most HCWs had average or above average knowledge scores. On the 
other hand, most had above average or good attitude or practice scores.  
 
Table 40.  Overall knowledge, attitude and practice scores for healthcare workers regarding 
tuberculosis and its management 
Score  Min Lower Quartile Upper Quartile Max Median Mean SD 
Knowledge  
Attitude 
Practice  
0.02 
0.00 
0.00 
0.42 
0.64 
0.75 
0.63 
0.82 
0.92 
0.90 
1.00 
1.00 
0.54 
0.73 
0.85 
0.52 
0.73 
0.81 
0.17 
0.15 
0.17 
Min; minimum, Max, maximum, SD; standard deviation 
 
Table 41. Levels of knowledge, attitude and practice of healthcare workers in relation to 
tuberculosis and its management 
Category 
(mean score) 
% poor 
(0-0.2) 
 
% below average 
(>0.2-0.4) 
% average 
(>0.4-0.6) 
% above average 
(>0.6-0.8) 
% good 
(>0.8-1) 
Knowledge 
(N=540) 
4.6 17.4 43.9 31.9 2.2 
Attitude  
(N=533) 
0.6 3.9 10.9 43.0 41.7 
Practice  
(N=519) 
1.0 3.3 5.6 27.4 62.8 
N; number of observations  
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4.9 Knowledge, attitude and practice scores and demographic variables 
4.9.1  Knowledge of tuberculosis and its management and demographic variables 
The difference in knowledge scores with respect to individual covariates is shown in Table 42. 
Females had marginally significantly more knowledge than males (mean scores 0.53 vs 0.50 
respectively, p= 0.04). Non-Saudi national had significantly more knowledge than Saudi nationals 
(mean scores 0.61 vs 0.44 respectively, p <0.0001). However, it is worth noting that a higher 
proportion of non-Saudi HCWs were physicians compared to Saudi HCWs (48.8% vs 13.9% 
respectively) and a higher proportion had a master or higher education level compared to Saudi 
HCWs (32.4% vs 5.37% respectively). In general, the majority of non-Saudi HCWs had a bachelor 
degree as the highest level of education (60.2%), while most of Saudi HCWs had a diploma as the 
highest level of education (57.8%).  
 
Knowledge scores were also significantly different according to age, level of education and 
occupation (p <0.0001). HCWs in the older age groups had a higher knowledge score than those 
in the younger age groups (Figure22). Specifically, HCWs in the 40-49 year age group had 
significantly (p<0.0001) more knowledge than those in the 30-39 years or <30 years age groups. 
Also, HCWs in the age >49 years had significantly (p = 0.0008) more knowledge than those in the 
<30 years group. Physicians had significantly more knowledge than nurses (<0.0001) and other 
HCWs (<0.0001), while nurses had significantly more knowledge than HCWs other than 
physicians (p<0.0001) (Figure 23).  
 
In general, HCWs with master or higher level of education had more knowledge than those with 
Bachelor or diploma (Figure 24). HCWs with a diploma were significantly less knowledgeable 
than those with Bachelor (p<0.0001), those with master (p<0.0001) and those with doctorate or 
specialty certificates (p<00001). The latter were also significantly more knowledgeable than 
HCWs with Bachelor degree (p= 0.02).  
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Knowledge scores were significantly different depending on length of experience in the current 
position (p= 0.0029), although this was mainly driven by the significant difference in knowledge 
between HCWs who had <10 years work experience compared to those who had 1-5 years work 
experience (p= 0.0017) (Figure 25). HCWs who deal with TB patients in their non-Hajj work had 
slightly higher mean knowledge score compared to those who do not (0.54 vs 0.50) but the 
difference was not statistically significant (p= 0.07). 
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Table 42. Overall tuberculosis knowledge score and the healthcare workers’ demographic 
variables 
Variable  N Min Mean Max SD P-value* 
Age       <0.0001 
 <30 158 0.02 0.48 0.79 0.16  
 30-39 190 0.02 0.51 0.88 0.17  
 40-49 71 0.12 0.62 0.90 0.13  
 >49 45 0.25 0.58 0.86 0.13  
        
Gender       0.0461 
 Female 277 0.02 0.53 0.83 0.14  
 Male 258 0.02 0.50 0.90 0.18  
        
Nationality        <0.0001 
 Saudi  246 0.02 0.44 0.84 0.15  
 Non-Saudi  226 0.02 0.61 0.90 0.12  
        
Education Level       <0.0001 
        
 Diploma 191 0.02 0.43 0.74 0.15  
 Bachelor 237 0.02 0.55 0.90 0.15  
 Master 53 0.23 0.59 0.84 0.11  
 
Doctorate/Specialty 
certificate 
40 0.13 0.62 0.86 0.16  
        
Occupation       <0.0001 
 Other 102 0.02 0.40 0.72 0.15  
 Physician 154 0.11 0.59 0.9 0.16  
 Nurse 275 0.02 0.51 0.82 0.15  
        
Current position length       0.0029 
 <1 year 30 0.08 0.50 0.83 0.16  
 1 - 5 years 177 0.02 0.50 0.88 0.15  
 >5 - 10 years 169 0.06 0.51 0.87 0.17  
 >10 years 145 0.11 0.56 0.90 0.15  
        
Non-Hajj TB patient contact       0.0749 
 No 249 0.02 0.50 0.88 0.17  
 Yes 
261 0.10 0.54 0.90 0.15  
Attended a TB seminar in the 
previous year 
      0.1942 
 No 394 0.02 0.51 0.90 0.17  
 Yes 129 0.14 0.53 0.79 0.14  
*p-value for the Mann–Whitney U or Kruskal-Wallis test 
N; number of observations, Min; minimum, Max; maximum, SD; standard deviation, TB; tuberculosis
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Figure 22. 
Wilcoxon Scores (Rank Sums) for knowledge (1), 
attitude (2) and practice (3) scores classified by 
healthcare workers' age groups 
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Figure 23. Wilcoxon Scores (Rank Sums) for knowledge (1), 
attitude (2) and practice (3) scores classified by healthcare 
workers' occupation 
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Figure 24. Wilcoxon Scores (Rank Sums) for knowledge 
(1), attitude (2) and practice (3) scores classified by 
healthcare workers' level of education 
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Figure 4. Wilcoxon Scores (Rank Sums) for knowledge (1), 
attitude (2) and practice (3) scores classified by healthcare 
workers' level of education 
 
  
 
2 
Figure 25. Wilcoxon Scores (Rank Sums) for knowledge (1), 
attitude (2) and practice (3) scores classified by healthcare 
workers' length of work experience 
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4.9.2  Attitude towards tuberculosis and its management and demographic variables 
The difference in attitude scores with respect to individual covariates is shown in Table 43. The 
overall attitude scores did not statistically significantly differ in relation to demographic variables.  
 
Table 43. Overall tuberculosis attitude score and the healthcare workers’ demographic  
       variables 
Variable  N Min Mean Max SD P-value* 
Age       0.8501 
 <30 158 0.00 0.73 1.00 0.15  
 30-39 190 0.20 0.73 1.00 0.16  
 40-49 71 0.20 0.73 1.00 0.15  
 >49 45 0.36 0.72 0.91 0.13  
        
Gender       0.0667 
 Female 277 0.00 0.74 1.00 0.13  
 Male 258 0.20 0.71 1.00 0.16  
        
Nationality        0.1623 
 Saudi  246 0.00 0.72 1.00 0.16  
 Non-Saudi  226 0.27 0.75 1.00 0.14  
        
Education Level       0.5845 
 Diploma 191 0.00 0.72 1.00 0.16  
 Bachelor 237 0.20 0.74 1.00 0.15  
 Master 53 0.33 0.72 0.91 0.12  
 
Doctorate/Specialty 
certificate 
40 0.45 0.74 1.00 0.12  
        
Occupation       0.5728 
 Other 102 0.20 0.72 1.00 0.18  
 Physician 154 0.25 0.72 1.00 0.13  
 Nurse 275 0.00 0.74 1.00 0.15  
        
Current position length       0.5606 
 <1 year 30 0.25 0.71 1.00 0.17  
 1 - 5 years 177 0.20 0.74 1.00 0.14  
 >5 - 10 years 169 0.00 0.73 1.00 0.16  
 >10 years 145 0.30 0.73 1.00 0.13  
Non-Hajj TB patient contact       0.1914 
 No 249 0.00 0.72 1.00 0.16  
 Yes 261 0.25 0.74 1.00 0.13  
Attended a TB seminar in the 
previous year 
       
 No 394 0.00 0.73 1.00 0.15 0.8862 
 Yes 129 0.27 0.73 1.00 0.14  
*p-value for the Mann–Whitney U or Kruskal-Wallis test; N; number of observations, Min; minimum, Max; maximum, 
SD; standard deviation, TB; tuberculosis 
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4.9.3  Tuberculosis practice and demographic variables 
The difference in practice scores with respect to individual covariates is shown in Table 44. Level 
of education was the only variable that showed marginally statistically significant difference 
(p=0.04). While HCWs with doctorate or specialty certifications had slightly better practice 
comparted to other HCWs (Figure 24), pairwise analysis did not show significant difference 
among the groups. Similarly, although there were differences in practice depending on age, 
occupation and years of experience (Figures 22, 23, 25), these differences were not significant in 
the pairwise analysis. 
 
Table 44. Overall tuberculosis practice score and the healthcare workers’ demographic   
       variables 
 
Variable 
  
N 
 
Min 
  
Mean 
 
Max 
 
SD 
 
P-value* 
Age       0.6622 
 <30 158 0.00 0.79 1.00 0.17  
 30-39 190 0.00 0.80 1.00 0.19  
 40-49 71 0.23 0.80 1.00 0.16  
 >49 45 0.54 0.83 1.00 0.10  
        
Gender       0.1404 
 Female 277 0.11 0.81 1.00 0.18  
 Male 258 0.00 0.80 1.00 0.20  
        
Nationality        0.3412 
 Saudi  246 0.00 0.79 1.00 0.20  
 Non-Saudi  226 0.22 0.80 1.00 0.13  
        
Education Level       0.0491 
 Diploma 191 0.00 0.81 1.00 0.19  
 Bachelor 237 0.11 0.79 1.00 0.15  
 Master 53 0.22 0.82 1.00 0.16  
 
Doctorate/Specialty 
certificate 
40 0.63 0.86 1.00 0.10  
       0.1663 
Occupation        
 Other 102 0.00 0.80 1.00 0.23  
 Physician 154 0.00 0.81 1.00 0.17  
 Nurse 275 0.27 0.80 1.00 0.14  
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Cont. Table 44. Overall tuberculosis practice score and the healthcare workers’     
demographic variables 
 
Variable 
  
N 
 
Min 
  
Mean 
 
Max 
 
SD 
 
P-value* 
 
Current position length       0.0711 
 <1 year 30 0.00 0.72 1.00 0.27  
 1 - 5 years 177 0.25 0.79 1.00 0.16  
 >5 - 10 years 169 0.22 0.82 1.00 0.15  
 >10 years 145 0.00 0.83 1.00 0.14  
        
Non-Hajj TB patient contact       0.3053 
 No 249 0.00 0.81 1.00 0.17  
 Yes 261 0.00 0.80 1.00 0.16  
Attended a TB seminar in 
the previous year 
       
 No 394 0.00 0.80 1.00 0.17 0.1473 
 Yes 129 0.11 0.82 1.00 0.17  
*p-value for the Mann–Whitney U or Kruskal-Wallis test 
N; number of observations, Min; minimum, Max; maximum, SD; standard deviation, TB; tuberculosis 
 
4.9.4  Quantile regression 
Due to the data being skewed, quantile regression was used to investigate the association between 
variables and the overall KAP scores across the different score levels (Figures 26-28). Results of 
quantile regression are presented for the 25th, 50th and 75th quantiles for the scores (Tables 45-53) 
and summarized in Table 54. The reference groups used were: male, >49 years old, Saudi national, 
physician, <1 year in current position and having contact with TB patients in non-Hajj work.  
 
4.9.4.1  Tuberculosis knowledge 
Results of quantile regression at the 25th, 50th, and 75th knowledge score quantiles show that all 
age groups had more knowledge than the reference group, but the regression coefficient was 
significant only for the 40-49 years old group and only at the 50th quantiles. Females were more 
knowledgeable than males and the regression coefficient was significant at the 25th and 50th 
quantiles (Tables 45, 46).  
  
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj mass 
gathering 
 
251 
Non-Saudis had better knowledge than Saudis and this was significant at all three quantiles. 
Physicians were more knowledgeable than both nurses and other HCWs.  This was significant at 
the three quantiles for other HCWs but only at the higher quantiles (50th and 75th) for nurses 
(Tables 46, 47). HCWs with <1 year in their current position were less knowledgeable than those 
who had longer experience at all quantiles, but the regression coefficient was only significant for 
those with >10 years work experience. HCWs who had contact with TB patients during their non-
Hajj work had more knowledge than those who did not at all three quantiles. The regression 
coefficient was however only statistically significant at the lowest quantile (25th).  
 
Results of quantile regressing across quantiles (Figure 26) show that compared to HCWs >49 years 
old, HCWs in other age groups were more knowledgeable across all quantiles. The regression 
coefficient was not statistically significant across all quantiles for HCWs in the <30 years old and 
30-39 years old groups. For those aged between 40 and 49 years old, the regression coefficient 
seems to be significant at most of the lower and middle knowledge score quantiles but not the 
higher quantiles. Females were more knowledgeable than males across all quantiles. However, the 
regression coefficient seems to be only significant at few of the low and middle quantiles. Non-
Saudis were more knowledgeable than Saudis across all quantiles and the regression coefficient 
was also significant across all quantiles. Physicians were more knowledgeable than nurses or other 
HCWs across all quantiles with the exception for nurses at the lowest quantiles. The regression 
coefficient was statistically significant across all quantiles for “other” HCWs. For nurses, the 
regression coefficient was significant at some of the lower quantiles and at the higher quantiles. 
Compared to HCWs with <1 year work experience, other HCWs were more knowledgeable across 
all quantiles with the exception of those with 1-5 years and 5-10 years work experience which 
were less knowledgeable at the lowest quantiles. The regression coefficients were not significant 
across most quantiles with the exception of some middle quantiles for all categories and higher 
quantiles for the >10 years group. HCWs with TB-patients contact were more knowable than those 
who do not deal with TB patients in their work, and this was evident across all quantiles. The 
regression coefficient was however only significant at the lower half of the knowledge score 
quantiles.  
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4.9.4.2  Tuberculosis attitude 
Results of quantile regression at the 25th, 50th, and 75th attitude score quantiles show that for age 
groups, HCWs in the 30-39 years and 40-49 years old had better attitude than those >49 years old 
but the regression coefficient was only significant at the 75th quantile for the 30-39 years old age 
group (Table 50). At the 50th quantile, HCWs <30 years old had worst attitude than those >49 
years old with no significant regression coefficient (Table 49). Females and non-Saudis had better 
attitude compared to males and Saudis respectively but the regression coefficient was not 
significant at any of the three quantiles. Similarly, nurses and other HCWs had better attitude than 
physicians across the three quantiles. The regression coefficient was however only significant at 
the 50th quantile for “other” HCWs (Table 49). HCWs with <1 year work experience had worst 
attitude compared to other HCWs at the three quantiles with no significant regression coefficient. 
HCWs who deal with TB patient had better attitude at the 25th quantile than those who do not but 
the regression coefficient was not significant (Table 48).  
 
Results of quantile regressing across all attitude score quantiles (Figure27) show that all age groups 
had better attitude than the reference group across all quantiles with the exception of the age group 
<30 years old which showed worst attitude at some of the middle attitude score quantiles. The 
regression coefficients were not significant with the exception of some of the high quantiles for 
the 30-39 age group. Females had better attitude than males across quantiles but the regression 
coefficient was only significant at some of the lowest quantiles. Non-Saudis had better attitude 
than Saudis across all quantiles with regression coefficients significant at some low and very high 
quantiles. Nurses and other HCWs had better attitude than physicians but this was not the case at 
the lowest quantiles. Regression coefficients were mostly not significant with the exception of 
some high and middle quantiles. Compared to HCWs with <1 year work experience other HCWs 
had better attitude, with the exception of highest quantiles. Regression coefficients were not 
significant with the exception of at some high quantiles. HCWs with TB-patients contact had better 
attitude than those who do not deal with TB patients in their work mainly at the low quantiles with 
the regression coefficient being significant at the lowest quantiles.  
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4.9.4.3  Tuberculosis practice 
Results of quantile regression at the 25th, 50th, and 75th practice score quantiles show that at the 
25th and 75th quantiles, compared to HCWs >49 years old, those <30 years old had worst practice 
while those 30-39 years and 40-49 years old had better practice. However, the regression 
coefficients were not significant (Tables 51, 53). Females had better practice than males with no 
significant regression coefficients. Non-Saudis had better practice than Saudis at the 25th quantile 
(Table 51) but worst practice at the 75th quantile (Table 53) with no statistically significant 
regression coefficients. Similarly, “other” HCWs had worst practice compared to physicians at the 
25th quantile (Table 51) but better practice at the 50th and 75th quantiles (Tables 52, 53). The 
regression coefficient at the latter quantile was statistically significant.  Nurses had worst practice 
than physicians at the 25th and 75th quantiles with no significant regression coefficients (Tables 51, 
53). HCWs with <1 year work experience had worst practice compared to other HCWs at the three 
quantiles with no significant regression coefficient. HCWs with no contact with TB patients had 
better practice at the 25th and 75th quantiles compared to those who have contact with TB patients, 
but the regression coefficients were not significant (Tables 51, 53).  
 
Results of quantile regressing across all practice score quantiles (Figure 28) show that all age 
groups had better practice than the reference group across most quantiles. However, at most 
quantiles between the 60th and 80th practice score quantiles, the reference group had better practice. 
The regression coefficients were not significant for any age group at any quantile. Females had 
better practice than males across most quantiles with the exception of some lower quantiles with 
no significant regression coefficients. Non-Saudis had better practice than Saudis at low quantiles 
but worst practice at higher quantiles. The regression coefficients were significant at some higher 
quantiles. Physicians had better practice than nurses across quantiles with no significant regression 
coefficients. However, physicians had better practice than “other” HCWs only at lower quantiles.  
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At higher quantiles, “other” HCWs had better practice compared to physicians with regression 
coefficients being significant at higher end of the quantiles range. Compared to HCWs with <1 
year work experience other HCWs had better practice across most quantiles, with the exception of 
at the highest quantiles. Regression coefficients were not significant with the exception of at some 
lower quantiles (around the 20th quantile) for all groups and at some higher quantiles for HCWs 
with >10 years experience. HCWs with TB-patients contact had worst practice than those who do 
not deal with TB patients in their work with no significant regression coefficients.  
 
Table 45. Association between variables and overall knowledge score of healthcare workers 
at the 25th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.363 0.2763 0.4498 <.0001 
Age      
 <30 0.0069 -0.0747 0.0885 0.8682 
 30-39 0.0192 -0.0548 0.0933 0.6095 
 40-49 0.0708 0.0015 0.14 0.0452 
      
Gender      
 Female 0.0452 0.0066 0.0838 0.022 
      
Nationality      
 Non-Saudi 0.145 0.1106 0.1794 <.0001 
      
Occupation      
 Other -0.1112 -0.183 -0.0394 0.0025 
 Nurse -0.039 -0.0872 0.0092 0.1126 
      
Current position length      
 1 - 5 years 0.0388 -0.0265 0.104 0.2438 
 >5 - 10 years 0.0397 -0.0302 0.1097 0.2646 
 >10 years 0.0764 0.0092 0.1436 0.0259 
      
Non-Hajj TB patient contact      
 No -0.0616 -0.0965 -0.0267 0.0006 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 46. Association between variables and overall knowledge scoreof healthcare workers 
at the 50th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.4413 0.3629 0.5197 <.0001 
Age      
 <30 0.0017 -0.0625 0.0659 0.9585 
 30-39 0.0116 -0.0417 0.0648 0.6693 
 40-49 0.0699 0.0318 0.108 0.0004 
      
Gender      
 Female 0.0381 0.0007 0.0754 0.0457 
      
Nationality      
 Non-Saudi 0.1065 0.0748 0.1383 <.0001 
      
Occupation      
 Other -0.1056 -0.1651 -0.0462 0.0005 
 Nurse -0.0455 -0.0881 -0.0029 0.0365 
      
Current position length      
 1 - 5 years 0.0591 -0.012 0.1302 0.1028 
 >5 - 10 years 0.066 -0.0021 0.1341 0.0573 
 >10 years 0.0756 0.0118 0.1394 0.0203 
      
Non-Hajj TB patient contact      
 No -0.0146 -0.0397 0.0105 0.2543 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 47. Association between variables and overall knowledge score of healthcare workers 
at the 75th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.5711 0.4684 0.6737 <.0001 
Age      
 <30 0.0125 -0.0469 0.0718 0.6804 
 30-39 0.0277 -0.0256 0.0811 0.3069 
 40-49 0.0383 -0.0254 0.1021 0.2381 
      
Gender      
 Female 0.0277 -0.0178 0.0732 0.2323 
      
Nationality      
 Non-Saudi 0.0804 0.0439 0.1168 <.0001 
      
Occupation      
 Other -0.1585 -0.2252 -0.0919 <.0001 
 Nurse -0.0977 -0.1532 -0.0421 0.0006 
      
Current position length      
 1 - 5 years 0.0601 -0.0062 0.1265 0.0757 
 >5 - 10 years 0.0653 -0.0011 0.1317 0.054 
 >10 years 0.0891 0.0107 0.1674 0.026 
      
Non-Hajj TB patient contact      
 No -0.0135 -0.0405 0.0134 0.3247 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 48. Association between variables and overall attitude score of healthcare workers at 
the 25th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.5758 0.4593 0.6923 <.0001 
Age      
 <30 0 -0.0934 0.0934 1 
 30-39 0.0303 -0.0508 0.1114 0.4632 
 40-49 0 -0.0871 0.0871 1 
      
Gender      
 Female 0.0333 -0.0148 0.0814 0.1738 
      
Nationality      
 Non-Saudi 0.0303 -0.009 0.0696 0.1304 
      
Occupation      
 Other 0 -0.0775 0.0775 1 
 Nurse 0.0273 -0.0362 0.0908 0.3988 
      
Current position length      
 1 - 5 years 0.0606 -0.0309 0.1521 0.1937 
 >5 - 10 years 0.0303 -0.0694 0.13 0.5504 
 >10 years 0.0606 -0.0377 0.1589 0.2263 
      
Non-Hajj TB patient contact      
 No -0.0303 -0.0665 0.0059 0.1006 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 49. Association between variables and overall attitude score of healthcare workers at 
the 50th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.6862 0.5788 0.7936 <.0001 
Age      
 <30 -0.016 -0.0899 0.0579 0.6702 
 30-39 0.0225 -0.0375 0.0826 0.4614 
 40-49 0.0216 -0.0413 0.0845 0.4999 
      
Gender      
 Female 0.0219 -0.026 0.0697 0.3692 
      
Nationality      
 Non-Saudi 0.0352 -0.0078 0.0783 0.1084 
      
Occupation      
 Other 0.0684 0.0075 0.1293 0.0279 
 Nurse 0.0298 -0.0274 0.0871 0.3061 
      
Current position length      
 1 - 5 years 0.0578 -0.0188 0.1343 0.1388 
 >5 - 10 years 0.0054 -0.0775 0.0883 0.898 
 >10 years 0.0058 -0.0751 0.0868 0.8871 
      
Non-Hajj TB patient contact      
 No 0 -0.0325 0.0325 1 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 50. Association between variables and overall attitude score of healthcare workers at 
the 75th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.7596 0.6649 0.8542 <.0001 
Age      
 <30 0 -0.0657 0.0657 1 
 30-39 0.0707 0.0142 0.1273 0.0144 
 40-49 0 -0.0429 0.0429 1 
      
Gender      
 Female 0 -0.0357 0.0357 1 
      
Nationality      
 Non-Saudi 0.0202 -0.0166 0.057 0.2815 
      
Occupation      
 Other 0.0202 -0.0361 0.0765 0.4808 
 Nurse 0.0202 -0.0266 0.067 0.3969 
      
Current position length      
 1 - 5 years 0.0384 -0.0244 0.1012 0.2304 
 >5 - 10 years 0.0384 -0.0271 0.1039 0.2501 
 >10 years 0.0384 -0.0317 0.1085 0.2823 
      
Non-Hajj TB patient contact      
 No 0 -0.0227 0.0227 1 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 51. Association between variables and overall practice score of healthcare workers at 
the 25th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.5974 0.4065 0.7882 <.0001 
Age      
 <30 -0.0037 -0.1246 0.1173 0.9525 
 30-39 0.0067 -0.0899 0.1032 0.8923 
 40-49 0.0009 -0.0951 0.0969 0.9856 
      
Gender      
 Female 0.0067 -0.0544 0.0677 0.8304 
      
Nationality      
 Non-Saudi 0.0143 -0.05 0.0786 0.6611 
      
Occupation      
 Other -0.0187 -0.1231 0.0857 0.725 
 Nurse -0.025 -0.0991 0.0491 0.5073 
      
Current position length      
 1 - 5 years 0.1067 -0.0342 0.2475 0.1373 
 >5 - 10 years 0.117 -0.0247 0.2586 0.1053 
 >10 years 0.1567 0.0014 0.3119 0.0479 
      
Non-Hajj TB patient contact      
 No 0.0183 -0.0247 0.0614 0.4021 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 52. Association between variables and overall practice score of healthcare workers at 
the 50th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.7778 0.663 0.8926 <.0001 
Age      
 <30 0 -0.0706 0.0706 1 
 30-39 0 -0.0542 0.0542 1 
 40-49 0 -0.0627 0.0627 1 
      
Gender      
 Female 0 -0.045 0.045 1 
      
Nationality      
 Non-Saudi 0 -0.0368 0.0368 1 
      
Occupation      
 Other 0.0128 -0.0509 0.0765 0.6925 
 Nurse 0 -0.0457 0.0457 1 
      
Current position length      
 1 - 5 years 0.0684 -0.0237 0.1604 0.1448 
 >5 - 10 years 0.0556 -0.0429 0.154 0.2679 
 >10 years 0.0684 -0.0324 0.1692 0.1831 
      
Non-Hajj TB patient contact      
 No 0 -0.0275 0.0275 1 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 53. Association between variables and overall practice score of healthcare workers at 
the 75th quantile  
Variable  Coef 95% CI p-value  
Intercept 
 
 0.8594 0.774 0.9448 <.0001 
Age      
 <30 -0.0002 -0.0533 0.0529 0.9933 
 30-39 0.0064 -0.0419 0.0548 0.7945 
 40-49 0 -0.0442 0.0442 1 
      
Gender      
 Female 0.0002 -0.0296 0.0301 0.9881 
      
Nationality      
 Non-Saudi -0.0066 -0.0411 0.0278 0.7053 
      
Occupation      
 Other 0.0639 0.0068 0.1209 0.0282 
 Nurse -0.0066 -0.0418 0.0285 0.7105 
      
Current position length      
 1 - 5 years 0.0629 -0.0063 0.1322 0.0747 
 >5 - 10 years 0.0639 -0.0024 0.1301 0.0587 
 >10 years 0.0639 0 0.1277 0.050 
      
Non-Hajj TB patient contact      
 No 0.0064 -0.0157 0.0285 0.5694 
Coef; regression coefficient, CI; confidence interval, TB; tuberculosis  
p-value in bold indicates statistically significant p-value  
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Table 54. Summary of the association between variables and overall scores of healthcare workers at the 25th, 50th and 75th quantiles 
Variable 
 
 Coef for knowledge scores Coef for attitude scores Coef for practice scores   
(SE) (SE) (SE) 
25th 50th 75th 25th 50th 75th 25th 50th 75th 
Intercept  0.363 0.4413 0.5711 0.5758 0.6862 0.7596 0.5974 0.7778 0.8594 
  (0.050) (0.041) (0.060) (0.059) (0.050) (0.051) (0.087) (0.052) (0.045) 
Age           
 <30 0.0069 0.0017 0.0125 0.000 -0.016 0.000 -0.0037 0.000 -0.0002 
  (0.045) (0.029) (0.033) (0.041) (0.037) (0.039) (0.058) (0.033) (0.023) 
 30-39 0.0192 0.0116 0.0277 0.0303 0.0225 0.0707 0.0067 0.000 0.0064 
  (0.038) (0.041) (0.029) (0.038) (0.032) (0.033) (0.053) (0.030) (0.021) 
 40-49 0.0708 0.0699 0.0383 0.000 0.0216 0.000 0.0009 0.000 0.000 
  (0.034) (0.020) (0.033) (0.042) (0.028) (0.023) (0.045) (0.029) (0.018) 
           
Gender           
 Female 0.0452 0.0381 0.0277 0.0333 0.0219 0.000 0.0067 0.000 0.0002 
  (0.017) (0.018) (0.024) (0.026) (0.023) (0.019) (0.034) (0.022) (0.015) 
           
Nationality           
 Non-Saudi 0.145 0.1065 0.0804 0.0303 0.0352 0.0202 0.0143* 0.000* -0.0066* 
  (0.018) (0.014) (0.018) (0.022) (0.020) (0.019) (0.029) (0.018) (0.016) 
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Cont. Table 54. Summary of the association between variables and overall scores of healthcare workers at the 25th, 50th and 75th quantiles 
Variable 
 
 Coef for knowledge scores Coef for attitude scores Coef for practice scores   
(SE) (SE) (SE) 
25th 50th 75th 25th 50th 75th 25th 50th 75th 
 
Occupation           
 Other -0.1112 -0.1056 -0.1585 0.000 0.0684 0.0202 -0.0187* 0.0128* 0.0639* 
  (0.036) (0.029) (0.033) (0.038) (0.030) (0.027) (0.052) (0.032) (0.020) 
 Nurse -0.039 -0.0455 -0.0977 0.0273 0.0298 0.027) -0.025 0.000 -0.0066 
  (0.023) (0.020) (0.027) (0.030) (0.024) (0.020) (0.039) (0.022) (0.018) 
           
Current position length           
 1 - 5 years 0.0388 0.0591 0.0601 0.0606 0.0578 0.0384 0.1067 0.0684 0.0629 
  (0.033) (0.033) (0.032) (0.048) (0.037) (0.030) (0.068) (0.042) (0.035) 
 >5 - 10 years 0.0397 0.066 0.0653 0.0303 0.0054 0.0384 0.117 0.0556 0.0639 
  (0.037) (0.032) (0.035) (0.051) (0.040) (0.034) (0.069) (0.044) (0.035) 
           
           
 >10 years 0.0764 0.0756 0.0891 0.0606 0.0058 0.0384 0.1567 0.0684 0.0639 
  (0.037) (0.033) (0.044) (0.052) (0.040) (0.038) (0.075) (0.044) (0.035) 
           
Non-Hajj TB patient contact           
 No -0.0616 -0.0146 -0.0135 -0.0303 0.000 0.000 0.0183 0.000 0.0064 
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Figure 26. Estimations of the regression coefficient and 95% confidence intervals (shaded 
area) for each quantile of the healthcare workers’ knowledge scores   
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Figure 27. Estimations of the regression coefficient and 95% confidence intervals (shaded 
area) for each quantile of the healthcare workers’ attitude scores   
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Figure 28. Estimations of the regression coefficient and 95% confidence intervals (shaded 
area) for each quantile of the healthcare workers’ practice scores  
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4.9.5  Correlations between tuberculosis knowledge attitude and practice among 
healthcare workers 
 
Figure 29 and Table 55 show that there is a weak but statistically significant positive correlation 
between knowledge and attitude (rs=0.11) and attitude and practice (rs=0.13).  
 
Table 55. Correlations between tuberculosis knowledge attitude and practice scores for 
healthcare workers 
Correlation variable   N Spearman correlation coefficient p-value 
Knowledge vs attitude  518 0.11362 0.0096* 
Knowledge vs practice  518 -0.0101 0.818 
Attitude vs practice  518 0.13142 0.0027* 
*statistically significant     N, number of observations  
   
 
Figure 29. Scattered plot matrix representing the correlation between total knowledge 
(totKnw), total attitude (totatt) and total practice (totprac) scores  
 
 
 
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj 
mass gathering 
269 
 
4.10  Discussion 
The current study conducted the first KAP survey regarding TB among HCWs serving during 
the Hajj. The results of this investigation have already been published (Alotaibi et al., 2019). 
 
4.10.1 Knowledge of tuberculosis among healthcare workers 
Knowledge maybe defined as ''what people know about certain subjects or as information that 
is acquired or gained'' (Wahab et al., 2016). We evaluated knowledge of HCWs regarding TB 
and its management across four general themes: nature of the disease (epidemiology and 
microbiology), diagnosis, treatment and infection prevention and control. We found that the 
mean overall knowledge score (0.52) fell within the average range (0.4-0.6). Most HCWs were 
deemed to have either average or above average knowledge, 43.9% and 31.9% respectively. 
According to our scale, only a small proportion of HCWs (2.2%) were found to have good 
knowledge. Various studies from around the word investigated knowledge of HCWs regarding 
TB and found varying results. Some reported poor knowledge(Noe et al., 2017, Shrestha et al., 
2017, Woith et al., 2010), and others found adequate (Buregyeya et al., 2016, Minnery et al., 
2013) or good knowledge (Bhebhe et al., 2014, Hashim et al., 2003).  However, interpretation 
of the results of these studies and comparison with our data should be done within the context 
of the methodology use in each study and the scales or cut of points used for the definition of 
the level of knowledge. For example, reports among HCWs from Peru (Minnery et al., 2013) 
Mozambique(Noe et al., 2017) and Russia (Woith et al., 2010) found average knowledge scores 
of 67.3%, 57.3% and 51.7% respectably, which are close to what we found among HCWs 
working in Hajj (52%). Still the study from Mozambique concluded that HCWs knowledge 
regarding TB patient characteristics, diagnosis and treatment was poor(Noe et al., 2017) while 
that from Russia deemed the overall score to below (Woith et al., 2010). 
 
A study from Iraq (Hashim et al., 2003) found that 95% of HCWs had “good” knowledge about 
TB, while another from Lesotho found 89.2% of HCWs had appropriate knowledge of 
transmission, diagnosis and prevention of TB. In the latter study, fair and good knowledge were 
defined as scores of 40-69% and >70% respectively. According to this scale, our study found 
similar results as 78% of HCWs in our study had a score of >40%. 
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In Thailand, 56% of healthcare providers were found to possess a “good” level of knowledge 
of TB (Lertkanokkun et al., 2013). The proportion of providers with good level of knowledge 
regarding the nature of disease, diagnosis, treatment and follow up were 71.2%, 37.2%, 65.1% 
and 55.2% respectively. In another study among health staff at basic healthcare facilities in 
rural Vietnam revealed that 90% of them were aware of the nature of TB disease (Hoa et al., 
2005).  In Uganda, 62% of HCWs were judged to have adequate basic TB knowledge based 
on a cut of point for knowledge score of >85 (Buregyeya et al., 2016). In Nepal, 54% of HCWs 
answered ≥ 60% of the knowledge questions on TB infection control correctly and were 
considered to have “good” level of knowledge (Shrestha et al., 2017). 
 
In our study, none of the HCWs surveyed answered all knowledge questions correctly and only 
2.2% had an overall mean knowledge score over 80%. Buregyeya et al. (Buregyeya et al., 2016) 
reported that 24% of HCWs from health facilities in the districts of Mukono and Wakiso in 
Uganda answered all TB basic knowledge questions correctly. However, it is worth noting that 
latter study only included 7 “yes/no” questions regarding TB basic knowledge compared to our 
study which had 23 questions, a number of which were multiple choice. Results reported by 
Bhebhe and colleagues (Bhebhe et al., 2014) were more similar to ours as they found that only 
3.1% of HCWs investigated from a hospital in Lesotho received a knowledge score of ≥ 70%. 
In a multinational study conducted among HCWs in China, India, Iran and Mexico, only 12% 
of respondents correctly answered all the 5 TB knowledge questions (Hoffman et al., 2016). 
 
4.10.1.1  Nature of tuberculosis disease (epidemiology and microbiology) 
Our study identified key knowledge gaps among HCWs working during Hajj with regards to a 
number of aspects of TB and its treatment. In relation to the nature of the disease (epidemiology 
and microbiology), 25% of HCWs did not correctly identify TB as a bacterial infection and 
nearly 12% did not know that PTB is curable. These were slightly higher rates than those 
reported from other countries. Studies from Russia, Peru, Iraq, Vietnam and Lesotho found that 
1-12.6% of HCWs did not know that TB was caused by a bacterium and 2.3-8% did not know 
that TB was curable (Bhebhe et al., 2014, Hashim et al., 2003, Hoa et al., 2005, Minnery et al., 
2013, Woith et al., 2010). 
  
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj 
mass gathering 
271 
 
Most HCWs in our study (83.6%) identified the airborne route as the mode of transmission of 
PTB and indicated coughing (93%) and sneezing (65%) as routes of transmission. This is in  
accordance with numerous other studies that reported that over 80% of HCWs are aware that 
TB is transmittable thought the airborne route (Bhebhe et al., 2014, Buregyeya et al., 2016, 
Ferreira Junior et al., 2013, Hashim et al., 2003, Minnery et al., 2013, Shrestha et al., 2017, 
Woith et al., 2010).  However, we found that in addition to coughing and sneezing, 17-
42%thought that PTB can be transmitted through sharing food or drinks, contaminated 
surfaces, kissing or handshaking. Such misconceptions have been reported among HCWs albeit 
to a lesser extent. For example, 1.8% of HCWs investigated in Iraq thought TB is transmitted 
thought a route other than breath (Hashim et al., 2003), while 2% of HCWs in a study from 
Uganda identified utensils and shaking hands as rotes of TB transmission (Buregyeya et al., 
2016).  In a study among public health workers in Sao Paulo, Brazil, 94.9% thought TB was 
transmitted thought the air, but similar misconceptions about routes of transmission found in 
our study were identified (Ferreira Junior et al., 2013). Nearly 40% and 24.7% respectively 
thought TB was transmitted thought sharing dishes/cutlery and through sharing food. 
Moreover, some public health workers also believed that TB was transmitted through other 
routes including handshaking (3.2%), saliva (1.3%), touching doorknobs (8.2%), and drug use, 
kissing and contaminated food (1.3%).   
 
HCWs, especially front-line staff are an important source of information for patients due to 
their involvement in patient support. As such lack of knowledge regarding the ways TB is 
transmitted among HCWs may also explain the similar misconceptions widespread among 
patients. For instance, in a recent study among patients at primary healthcare facilities in South 
Africa, only 15.0% knew that TB cannot be transmitted through sharing toothbrushes and only 
35.5% were aware that TB cannot be transmitted through kissing (Kigozi et al., 2017). 
 
Another concerning result from our study is the lack of knowledge of HCWs regarding drug-
resistant TB (MDR- and XDR-TB). Drug-resistant TB is a global health threat with significant 
morbidity and mortality and an important challenge to the WHO’s End TB Strategy (Marahatta, 
2010, Seung et al., 2015, World Health Organization, 2017b).  Only a quarter of HCWs knew 
the definition of MDR-TB and even a smaller proportion (12.7%) knew the definition of XDR-
TB. In addition, only half of the HCWs thought MDR-TB was curable.  
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Although it is generally assumed HCWs know about MDR-TB and its implications, the 
evidence from several studies worldwide have found that HCWs do not always have sufficient 
knowledge of MDR-TB, even those working in TB facilities (Isara and Akpodiete, 2015, 
Malangu and Adebanjo, 2015, Minnery et al., 2013, Woith et al., 2010). A study among HCWs 
participating in the Peruvian national TB control program found that only 37.2% knew the 
definition of MDR-TB (Minnery et al., 2013). The proportion among medical doctors, nurses, 
nurse technicians, health promoters and other HCWs were 40.4%, 38.4%, 40.3%, 39.5% and 
30.7%. In a study from Russia, only 59% of TB HCWs from 5 TB facilities recognised that 
MDR-TB was curable (Woith et al., 2010). A study among HCWs in Lesotho reported that less 
than half (47.3%) had good level of knowledge about MDR-TB (Malangu and Adebanjo, 
2015). Although patients harboring MDR and XDR strains present a formidable challenge for 
treatment, cure is often possible with early identification of resistance and use of a properly 
designed regimen(Seung et al., 2015).  Hence, it is important that HCWs, especially front-line 
staff, are aware of MDR-TB, able to diagnose it early and are aware of the fact that patients 
with MDR- and XDR-TB can be cured and communicate this information to patients and the 
community at large. 
 
BCG vaccines are among the oldest vaccines first used in humans back in 1921. The BCG is a 
live attenuated bacterial vaccine derived from Mycobacterium bovis that was originally isolated 
in 1902 from a tuberculous cow (Luca and Mihaescu, 2013). While BCG has demonstrated 
significant effectiveness in several populations, protection has not been consistent against all 
forms of TB and in all age groups. However, there is no evidence of effectiveness when BCG 
is used as post-exposure prophylaxis (World Health Organization, 2018a). The WHO 
recommends BCG vaccination for unvaccinated TST- or IGRA-negative HCWs at risk of 
occupational exposure in low and high TB incidence areas (World Health Organization, 
2018a). In the USA, the CDC recommends that BCG vaccination of HCWs should be 
considered on an individual basis in settings in which a high percentage of TB patients are 
infected with M. tuberculosis strains resistant to both INH and RIF; there is ongoing 
transmission of such drug-resistant strains to HCWs and subsequent infection is likely; or 
comprehensive TB infection-control precautions have been implemented, but have not been 
successful (Centers for Disease Control and Prevention, 2012).  
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Vaccination is also recommended in number of other countries (La Torre et al., 2017). Our 
results showed that there is genuine confusion among HCWs regarding the role of the BCG 
vaccine in the protection against TB with nearly an equal number (about a third) of HCWs 
thinking it is protective, not protective, or did not know the answer. This confusion is seen even 
among HCWs from high TB settings such as South Africa, where one study reported that 
among HCWs in a hospital in Lesotho, BCG vaccination was identified by 58.6% of the 
respondents as not being a preventive measure against contracting PTB, while the rest thought 
it was (Bhebhe et al., 2014). 
 
We found that most HCWs (81%) were aware that HIV patients were more vulnerable to 
contracting TB. HIV patients are at increased risk of contracting TB and TB recurrence 
(Mirsaeidi and Sadikot, 2018).  In fact, concurrent HIV infection has been reported to be the 
greatest single risk factor for developing TB from infection (Davies, 2005). The ability to 
identify individuals at risk of TB has important implication for early detection of the disease 
and appropriate treatment and supportive interventions as well as infection prevention and 
control measures. As with our results, reports from a number of countries found that in general 
most HCWs were aware that HIV patients are more vulnerable to TB. For example, Bhebhe et 
al. (Bhebhe et al., 2014) reported that 96.1% of HCWs investigated from a hospital in Lesotho 
thought that HIV patients are predisposed to contracting TB. Similarly, Buregyeya and 
colleagues (Buregyeya et al., 2016) found that 97% of HCWs from healthcare facilities in two 
districts in Uganda indicated that HIV infection increased the risk of developing TB. However, 
knowledge of other individuals at higher risk of TB apart from HIV patients may not be as high 
among HCWs. A number of risk factors have been identified related to increasing the risk of 
TB infection and active disease including diabetes, smoking, alcohol use, and the use of drugs. 
Silva et al (Silva et al., 2018) and Minnery et al. (Minnery et al., 2013) reported that when 
HCWs participating in the Peruvian national TB control program were asked to identify people 
at higher risk of developing TB disease from a list that included people with HIV, diabetes, 
chronic diseases, people in close contact with TB patients and pregnant woman, only 58.8% 
had a correct response. Medical doctors and nurses performed better (70% and 63% 
respectively), but only 42% of health promoters gave the correct answer. Our study did not 
investigate knowledge of HCWs regarding people at risk of TB beyond HIV patients.  
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4.10.1.2 Tuberculosis diagnosis 
Overall, only 3.6% of HCWs in our study correctly identified all of the main symptoms of PTB 
given in the multiple-choice question. This is in contrast to two studies from Russia and Peru 
which reported around 75% of HCWs correctly identified the most common symptoms of PTB 
(Minnery et al., 2013, Woith et al., 2010). It is worth nothing however, that unlike our study 
population, the latter studies were conducted among specifically TB HCWs working in TB 
facilities or HCWs participating in national TB control programs, which may explain the high 
level of knowledge regarding TB symptoms. While the majority of HCWs (63-80%) in our 
study correctly identified some common symptoms of PTB such as cough ≥ 3 weeks, cough 
with blood, fever/chills and weight loss, confusion was apparent for other common symptoms 
of PTB such as tiredness and fatigue, chest pain, loss of appetite and night sweats, as only 
around half of the HCWs (40-57%) correctly identified these as symptoms of PTB. A 
proportion of HCWs (1.3-16.1%) identified symptoms not commonly associated with PTB as 
main symptoms of the disease including headaches, dizziness, pain when urinating, diarrhoea, 
memory loss and blurry vision. This gap in knowledge regarding the main symptoms of PTB 
was observed even among physicians although the proposition of correct answers, in general, 
were higher among physicians compared to other HCWs.  
 
Numerous studies found similar results to ours. In a study from Lesotho, most HCWs were 
able to identify constitutional symptoms of TB (chronic cough (94.7%), night sweats (84.5%) 
and weight loss (79.1%) but only 53.3% cindered fever to be a symptom of TB (Bhebhe et al., 
2014).  A study from Nepal, found that most (67.4%) of HCWs investigated were aware of the 
major symptoms of TB. Cough ≥ 2 weeks, weight loss, fever, loss of appetite, chest pain and 
blood in sputum were identified as symptoms of TB by 67.4%, 75.3%, 85.3%, 57.9%, 67.2% 
and 61.6% of HCWs respectively. As with our results, the proportions of HCWs correctly 
identifying symptoms were generally higher among clinical staff compared to other HCWs 
such as laboratory, ward support or administrative staff (Shrestha et al., 2017).  Among HCWs 
in Vietnam, persistent cough was chosen as the most frequent symptom (98%) of TB (Hoa et 
al., 2005). 
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Among public health workers in Brazil, the TB symptoms were identified as follows: 2-weeks 
cough (86.7%), cough with blood (56.3%), fever (39.9%), weight loss (67.7%), chest pain 
(30.4%) and fatigue (51.9%)(Ferreira Junior et al., 2013). Among HCWs in Iraq, 93.2% 
identified cough >3 weeks as a sign of TB. Fever, haemoptysis, and night sweats were 
identified as signs of TB by 70-76% of HCWs, while 51-60% identified loss of appetite, chest 
pain, loss of weight and general weakness as signs of TB (Hashim et al., 2003). 
 
Gaps in knowledge regarding common symptoms of TB are concerning especially in the 
context of HCWs working during Hajj. Key factors facilitating TB transmission, both in the 
community and in healthcare settings, include undiagnosed TB or delays in diagnosing and 
treating TB patients (Golub et al., 2006, Greenaway et al., 2002, Jensen et al., 2005, Menzies 
et al., 2007).  Undiagnosed TB, both among hospitalized and non-hospitalised Hajj pilgrims 
have been reported, representing a risk for TB transmission among pilgrims, local population 
and international spread of infection (Al-Orainey, 2013, Alzeer et al., 1998, Yezli et al., 2017b).  
Hence, lack of knowledge regarding symptoms of TB may translate into delays in identifying, 
isolating and treating patients with TB or in TB patients not being diagnosed with the disease 
and consequent transmission.  
 
We found important knowledge gaps with regards to other aspects of TB diagnosis among the 
HCWs. Very few HCWs (1.6%) correctly identified all diagnostic tests for PTB from the list 
of options presented to them and only 0.2% correctly identified all the screening tests for LTBI. 
There was clear confusion regarding the purpose of the tests and the difference between tests 
to diagnose active disease and those used to screen for latent infection. For instance, 71% of 
HCWs identified chest X-ray as diagnostic tests for PTB. In addition, while 57-71% of HCWs 
identified chest X-ray, sputum culture and sputum AFB smear tests as diagnostic tests for PTB, 
35-53% also identified these tests as screening tests for LTBI. Also, a smaller proportion of 
HCWs (60%) identified TST as a LTBI screening tests than those who thought it was a test for 
diagnosing PTB (65.7%). Interestingly, IGRA was identified as a LTBI screening tests and as 
a PTB diagnostic test in a similar but small proportion of HCWs (12.7% and 13.3% 
respectively). This was similar to the GeneXpert MTB/RIF test where only 12% of HCWs 
knew it was a diagnostic test for PTB, while 7% thought it was a screening test for LTBI. 
Additionally, while most HCWs correctly identified the most useful sputum collection method, 
only 16% knew the percentage of active PTB that would be positive on a smear microscopy. 
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These gaps appear not only to be related to lack of knowledge of the tests, especially modern 
techniques, but also to a confusion between active TB disease and LTBI. This confusion has 
been reported in other studies. Only 54.7% of all HCWs and 68% of clinical staff investigated 
from healthcare facilities in Nepal knew the difference between TB infection and disease 
(Shrestha et al., 2017), while a study from Uganda reported that 42% of HCWs thought there 
was no difference between TB infection and TB disease (Buregyeya et al., 2016). Among TB 
HCWs in Peru, only 54% knew that not all people infected with TB develop TB disease 
(Minnery et al., 2013). Lack of knowledge regarding diagnostic techniques have also been 
reported in various studies around the world, although in most to a lesser extent to what was 
found in our study. A study among HCWs in Iraq found that while 78.8% defined active PTB 
correctly according to the national guidelines, 19% believed that the disease could be detected 
only by chest X-ray (Hashim et al., 2003). In South Africa, although most (97%) HCWs 
investigated knew that smear examination was a major diagnostic tool for PTB, only 22% knew 
the appropriate place to collect sputum (Bhebhe et al., 2014).  This is in contrast to a report by 
Hong et al.(Hong et al., 1995) which found that sputum examination was considered neglected 
in cause-finding among private general practitioners in Korea as more than 50% did not 
consider sputum examination essential in case finding/diagnosis. Hoa et al. (Hoa et al., 2005) 
reported that although most (89%) HCWs they surveyed in Vietnam correctly identified the 
most effective diagnostic tool for PTB. Around (65%) knew how many sputum samples are 
needed to be collected for diagnosis but only 19% reported the correct number and method of 
collecting these samples. Minnery et al. (Minnery et al., 2013) also reported that most HCWs 
in a study from Peru were aware of the number of sputum samples needed for TB diagnosis. 
However, a disappointing proportion (24%) correctly identified the most effective tool in 
diagnosing PTB from a list that contained sputum examination, chest X-ray, blood culture and 
TST. A study from Uganda reported that 19% of HCWs agreed that the first step in assessing 
a TB suspect was to send them for a chest X-ray and 94% indicated that sputum smear 
microscopy for AFB was the quickest and cheapest way to identify infectious TB patients 
(Buregyeya et al., 2016). 
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A striking observation in our results was the poor knowledge among HCWs regarding the use 
of GeneXpert MTB/RIF for TB diagnosis. Similar results were reported among HCWs in rural 
Mozambique, where less than 30% of those surveyed had heard of the test (Noe et al., 2017). 
GeneXpert MTB/RIF is a relatively new nucleic acid amplification test used for diagnosis of 
TB and resistance testing especially in a low-resource high-TB burden settings. It is clear that 
despite the WHO issuing recommendations endorsing this technology in 2010, and the 
widespread uptake of its use worldwide since (World Health Organization, 2014c), knowledge 
of its existence and purpose remains low in our study as well as in others (Noe et al., 2017). It 
is worth noting that GeneXpert MTB/RIF is available in the Kingdom, hence lack of knowledge 
among HCWs may suggest that the roll out of this technology might not have been 
accompanied with sufficient education for HCWs (Noe et al., 2017). Some argued that while 
this technology is lauded as “a major advance for TB diagnostics”, without a widespread 
understanding of its potential among HCWs and the critical operational requirement of trained 
laboratory and clinical staff, GeneXpert MTB/RIF may not be fully adopted (Piatek et al., 
2013).  
 
The use of rapid molecular diagnostic techniques for TB such as GeneXpert MTB/RIF is 
important in the context of Hajj given the characteristics of the pilgrims’ population, the 
crowded environment, the short duration of the mass gathering, and potential for international 
transmission. It is likely that in the future the technology will become a stable point-of-care 
test in healthcare facilities in the Hajj area; hence, improving HCWs knowledge regarding this 
test is of great importance. Lack of knowledge regarding IGRA in our study is also surprising 
given that the test is used in Saudi Arabia and commonly reported in studies from the Kingdom 
(Al Wakeel et al., 2015, Balkhy et al., 2016, 2017, Bukhary et al., 2018). Given that there is no 
gold standard test for LTBI (Lamberti et al., 2015), the WHO recommends either TST or IGRA 
to test for LTBI (World Health Organization, 2018c). The above maybe also be an indication 
that HCWs working during Hajj are not up-to-date regarding modern TB diagnostic and 
screening techniques and recent literature as well as national and international guidelines in 
relation to TB and LTB (Al Jahdali et al., 2010, Lamberti et al., 2015, World Health 
Organization, 2017b, 2018c). 
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4.10.1.3 Tuberculosis treatment 
We identified key knowledge gaps regarding TB treatment among HCWs in our study. Overall 
only 6% of HCWs correctly identified all the 1st-line anti-TB drugs on the survey, and even 
lower proportion (4.5%) identified all 2nd-line anti-TB drugs. Commonly used and known 
drugs such as INH and RIF were better recognised than other drugs such as EMB and PZA as 
1st-line anti-TB treatments. For 2nd-line anti-TB drugs, there was clear confusion as the 
proportion of HCWs who identified the various drugs as 2nd-line anti-TB drugs was similar. 
This confusion combined with the observed lack of knowledge regarding the definitions of 
MDR- and XDR-TB among HCWs in our study is concerning. Also, the fact that nearly 64% 
of the HCWs did not know or chose a shorter duration of treatment for TB patients is also 
alarming. Treatment with too few drugs and for a too short duration has been shown to result 
in ineffective treatment outcomes of patients and an increased risk of acquiring resistance 
(Menzies D. et al., 2009).  In addition, treatment of TB patients with fewer than four drugs in 
the intensive phase has been shown to result in higher percentages of relapse cases (Fox et al., 
1999). 
 
Studies on knowledge of HCWs relating to TB found that questions related to TB treatment 
and follow up had usually the biggest knowledge gaps. For example, a study among TB care 
teams from 30 hospitals in Thailand reported that the mean scores of the knowledge questions 
relating to TB treatment were lower than those related to either the nature of the disease of 
diagnosis (Lertkanokkun et al., 2013).  Around 65% and 55% of the participants were deemed 
to have good knowledge regarding TB treatment and follow up respectively. A similar 
observation was reported in a study among TB HCWs in Peru where investigators found that 
among knowledge questions, the worst knowledge scores were seen in the TB treatment section 
with a total participants average of 4.2 out of 7 or 60% correct answers (Minnery et al., 2013). 
In the later study, HCWs were knowable regarding the number of drugs used for the treatment 
of PTB and the appropriate treatment duration (87.4% and 95% respectively). However, poor 
knowledge was observed regarding the consequences of an incomplete or abounded treatment, 
the most effective form for evaluating the results of a complete treatment scheme and the 
frequency of follow up sputum tests under the TB treatment scheme (48.8%, 35.5% and 16.9% 
respectively).  
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These results were not very different when the analysis was restricted to only medical doctors 
or nurses (Minnery et al., 2013). Similarly, among HCWs in rural Vietnam, around 65% knew 
how many drugs are used in treatment of TB, how many times follow-up sputum is carried out 
and the major elements to assess treatment outcome (Hoa et al., 2005). However, only 49% 
knew what are the consequence of inadequate/incomplete treatment. A study among TB HCWs 
in Russia reported that only one-third were able to identify why TB should be treated for at 
least 6 months, 58% understood the importance of a four-drug regime and only 43% knew the 
adverse reactions that may be cause by INH (Woith et al., 2010).  Gaps in knowledge regarding 
possible side effects of INH appear to be common among HCWs from different countries. A 
study from 4 countries in Asia, the Middle East and South America also reported that only 45% 
of HCWs investigated knew the major side effects of INH therapy (Hoffman et al., 2016). 
 
Unlike the results seen in our study where only 31% of HCWs correctly identified the 
appropriate treatment duration for drug-sensitive TB, many studies among HCWs worldwide 
reported much better knowledge. Among HCWs in studies from Lesotho, Iraq, and Vietnam, 
99.2%, 87% and 65.6% correctly identified the treatment duration for TB (Bhebhe et al., 2014, 
Hashim et al., 2003, Hoa et al., 2005). Similarly, a study among HCWs from China, India, Iran 
and Mexico found that most (83%) HCWs surveyed knew the minimum duration of therapy 
for culture-proven active TB (Hoffman et al., 2016). In the latter study, 87% of HCWs were 
able to identify a TB therapy that was not a 1st-line treatment for TB. In our study, 1.3-9.5% of 
HCWs wrongly identified various antibiotics as 1st-line anti TB drugs. In general, available 
data from around the world indicate a lack of knowledge of national and international TB 
treatment guidelines and recommendations among HCWs.  
 
In a systematic review reporting on 31 studies from 14 counties in Asia, America, and Africa, 
HCWs with inappropriate knowledge of treatment regimens (8-100%) or treatment duration 
(5-99%) were observed in all studies (van der Werf et al., 2012). The few studies providing 
detailed data showed that HCWs mainly reported giving treatment regimens with too many 
drugs and for too long. Knowledge of appropriate doses was also insufficient in most studies.  
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Such gaps in knowledge and deficiencies in practice related to TB treatment have negative 
implications with regards to treatment outcome as well as development of resistance. Indeed 
one of the greatest contributors to MDR-TB is improper treatment that may be prescribed or 
administered by health professionals, either because of inaccurate diagnosis, insufficient 
treatment supplies, or limits in their knowledge of evidence-based TB control practices 
(Langendam et al., 2012, Smetana et al., 2007). Despite numerous national and international 
guiltiness relating to the treatment of TB, including various updates of the WHO guidelines 
(van der Werf et al., 2012, World Health Organization, 2010c),  inappropriate treatment of TB 
is common worldwide. In a systematic review, Langendam et al (Langendam et al., 2012) 
assessed the percentage of TB patients that received an inappropriate treatment regimen from 
37 studies from 22 countries, and one study was from multiple countries. Almost all continents 
were represented. Inappropriate treatment regimens were prescribed in 67% of the studies. The 
percentage of patients receiving inappropriate regimens varied between 0.4% and 100%. The 
authors highlighted the need to improve implementation of the WHO TB treatment guidelines. 
 
4.10.1.4 Tuberculosis infection prevention and control 
Infection prevention and control in healthcare settings is one of the key strategies for TB 
control. The WHO recommends TB infection prevention and control in healthcare institutions 
based on four levels: managerial, administrative, environmental and personal protective (World 
Health Organization, 2009b). These measures have been found to minimize TB transmission 
(Basu et al., 2007, Dharmadhikari et al., 2012).  However, implementation of these 
recommendations seems to be inadequate. Several studies have reported poor TB infection 
control measures in health facilities (Demissie Gizaw et al., 2015, Farley et al., 2012, He et al., 
2010, Ogbonnaya et al., 2011).  Further, many HCWs are practicing without adequate infection 
control training and often lack knowledge on TB infection control strategies (Demissie Gizaw 
et al., 2015, Kanjee et al., 2011, Shrestha et al., 2017, Woith et al., 2012).  This is likely to 
contribute to the increased risk of nosocomial transmission of TB. In our study, we report good 
overall knowledge regarding TB infection prevention and control among HCWs, but important 
knowledge gaps were identified. While we found that most HCWs knew that PPE was 
important when dealing with TB patients and could identify the appropriate PPE to be used, 
nearly 5% thought PPE use was not important for their protection from TB and 18% indicated 
that surgical masks are appropriate PPE to use when dealing with patients with active TB. In 
addition, a large proportion of HCWs thought that patient with LTBI were infectious. 
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Respiratory protection is an important aspect of TB infection control programs and consists of 
the use of protective equipment in situations of a high risk for exposure to TB disease. The 
WHO recommends HCWs to use particulate respirators that meet or exceed the N95 standards 
set by the USA CDC/National Institute for Occupational Safety and Health (NIOSH) or the 
FFP2 standards that are CE certified (World Health Organization, 2009b).  However, our study 
showed that nearly 24% of the HCWs did not identify the appropriate respirator to be used 
when dealing with active TB patients and that 18% thought surgical masks were protective. 
These results are in line with other reports in the literature. A study from Ethiopia found that 
the majority (67.2%) of HCWs surveyed wrongly believed surgical mask can protect health 
workers from inhaling M. tuberculosis containing droplets (Demissie Gizaw et al., 2015). In 
Uganda, only 34% of HCWs investigated knew that surgical masks do not protect the wearer 
from getting TB (Buregyeya et al., 2016) and Kanjee et al. (Kanjee et al., 2011) reported that 
11% of HCWs from a hospital in South Africa could not differentiate between a N95 and a 
surgical mask when presented with one. The proportion was higher in a study from Ethiopia 
where 68% of HCWs could not identify different types of mask (Demissie Gizaw et al., 2015). 
Among Russian TB HCWs, 40% knew to wear respirators in units with infectious patients, but 
many did not know respirators should also be worn where cough-inducing procedures are done 
or in homes of infectious patients (Woith et al., 2010). 
 
Studies have also reported varying knowledge regarding other TB infection prevention and 
control measures. HCWs from a hospital in South Africa were found to have high knowledge 
regarding TB transmission including being generally well informed regarding key routes of TB 
transmission (Kanjee et al., 2011). A report from healthcare facilities in Ethiopia found that 
nearly two-third (63.9%) of HCWs had good overall knowledge about TB infection control 
(Demissie Gizaw et al., 2015). This proportion was lower than that reported in a study 
conducted in West Gojam which was 74.4% (Temesgen, 2011) and survey results of hospital 
staff in South Africa (Kanjee et al., 2011). In Uganda, 62% of HCWs were judged to have 
adequate knowledge of TB infection control, but only 7% answered all related questions 
correctly (Buregyeya et al., 2016).  On the other hand, in Nepal, knowledge on TB infection 
control was poor among nearly half (45.5%) of HCWs (Shrestha et al., 2017). Only 55% of 
HCWs could differentiate between TB infection and TB disease. Regarding the infection 
control measures to be implemented in health facilities, 55% of them stated personal respiratory 
protection followed by environmental controls (47.4%) and administrative controls (14.7%). 
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Similarly, poor knowledge regarding infection prevention and control were observed among 
Russian TB HCWs with only 9% correctly identifying the factors that affect infectiousness of 
a TB patient (Woith et al., 2010).  Moreover, less than 45% knew when personal respirators 
should be used, what methods can help decrease the presence of the TB organism in the air and 
only 17% could identify the three types of controls which should be part of a TB program. 
While some of the difference in results among studies may relate to difference in 
methodologies and settings, they all identify gaps in knowledge relating to TB infection 
prevention and control among HCWs. These may be translated to poor practices contributing 
to TB transmission among patients and HCWs.  
 
4.10.2 Factors associated with knowledge of tuberculosis and its management among 
healthcare workers 
In our study, TB knowledge scores among HCWs differed with respect to a number of factors. 
Scores differed significantly depending on Age, level of education and occupation. HCWs in 
the older age groups had a higher knowledge score than those in the younger age groups. 
Physicians had significantly more knowledge than nurses and other HCWs, while nurses had 
significantly more knowledge than HCWs other than physicians. In general, HCWs with higher 
level of education had more knowledge than those with Bachelor or diploma. Knowledge 
scores also differed significantly depending on the length of work experience. Although not 
strongly significant, HCWs who deal with TB patients in their non-Hajj work, those who 
attended a TB seminar in the previous year, and those who were female had slightly higher 
median knowledge score compared to those who do not deal with TB patients, did not attend 
TB seminar in previous year or those who were males respectively.   
 
4.10.2.1 Age, gender and tuberculosis training and education 
Reports from many countries including Nepal, Uganda, China, India, Iran, Mexico, 
Mozambique, Ethiopia, Peru, South Africa, Nigeria, and Vietnam did not find significant 
association between HCWs age or gender and knowledge of TB (Demissie Gizaw et al., 2015, 
Hoa et al., 2005, Hoffman et al., 2016, Isara and Akpodiete, 2015, Malangu and Adebanjo, 
2015, Minnery et al., 2013, Noe et al., 2017). 
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However, some did find association. For example, Hashim et al. (Hashim et al., 2003), fund 
significant association between age and TB knowledge among HCWs in Iraq and attributed 
that to older HCWs having more experience, hence better knowledge. Buregyeya et al 
(Buregyeya et al., 2016) noted that poor basic TB knowledge was significantly associated with 
female sex (OR= 0.65; 95% CI: 0.43-1.00). However, in the same study, gender was not a 
significant factor in relation to specifically knowledge about TB infection prevention and 
control.  
 
It is reasonable to assume that receiving specific training regarding TB or attending TB 
seminars, workshops and courses, as well as experience in dealing with TB patients would lead 
to better knowledge regarding the disease. A number of studies reported such results. Shrestha 
et al.(Shrestha et al., 2017) found that TB training or orientation received by HCWs in Nepal 
was significantly associated with knowledge level. These results are in accordance with other 
reports from Vietnam and Thailand (Hoa et al., 2005, Lertkanokkun et al., 2013). Demissie 
Gizaw et al. (Demissie Gizaw et al., 2015) found that among HCWs in Addis Ababa in 
Ethiopia, having been trained in TB infection prevention and control was significantly 
associated with good knowledge on the subject (OR= 2.41; 95% CI: 1.33-4.36). We found 
similar association between attending TB seminar in the previous year and level of knowledge 
of TB among HCWs, although the association was not significant. Yet a study from Nigeria 
reported that receiving training in MDR-TB was not associated with better knowledge on the 
topic among HCWs (Isara and Akpodiete, 2015). Similarly, Minnery et al. (Minnery et al., 
2013) found that the mean knowledge score among HCWs in Peru was not significantly 
different in relation to having had training related to TB in the last 12 months or having had 
TB and/or having lived with someone who had TB. 
 
4.10.2.2 Length of work experience and experience with tuberculosis patients 
A study from Mozambique reported the association between experience with TB patients and 
level of TB knowledge among HCWs. It was found that working with TB patients for one year 
and between one and 5 years were both associated with increase in knowledge score compared 
to having never worked with TB patients. Having cared for more than 40 TB patients over the 
HCWs’ career was also associated with increase knowledge compared to those who had cared 
for less than 10 patients (Noe et al., 2017).  
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We found similar results in our study, although the association between experience with caring 
for TB patients and TB knowledge was not significant. In general healthcare work experience 
has been reported to be associated with better knowledge of TB in some studies but not all. In 
one study, HCWs with more than 10 years in their job were significantly more knowledgeable 
about TB than those with less than 10 years' work experience (Hashim et al., 2003).In another 
study, HCWs who had more than 6-year working experience in health facility were 2 times 
more likely be knowledgeable about TB compared to those who had less than 3-year experience 
(OR= 1.97; 95% CI: 1.1-3.5) (Demissie Gizaw et al., 2015).  These results are in agreement 
with our findings and it is argued that more experience and a longer duration of work subject 
the HCWs to more intensive training courses and evaluation of their promotion by the 
specialized supervision systems in place under national TB programmes (Hashim et al., 2003).  
However, a report from Nepal found that duration of employment was not significantly 
associated with better knowledge among HCWs regarding TB infection prevention and control 
(Shrestha et al., 2017).  Similarly, in South Africa, HCWs with more than 5-years work 
experience were found not to have better knowledge regarding MDR-TB than those with less 
than 5-years work experience (Malangu and Adebanjo, 2015). 
 
4.10.2.3 Level of education and occupation 
In accordance with results of our study, education level and occupation have consistently been 
reported to be associated with TB knowledge. A study among HCWs in Southern Mozambique 
found that greater educational attainment levels were associated with higher TB knowledge 
scores. Respondents that had attended secondary school and technical college had significantly 
lower mean knowledge scores than university-educated respondents (Noe et al., 2017).  
Another report from Ethiopia found that HCWs who had first degree and above were 1.5 times 
more knowledgeable about TB infection prevention and control compared to those with 
diploma level (Demissie Gizaw et al., 2015).  The above results are in line with data regarding 
HCWs from Nepal, Ethiopia, Nigeria and Peru and Vietnam (Demissie Gizaw et al., 2015, Hoa 
et al., 2005, Minnery et al., 2013, Shrestha et al., 2017). Isara and Akpodiete (Isara and 
Akpodiete, 2015) argued that given the association between education level and knowledge on 
TB, found in his study,  efforts can be made to increase the knowledge of TB in less educated 
HCWs. In our study, physicians had the highest knowledge scores followed by nurses then 
other HCWs. In general, clinical staff have been reported to be more knowledgeable about TB 
than non-clinical staff (Buregyeya et al., 2016).  
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Physicians in particular were more knowledgeable than nurses and other HCWs and axillary 
staff such as administrative staff, midwives, laboratory and medical technicians, counsellors 
and health promoters. In an international study involving HCWs from 4 countries in Asia, 
South America and the Middle East, being a specialist physician was found to be statistically 
significant factor associated with health professionals’ knowledge scores related to TB 
treatment (OR= 2.84, 95% CI:1.15–7.05)(Hoffman et al., 2016).  In Thailand, Lertkanokkun et 
al. (Lertkanokkun et al., 2013) reported that various professions had a significantly different 
level of TB knowledge. Over 70% of physicians had a good level of TB knowledge but only 
18.4% of medical technologists / laboratory technicians demonstrated a corresponding level of 
understanding. Shrestha et al. (Shrestha et al., 2017) also reported significant differences in 
level of knowledge regarding TB infection prevention and control among different categories 
of HCWs. They reported that knowledge level was relatively good among medical staff 
compared to administration staff and was much lower among ward/support staff. They 
attributed this difference to the fact that medical staff have TB and infection control 
components covered during their study and are also likely to have received relevant training. 
Noe and colleagues (Noe et al., 2017) found that among HCWs in Sothern Mozambique, 
doctors had the highest knowledge scores, and nurses and midwives were the two poorest 
performing professions in the knowledge section. Similarly, among Russian TB HCWs, 
physicians had significantly higher TB knowledge scores than nurses, laboratorians, and 
support staff (Woith et al., 2010).  Nurses and laboratorians scored significantly higher than 
support staff. Minnery et al. (Minnery et al., 2013) found that among front-line TB HCWs in 
Peru, doctors and nurses had the highest mean TB knowledge scores compared to other HCWs.  
 
Gaps in knowledge regarding TB among HCWs in generals can have important implications 
not only in increasing the risk of infection among HCWs and patients but it could also lead to 
inadequate or incomplete information passed on to TB patients. This may create wrong 
perceptions in them or strengthen the patients’ own perceptions, which are often times based 
on cultural beliefs and misconceptions (Isara and Akpodiete, 2015). This is particularly 
relevant for first-line staff who are usually at close contact with TB patients and are an 
important source of information regarding the disease.  
  
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj 
mass gathering 
286 
 
The observation that nurses have significantly lower knowledge regarding TB than doctors can 
have clinical implications as well, as generally doctors develop care plans for patients which 
nurses then implement. As a result, patient care may be adversely affected if a nurse fails to 
comprehend the fundamentals behind clinical decisions (Noe et al., 2017). 
 
Lack of knowledge regarding TB among axillary and non-clinical staff is particularly 
concerning. This is especially true among health promoters and counsellors who are an 
important group in educating and informing patients regarding TB. Minnery et al. (Minnery et 
al., 2013) found that among front-line TB HCWs in Peru, doctors and nurses had the highest 
mean TB knowledge scores compared to nurse technicians, other HCWs and health promoters. 
The latter group had the lowest level of TB knowledge among HCWs in the study. Another 
study from South Africa reported that while more nurses and pharmacists had an insufficient 
level of knowledge regarding MDR-TB as compared with medical doctors, this deficit in 
knowledge was even more pronounced amongst counsellors, as 71.4% of them were deemed 
to have insufficient level of knowledge (Malangu and Adebanjo, 2015).  The latter findings are 
similar to reports by other investigators such Kiefer et al. (Kiefer et al., 2009) and Ahmed et 
al. (Ahmed M. et al., 2009) raising some concerns in that counsellors who educate patients 
about TB are themselves not so knowledgeable about it. Thus, there have been calls for TB 
educational needs among HCWs to be determined according to job categories and programs 
designed to address knowledge gaps according to occupation and educational backgrounds 
(Woith et al., 2010). This include the need to train non-clinical, auxiliary and support staff 
(Buregyeya et al., 2016, Shrestha et al., 2017, Woith et al., 2010). 
 
4.10.3 Attitude of healthcare workers toward tuberculosis 
Attitude may reflect on how people feel about certain subjects or issues or describes a way of 
thinking about a situation. Attitude may also refer to the tendency to react in a distinctive way 
to certain situations, to see and interpret events pertaining to certain tendencies or to assemble 
opinions into an interrelated structure (Wahab et al., 2016). Our data suggest that HCWs in 
general had positive attitude regarding TB and TB patients with nearly 85% scoring above 
average or good attitude score. Most HCWs were willing to be educated on TB and teach 
others, follow infection prevention measures and trust lab diagnostic results. Also, most would 
not resign if they were posted to a TB clinic/ward and had no issues examining or treating a 
TB patient.  
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Yet, we identified some poor attitudes especially in relation to willingness to work in TB 
clinic/ward and management and treatment of TB patients. We also found that HCWs were not 
aware of the actual risk of TB infection related to their work as 30% thought they had very low 
risk of acquiring TB from their patients but a sizable proportion (69%) were worried about 
acquiring active TB from work. These results are in line with those reported by Tenna et al. 
(Tenna et al., 2013) among HCWs from Addis Ababa, Ethiopia, where 20% of HCWs thought 
they had a very low risk of acquiring TB from patients while 71% worried about acquiring the 
disease from work. Similarly, a report from Uganda found 63% of HCWs surveyed regarding 
TB infection control were considered to have a high perceived threat of acquiring LTBI at work 
(Buregyeya et al., 2016). Multivariable analysis found that not having attended TB infection 
control training was significantly associated with having a low perceived threat of acquiring 
LTBI at work, (OR= 0.54; 95% CI 0.36-0.81). Suboptimal knowledge regarding TB, its 
transmission and treatment, HCWs own experiences, the stigma attached to the disease and 
worry about TB infection among HCWs may explain why 60% of the HCWs in our study were 
not willing to work in TB clinic/ward.  
 
In a study among staff in a resource-limited rural South African hospital where nosocomial 
transmission of MDR- and XDR-TB had been reported resulting in death among staff, 82.1% 
and 42.9% of HCWs were less willing to work in high-risk areas of the hospital or to continue 
work as a HCW, respectively (Kanjee et al., 2011). Studies reported that HCWs believe there 
is a stigma associated with TB. In one study from Mozambique, 70% of HCWs agreed that 
there was a stigma associated with TB and 48.2% of them believed that this stigma was greater 
than that which is associated with HIV (Noe et al., 2017).  About a third of the HCWs believed 
that their clinical conduct did not contribute to this stigma, while, conversely, many believed 
that their actions did stigmatise TB patients, citing their use of PPE as sufficient to perpetuate 
the stigma. The causes and potential impact of stigma relating to TB vary across countries. In 
a systematic review of 83 studies from across 35 countries, Chang et al.(Chang and Cataldo, 
2014) revealed that there were significant cultural variations with respect to TB and the 
development of stigma and both variations and similarities in the influence of TB stigma on 
knowledge, attitudes and responses to TB across countries were identified. Two studies from 
Ghana found that fear of infection is a major cause of TB stigma and this fear results in TB 
patients being shunned, avoided and segregated (Dodor and Kelly, 2010, Dodor et al., 2008). 
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In a study done in the Berea district of Lesotho, almost all HCWs (93%) were found to have 
positive attitudes towards TB infection prevention (Bhebhe et al., 2014). Most (87.6%) were 
willing to be tested for HIV if diagnosed with TB and would complete TB treatment (97.7%). 
Furthermore, over 80% were also willing to improve their eating habits to avoid malnutrition 
or change their work environment as an approach to TB prevention. In addition. most HCWs 
served were always ready to be screened for TB if they had suggestive symptoms (95.4%), 
were willing to teach patients and co-workers about TB prevention (96.1%) and were willing 
to attend seminars for TB prevention (94.6%). We report very similar results as the proportions 
of HCWs with similar attitudes in our study were 94.4%, 93.6% and 95.2% respectively. 
However, other studies reported less positive attitude towards HIV and TB testing among 
HCWs. For example, Kanjee et al. (Kanjee et al., 2011) found that among HCWs in rural South 
Africa, 40.4% said they would not have felt comfortable undergoing HIV testing and 28.1% 
would not seek personal TB diagnosis at the hospital if symptomatic. A number of respondents 
cited stigma or confidentiality concerns as barriers to staff TB or HIV testing. These results are 
in line with a review findings that the stigma of HIV prevents HCWs from undertaking 
prevention activities and accessing care (Nyblade et al., 2009).  Efforts to reduce the stigma 
and improve confidentially have been linked to increased staff testing (Uebel et al., 2004, Uys 
et al., 2009). 
 
General positive attitudes towards TB found in our study are in line with findings from a 
number of other studies (Bhebhe et al., 2014, Isara and Akpodiete, 2015, Shrestha et al., 2017). 
Among HCWs in Nigeria, 72% reported to have positive attitude regarding MDR-TB (Isara 
and Akpodiete, 2015).  Similarly, 73% of HCWs from Nepal had positive attitude towards TB 
infection control(Shrestha et al., 2017).  In the latter study, almost all HCWs (98.4%) agreed 
that they should wear respirators while caring for TB patients. In our study, 82.2% of HCWs 
declared that they would use facemasks when dealing with pulmonary TB patients even when 
it is uncomfortable. However, positive attitudes in relation to TB and TB patients are not always 
common among HCWs. A study from Thailand found that 56.2% of healthcare providers had 
positive attitudes towards TB, especially in terms of providing TB services (66.98%) and the 
use of TB-control systems (60%) (Lertkanokkun et al., 2013).  Most providers were proud to 
take responsibility for TB care and said it was their responsibility to increase treatment success 
rates. However, a majority (60%) expressed negative attitude towards TB patients. 
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Studies have shown that providers’ attitudes towards patients affect actual treatment success. 
If patients perceived a stigma or they had a feeling providers were showing a negative attitude 
towards them, there was a greater tendency to drop out of treatment (Dodor and Afenyadu, 
2005, Reyes-Guillen et al., 2008).  Therefore, positive HCW’s attitude to TB patient is an 
important factor in improving patient’s health‑seeking behaviour, compliance with prescribed 
treatment regimen and treatment outcome (Isara and Akpodiete, 2015). It is also important in 
preventing the development of drug resistance given that peoples’ perceptions of TB and 
patients' non-adherence to anti-TB treatment were reported to be the most important factors in 
the emergence of acquired resistance (Yu et al., 2002). 
 
In the univariate analysis, our study did not identify statistically significant differences in 
attitude scores in relation to various factors. However, attitude scores were lower among HCWs 
who were male, Saudi, physicians, >50 years old, with a master and <1 year work experience. 
Also, in the quintile regression analysis, occupation and age were significant at the 50th and 
75th quintiles respectively. Attitude score was also lower among those HCWs who do not deal 
with TB patients during their work compared to those who do. In Peru, HCW’s attitude scores 
were reported to differ among different employment groups (Minnery et al., 2013). A study 
from Thailand found that age of HCWs was significantly linked to attitude towards TB 
(Lertkanokkun et al., 2013). More HCWs aged <30 years displayed a positive attitude towards 
TB than older groups. A report from Uganda found that having not attended a TB infection 
control training was significantly associated with low self-efficacy and low perceived threat of 
acquiring TB infection among HCWs (Buregyeya et al., 2016).  
 
4.10.4 Tuberculosis practice among healthcare workers 
The WHO defines practice as'' how people behave'' (World Health Organization, 2008a). It 
means, the reflection and application of rules and knowledge that lead to actions (Wahab et al., 
2016).  We report that HCWs in our study had generally good practice in relation to TB and its 
management. The overall mean practice score was higher than that for knowledge or attitude 
and over 62% of the HCWs were deemed to have good overall practice scores. Only 1% of 
HCWs were considered to have poor overall practice scores. While this is encouraging, there 
were a number of poor practices identified among HCWs. 
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These are in line with other reports from around the world which found either low overall 
practice score among HCWs regarding TB and its management or found specific poor practices 
widespread among HCWs (Hashim et al., 2003, Hoa et al., 2005, Kanjee et al., 2011, 
Lertkanokkun et al., 2013, Noe et al., 2017, Wahab et al., 2016).  For example, Demissie Gizaw 
et al. (Demissie Gizaw et al., 2015) found that practice among 48.6% of HCWs from healthcare 
facilities in Addis Ababa, Ethiopia, was not satisfactory. They reported an average practice 
score of 10.3 points out of 17 (60.7%). Noe et al. (Noe et al., 2017) reported that the practice 
competency regarding TB care among HCWs in Southern Mozambique was low with the 
average practice score being 3.2 points out of 9 (35.6%).  
 
As with our results, they identified deficiencies in the initial investigation of TB suspects as 
well as unfamiliarity with anti-TB drugs and regimes. Only 11% of respondents correctly 
identified the course of action to take when a patient presents with jaundice after recently 
commencing TB intensive phase treatment. While the majority of respondents noted that they 
would monitor the liver enzymes, they failed to relate the occurrence of jaundice to TB 
treatment (Noe et al., 2017).  In our study, the majority of HCWs (90.7%) who the question 
was applicable to, declared that they request liver function tests before starting anti-TB 
treatment. Noe et al. (Noe et al., 2017) noted that a possible reason for the low practice scores 
in their study may have been the fact that the survey was administered among all HCWs 
regardless of profession or department; as such professionals may have a lack of experience in 
dealing with common TB scenarios. 
 
Our study also investigated all HCWs regardless of profession, but we aimed to reduce the 
effect of this factor by using the option “not applicable” for practice questions, so that HCWs 
could answer only questions that are applicable to them and their practice. Lertkankkun and 
colleagues (Lertkanokkun et al., 2013) assessed KAP regarding TB care among healthcare 
providers in 30 governmental hospitals across Thailand. They reported that some healthcare 
providers, especially physicians, were not following the national TB control guidelines. Similar 
findings have been reported from other countries including India, Pakistan, Korea, Ethiopia 
and South Africa (Ahmed M. et al., 2009, Demissie Gizaw et al., 2015, Hong et al., 1995, 
Kanjee et al., 2011, Malangu and Adebanjo, 2015, Singla et al., 1998, Vandan et al., 2009).  
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One study in India revealed some practitioners were not even aware of the practice guidelines 
(Singla et al., 1998),  while others reported that certain HCWs misunderstood the TB control 
guidelines and were not practicing as per the recommendations (Hong et al., 1995). Other 
studies highlighted that the availability of guidelines was an issue. In a report from Ethiopia, 
direct observations indicated that TB treatment guidelines were always available only22.7% of 
the time (Demissie Gizaw et al., 2015).  Availability of TB treatment and control guidelines as 
well as referring to them and understanding them by HCWs are important in the appropriate 
implementation of these guidelines and in improving knowledge and practice among healthcare 
providers.  
 
A study from South Africa found that 62% of HCWs surveyed about MDR-TB indicated that 
they had their own copy of MDR-TB treatment guidelines and 55% stated that they referred to 
these guidelines (Malangu and Adebanjo, 2015).  Interestingly, level of knowledge regarding 
MDR-TB was significantly higher among those who referred to the MDR-TB management 
guidelines compared to those who did not.  
 
4.10.4.1 Personal protection measures 
In terms of personal protection measures, our study found that the majority (92.1%) of HCWs 
stated that they usually perform hand hygiene and wear PPE before contact with PTB 
patient/TB samples and 83.3% usually wear N95 respirator when performing such duties. 
However, 16.7% stated that they do not use a respirator when dealing with TB patients or TB 
samples and 12% declared that they do sometimes use wet or soiled N95 respirators. These 
results in combination with the lack of knowledge among many HCWs regarding TB 
transmission routes as well as PPE and facemasks’ types and purposes found in this study are 
concerning. However, the results are not uncommon, as many studies reported similar findings 
related to lack of knowledge regarding PPE and infection prevention guidelines, to poor 
practices and not following guidelines or to personal comfort and/or unavailability and cost of 
PPEs in question (Bhebhe et al., 2014, Kanjee et al., 2011, Nettleman et al., 1994). A study 
from Ethiopia, reported that 50.2% of participants use respirator whenever they are 
approaching TB suspected patient (Demissie Gizaw et al., 2015).  
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During data collection, only 21.3% of the respondent had surgical masks for TB patients and 
17.9% had N95 mask for HCWs or patient supporters. These results are better than previously 
reported from the same country where only 12-21% of HCWs reported wearing a mask or 
respirator when caring for patients with active TB disease (Temesgen, 2011, Tenna et al., 
2013).  Even lower figures were reported from Nepal where although 48% of the HCWs 
questioned were exposed to TB patients up to 25% of their working day, 83% of them never 
used a respirator and only 10% reported using an N95 mask (Shrestha et al., 2017). 
 
Studies from South Africa, a country with high prevalence of TB, provided more insight into 
HCWs practice with regards to PPE use. Kanjee et al. (Kanjee et al., 2011) found 54.7% of 
HCWs surveyed in a government district hospital reported that they “always” use a respirator 
when in a room with a TB case/suspect, while 37.7% claimed that they “often” do so. However, 
direct observation showed actual compliance was variable, ranging from 24.1-98.5% by 
department (Kanjee et al., 2011).  Many (43.6%) respondents claimed that they “always” check 
for a tight facial seal when using a respirator, while 19.6% reported that they did not know how 
to do so. Staff reported that and insufficient supplies, discomfort and appearance were barriers 
to wider use of respirators. Bhebhe et al. (Bhebhe et al., 2014) found that while HCWs at a 
hospital in Lesotho practiced hand hygiene (76%) and used respirator masks (71.3%) for 
personal protection measures, only half (54.4%) made use of the appropriate respirator (N95). 
The latter represented only 38.8% of the entire sample size. Even more concerning, a study 
among HCWs in Botsabelo Hospital in Maseru, Lesotho, found that nearly 17% of HCWs 
questioned reported that they did not use protective masks when they were in contact with 
MDR-TB patients (Malangu and Adebanjo, 2015). While most medical doctors and nurses 
(91.7% and 90.2% respectively) reported wearing protective masks; only 57.1% of the 
counsellors and 22.2% of the pharmacists reported doing so. 
 
Authors argued that these results are particularly important for pharmacists and counsellors 
who are, routinely, not provided with protective masks and are thus exposed to infection. 
Protecting such non-clinical and supporting staff means that their family members and all other 
persons they interact with will also be protected (Malangu and Adebanjo, 2015). 
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4.10.4.2 Environmental control measures 
With regards to environmental control measures, we report that only 48.8% do open windows 
when possible in TB patient rooms to increase natural ventilation. A study from South Africa 
reported that 69% of HCWs questioned stated that they open windows for ventilation and 
sunlight in TB patients’ rooms (Bhebhe et al., 2014). However, 27.1% observed controls to 
avoid air recirculation into other (non-TB) wards. Another study from Ethiopia reported poor 
environmental control measures among HCWs in a university hospital in the capital Addis 
Ababa, where only 43% of HCWs opened windows to increase ventilation in crowded wards 
(Tenna et al., 2013). 
 
However, two other studies from the same country found better practice.  Temesgen 
(Temesgen, 2011) found that 65% of HCWs from 4 hospitals northwest of Addis Ababa stated 
that they do open windows before they start work to improve the natural ventilation of the 
rooms (Temesgen, 2011). In addition, 40% said that they use fan (ventilator)to augment the 
natural ventilation. Demissie Gizaw et al. (Demissie Gizaw et al., 2015) assessed KAP of 
HCWs from public health facilities in Addis Ababa in relation to TB infection control and 
found that 94% of HCWs were opening the window whenever TB suspected or confirmed 
patients were in the room. However, only 53% of the respondents had opened the window at 
the time of data collection. Discrepancies among reported and observed practices regarding TB 
and its prevention and control were also highlighted in study among HCWs in a hospital in 
rural South Africa. Kanjee et al. (Kanjee et al., 2011) found that most respondents (65.5% and 
69.1%) reported that doors and windows, respectively, were “always” open in their work area. 
Direct observation (during winter days) however, showed large interdepartmental differences 
in natural ventilation, with open windows ranging from 35.3% in the outpatient TB office to 
7.6% in male MDR-TB ward to 99.0% in the radiology department.  
 
Environmental infection control measures for TB are dependent on institutional infrastructural 
design, the use of ventilation and irradiation, which all require capital investment and may 
differ from healthcare facility to another. These factors may explain some of the differences 
among studies highlighted above. However, simpler effective methods have been proposed 
based on adequate ventilation through the opening of windows and in some settings natural 
ventilation may outperform mechanical ventilation (Escombe et al., 2007). 
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Hence, educating HCWs on how to maximize natural ventilation by opening windows is an 
easy, low cost intervention that may reduce patients’ and HCWs’ exposure to airborne TB. Yet, 
some of the constraints reported with natural ventilations may limit its application, including 
patient comfort and weather. Bhebhe et al. (Bhebhe et al., 2014) argued that the relatively low 
compliance with opening windows for natural ventilation among HCWs found in their study 
from Lesotho could be partially explained by the harsh weather conditions in the region with 
temperatures reaching below 0 oC during winters. They note that this could possibly contribute 
to some HCWs not opening the windows for ventilation and keeping doors closed. Weather 
conditions could also explain the low percentage of HCWs opening windows in TB patient 
rooms in our study. Saudi Arabia has a hot climate and temperatures are high for many months 
of the year. Hence, this may discourage HCWs from opening windows in patients’ rooms. 
 
4.10.4.3 Administrative control and other tuberculosis patients’ management measures 
In relation to administrative TB control measures and other TB patients’ management practices, 
we found these varied among HCWs in our study. The majority (>89%) of HCWs stated that 
they always isolate patients with active TB and separate such patients from those with HIV. A 
study from South Africa reported that 78.3% of HCWs isolate TB patients or use separate TB 
wards to house them (Bhebhe et al., 2014),  but another study from Ethiopia found a low 
proportion of HCWs reported patients with active TB disease were separated from other 
patients (18%), including those infected with HIV (10%) (Tenna et al., 2013). 
 
In our study, most (>88%) HCWs request a sputum test, ensuring that the sample is not saliva, 
for a suspected TB patient and request contact tracing for all confirmed TB cases. However, 
only around 74%% order HIV tests for patients diagnosed with active TB and 79% start 
contacts of the active TB cases who are positive for IGRA/TST on INH/RIF prophylaxis. Over 
33% of HCWs would commence anti-TB drugs on suspected TB cases before lab confirmation. 
Bhebhe et al. (Bhebhe et al., 2014) reported that a higher proportion of HCWs from South 
Africa screen TB patients for HIV (93.8%), probably given the high rate of HIV in the country. 
However, they found that only 17.8% of HCWs had good knowledge regarding appropriate 
collection of sputum. Similar to our results, Hashim et al. (Hashim et al., 2003) reported that 
most (90%) HCWs from Iraq would trace TB patient’s contacts, yet only 38% would ask for 3 
direct smear tests for suspected TB patients. The latter proportion increased to 99.5% among 
HCWs deemed to have good knowledge of TB in the study.  
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Similarly, a study from Ethiopia reported that less than the third of physicians (27%) and 31% 
of all HCWs, order sputum examination when suspecting TB, which is much lower than that 
found in our study (Tenna et al., 2013).  In general, several studies from around the world 
reported poor or inadequate administrative measures and TB patients’ management and 
treatment practices among HCWs (Bhebhe et al., 2014, Hashim et al., 2003, Hoffman et al., 
2016, Shrestha et al., 2017). 
 
4.10.5 Factors associated with tuberculosis practice among healthcare workers 
Level of education was the only variable that showed statistically significant difference in the 
univariate analysis. However, length of work experience and occupation were significantly 
associate with practice scores at the 25th and 75th quantiles respectively. In general, HCWs with 
higher education and longer work experience exhibited better practice scores. No statistically 
significant difference in practice scores was found in relation to age, gender, nationality, 
contact with TB patients or attending TB seminar in the previous year. A number of studies 
found various factors associated with good TB practice among HCWs (Hoa et al., 2005, 
Lertkanokkun et al., 2013, Noe et al., 2017, Temesgen, 2011).  Demissie Gizaw et al. (Demissie 
Gizaw et al., 2015) reported that independent predictors for having good TB infection control 
practice among HCWs from healthcare facilities in Addis Ababa, Ethiopia, were TB work 
experience, TB training and level of education. HCWs who had experience in TB clinic were 
2 times more likely to have good practice than those who had no experience (OR= 1.93; 95% 
CI: 1.12-3.34) and TB-related training had statistical significant association with practice (OR= 
1.48; 95% CI: 1.87-2.51). HCWs who had first degree and above had less likely satisfactory 
practice compared to diploma (OR= 0.64; 95% CI: 0.47-0.88). Similarly, in Vietnam, Hoe and 
colleagues (Hoa et al., 2005) found that level of medical education, participation in a TB 
training course and involvement in TB control activities were all significantly associated with 
TB practice scores among HCWs.  
 
In multiple regression analysis, attending a TB course and higher medical education were 
significantly associated with increased practice scores of 0.4 point (95% CI: 0.1–0.8) and 0.2 
point (95% CI: 0.1–0.3), respectively. 
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A study from Mozambique found significant association between TB practice scores among 
HCWs and level of education, occupation and experience with TB patients (Noe et al., 2017). 
University educated respondents had greater average practice scores when compared to 
technical college educated respondents (4.71 points vs 2.97 points, p= 0.009). Doctors on 
average scored 2.77 (p= 0.033) and 3.50 (p= 0.015) points greater than midwives and other 
HCWs. HCWs who had never worked with TB patients had lower practice scores than those 
that had been working with patients for less than one year and between one and 5 years (2.31 
points, p< 0.001 and 1.66 points, p= 0.004, respectively). In our study, we found no statistically 
significant association between practice scores and HCWs’ experience with TB patients. A 
study among HCWs from China, India, Iran and Mexico reported that several factors were 
associated with HCWs’ practices related to TB treatment. These included: training relating to 
the care of patients with TB since their last degree (OR= 2.63; 95% CI: 1.05–6.60); being based 
in a hospital (OR= 1.35; 95% CI: 1.18–1.54); trusting somewhat or completely a systematic 
review of randomized controlled double-blind trials (OR= 1.78; 95% CI: 1.36–2.35); and 
reading electronic or paper versions of summaries of articles, reports, and reviews from public 
and not-for-profit health organizations (OR= 1.42; 95% CI: 1.05–1.92) (Hoffman et al., 2016). 
 
4.10.6 Correlation between tuberculosis knowledge, attitude and practice among 
healthcare workers 
We reported a weak but statistically significant positive correlation between knowledge and 
attitude and between attitude and practice. This suggests that better knowledge about TB 
among HCWs translated to a better attitude, which in turns was associated with better practice. 
Yet, the association was weak and there was no significant association between knowledge and 
practice scores. Reports in the literature support the notion that there is no simple relationship 
between the level of knowledge, attitude and behaviours regarding TB and its management 
among HCWs. In a study from Iraq, Hashim et al. (Hashim et al., 2003) concluded that the 
relatively good TB knowledge found among their HCWs was not reflected in their practices. 
This despite the finding that HCWs with good knowledge had statistically significantly better 
attitude and practice than those with poor TB knowledge. Another study from Ethiopia found 
that TB knowledge among HCWs was not significantly associated with infection control 
practice (OR= 1.12; 95% CI: 0.85-1.49) (Demissie Gizaw et al., 2015). 
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However, similar to our results, the study showed significant positive linear correlations 
between knowledge and practice (r = 0.237, p= 0.001). Temesgen and Demissie (Temesgen, 
2011) reported that although HCWs in Northwest Ethiopia were found to have high knowledge 
regarding TB infection control, the majority did not demonstrate appropriate practice. 
However, they found that knowledge was a strong predictor for good practice (OR= 10.66; 
95% CI: 5.76-19.72). They attributed the discrepancy between HCWs’ knowledge on the one 
hand and practice on the other to probable shortage or unavailability of infection prevention 
supplies such as fans and respirators. Engelbrecht et al. (Engelbrecht et al., 2016) investigated 
factors associated with good TB infection control practices among HCWs in South Africa. 
They reported that good attitudes and high levels of knowledge were statistically significantly 
associated with good TB practices after controlling for all other variables. For every unit 
increase in attitudes, good practices increased 1.090 times (95% CI:1.016–1.169). Respondents 
with high levels of knowledge (≥80 %) were 4.029 times (95% CI: 1.550-10.469) more likely 
to have good practices when compared to respondents with poor levels of knowledge (<65 %).  
 
4.10.7 Interventions to improve knowledge, attitude and practice regarding 
tuberculosis among healthcare workers 
 
4.10.7.1 Education and training 
The WHO Global Plan to Stop TB (World Health Organization, 2006a) acknowledges that the 
main human resource issues affecting TB control are insufficient quality, quantity and 
distribution of HCWs. According to the Stop TB Partnership, $US 250 million is required 
annually to provide training and technical support to TB endemic regions. Training of HCWs 
is an important strategy for improving their productivity and KAP in relation to TB, and the 
WHO has produced a number of TB training modules for HCWs (World Health Organization, 
2006c, 2009a). In such regard, studies from around the world report that health education and 
training have an impact in improving KAP relating to TB not only among HCWs but also 
among patients and the community (Bisallah et al., 2018, Hatzenbuehler et al., 2017, Jadgal et 
al., 2015, Liu et al., 2015, Olayemi et al., 2009). For example, Bisallah et al. (Bisallah et al., 
2018) reported that a health education intervention program implemented at a general hospital 
in Nigeria was effective in improving KAP regarding TB among HIV patients.  
  
Chapter 4: Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 hajj 
mass gathering 
298 
 
The program was delivered through a 6-hour module and a booster session at 3 months using 
various methods and materials included lectures using PowerPoint slides and posters, 
discussion sessions and questions and answers to re-enforce learning. The module 
compromised of an information component and a motivation section. The information 
component provided information on basic facts about TB, modes of transmission, prevention, 
risk factors as well as vulnerability and misconception related to the disease. The motivation 
component was aimed at countering misconceptions about TB leading to positive attitudinal 
change. Similarly, a brief, one-time, TB educational intervention discussing TB bacteriology, 
epidemiology, symptoms, and indications for TB testing/treatment, was an effective method to 
encourage adolescents in the USA to learn about TB and motivate their uptake of TB risk-
factor screening, testing and treatment (Hatzenbuehler et al., 2017). 
 
In relation to HCWs, TB training is incorporated into the basic training curriculum of most 
HCWs including physicians, nurses, community health officers and laboratory technicians in 
most developed and developing countries. However, the quality of such training varies widely 
within and between countries (Awofeso et al., 2008, World Health Organization, 2002). The 
quality and sustainability of integrated TB programs depend critically on the extent to which 
such basic training is of uniformly high quality (World Health Organization, 2002). Post-basic 
training for TB control is inadequately funded by most developing countries (Awofeso et al., 
2008).  Given that HCWs deployed for Hajj come from varied geographic and educational 
systems backgrounds (in our study, HCWs originated from 17 different countries in North 
Africa, Middle East and Asia) it becomes important that these HCWs receive tailored, high 
quality and periodic education on TB and its management as part of their standard work and 
before deployment to Hajj.  
 
The results of our study indicate the importance of HCWs training and education in relation to 
all aspects of TB and its management. There is as yet no international consensus regarding the 
relative emphasis that should be placed on the training of HCWs in order to produce an optimal 
human resources mix for TB control (Buchan and Dal Poz, 2002). However, relatively small 
investments focused on HCWs may result in considerable knowledge gains across large 
populations, hence wider benefits (Laxminarayan et al., 2009). Training is considered to be one 
of the related factors that influences HCWs regardless of cultural and ethnic background, 
practice settings, preferred sources of information and learning styles (Wahab et al., 2016). 
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This is important in the context of HCWs deployed during Hajj as these come from various 
geographic, ethnic, cultural and institutional backgrounds. A comprehensive approach to TB 
education and training which includes not only imparting adequate knowledge, but also the 
much more difficult task of influencing the practices of HCWs, is required. Enhanced teaching 
and learning methods that deliver information so as to maximise its effect on attitudes and 
practice patterns are needed. These should not only emphasise the theoretical aspects of 
training but also skill-based components utilizing adult learning approaches aimed at 
modifying HCWs’ behaviour in order for training to have an impact on practice (Shrestha et 
al., 2017, Temesgen, 2011).  In addition, TB educational needs among HCWs should be 
determined according to job categories and TB programs designed to address knowledge gaps 
according to occupation and educational backgrounds (Woith et al., 2010).  However, training 
on the basics of TB and TB infection prevention and control should be provided for all HCWs. 
Particularly, there is a need to train non-clinical, auxiliary and support staff on TB and TB 
infection control in order to improve their knowledge, attitudes an practice and prepare them 
to safely work in high risk settings such as TB care (Buregyeya et al., 2016, Shrestha et al., 
2017, Woith et al., 2010).  The education of support staff is challenging because of their 
educational background and special attention may be required to develop appropriate 
educational programs and materials for this category of workers. 
 
Several means of bringing about behavioural change among health professionals have been 
reported and may be used to inform the appropriate education and training interventions for 
HCWs during Hajj. These include traditional and non-traditional methods such as audit and 
feedback, distribution of education materials, educational meetings, local opinion leaders, 
outreach visits, reminders, small group discussions and simulated cases, to teach management 
and role-plays to teach methods of evaluation of case-finding and treatment (Hoa et al., 2005, 
Hoffman et al., 2016). Rather than single training sessions, some called for multiple 
behavioural change interventions to be used with ongoing monitoring and evaluation of 
effectiveness to ensure successful implementation (Kanjee et al., 2011). Promoting distance 
learning as well as on-site training programs is also important. Distance learning is not 
necessarily synonymous with Internet-based learning, since other means such as postal 
correspondence courses and radio and television media may be used to supplement on-site 
clinical training for improving knowledge and skills for TB control (Awofeso et al., 2008). 
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Specifically educating and training HCWs in relation to TB infection prevention and control 
are paramount given that all HCWs are at risk of TB infection and they represent an essential 
component for the success of TB programs. For instance, simply making HCWs aware of 
necessary infection control measures like triage, proper sputum handling, respiratory hygiene 
and patient education can significantly minimise the risk of TB transmission in healthcare 
settings (Shrestha et al., 2017, Wu et al., 2017a).  Some argued that such educations should be 
delivered as part of a larger effective and sustainable TB infection control program that works 
within the financial and structural limitations of the healthcare environment and involve the 
healthcare community in the planning and subsequent implementation of infection control 
interventions including staff education and training (Tenna et al., 2013). 
 
In the context of Hajj, the Saudi Ministry of Health has a rigorous infection prevention and 
control training and educational program for HCWs deployed for Hajj, beyond the standard 
training programs these HCWs undertake throughout the year in their own healthcare facilities 
across the Kingdom. All HCWs deployed during Hajj are required to complete training to 
acquire a Basic Infection Control Skills License (BICSL). The latter involve five basic 
components: proper hand hygiene, proper use of PPE, application of the N95 fit test, principles 
of safe injection practice as well as compulsory influenza and meningococcal vaccination. The 
Kingdom also ensures that healthcare centers and hospitals providing services for pilgrims are 
equipped with the necessary facilities for infection prevention. During the 2017 Hajj, 403 
isolation rooms, 168 negative pressure rooms and 461 HEPA filters were available at the Hajj 
healthcare facilities (General Directorate of Infection Prevention and Control, 2017).  The 
Saudi Ministry of Health also has developed various policies and procedures in relation to 
infection prevention and control including those specifically for Hajj and it has published 
various related guidelines, to help HCWs develop their knowledge and skills in the area and 
adhere to best practices. In addition, various trainings and drills are conducted pre-Hajj for 
HCWs as per their function and in relation to a number of possible infectious risks. Despite all 
these efforts, deficiencies in HCWs knowledge and practices in relation to infection prevention 
and control during Hajj have been documented (Ghabrah et al., 2007) including in our study.  
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In addition, the above activities are not specifically related to TB but more general overarching 
infection prevention and control principles or to topical diseases such as the Middle East 
Respiratory Syndrome (MERS). Specific TB infection prevention and control training may be 
required for HCWs participating in Hajj or those working in the holy cities serving Umrah 
pilgrims all-year round.  
 
Educational and training activities alone or in combination with other intervention were 
reported to have improved HCWs’ KAP regarding TB and reduced nosocomial transmission 
of the disease (Awofeso et al., 2008, Naidoo et al., 2011, Okeyo and Dowse, 2018, Schmidt et 
al., 2018).  Reports by Blumberg et al. (Blumberg et al., 1998, Blumberg et al., 1995) found 
that expanded staff TB education as well as other TB prevention measures reduced the risk of 
TB infection among HCWs. Similarly, Jarvis et al. (Jarvis, 1995) reported that education of 
HCWs for earlier recognition, diagnosis and rapid isolation of TB patients alongside other TB 
prevention interventions reduced nosocomial transmission. Naidoo and colleagues(Naidoo et 
al., 2011) reported that a 28-day comprehensive TB training program based on WHO training 
modules lead to improvement in the overall knowledge of nurses, doctors, and other HCWs. 
Although the change was not clinically significant, it was statistically significant, with mean 
total knowledge score increasing from 59.5% pre-training to 66.5% post-training (p<0.001). 
The authors concluded that periodic field training and supervision should be considered to 
ensure TB knowledge improvement. Experiences in Kyrgyzstan (Awofeso et al., 2008) and the 
Democratic Republic of Congo (Vanden Driessche et al., 2009) show that periodic training and 
supervision in the field can improve HCWs’ TB knowledge and skills. In Malawi, lay HCWs 
who underwent a knowledge translation strategy, combining educational outreach and 
reminders, reported that the intervention was beneficial in increasing their TB, HIV, and job-
specific knowledge; improving their clinical skills; and increasing their confidence and 
satisfaction with their work (Puchalski Ritchie et al., 2016). 
 
Simple and innovative ways of communicating information and training can have great 
benefits. Okeyo and Dowse (Okeyo and Dowse, 2018) reported that in South Africa, a user-
friendly, simple, pictorial-based booklet significantly improved community health workers’ 
knowledge regarding TB (overall knowledge increased from 70.6% to 85.3%, p<0.001).  
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The booklet also contributed to enhanced confidence in their role by facilitating better 
communication with patients and improving patient trust. They found that key factors 
influencing the ease of use, and therefore the acceptability, of the booklet was the collaboration 
with the community health workers during the design process, careful consideration of booklet 
content and format as well as the inclusion of well-designed pictograms. These findings are in 
line with reports from the literature highlighting the fact that simply producing written 
materials for HCWs is not sufficient to improve training and education. There is also a need to 
improve the usability of written materials such as guidelines to ensure they are clear, easy to 
use, visually attractive and in the appropriate language. This should be coupled with a better 
understanding of local needs prior to the design of materials, which can be achieved by ensuring 
active participation of HCWs (Pakenham-Walsh and Bukachi, 2009). Similar techniques could 
be used for Hajj as it is the case for some other health-related information, to improve KAP of 
HCWs in relation to TB especially among non-clinical staff and heath consolers. Such written 
information, enhanced by visual aids such as pictograms, can enhance comprehension and 
recall of information and strengthen patient communication by guiding health providers in 
consistently offering accurate information, which promotes adherence with guidelines and 
reduces guesswork (Houts et al., 2006, Okeyo and Dowse, 2018). 
 
Finally, training HCWs in research methodologies and understanding and interpreting findings 
of studies in the area of TB, as well as encouraging them to participate in research, and to read 
and keep up with relevant recent scientific literature in the field would also be beneficial. This 
is important given that in our study it was apparent that not all HCWs were up-to-date on new 
techniques for TB diagnosis and management. Working with researchers, trusting systematic 
reviews of randomized controlled double-blinded trails, and reading summaries and articles, 
reports and reviews were all reported to be factors associated with better knowledge and 
practice relating to TB treatment among HCWs (Hoffman et al., 2016). 
 
A crucial part of any training intervention is its evaluation to determine whether it has been 
successful, and to inform decisions about future investments (Habicht et al., 1999). Such 
systematic measurement of intended outcomes of training activities also helps determine 
whether training objectives were achieved, and whether the accomplishment of those 
objectives resulted in enhanced performance on the job as well as helping to ensure training 
meets the needs of learners and organizations (Kraiger et al., 1993, Wu et al., 2017a). 
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Awofeso et al. (Awofeso et al., 2008) argued that evaluation of the contribution of training to 
improving HCWs' productivity and the quality of TB control programs should occur at three 
levels. First, during training, through feedback from participants, quality of written and 
practical training-related assignments undertaken by participants, and pre-/post-test 
evaluations. Second, within 1 year following training, through the use of questionnaires to 
facilitate participants' assessment of the impact of training on their performance, as well as site 
visits by trainers, to observe participants in clinical and field conditions. Finally, evaluation of 
TB program outcomes, with particular attention to improvements in case detection rates and 
cure rates (Awofeso et al., 2008) 
 
Evaluators of the impact of any future Hajj-specific TB training for HCWs should take the 
above into account as well as being aware of the best approach for evaluation of such training 
including the limitations of each evaluation strategy (Wu et al., 2017a, 2017b)  for instance, 
pre-and post-training tests, a method that is best suited for testing retention of factual 
knowledge, does not evaluate improvement in service quality as it does not assess behavioural 
change among HCWs. Post-training tests conducted immediately after the training sessions do 
not evaluate long-term knowledge gains. Assessment of behavioural change that is based on 
qualitative research largely relies on self-reported information and the actual on-the-job 
performance and practice of trainers is not objectively evaluated.  
 
Wu et al (Wu et al., 2017a) systematically reviewed the literature on the methods and outcome 
indicators used in evaluating the impact of healthcare provider training to improve TB 
management. In the 21 eligible studies included in the review, the most common evaluation 
methods were a review of patient records (38%), post-training interview with trainees (33%) 
and pre- and post-training tests (28%). In terms of outcomes, more than half of the studies 
(57%) evaluated knowledge acquisition of trainees, with only (29%) assessing on-the-job 
behaviour change. The review concluded that publications from robust evaluations assessing 
the impact on quality of care and behaviour change of TB training among HCWs was limited.  
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4.10.7.2 Addressing other factors beyond training and education 
While appropriate training and education of HCWs are crucial to improving their KAP 
regarding TB, such activities alone may not be sufficient for improving HCWs performance as 
well as the quality of TB control outcomes (Awofeso et al., 2008).  This is because trained 
human resources operate in a “productivity mix” involving other factors including personal 
and lifestyle-related factors, living circumstances, adequacy of preparation for work during 
pre-service education; health-system related factors such as human resources policy and 
planning as well as availability of required chemotherapy and supplies for appropriate patient 
care; job satisfaction-related factors such as financial remuneration and incentives, working 
conditions, management capacity and styles, professional advancement and safety at work 
(Dielman and Harmmeijer, 2006).  It is important that interventions to improve HCWs KAP 
address other factors of the 'productivity mix', beyond training, so as not to reinforce the 
limitations and weaknesses of current practices. 
 
It has been shown that absence of TB management and infection control policies and 
guidelines, both at national and institutional levels, deficiency in the required protective 
equipment, shortage or maldistribution of medical personnel as well as structural contains 
within healthcare facilities can all lead to poor practices among HCWs in relation to TB 
(Hoffman et al., 2016, Malangu and Adebanjo, 2015, Shrestha et al., 2017).  Appropriate funds 
should be allocated for the purchase of required protective equipment and supplies and clinical 
practice management guidelines and manuals as well as addressing lack of ventilation and 
irradiation and structural issues within healthcare facilities to improve TB management and 
control and reduce the risk of nosocomial transmission (Malangu and Adebanjo, 2015, Tenna 
et al., 2013).  Our study did not investigate the above factors and whether they impacted HCWs 
knowledge and practice, however, such factors have been identified as possible contributors to 
poor knowledge and practice among HCWs in relation to TB and its prevention and control 
(Bhebhe et al., 2014, Demissie Gizaw et al., 2015, Hoffman et al., 2016, Lehmann et al., 2008, 
Malangu and Adebanjo, 2015, Shrestha et al., 2017, Wajanga et al., 2014).  During the Hajj 
mass gathering, HCWs have to work within the structural limitations of the healthcare facilities 
they are assigned to as well as within a health system that is performing to near surge capacity 
for the duration of the pilgrimage.  
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Although 1000s of HCWs are deployed to work in Hajj health facilities and a huge investment 
is dedicated each year to supplying and maintaining these facilities for Hajj, the overwhelming 
number of pilgrims seen at these health facilities during the Hajj may also result in suboptimal 
practices in relation to TB.    
 
4.11 Study strengths and limitations 
The current study investigated KAP related to TB, a disease of national and global concern, 
including during mass gatherings such as the Hajj (World Health Organization, 2017b, Zumla 
et al., 2016). The survey instrument used in our study was developed based on existing 
questionnaires published in the literature and was pilot tested and assessed for both reliability 
and validity, ensuring a rigorous methodological process. The study enrolled a large number 
of HCWs of different occupations from numerous healthcare facilities in Hajj. The sample size 
however represents a small proportion of the 1000s of HCWs deployed to work in Hajj each 
year. The latter in addition to the cross-sectional design of the study limits the generalizability 
of the findings as the results may not be representative of all HCWs working cross all Hajj 
healthcare facilities.  
 
Being a KAP study, it does underestimate the psychological variables that have proved 
influential in health-related behaviors (Sridhar et al., 2016). Similar with other public surveys, 
the data collected in our study is based on self-reported information which depends on the 
honesty and recall ability of the respondents, as well as their understanding of the 
questionnaire. In such regards, the study collected data using an anonymous self-administered 
questionnaire, which increased the likelihood of obtaining honest answers from participants. 
Although it is expected that participants would answer questions honestly, studies that used 
researches to collect data report that the presence of the researchers might influence HCWs in 
such a way that they might answer in a manner that they perceived as correct. Presence of 
researches could also lead to social desire bias as some respondents might give the answers 
that they thought the researcher was looking for and thus not their true response (Demissie 
Gizaw et al., 2015). In addition, some argued that even with anonymous surveys, presence of 
researcher at the time of data collection can also lead respondents to not be truthful about their  
knowledge, attitudes and practices, fearing that their supervisors would be informed of their 
responses (Kanjee et al., 2011). 
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The study did not restrict the participants to a specific occupation and included various HCWs 
such as physicians, nurses, laboratory staff and other supporting and non-clinical staff. It may 
be argued that if the study was restricted to only clinical personal, better KAP scores would 
have been observed. Noe et al. (Noe et al., 2017) stated that the low scores reported in their 
KAP study regarding TB among HCWs in Southern Mozambique may have been related to the 
fact that the survey included all HCWs regardless of profession or department. As such, HCWs 
may have lacked experience in dealing with common TB scenarios affecting their scores. 
Numerous studies report that clinical staff have better knowledge attitude and practice 
regarding TB than supporting and non-clinical staff  (Buregyeya et al., 2016, Demissie Gizaw 
et al., 2015, Lertkanokkun et al., 2013, Malangu and Adebanjo, 2015, Minnery et al., 2013, 
Noe et al., 2017, Shrestha et al., 2017). We have addressed this issue in our study by doing ad-
hoc analysis by occupation and also by including the “non-applicable” options in appropriate 
questions. Moreover, including all HCWs (clinical and non-clinical) in our KAP is considered 
by some as a strength (Buregyeya et al., 2016, Demissie Gizaw et al., 2015). This is because 
the resulting data gives a more general picture of the KAP of HCWs who are all, directly or 
indirectly, part of the management of TB patients and infection prevention in healthcare 
facilities. In addition, HCWs working at a healthcare institution were found at risk of 
nosocomial transmission of TB regardless of actual profession, including axillary staff and 
non-clinical staff (Menzies et al., 2007). 
 
Another limitation of the study is that information on attitude regarding TB was assessed using 
a questionnaire therefore responses obtained are prone to information bias. A qualitative 
method such as focus group discussion would be more beneficial to explore beliefs and 
attitudes relating to TB (Isara and Akpodiete, 2015). Similarly, we did not measure actual 
practice by observing staff behaviour in a specific situation or by using the simulated client 
method. The use of self-reported data to assess health professionals’ practices may have 
predisposed study findings to social desirability bias, which may have caused reported practices  
to differ from actual behaviour. A review performed by Adams et al. (Adams et al., 1999) 
suggested that self-reporting of practices might overestimate actual behaviour by up to 27%.  
Hence, there may have been an overestimation of good practice among HCWs. Studies 
observing practices would yield more accurate data than using self-administered 
questionnaires.  
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On the other hand, measures of actual practice alone will not be able to separate the impact of 
knowledge and competency, or what is missing on these levels, from other factors (Hoa et al., 
2005).  
 
It is also noteworthy that the current study only measured variables that were self-reported by 
the HCWs and did not take into consideration other factors that may impact practice such as 
availability of resources required for the implementation of TB infection prevention and control 
measures. This could have affected the results, as the respondents who reported poor practice 
may have done so because of non-availability of resources (Bhebhe et al., 2014). 
 
4.12 Summary  
In summary, a KAP survey was conducted among 540 HCWs from 13 hospitals serving 
pilgrims during the 2016 Hajj. In general, we report that HCWs had average knowledge, above 
average attitude and good practice regarding TB, based on our scoring system and cut-off 
points. Knowledge gaps were identified in relation to the definition of MDR-/XDR-TB and 
LTBI, smear microscopy results, length of standard TB treatment for drug-sensitive TB, 2nd-
line anti-TB drugs, BCG vaccination, and appropriate PPE to be used with active PTB patients. 
Poor attitudes were found in relation to willingness to work in TB clinic/ward and to the 
management and treatment of TB patients. In addition, HCWs were not aware of the actual risk 
of TB infection connected with their work. Poor practices were reported for commencing anti-
TB treatment on suspected TB cases before laboratory confirmation and in increasing natural 
ventilation in TB patients’ rooms. The findings can serve as a baseline to identify key 
knowledge gaps and poor attitudes and practices in relation to TB and its management among 
HCWs during Hajj and to design effective interventions to address these shortcomings. Further 
studies at larger scales including qualitative methods and observation of actual practices as well 
as considering availability of resources and other possible infrastructure constrains are 
warranted. 
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 Chapter 5: Summary, strength, limitations and recommendations  
 
5.1 Summary 
TB remains a global public health problem with significant morbidity and mortality. In 2017, 
the WHO estimated that 10 million people developed TB, 9% of whom were infected with 
HIV. International travel, migration and movement of human populations facilitate the spread 
of TB. 
 
Undiagnosed and unreported TB are significant issues that contribute to the transmission of TB 
and challenge TB control efforts worldwide. The WHO estimates that around 36% of people 
with TB worldwide are either not reported or not diagnosed (World Health Organization, 
2015b, 2018b). Under-diagnosis can occur for reasons such as poor geographical and financial 
access to healthcare, lack of or limited symptoms that delay seeking of healthcare, failure to 
test for TB when people do present to health facilities, and diagnostic tests that are not 
sufficiently sensitive or specific to ensure accurate identification of all cases (World Health 
Organization, 2018b). Numerous studies reported that a sizable proportion of hospitalised 
patients as well as individuals in the community have undiagnosed active PTB.  
 
International travel, migration and movement of human populations facilitate the spread of TB. 
In this context KSA is particularly relevant because of its large expatriates’ population, mainly 
from TB-endemic regions, and its yearly hosting of the Hajj and Umrah mass gatherings. Hajj 
represents many of the risk factors for transmission of respiratory infections including TB. The 
event is one of the largest mass gatherings in the world characterized by a large elderly 
population, frequently with underlying health conditions, many of which originate from low 
income countries where TB is endemic (Al-Orainey, 2013). Pilgrims gather in close contact to 
perform physically exhausting religious rites, conditions that facilitate TB transmission. In 
addition, participating in Hajj may also render pilgrims susceptible to reactivation of LTBI (Ai 
et al., 2016, Al-Orainey, 2013). 
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With respect to Hajj, as pilgrims are not screened before entry to the Kingdom, it is likely that 
some may enter Saudi Arabia with active PTB. Because respiratory tract infections and cough 
are common among pilgrims, patients are often diagnosed with upper respiratory tract 
infections and only those requiring hospitalisation may be thoroughly investigated (Al-
Orainey, 2013). This means that potentially many undiagnosed and untreated active PTB cases 
are brought to the Kingdom and infection could be transmitted to other pilgrims and to local 
citizens (Yezli et al., 2017b). Pilgrims infected during the pilgrimage may also spread the 
infection to contacts in their countries. Transmission of MDR-TB is a real concern as MDR-
TB requires long, expensive and extensive treatment with multiple, potentially toxic drugs and 
outcomes are poor (Orenstein et al., 2009). Also, given the short period pilgrims stay in the 
Kingdom, short inpatient stay and patients load at healthcare facilities during Hajj, TB cases 
may be missed among hospitalised pilgrims This may contribute to poor outcome and represent 
a potential source of TB infection among pilgrims, other patients and HCWs. While both 
diagnosed and undiagnosed TB has been reported in Hajj among pilgrims, little data is available 
on the prevalence of active or LTBI during Hajj or the true burden of the disease during the 
event (Zumla et al., 2016). To address this knowledge gap, the current study aimed to determine 
the burden of undiagnosed TB among non-hospitalised and hospitalised pilgrims during Hajj. 
 
For non-hospitalised pilgrims, a large-scale screening for active PTB was conducted among 
pilgrims attending the 2016 Hajj. The 1,510 pilgrims screened originated from 16 countries in 
Africa, former Soviet countries and South Asia. The study found that 0.66% of pilgrims with 
cough from medium/high TB burden countries (mostly from India and Afghanistan) had active 
PTB. TB prevalence was higher among males, the elderly, those with low level education, those 
residing in South Asia, those with underlying health conditions, those with previous TB 
treatment, those coughing for more than a week, those who have contacts diagnosed or treated 
for TB, those who lived recently in a household with an adult with cough and those who 
traveled outside their current country of residency in the previous year. However, the difference 
was not statistically significant with the exception for underlying health conditions and cough 
duration. Underlying health conditions and cough in the household were independent risk 
factors for TB after adjusting for other variables. Pilgrims with underlying health conditions 
were nearly 6 times more likely to develop TB (aOR= 5.89; 95% CI= 1.25-27.80). Similarly, 
those who recently lived in a household with an adult with cough were 4.5 times more likely 
to have TB (aOR= 4.46; 95% CI= 1.01-19.58). 
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For hospitalised pilgrims, the study conducted the first screening for active PTB among this 
population during the 2016 and 2017 Hajj seasons. The 347 inpatient pilgrims screened 
originated from 44 countries in Africa, Asia, Europe and the USA. Most (over 60%) of patients 
had an initial and/or final diagnosis of diseases of the respiratory system, particularly 
pneumonia. The study found that 2.9% of inpatients with cough (mostly from Indonesia and 
India) had active PTB and most (77.7%) of these were missed by the hospitals including MDR-
TB cases. TB prevalence was higher among those with no formal education, those residing in 
Asia, those with underlying health conditions, smokers, those with previous TB treatment, 
those coughing up blood, those coughing for more than a week and those admitted to an 
isolation ward. However, the difference was statistically significant only for previous TB 
treatment and admission ward. Previous TB treatment was independent risk factor for TB after 
adjusting for other variables.  
 
Hence, we conducted the first screening for active pulmonary TB (PTB) among hospitalised 
pilgrims attending the 2016 and 2017 Hajj seasons to determine the burden of TB among this 
population. We found that 2.9% of inpatients with cough (mostly from Indonesia and India) 
had active PTB and most (77.7%) of these were missed by the hospitals including MDR-TB 
cases. TB prevalence was higher among those with no formal education, those residing in Asia, 
those with underlying health conditions, smokers, those with previous TB treatment, those 
coughing up blood, those coughing for more than a week and those admitted to an isolation 
ward. However, the difference was statistically significant only for previous TB treatment and 
admission ward. Previous TB treatment was independent risk factor for TB after adjusting for 
other variables. Patient who had history of TB treatment were 8 times more likely to be TB 
positive after adjusting for other factors (aOR= 8.1; 95% CI= 1.351-48.464, p= 0.022).   
 
In light of the above results, further studies investigating TB during Hajj and the impact of this 
mass gathering on TB transmission and epidemiology worldwide are warranted. These 
investigations will help inform public health policies and direct interventions for the optimal 
awareness, surveillance, screening, treatment and management, prevention, and control of TB 
during Hajj and other mass gatherings worldwide. 
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Appropriate management of TB cases during mass gatherings such as the Hajj is crucial for 
better patient outcome and prevention of transmission. Although there are national and 
international TB guidelines on the management of TB, currently there are no specific 
guidelines on the management of the disease at mass gatherings. In general, early detection 
through systematic screening of TB suspects is a major strategy for improving TB case 
detection. The WHO recommends that persons with signs and symptoms consistent with TB 
should be evaluated for TB to ensure prompt diagnosis and treatment (World Health 
Organization, 2011a, 2017a). Similarly, the Saudi TB guideline recommends that HCWs 
should be knowledgeable about TB symptoms to facilitate the efficient identification of TB 
suspects for diagnosis and treatment (Saudi Ministry of Health, 2014). The safe and efficient 
diagnosis of TB disease is also important and depend on the existence of an integrated network 
of multi-level laboratories with adequate biosafety standards, quality-assured capacity, 
mechanism for specimen referral and complimentary TB and HIV testing capability (World 
Health Organization, 2017a). Various diagnostic techniques are available and used including 
smear microscopy for AFB, culture and modern molecular methods such as the Xpert 
MTB/RIF and Xpert Ultra assays (World Health Organization, 2017e). 
 
Starting TB treatment early and ensuring people with TB stay on treatment for the entire 
duration of treatment is a global TB control strategy. TB is curable, but inappropriate regimen 
prescription and non-adherence to recommended dosages contribute to poor treatment 
outcomes. The WHO and KSA guidelines both recommend the administration of standardized 
first-line anti-TB treatment regimen, consisting of an initial 2 months of treatment with INH, 
RIF, PZA and EMB and subsequently treatment with INH-RIF for the next 4 months. The 6 
months TB treatment regimen is recommended for TB patients with drug-susceptible TB, those 
without prior history of starting treatment with anti-TB agents and those without recognized 
risk factors for drug resistance, while awaiting DST results (Saudi Ministry of Health, 2014, 
World Health Organization, 2017a, 2017c). Treatment of RR-TB or MDR-TB is longer and 
involve more agents (Falzon et al., 2017).  
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Both the KSA and WHO TB guidelines consider the pursuit of a patient-centered approach to 
TB treatment, a necessary strategy for promoting treatment adherence, improving the quality 
of life of TB patients and alleviating suffering (Saudi Ministry of Health, 2014, World Health 
Organization, 2017a). Treatment monitoring as well as supportive TB management approaches 
including IPC measures are also crucial for better outcome and prevention of development of 
drug-resistance and as well as transmission of the diseases.  
 
The TB management approaches during Hajj remained largely undocumented, and it is 
unknown whether these are consistent with the KSA and international TB management 
guidelines. The current study documented the management of TB patients during the 2016 and 
2017 Hajj seasons and explored the compliance of healthcare providers with the KSA TB 
management guidelines in the Saudi MOH hospitals during the mass gathering.  
 
The study was conducted over a one-month period (1-30thDulHija, Hajj lunar month) in 
hospitals in Makkah and holy sites including temporary hospitals operational only during Hajj 
days. There were 31 cases of drug-susceptible TB and 1 case of extensively drug-resistant TB 
(XDR-TB). Although the TB patients were nationals of 10 countries, 66.7% of them were KSA 
residents. Out of a maximum score of 10 for the selected TB management themes, the guideline 
compliance score was highest for IPC and surveillance (9.6) and identifying TB suspects (7.2). 
The least scores were obtained for treating TB (5.0) and diagnosing TB (3.0).  
 
About half of the TB patients were separated from other patients at registration in the hospitals. 
The proportion of TB patients that were isolated in designated isolation rooms/wards rose from 
77.4% pre-diagnosis to 96.7% on confirmation of TB diagnosis. All suspected TB patients 
were correctly screened using appropriate TB symptoms and chest X-ray was conducted for 
67.7% of TB patients. Contrary to guideline recommendations, culture was the only diagnostic 
test applied in nearly 2/3rd of the TB patients. Smear microscopy was done sparingly and no 
Xpert MTB/RIF assay was conducted for the TB patients. Additionally, only a fraction of TB 
patients were questioned about their HIV status (20.7%) or tested for HIV (12.9%).  
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Regarding treatment of drug-susceptible TB, only 37% of TB patients received four 1st-line 
anti-TB drugs, the majority received either three 1st-line anti-TB drugs (40.7%) or two 1st-line 
anti-TB drugs (11.1%). For TB notification, all confirmed TB cases with known notification 
status were reported to the KSA MOH, but the confirmed-TB status of two international 
pilgrims was not reported to their country health representatives/medical missions. 
 
TB is a global health issue with significant morbidity and mortality.(World Health 
Organization, 2017b) The WHO’s The End TB Strategy has a vision of a world free of TB with 
the following milestones to be achieved by 2035: 95% reduction in TB deaths compared with 
2015, 90% reduction in TB incidence rate, and no affected families facing catastrophic costs 
due to TB (World Health Organization, 2014b). The early diagnosis and appropriate 
management of TB cases by a knowledgeable and skilled healthcare workforce are integral for 
the success of the strategy. HCWs are key component of the success of any TB program, yet 
they are also at increased risk of TB infection and disease. TB has long been an occupational 
risk for HCWs although consensus on the matter is relatively recent (Sepkowitz, 1994). High 
level of knowledge, good attitude and correct practice among HCWs in relation to TB are 
important factors in the appropriate management of TB cases and reducing the risk of 
transmission of the disease including in the healthcare setting and to HCWs themselves.  
 
Knowledge deficit regarding TB among HCWs may result in substandard care, ineffective 
service provision, inefficient resource use, and further inequities in health outcomes as well as 
risk of TB transmission and development of resistance. Indeed, one of the greatest contributors 
to MDR-TB is improper treatment that may be prescribed or administered by health 
professionals, either because of inaccurate diagnosis, insufficient treatment supplies, or limits 
in their knowledge of evidence-based TB control practices (Langendam et al., 2012, Marahatta, 
2010). In addition, the knowledge and attitude of HCWs towards TB will determine the type 
and quality of information passed on to the patients during health education. Inadequate or 
incomplete information passed on to the patients create wrong perceptions in them or 
strengthen the patients’ negative perceptions which are often times based on cultural beliefs 
and misconceptions (Isara and Akpodiete, 2015).  
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These negative perceptions are mostly inimical to appropriate health seeking behaviour, hence 
reducing the likelihood of completing treatment and achieving cure and increasing the risk of 
spread of the disease (Matebesi and Timmerman). As such, the knowledge, attitude and 
practices of health professionals related to TB affect not only themselves and their individual 
patients, but also the global population as a whole.  
 
The Hajj religious mass gathering in KSA attracts over 2 million pilgrims from over 180 
different countries (Yezli et al., 2017a). Many pilgrims come from TB endemic areas and have 
risk factors for TB. The event has been linked in increased risk of TB infection and both 
diagnosed and undiagnosed TB have been reported at the pilgrimage (Alzeer et al., 1998, 
Wilder-Smith et al., 2005, Yezli et al., 2017b). During Hajj 1000s of HCWs are deployed from 
across the Kingdom to ensure healthcare for pilgrims. These HCWs receive various specific 
training before deployment including in infection prevention and control. However, this work 
force includes HCWs from varying occupations, having different educational levels and work 
experience and originating from numerous countries. Knowledge gaps as well as poor attitudes 
and practices in relation to infection prevention and control have been documented among 
HCWs working in Hajj (Ghabrah et al., 2007). No study investigated KAP of HCWs deployed 
in Hajj in relation to TB and its management. The current study investigated the latter with the 
aim of identifying knowledge gaps regarding TB and its management and attitudes and 
behaviours among HCWs that could facilitate TB transmission or impact on TB management 
during the event. Hence, exploring potential interventions for improvement. 
 
We conducted a KAP survey among 540 HCWs from 13 hospitals serving pilgrims during the 
2016 Hajj. HCWs originated from 17 different countries and included physicians, nurses as 
well as other HCWs. Nearly half of the participants declared dealing with TB patients during 
their day-to-day work. In general, we report that HCWs had average knowledge (mean 
knowledge score of 52%), above average attitude (mean attitude score of 73%) and good 
practice (mean practice score of 81%) regarding TB, based on our scoring system and cut-off 
points. Most HCWs (78%) had average or above knowledge score (mean knowledge score 
>40%) and 84.7% and 90.2% had above average or higher attitude and practice scores 
respectively (mean attitude or practice scores >60%).  
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Overall, HCWs were knowledgeable about the cause, main symptoms and mode of 
transmission of TB, diagnostic and screening tests for TB and LTBI, 1st-line anti-TB treatment, 
HIV patients’ vulnerability to contracting TB and the importance of PPE when dealing with 
active TB patients. However, knowledge gaps were identified in all the knowledge themes 
explored in our study. These include the disease’s microbiology and epidemiology (especially 
questions related to the definition of MDR-/XDR-TB and LTBI), TB diagnosis (especially 
questions relating to smear microscopy results), TB treatment (especially questions relating to 
the length of standard TB treatment for drug-sensitive TB and 2nd-line anti-TB drugs) and TB 
prevention (especially questions relating to LTBI, BCG vaccination, and appropriate PPE to 
be used with active PTB patients).  
 
In relation to HCWs’ attitude to TB and TB patients, it was in general positive. Most HCWs 
were willing to be educated on TB and teach others, follow infection prevention measures and 
trust lab diagnostic results. Also, most would not resign if they were posted to a TB clinic/ward 
and had no issues examining or treating a TB patient. Yet, we identified some poor attitudes 
especially in relation to willingness to work in TB clinic/ward and to the management and 
treatment of TB patients. In addition, HCWs were not aware of the actual risk of TB infection 
connected with their work. 
 
Most HCWs reported good practice regarding TB management and infection prevention. Most 
reported following administrative and personal protection measures such as performing hand 
hygiene and using PPE when dealing with PTB patients or handling TB samples as well as 
isolating TB cases from other patients and separating them from those with HIV. Also, good 
practice was reported in relation to the appropriate measures for contacts of confirmed TB 
patient and those for suspected TB cases. Poor practice was reported for commencing anti-TB 
treatment on suspected TB cases before laboratory confirmation and not opening the windows 
in patient rooms to increase natural ventilation. The latter was probably in part related to the 
hot weather conditions in KSA, which may discourage HCWs from the practice.  
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There was a statistically significant difference in knowledge scores in relation to age, gender, 
nationality, level of education, occupation and length of work experience as well as a 
significant difference in practice scores in relation to the level of education. Attitude scores did 
not significantly differ with respect to individual covariates. The significance of the association 
of the variables with the KAP scores differed across the various KAP score quantiles.  
 
In general, HCWs in the older age groups had better knowledge than other HCWs but there 
was no difference in attitude or practice among the age groups. Females and non-Saudi HCWs 
had better knowledge and attitude but worse practice compared to males and Saudi HCWs 
respectively. Physicians had better knowledge than nurses and “other” HCWs, but this was not 
apparent for attitude or practice, where “other” HCWs scored better practice than both 
physicians and nurses. HCWs with longer work experience seem to have better knowledge, 
attitude and practice than those with shorter work experience. Similarly, HCWs who attended 
TB seminar/lecture in the previous year seem to have better knowledge, practice and 
marginally better attitude than those who did not. HCWs with higher level of education had 
better knowledge and practice than those with lower level of education, but not better attitude. 
HCWs who had experience with TB patients had better knowledge and attitude than those who 
did not, but lower practice scores.  
 
There was a weak but statistically significant positive correlation between knowledge and 
attitude and between attitude and practice. This suggests that better knowledge about TB 
among HCWs translated to a better attitude, which in turns was associated with better practice. 
Yet, the association was weak and there was no significant association between knowledge and 
practice scores. 
 
5.2 Study strength and limitations  
The current study has some strength and limitations: 
• The investigation into undiagnosed TB among non-hospitalised pilgrims is only the second 
study to report on this important issue, with a larger sample size from more countries. 
However, in the non-hospitalised pilgrims’ cohort we only screened 1,512 pilgrims from 
16 countries which represent only a small proportion of the Hajj pilgrims’ populations 
which exceeds 2 million and originates from over 180 different countries. 
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Also, the study detected a small number of TB cases among the population investigated. 
However, As many reports suggest that a sizable proportion of people with TB do not 
present with cough, the results may be an undestimation of the true prevalence of TB among 
non-hospitalised Hajj pilgrims. Future studies investigating a larger number of pilgrims 
from a greater number of countries with large pilgrims’ populations and high TB and MDR-
TB burdens such as Turkey, Egypt, China, Kenya, Myanmar, Russian Federation, Tanzania 
and Zambia, are warranted. Finally, while remote, we cannot eliminate the possibility that 
some of the non-hospitalised pilgrims investigated were already TB patients but chose not 
to disclose this information to the study investigators.  
 
• The investigation into missed TB among hospitalised pilgrims in Hajj is the first study to 
report on this significant issue. However, for the hospitalised pilgrims’ cohort, the study 
only screened 304 inpatients symptomatic for cough. While the study systematically 
enrolled eligible patients, this number represents a small proportion of the total Hajj 
pilgrims admitted to healthcare facilities each year. Also, the study detected a small number 
of TB cases among the population investigated. Similar as above, numerous studies have 
reported TB cases among patients who were asymptomatic or did not have cough. Hence 
the reported prevalence of TB in the study may be an underestimation of the true prevalence 
of undiagnosed TB among hospitalised pilgrims in Hajj. On the other hand, the study 
population is not representative of the broader hospital's population. Future studies 
investigating a larger number of patients may be warranted.  
 
• For both hospitalised and non-hospitalised pilgrims cohorts, due to cultural and ethical 
considerations, our study did not collect data on the HIV status or on alcohol or substance 
abuse among pilgrims, which are established risk factors for TB.(Marais et al., 2013) 
 
• In relation to TB management, the current study is among the foremost surveys of TB 
management at international mass gatherings. However, the study investigated only a small 
number of cases and there was a high proportion of unknown responses for some variables. 
Nevertheless, the TB management indices obtained was a fair representation of the 
compliance of providers with national and international TB guidelines in MOH hospitals 
during the Hajj. 
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• In relation to the KAP of HCWs regarding TB, the current study is the first to investigated 
this issue Saudi Arabia in relation to a disease of national and global concern, including 
during mass gatherings such as the Hajj.(World Health Organization, 2017b, Zumla et al., 
2016) The survey instrument used in our study was developed based on existing 
questionnaires published in the literature and was pilot tested and assessed for both 
reliability and validity, ensuring a rigorous methodological process. The study enrolled a 
large number of HCWs of different occupations from numerous healthcare facilities in Hajj. 
The sample size however represents a small proportion of the 1000s of HCWs deployed to 
work in Hajj each year. The latter in addition to the cross-sectional design of the study 
limits the generalizability of the findings as the results may not be representative of all 
HCWs working cross all Hajj healthcare facilities.  
 
• Being a KAP study, it does underestimate the psychological variables that have proved 
influential in health-related behaviors.(Sridhar et al., 2016) Similar with other public 
surveys, the data collected in our study is based on self-reported information which depends 
on the honesty and recall ability of the respondents, as well as their understanding of the 
questionnaire. In such regards, the study collected data using an anonymous self-
administered questionnaire, which increased the likelihood of obtaining honest answers 
from participants. Although it is expected that participants would answer questions 
honestly, studies that used researches to collect data report that the presence of the 
researchers might influence HCWs in such a way that they might answer in a manner that 
they perceived as correct. Presence of researches could also lead to social desire bias as 
some respondents might give the answers that they thought the researcher was looking for 
and thus not their true response (Demissie Gizaw et al., 2015). In addition, some argued 
that even with anonymous surveys, presence of researcher at the time of data collection can 
also lead respondents to not be truthful about their knowledge, attitudes and practices, 
fearing that their supervisors would be informed of their responses (Kanjee et al., 2011). 
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• The KAP study did not restrict the participants to a specific occupation and included 
various HCWs such as physicians, nurses, laboratory staff and other supporting and non-
clinical staff. It may be argued that if the study was restricted to only clinical personal, 
better KAP scores would have been observed. Noe et al. (Noe et al., 2017) stated that the 
low scores reported in their KAP study regarding TB among HCWs in Southern 
Mozambique may have been related to the fact that the survey included all HCWs 
regardless of profession or department. As such, HCWs may have lacked experience in 
dealing with common TB scenarios affecting their scores. Numerous studies report that 
clinical staff have better knowledge attitude and practice regarding TB than supporting and 
non-clinical staff (Buregyeya et al., 2016, Demissie Gizaw et al., 2015, Lertkanokkun et 
al., 2013, Malangu and Adebanjo, 2015, Minnery et al., 2013, Noe et al., 2017, Shrestha et 
al., 2017). We have addressed this issue in our study by doing ad-hoc analysis by 
occupation and also by including the “non-applicable” options in appropriate questions.  
Moreover, including all HCWs (clinical and non-clinical) in our KAP is considered by 
some as a strength (Buregyeya et al., 2016, Demissie Gizaw et al., 2015). This is because 
the resulting data gives a more general picture of the KAP of HCWs who are all, directly 
or indirectly, part of the management of TB patients and infection prevention in healthcare 
facilities. In addition, HCWs working at a healthcare institution were found at risk of 
nosocomial transmission of TB regardless of actual profession, including ancillary staff 
and non-clinical staff (Menzies et al., 2007). 
 
• Another limitation of the KAP study is that information on attitude regarding TB was 
assessed using a questionnaire therefore responses obtained are prone to information bias. 
A qualitative method such as focus group discussion would be more beneficial to explore 
beliefs and attitudes relating to TB (Isara and Akpodiete, 2015). Similarly, we did not 
measure actual practice by observing staff behaviour in a specific situation or by using the 
simulated client method. The use of self-reported data to assess health professionals’ 
practices may have predisposed study findings to social desirability bias, which may have 
caused reported practices to differ from actual behaviour. A review performed by Adams 
et al. (Adams et al., 1999) suggested that self-reporting of practices might overestimate 
actual behaviour by up to 27%. Hence, there may have been an overestimation of good 
practice among HCWs. Studies observing practices would yield more accurate data than 
using self-administered questionnaires.  
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On the other hand, measures of actual practice alone will not be able to separate the impact 
of knowledge and competency, or what is missing on these levels, from other factors (Hoa 
et al., 2005). It is also noteworthy that the current study only measured variables that were 
self-reported by the HCWs and did not take into consideration other factors that may impact 
practice such as availability of resources required for the implementation of TB infection 
prevention and control measures. This could have affected the results, as the respondents 
who reported poor practice may have done so because of non-availability of resources 
(Bhebhe et al., 2014). 
 
5.3 Recommendations 
The results of the different arms of the current study identified a number of key issues in 
relation to TB and its management during the Hajj mass gathering (Figure 30). These issues 
require immediate attention from the Hajj stakeholders including the Saudi MoH, Hajj medical 
missions as well as the national and international health organizations and regulators such as 
WHO, the Saudi CDC and international community at large. A number of recommendations 
can be drawn from the results of the current study as follows: 
 
For the undiagnosed TB among hospitalised and non-hospitalised pilgrims: Given the results 
of the current study and the potential impact of undiagnosed TB among inpatients and non-
hospitalised pilgrims during Hajj, the following recommendations are proposed:  
 
1. Further studies are needed to define the burden and risk of TB as well as its management 
during Hajj.  
2. Further communication and collaboration with the WHO and other stakeholders regarding 
the outcome of this study and the way forward. 
3. Formulate appropriate policies and interventions to prevent infection and transmission of 
PTB during the Hajj mass gatherings. These may include: 
a. Increase education and awareness regarding TB and its prevention among pilgrims 
through targeted campaigns to encourage health-seeking behaviour in case of 
symptoms and adherence to treatment and to general infection prevention measures.  
b. Increase education and awareness regarding TB and its prevention among workers 
including healthcare workers deployed during the Hajj/Umrah.  
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c. Explore the idea of a pre-Hajj TB screening for pilgrims from certain endemic countries 
to prevent TB importation by prompt detection of cases and initiation of effective 
treatment to rapidly render them non-infectious.  
d. Revise/develop TB-management policies including screening criteria and techniques to 
best fit the unique Hajj/Umrah conditions. 
e. Deployment and the use of rapid, sensitive and specific point-of-care molecular 
techniques for TB/MDR-TB screening and diagnosis such as the Xpert MTB/RIF and 
Xpert Ultra assays.  
 
For the TB management study in Hajj: The study results showed high level of compliance with 
the assessed indices for systematic screening of TB suspects, IPC and case notification, but low 
compliance scores were obtained for prompt TB diagnosis and use of standardized treatment 
regimen for drug susceptible TB. Based on observations from the current study a number of 
recommendations can be proposed. These are as follows: 
 
1. Develop and disseminate an international Hajj and Umrah-specific TB control and 
management protocol to provide guidance on: TB surveillance, IPC, screening and 
diagnostic methods, choice of treatment and care models and patient transfer, including 
strategies for maintaining the continuum of care during and after the mass gatherings. 
2. Update the current KSA TB national guidelines to adopt new diagnostic 
recommendations and to highlight the treatment pathway for drug-resistant TB, in line 
with current global standards. 
3. Improve knowledge and practice of healthcare providers regarding TB management 
through the provision of training and periodic refresher courses as well as guidance 
materials. 
4. Monitor the TB management practices in MOH and non-MOH health facilities 
regularly to make recommendations for improvement. 
5. Provide the Xpert MTB/RIF Ultra assay testing capability at the point of care to 
facilitate same day TB diagnosis including MDR-TB. 
6. Raise awareness among healthcare providers about the need for mandatory screening 
and testing for HIV and other comorbidities in suspected TB patients.  
7. Consider conducting systematic/targeted TB screening for pilgrims arriving from 
within the Kingdom for the Hajj, based on a pre-established criteria. 
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8. Provide at least the full initial 2 months TB regimen to the pilgrims during Hajj and 
direct them to report and follow with healthcare facilities for the follow up 4 months 
treatment whether they are in KSA or in their country of residency   
 
For the HCWs KAP study; Given the context of Hajj, the potential global health consequences 
of mismanagement of TB cases at the event and the results of the current study, and number of 
recommendations can be made to improve HCWs KAP regarding TB, improve TB 
management during the event and reduce the risk of local and international TB transmission. 
These are as follows:  
 
1. Develop tailored, high quality and periodic education and training programmes on all 
aspects of TB and its management for all HCWs according to job categories and 
educational backgrounds.  
2. Develop training programmes for non-clinical, auxiliary and support staff on TB and 
TB infection prevention and control in order to improve their KAP and prepare them to 
safely work in high risk settings such as TB care. 
3. A comprehensive approach to TB education and training, which includes not only 
imparting adequate knowledge, but also the much more difficult task of influencing the 
practices of HCWs, is required. Such training should not only emphasise the theoretical 
aspects of training but also skill-based components utilizing adult learning approaches 
aimed at modifying HCWs’ behaviour in order for training to have an impact on 
practice. 
4. Training and education should utilize various means shown affective in bringing about 
behavioural change among HCWs including traditional and non-traditional methods 
such as audit and feedback, distribution of education materials, educational meetings, 
local opinion leaders, outreach visits, reminders, small group discussions and simulated 
cases, to teach management and role-plays to teach methods of evaluation of case-
finding and treatment. Distance learning in the area should also be promoted. 
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5. Training and education on TB among HCWs should be a continuous process with 
multiple behavioural change interventions to be used with ongoing monitoring and 
evaluation of effectiveness to ensure successful implementation. The methods to be 
used for evaluation have to be appropriate for an objective assessment of the impact of 
the training interventions not only on knowledge but also on attitudes and behaviours 
as well.  
6. Infection prevention and control training specific for TB may be required for HCWs 
participating in Hajj. This training could be incorporated as part of the general infection 
prevention and control preparative measures taken by the Saudi Ministry of Heath Pre-
Hajj deployment or could be conducted separately.  
7. Special attention should also be given to addressing factors beyond training that could 
influence HCWs’ KAP regarding TB, so as not to reinforce the limitations and 
weaknesses of current practices. Appropriate funds and resources should be allocated 
to address lifestyle, health system, job satisfaction as well as Hajj-related factors that 
could undermine appropriate TB management and control in healthcare facilities during 
the mass gathering.  
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Figure 30. Study findings (by the author) 
 
  
TB miss-management 
TB diagnosis issues  
• Lack of appropriate diagnostic tools 
• Use of inappropriate diagnostic tools 
• Limitations of diagnostic tools 
 
Unsuspected TB 
• Lack of symptoms  
• Unrecognized/missed symptoms  
• Inadequate/lack of screening  
• Symptoms masked by other comorbidities   
 
Failures in TB IPC 
• Failure to isolate 
• Unavailability/misuse of PPE 
• Inadequate IPC practices 
• Infrastructure/weather-related issues 
Inappropriate TB treatment   
• Inappropriate regiment (agents/duration) 
• Failure to adhere to regiment  
Follow up and notification 
• Lack of post-Hajj follow up   
• Variable heath system capabilities in countries of origin 
 
Contributing factors  Consequences  
Undiagnosed/missed 
active TB 
TB transmission (local 
and global) 
Poor TB case outcome 
Development of MDR-
TB 
HCWs poor KAP in relation to TB 
Inadequacy of TB prevention and 
management guidelines in the context of Hajj   
Many pilgrims from endemic TB areas 
International travel and crowding 
Pressured health system during Hajj 
Pilgrims’ lack of knowledge about TB and its 
prevention 
Eagerness to fulfill Hajj rites 
Short hospitalization 
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